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Abstract 
Recently,  hydroxypropyl  methylcellulose  (HPMC)  has  been  made  available  
as an alternative to gelatin for the manufacture of two piece hard capsules. Hard 
Capsules manufactured from HPMC with carrageenan as a gelling agent have 
demonstrated rapid and comparable in vivo disintegration times to gelatin and 
overcome  some  of  the  disadvantages  gelatin  capsules  present.  Gelatin 
becomes brittle when stored at low humidity and shell dehydration may occur 
with  hygroscopic  fillings.  In  addition, the presence  of aldehyde  groups  in  the 
filling material can reduce the solubility of the gelatin capsule shell by cross  
linking. HPMC capsule shells demonstrate lack of brittleness even at moisture 
levels  below  2%,  no  cross linking  and  improved  chemical  stability,  however 
there  is  a  lack  of  information  relating  to  the  physico   chemical  properties  of 
HPMC  capsule  shells  and  their  dissolution  behaviour.  The  aims  of  this  work 
were  to  develop  and  use  different  techniques  to  investigate  the  physico 
chemical properties of HPMC and gelatin hard capsule shells and to study the 
possible  interactions  between  the  capsule  shell  (after  different  storage 
conditions) and dissolution media (composition, pH and ionic strength) with and 
without filling materials.  
 
Thermal analysis was undertaken using MDSC to determine and compare the 
glass transition temperatures of gelatin and three batches of HPMC, which gave 
an  insight  into  their  fundamental  physico chemical  properties.  Rheological 
studies were undertaken using DMA, which is a novel method that has not been 
used  previously  on  capsule  shells,  to  investigate  and  compare  the  different 
viscoelastic properties of the capsules. These included: static scans to study the 
elastic modulus, linear creep to determine the behaviour of the capsule shells 
under  stress,  and  dynamic  scans  to  determine  the  storage  modulus  and 
viscosity. The influence of storage RH and time (35% and 53% RH for 24 hours 
and 3 days), dissolution media composition, ionic strength and pH on the shell 
dissolution time, and drug release properties of the capsules (using theophylline 
as the model drug) was also investigated. 
 
The  findings  show  that  the  gelatin  capsules  became  brittle  at  low  moisture 
content and show some degree of aging upon storage, this was not seen for 
HPMC.  Capsules  made  form  HPMC  were  more  elastic  than  gelatin  and 
gelatin/Polyethylene  glycol,  with  a  greater  degree  of  recovery  to  an  applied 
stress  (e.g.  the  Young’s  Modulus  for  New  HPMC  and  gelatin  capsules  was 
0.728 MPa vs 1.092 MPa respectively after storage at 53%RH/3 days, and % JR 
for  both  capsules  was  99.26%  vs  98.47%  respectively  after  storage  at 
35%RH/24 hr). It was also found that storage conditions showed no significant 
effect on the capsule shell dissolution time, and pH had minimal effect on shell 
dissolution time of the HPMC capsules. The Changes seen with change in pH 
were attributed to dissolution media composition, salt concentration and ionic 
strength of the different dissolution media. For HPMC shells, dissolution time in 
Sörensen phosphate buffer  decreased by 13 – 22 % as pH increased from 5 to 
8,  however,  in  citro phosphate  buffer  there  was  a  19  –  36  %  increase  in 
dissolution time from pH 5 to 7, In acetate buffer, HPMC shells did not dissolve 
in pH 6, whereas gelatin dissolution time increased from 2.0 to 3.5 mins as pH 
increased. Drug dissolution rate was highest from HPMC capsules in all 0.1 M      
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dissolution media compared with gelatin and was affected by the presence of 
high  concentrations  of  K+  and  Na+  ions,  whereas  gelatin  capsules  were 
influenced mostly by the presence of Na+ ions. For example in 0.1 M potassium 
phosphate buffer (KPB) 100% drug release from HPMC capsules occurred after 
35 mins, however, this occurred after 180 mins for gelatin capsules, and in 0.1 
M sodium phosphate buffer (NaPB) 100% drug release from HPMC and gelatin 
capsules occurred after 27 mins and 120 mins respectively. After 5 hours, < 4 % 
and 10 % drug release was obtained in 0.5 M KPB and NaPB respectively. The 
mechanism of drug release from gelatin capsules was found to be different in 
both  basic  and  acidic  media.  This  was  constant  for  the  HPMC  capsules, 
showing that the change in pH did not affect the release mechanism.  
 
These investigations support work that has been previously reported concerning 
the properties of the HPMC capsules, and provide new information In terms of 
their viscoelasticity, interactions with various ions present in different dissolution 
media,  drug  dissolution  behaviour  before  and  after  storage  for  prolonged 
periods, and the mechanisms of drug release. 
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1  INTRODUCTION 
1.1  Background 
 
Dosage  forms  are  drug  delivery  systems  that  deliver  the  drug  to  the  site  of 
action, in a given amount and at the appropriate rate, safely and reproducibly 
(Barba  et  al.,  2009).  Drug  delivery  systems  can  be  administered  by  various 
routes,  including:  topical,  nasal,  inhaled,  ocular,  oral,  parenteral,  rectal  and 
others. The bioavailability of a given drug administered in a dosage form can be 
influenced  by  factors  associated  with  the  formulation  and  production  of  the 
dosage  form.  Therefore,  in  order  for  an  active  ingredient  to  provide  a 
pharmacological activity or other direct effect in the diagnosis, cure, treatment, 
or prevention of a disease, it must be formulated or placed in a dosage form that 
enables it to be released and delivered to its target areas in the desired fashion. 
However,  a  number  of  factors  need  to  be  considered  before  formulating  a 
dosage form, such as chemical and physical properties of the drug, the disease 
state to be treated, and factors affecting the absorption of the drug substance 
(York, 2007). 
 
The oral route when compared to other routes is the simplest, safest and most 
convenient  means  of  drug  administration.  The  majority  of  dosage  forms  are 
orally  administered  as  solid  products  such  as  tablets  and  capsules.  Other 
popular oral dosage forms include suspensions, solutions and emulsions (York, 
2007).  The incorporation of a drug substance into a hard capsule, soft capsule, 
tablet or suspension will influence the rate and extent of absorption of that drug 
from the gastrointestinal tract.  
In general terms, the type of dosage form will influence the release of drug into 
solution in the GI fluids (Proudfoot, 1999). 
  
A number of features need to be considered, to ensure manufactured medicines 
are of good quality, such as their physical and chemical stability, uniformity of 
drug content, acceptability to users including both the prescriber and the patient 
and the suitability of packaging and labelling. In order for the dosage form to be 
successful  on  an  industrial  scale,  it  must  be  capable  of  being  produced  by Chapter One                                                                                        Introduction 
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appropriate machinery (Jones, 1988). 
 
Capsules  are  solid  dosage  forms  that  have  become  very  popular  for 
pharmaceuticals (Ogura et al., 1998; Cade et al., 2003). Medicinal ingredients 
and excipients are enclosed within a hard or soft shell of gelatin (Ansel et al., 
1999; York, 2007). Gelatin capsules are frequently more expensive than tablets 
to  produce  but  this  can  be  overlooked  due  to  some  of  the  advantages  they 
possess. They were developed as an edible container to mask the taste and 
odour of medicines (Ogura et al., 1998). The contents of the capsules are tightly 
enclosed by the capsules shell, this protects the drug from oxygen, moisture, 
light and physiological fluids, which in turn improves drug stability (Sakata and 
Otsuka, 2009). For some people capsules may be easier to swallow than tablets 
and although they are intended to be swallowed whole, it is still possible with 
some formulations to empty its contents and mix it with food or drink, which is 
commonly seen in a hospital. As with tablets, various sizes, shapes and colours 
of shells are readily available (York, 2007).  The bioavailability of a drug from a 
powder filled capsule is better or equal to that from a compressed table. Particle 
size  of  the  drug  formulation  rarely  needs  to  be  altered  during  capsule 
manufacture,  and  powders  or  fine  particles  can  be  dispensed  in  an 
uncompressed  form,  subsequently  a  relatively  large  surface  area  will  be 
exposed to the gastrointestinal fluids, which will allow for quicker dissolution and 
absorption  of  the  drug  (Proudfoot,  1999;  Ashford,  2007).  There  are  also 
unlimited  possibilities  for  printed  identification  markings  such  as  the 
manufacturer’s  name  and  product  code  number,  which  will  improve  patient 
compliance and enhance the communication between the patient and the health 
care professional (Ansel et al., 2005). As described by Podczeck and Newton 
(1999) only small amounts of excipients may be required, in particular fillers.  
 
1.2  Capsules 
1.2.1  History of Capsules 
 
The word capsule is derived from the Latin word ‘capsula’ meaning small box 
(Jones,  2007).  They  are  one  of  the  oldest  dosage  forms  known  in  the 
pharmaceutical  history,  dating  back  to  the  days  of  ancient  Egyptians.  The Chapter One                                                                                        Introduction 
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earliest European reference that mentioned the pharmacist de Pauli from Vienna 
was in 1730. He produced oval shaped capsules hoping to mask the taste of 
pure turpentine he prescribed for people suffering from gout. It was not until 100 
years later that the gelatin capsules appeared (Stegemann, 2002).  
 
The French pharmacy student, Mr François Achille Barnabe Mothes (F. A. B. 
Mothes), first invented gelatin capsules in France. Notice of his discovery having 
first been made in a report to the Academie Royale de Medecine and the first 
patent granted in 1834 to the pharmacist Joseph Gerard Auguste Dublanc and 
F. A. B. Mothes (Mothes, 1834; Wilkie, 1913; Jones et al., 1999a; Stegemann, 
2002;  Jones,  2004b).  The  patent  describes  his  methods  where  bubbles  of 
gelatin were filled with the drug and sealed with a drop of gelatin solution. These 
were one piece capsules, and were formed on moulds that consisted of a thin 
leather pouch that was attached to the end of a small long necked funnel. These 
were then filled with mercury in order to make them firm, and then dipped into 
solutions of 1 part gelatin to 3 parts of water. A second dipping could be made if 
necessary to obtain sufficient thickness. The mercury was then emptied causing 
the pouch to collapse. The gelatin film could then be easily removed from the 
mould and allowed to dry by placing on a heating box at 40
oC (Wilkie, 1913, 
Jones, 1974; Jones et al, 1999a;  Jones, 2004b).  
 
 At  the  end  of  the  19
th  century  the  elastic  soft  gelatin  capsule  was  invented 
which is the form that we know today. Dentenhoff was the originator of the idea: 
he suggested that glycerin could be incorporated into the formula to make them 
soft and easier to swallow (Jones, 2004b). 
 
Jules  Cesar  Lehuby  (J.C.  Lehuby),  a  Parisian  pharmacist,  invented  the  hard 
two piece capsule by dipping silver coated metal pins into a solution of suitable 
materials.    He  was  granted  French  patent  No.  4435  for  “Mes  Enveloppes 
Medicamenteuses”  on  20
th  October  1846  (Lehuby,  1846,  Stegemann,  2002; 
Jones, 2004b). The patent was followed by three additions in the space of four 
years. The last addition was granted in 1850 being an improvement to the two Chapter One                                                                                        Introduction 
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previous ones. It was stated that the earlier capsules either had a bad aroma or 
were brittle and in this one he suggested the use of gelatin.  
 
On  a  commercial  scale,  some  technical  problems  caused  delays  in  their 
production.  The  main  problem  was  the  cost  of  making  large  numbers  of 
accurately  made  moulds  to  produce  two piece  capsules  that  fitted  together 
properly. Wilkie (1913) described that a variation of 1/1000 of an inch in the 
thickness of the capsule would make them either too tight or too loose fitting. An 
American  pharmacist  from  Detroit  F.  A.  Hubel  was  the  first  successful  large 
scale manufacturer of the hard gelatin capsules and was able to overcome the 
problem of cost by making low cost moulds using pieces of gauged iron rod set 
in a wooden block. Two sets of mould pins with different diameters, one for the 
cap and one for the body, were dipped into gelatin solution and withdrawn, thus 
producing a film that was cut to the required length using a penknife while still 
wet.  After  that,  the  coated moulds  were  left  to  stand for  the films  to  air  dry. 
Capsule pieces were then removed from the moulds with brass tongs and joined 
(Jones, 2004b). Mr Hubel commenced the first industrial scale manufacture in 
1874  and  after  his  great  success  other  companies  soon  followed  on  in  the 
manufacture of hard gelatin capsules. The two major companies were Eli Lilly 
and Company in 1896 and Parke Davies Company of Detroit in 1901 (Jones et 
al.,  1999a).  The  hard  gelatin  capsules  have  survived  until  this  present  day 
practically unchanged since Mr Lehuby’s patent in 1846. Only slight changes 
have been made in order to produce self locking capsules (Jones, 2004a). In 
1963, Eli Lilly & Company was granted a patent for Lok Caps. This self locking 
system  overcame  the  problem  of  capsule  separation  therefore  preventing 
content  spillage  during  and  after  the  filling  process  (Eli  Lilly,  1963;  Jones, 
2004b). 
 
1.2.2 Development of Self locking Capsules 
 
The need for self locking capsules only came about when capsules were filled 
and packaged on an industrial scale (Jones, 2004b). During the manufacturing 
process of hard capsules, the high speed used during the closing process, and 
the mechanical strain during production, causes pressure to build up inside the Chapter One                                                                                        Introduction 
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capsules. This often results in capsules with varying lengths and thus presenting 
the risk of capsules bursting after they have been filled, as a result, positive 
closure  is  essential  to  prevent  the  involuntary  separation  of  capsules  during 
shipping  and  handling  (Augsburger,  2002;  Stegemann,  2002).  The  first  self 
locking hard capsule (Figure 1.1) was patented in 1894 by Hobbs (Pat. no. 525 
844). Chapter One                                                                                        Introduction 
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Figure 1. 1: The patent for the first self locking hard capsule (Taken from   Hobbs, 
1894) 
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In 1963, Eli Lilly patented the LOK CAPS and was the first successful company 
to  do  so.  Since  then  new  locking  features  have  been  developed  by  other 
companies including: Posilok (Lilly Qualicaps), Coni Snap (Capsugel, Div. Pfizer 
Inc.),  Loxit  (R.P.  Scherer),  Snap  –  Fit  (Parke  Davis).  Two  indentations  or 
grooves were introduced, one placed around the body just below the rim, and 
the other around the cap just under the top thus creating a positive interlock 
when  body  and  cap  are  pressed  together.  However,  this  did  not  solve  the 
problem  as  the  cap  and  body  still  tend  to  fall  apart  when  empty.  Therefore, 
indentations were also added on the cap just below the rim, which allows for 
temporary closure of the sections, called a prelock, the prelock was invented by 
Qualicaps and was first seen on their LOkCAPS (see Figure 1.2).  (Jones, 1970; 
Stegemann, 2002; Augsburger, 2002).   
The Prelock feature on Qualicaps capsules consisted of four rectangular shaped 
indents aligned around the long axis. For the Capsugel capsule this consisted of 
a series of circular indents (Jones 2004d) 
 
As  the  speed  of  the  machines  increased,  it  was  necessary  to  improve  hard 
capsules in terms of their speed of closure following filling to prevent the capsule 
damage.  One  solution  was  a  tapered  rim  on  the  body  section  designed  by 
Capsugel, as shown in Figure 1.2. The tapered rim is referred to as CONI ring in 
patent 5769267 by Duynslager et al (1998) and is described as an “endside, 
annular taper”; it is present on the outer cylindrical cavity wall of the capsule 
body.  This  tapered  rim  enables  the  two  units  to  be  aligned  and  telescoped 
together  accurately  after  filling  and  hence  preventing  faulty  joints  occurring 
(Stegemann, 2002).  
 
 
All hard capsules are designed with air vents as part of the locking feature vents 
to prevent build up of pressure that can occur as a result of the high speed 
capsule filling process. When the capsule parts are joined together the air is 
able  to  escape  from  between  the  cap  and  body  thus  preventing  capsules 
reopening after closure (Duynslager et al., 1998; Stegemann, 2002). 
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Figure 1. 2:  Self locking capsules (Adapted from Stegemann, 2002; Augsburger, 2002; Ansel et 
al, 2005). 
 
1 = The rim (grooves): locks the two capsule ends together once the capsule 
has been filled. 
2 = Indentation: prevent premature opening of the capsule 
3 = Tapered rim: to prevent splitting and denting of the capsule 
 
1.2.3  Hard and Soft Capsules  
 
In simple terms, capsules can be said to be of two types, the hard and soft. Hard 
capsules  are  generally  referred  to  as  “two piece”  capsules,  and  the  soft 
capsules (soft gels) as “one piece” capsules (Jones, 2007). Up until this present 
day, their main component used has been gelatin.  The hard gelatin capsule 
comprises simply of gelatin, water colouring and opacifying agents, as opposed 
to the soft gelatin capsules that contain in addition a plasticizer usually glycerol 
at a level of about 30% (Cole, 1999). Glycerol as a plasticizer is what makes the 
shell soft and elastic if incorporated or hard and firm if absent (Jones, 2004b).  Chapter One                                                                                        Introduction 
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One piece capsules are a single unit dosage form with flexible walls that may be 
either seamed along their axis, or seamless and can be filled with liquids or semi 
solids (Jones, 2004b). They have variable shapes (oval, oblong or round). The 
manufacture of these soft capsules and the filling, then the sealing is completed 
in one continuous process (Jones, 2004b). Two piece capsules as the name 
suggests, consist of a cap and a body where one fits inside the other. The cap 
has a slightly larger diameter than the body. In relation to manufacturing of the 
two piece capsules, opposed to the soft gelatin capsules, the shells and the fill 
are  manufactured  separately.  Traditionally  were  filled  only  with  powders  and 
granules, but in the last few years there has been significant development in 
formulation techniques and in the filling equipment. This has enabled a range of 
types of filling material to be used including; powders,  granules, tablets, and 
pellets, or a combination of those (See Figure 1.3). They can also be filled with 
oily liquids and powders for inhalation (Ogura, 1998; Jones et al., 1999a; Ansel 
et al., 2005). The filling with granules is especially useful for hydrophobic drugs 
and improves bioavailability, owing to the enhanced drug release, due to higher 
porosity of the filled mass (Podczeck and Newton, 1999). The filling with pellets 
and tablets, provides a modified or delayed release and is a simple solution to 
overcome  stability  problems  between  two  incompatible  drug  substances 
(Capsugel,  2005).  The  filling  of  powders,  pellets  or  tablets  has  the  general 
advantage  of  using  fewer  excipients  to  provide  a  range  of  drug  release 
characteristics  e.g.  immediate  and  controlled  delivery.  It  is  even  possible  to 
include  a  number  of  filling  material  within  a  single  formulation.  In  this  way, 
incompatibilities  and  interactions  between  the  different  drug  substances  in 
combination  products  can  be  prevented  (Stegemann,  2002)  and  patient 
compliance will be improved. Hard capsules can also be filled with liquids and 
semisolids, such as thermosoftening mixtures, thixotropic mixtures, and pastes 
(Ogura, 1998; Ansel et al., 1999; Jones, 2007).  
 
The encapsulation of aqueous liquids into gelatin capsules is not recommended, 
as  this  will  lead  to  the  leakage  of  the  contents  due  to  the  distortion  of  the 
capsule and softening of the gelatin shell. However, some non aqueous liquids 
such as fixed or volatile oils do not interfere with the stability of the gelatin shells 
and may be filled in locking gelatin capsules (Ansel el al., 1999). The filling of Chapter One                                                                                        Introduction 
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semi solid formulations into hard gelatin capsules can provide rapidly dispersing 
dosage forms for poorly soluble drugs (York, 2007).  
Hard  capsules  may  also  be  enteric  coated  which  allows  the  dosage  form  to 
remain  undamaged  in  the  stomach,  and   release  their  contents in  the  upper 
intestine (Jones B. 1971; Cole, 2002). There are several reasons for using such 
coatings: i) drugs maybe unstable at the pH of gastric juice, ii) the drugs may 
interfere with gastric metabolism, iii) the site of drug absorption may be in the 
duodenum or intestine (Jones, 2004e). In relation to manufacturing of the two 
piece capsules, opposed to the soft capsules the shells and the fill of the hard 
capsules are manufactured separately  
 
 
 
 
 
 
 
 
 
 
 
 
 Chapter One                                                                                        Introduction 
  33 
 
 
Figure 1. 3: Various fill combinations in hard gelatin capsules    
 
1 = Powders or granules                            6 = Pellet and tablet mixture 
2 = Powder and pellet mixture                   7 = Pellet and capsule mixture 
3 = Pellet Mixture              8 = Liquids, semisolids 
4 = Solid, formed drug preparations                     
5 = Powder and tablet mixture 
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1.2.4  Characteristics of Two Piece Capsules 
 
Only  17.5%  of  newly  –  licensed  products  were  presented  as  hard  gelatin 
capsules in 1982, however by the year 1996 this figure was increased to 34% 
(Stegemann; 2002). The ability to develop these capsules on a large scale and 
the rapid capsule filling machine made them very popular (Nagata, 2001). They 
are manufactured to universal standards, which allows for multi sourcing and 
runnability on all types of filling equipment. Hard capsules also do not require as 
many excipients as other dosage forms and it may be possible to direct fill into 
capsules  many  large  dose  actives  that  could  not  be  tabletted  without  a 
granulation step. They can have a diversity of colours, and as many as 200,000 
capsules / hour can be produced. Two piece capsules also appeal to consumers 
worldwide because they are tasteless, easy to swallow since the shell is smooth 
and hydrates in the mouth, mask odours and are versatile. (Augsburger, 2002; 
Qualicaps, 2010). The two piece capsules can be filled with both dry solids and 
liquids as detailed previously (Ogura, 1998; Ansel et al., 1999; Jones, 2007). 
 
Another important feature of hard gelatin capsules is that they are produced with 
different sizes to accommodate a range of fill weights (Honkanen, 2004). For 
human use, hard gelatin capsules are made in eight different sizes. The sizes 
and filling capacities are shown in Table 1.1, starting from size 000, which is the 
largest, to size 5, which is the smallest. Size 0 to 4 are the most popular sizes 
acceptable to patients. (Jones et. al.,1999a; Jones, 2004b). Three larger sizes 
are available for use in veterinary practices. Those are sizes 10, 11, and 12 with 
a fill capacity of 30, 15, and 7.5g respectively (Augsburger, 2002).  
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Table 1. 1: Capsule sizes and filling capacities (Adapted from Augsburger, 
2002; Jones, 1999a; Jones, 2007) 
 
 
Capsule Size 
 
Actual Size 
 
Volume 
(ml) 
Fill Weight (g) 
Powder density 
0.8g/cm
3 
000    1.37  1.096 
00    0.95  0.760 
0    0.68  0.544 
1    0.50  0.400 
2    0.37  0.296 
3    0.30  0.240 
4    0.21  0.168 
5    0.13  0.104 
 
The larger capsules are more difficult to swallow, and the small capsules may be 
more  difficult  to  handle,  especially  for  the  elderly.  If  the  amount  of  active 
ingredient is small, extra diluent can be added enabling the use of larger sized 
capsules for handling convenience (Loyd and Allen, 2007).  
 
1.2.5  Types of Hard Capsules 
 
The  increasing  demand  of  hard  capsules  has  meant  that  specialist  capsule 
types are made to meet all the different requirements. These include, capsules 
for  liquid  filling,  capsules  for  administration  to  animals  and  capsules  used  in 
certain clinical trials (Stegemann, 2002; Augsburger, 2002; Jones, 2004d). 
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1.2.5.1  Capsules for Liquid Filling  
 
Ghirardi et al (1977) found that the poorly water soluble drug digoxin had an 
improved bioavailability when formulated as a liquid in a soft gelatin capsule.  
However, in the early 80’s studies demonstrated that molten formulations could 
actually  be  encapsulated  into  hard  gelatin  capsules  (Walker,  1980).  In 
comparison  to  soft  gelatin  capsules,  hard  capsules  offer  several  advantages 
including simplified manufacture, in house scale up, higher filling temperatures, 
enable use of excipients with higher melting points, i.e. > 35
oC (which is the 
maximum for soft gelatin capsules, since this is the temperature used by the 
sealing rollers during their manufacture) (Cole, 1999; Mei et al, 2006; Jones, 
2007).  The  capsules  for  liquid  filling  (Figure  1.4)  are  identical  to  the  normal 
capsules, excluding the air vent to prevent leakage before sealing. However, for 
a successful sealing the main criteria is that the filling material does not leak into 
the area between the cap and the body before the sealing takes place (Cole, 
1999). One way to do this is by “banding” which is the sealing of the intersection 
between the two parts, the cap and the body, with a layer of gelatin, or by using 
a sealing liquid. Another more recent way is by simply spraying small quantities 
of alcohol / water mixtures into the cap / body intersection. The liquid is taken up 
into  the  gap  between  the  cap  and  the  body,  and  the  capsule  is  sealed  by 
heating, where a stream of warm air (40
o   60
oC) is blown across the capsules, 
causing the two gelatin layers to melt and fuse together. The capsules are then 
left  overnight  to  set  and  cool  (Rowley,  2004).  This  process  is  however  not 
suitable  for  capsules  that  are  blister  packed  because  it  makes  the  capsule 
brittle.  
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Figure 1. 4: Capsules for liquid filling (e.g. LICAPS) (Adapted from Stegemann, 2002) 
 
1.2.5.2   Capsules for Administration to Animals 
 
There is a wide range of special size capsules for administration into animals. 
Very small sizes are used for rodents, and very large one for administration to 
cattle. The large sizes have volume capacities ranging from 3ml up to 28ml, with 
diameters between 15 to 24 mm and lengths ranging from 3 – 9 cm (Jones, 
2004d). 
 
These minature,  size 9  capsules for  administration  to  rats and  other  rodents  
were first devised by  the Elanco Qualicaps, and are used for preclinical and 
animal trials. They are suitable for administering an exact and precise quantity of 
substance to rodents because each capsule can be filled individually and this 
can be adjusted to the weight of the individual rodent. Lax et al (1983) devised a 
method using a stainless steel tube to administer these capsules directly into the 
stomach of unconscious rats, which was said to cause less shock and tissue 
damage to the rats. The Shionogi Qualicaps have a capacity of 0.025ml and is 
8.4mm in length with a diameter of 2.65mm. The Capsugel PC caps version are 
7.18  mm  in  length,  with  a  volume  capacity  of  0.02ml.  (Lax  et  al.,  1983; 
Stegemann, 2002; Jones, 2004d).  
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1.2.5.3   Capsules Used in Double Blind (DB) Clinical Trials 
 
The  hard  gelatin  capsules,  DB  caps  developed  by  Capsugel,  are  suited  for 
double  blind  clinical  trials.  They  come  in  different  neutral  colours  and  are 
available in three different sizes, (AA, A, B), which are suitable as single doses 
or formulations up to a diameter of 9mm. Their capacities are 0.94, 0.68, and 
0.50ml  with  internal  diameters  9.08,  7.81,  and  7.55mm  respectively  (Jones, 
2004d). Once the capsules have been closed, they cannot be re opened either 
which  ensures  that  the  doctor  and  the  patients  cannot  identify  either  of  the 
placebo, test drug, or reference preparations (Stegemann, 2002). 
 
 
1.3  The Manufacture of Two Piece Capsule Shells 
 
The manufacture of hard capsules has at this present time developed from a 
very slow and difficult process to a very speedy one with extraordinary precision. 
The three producers of hard gelatin capsules in North America are Qualicaps 
(Whitsett,  NC)  Capsugel  Div.  Pfizer,  Inc.  (Greenwood,  SC),  and  Pharmaphil 
(Windsor,  Ontario)  now  part  of  Qualicaps  (Augsburger,  2002).  The 
manufacturing sequence has however remained more or less the same as that 
described in the original patent in 1846 starting with the dipping of sets of metal 
moulds at room temperature into a solution of gelatin. A film is then formed on 
the surface of each mould by gelling. After dipping, the pins are withdrawn from 
the dipping solution. As this is done, the pins are transferred to the upper level of 
the machine and rotated about a horizontal axis in order to spread the gelatin 
evenly over the surface of the mould pins. Groups of pin bars are then passed 
through  a  series of  drying  kilns  with  large  volumes  of  controlled  humidity  air 
passing over them, this helps to set the gelatin solution and fix the film on the 
mould.  When  they  reach  the  rear  of  the  machine,  the  bars  are  transferred 
through  further  drying  kilns  until  they  reach  the  front  of  the  machine 
(Augsburger, 2002; Jones, 2007) Over drying should be avoided, as this may 
cause films to split on the pins due to shrinkage, or may make them too brittle 
for the later trimming operations. Once the pins reach the rear of the machine, 
they  are  transferred  to  the  lower  level  and  pass  through  another  stream  of Chapter One                                                                                        Introduction 
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controlled air and back to the front of the machine. At this point, the films are 
removed  from  the  pins  automatically  and  the  ends  are  cut  to  produce 
appropriate  lengths.  The  two  halves  are  then  joined  together  producing  a 
complete capsule (Augsburger, 2002; Jones, 2004d; Jones, 2007). 
 
1.3.1  Capsule Defects 
 
Capsules are made by a continuous process, during which some defects are 
produced.  In  order  to  remove  as  many  defective  capsules  as  possible,  the 
finished capsules usually pass through a series of checking processes, either 
manually, mechanically or electronically. The faults that are looked for can be 
caused  by  poor  initial  formation  of  the  capsule  film,  where  one  sees  the 
formation of bubbles or thin areas. On the other hand, the faults can be caused 
while the capsules pass through the automatic section of the machine producing 
poorly cut edges, splits, or holes. 
 
Generally,  capsule  shell  defects  are  classified  according  to  their  nature  and 
potential to cause problems. They can be classified into 3 categories: Major A, 
Major B and Minor defects. Major A defects usually cause failure of the capsule 
as a container or major filling problems due to a number of reasons, some of 
which include: i) The capsules being too long or too short, ii) the presence of 
holes or splits in the cap or body, iii) presence of the trimmed end of the cap or 
body inside the capsule, iv) the capsule maybe locked in position, v) the capsule 
may also be squashed flat, or vii) could have an uncut cap or body. 
Major B defects: these usually cause problems on a capsule filling machine and 
can result in reduced effectiveness of the filled capsule. Defects in this category 
include: i) capsules that cannot maintain tight closure, ii) presence of a dye spot 
that is different in colour to the actual capsule, iii) thin areas in the cap and body 
that may rupture during capsule filling, iv) or the capsule may have an inverted 
end at either end of the cap or body. 
 
Minor defects as their name suggests, do not affect the overall performance of 
the capsule, however, these defects have an effect on the visual appearance of Chapter One                                                                                        Introduction 
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the capsule and include: i) scrapes or scratch marks on the surface of the cap 
shell or body, ii) small marks of grease, iii) presence of an air bubble in the cap 
or  body  wall,  or  iv)  the  presence  of  black  specks  (Jones,  2004c;  Qualicaps, 
2006). 
 
1.3.2  Print Defects 
 
Capsules  are  printed  by  the  empty  capsule  manufacturers,  this  industrial 
process  also  produces  some  defects.  Print  defects  are  classified  into  three 
categories: Major A, Major B and minor defects. 
 
Major A print defects result in an unprinted capsule or a missing logo. Major B 
print defects result in illegible print, leading to difficulty in identification; this could 
be an incomplete or missing legend. Minor print defects do not interfere with the 
identification of the product but are cosmetic in nature. For example the legend 
may  have  part  of  a  letter  missing  or  logo  missing,  or  the  legend  maybe 
misplaced or could be smudged (Jones, 2004c; Qualicaps, 2006). 
 
 
1.4  Methods for Hard Capsule Shell Filling 
 
There  are  two  methods  for  the  filling  of  medicament  into  capsules.  These 
methods are either manually (on the bench for extemporaneous preparation) or 
by machine (for industrial products) (Jones, 2007).  
 
There is a wide range of types of capsule filling machinery that have different 
sizes and outputs. They vary from semi to fully automatic and from continuous to 
intermittent motion with an output, from 5,000 to 150,000 per hour. However, the 
one thing that they have in common is the way in which they handle the empty 
capsules. The sequence they go through is aligning and rectification, separation 
of cap from body, filling the body, and then the rejoining and closing of the cap 
and the body (Jones, 1988; Jones et al, 1999b, Podczeck, 2004a, Augsburger 
2002). 
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1.4.1  Powder Filling  
1.4.1.1  Manual Filling of Capsules 
 
Manually operated bench top equipment are used in hospital and community 
pharmacies  or  in  industry  for  special  prescriptions  or  for  clinical  trials,  when 
small quantities of capsules need to be filled e.g. 50 – 100 capsules. Simple 
pieces of equipment, the ‘Feton’ form Belgium or the ‘Labocaps’ from Denmark 
are used (See Figure 1.5). The system  comprises a loading device and filling 
machine which consist of sets of plates with holes drilled into them. The holes 
match  the  capsule  body  or  cap  diameters.  These  plates  can  be  changed 
depending upon the size of capsule to be filled, and can hold from 30 to 100 
capsules.  Empty  capsules  are  placed  into  the  holes  in  the  upper  plate.  The 
bodies  are  locked  in  their  plate  by  a  screw  and  the  caps  in  their  plate  are 
removed. A quantity of powder is filled into the capsule bodies placed on the 
surface  of  the  body  plate  and  a  spatula  is  used    to  spread  evenly  over  the 
surface and into the bodies. The disadvantage of this is that air pockets may 
form if the powder flow properties are not good enough, and an even distribution 
will not be achieved. Therefore, some apparatuses are provided with tamping 
devices  that  compress  the  powder  inside  the  capsule  body  by  removing 
entrapped air. The cap plate is then repositioned over the body plate and the 
capsules are rejoined (Podczeck, 2004a; Jones, 2007). 
 
Figure 1. 5: The Feton capsule filling machine (Adapted from Ansel et al., 2005). 
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1.4.1.2  Capsule Machine Filling 
 
Machines developed for industrial use, automatically separate the caps from the 
empty  capsules,  fill  the  bodies,  replace  the  caps,  reclose  the  capsules,  and 
clean the outside of the filled capsules at up to 165,000 capsules per hour.  
 
The  dosing  mechanisms  of  capsules  can  be  divided  into  two  types;  the 
dependent  type  machines  e.g.  Auger  or  Screw  and  the  independent  type 
machines e.g. the Dosator or Dosing tube and the Tamp filling also called the 
Dosing disc (Jones, 2001; Jones, 2007). 
 
1.4.1.2.1  The Dependent Type (Auger or Screw) 
 
The  dependent  type  machines  use  the  capsule  body    to  measure  the  dose, 
which is filled as a loose mass (Jones, 2007).  The Auger type was the first 
semi automatic machines used on an industrial scale and the most used was 
the model No.8  designed by Arthur Colton in the first half of the 20
th century. It 
is semi automatic because someone is required to transfer the capsules from 
one operation to another. In this machine the powder or granules are contained 
in a hopper, inside which is a rotating auger with a stirrer attached to it. Powder 
is continuously fed outside the hopper outlet. The empty capsule bodies are held 
in a filling ring that rotates on a turntable under the powder hopper. The quantity 
of the powder  filled into the capsules depends upon the rate of rotation of the 
filling  ring,  the  design  of  the  auger,  the  time  the  capsule  body  spends 
underneath the hopper intlet. Their output varies between 15 000 and 25 000 
depending  on  the  skill  of  the  operator  (Jones,  1988;  Podczeck,  2004a; 
Augsburger, 2002; Jones, 2007). 
 
 
A  fully  automated  auger  capsule filling  machine  is  the  Liqfil
super  JCF  40/80, 
manufactured by Qualicaps (Japan). This machine can produce up to 80,000 
capsules  per  hour  and  can  fill  capsule  sizes  between  00  and  5  (Podczeck, 
2004a).  The general filling principle with the auger method is shown below in 
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Figure 1. 6: General capsule filling principle with the auger method (Adapted from Podczeck, 
2004)  
 
 
1.4.1.2.2  The Independent Types 
 
Most independent dosing systems are fully automated and use dosing systems 
that form soft plugs of powder (compression forces between 10 and 100 N). Two 
types of plug forming machines are available: the dosator and the tamping finger 
(Jones, 2007). There is larger amount of literature on capsule filling on dosator 
nozzle machines than on tamp filling. This is due to the greater availability of 
instrumented  machines  for  the  former  (Podczeck  and  Newton,  1999).  The 
tamping  system  was  also  adapted  to  modern  machines  after  the  dosator. 
(Jones, 1988). 
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1.4.1.2.2.1   Dosator Nozzle Machines 
 
The  dosator  system,  shown  in  Figure  1.7,  is  one  of  the  most  widely  used 
systems. Machines using it can be either intermittent or continuous in motion 
and consists of a dosing tube inside which there is a spring loaded piston. A 
typical  intermittent  machine  feeds  the  powder  via  a  powder  hopper  into  a 
rotating  dosing  hopper.  A  metal  plate,  which  is  positioned  inside  the  dosing 
hopper behind the hopper inlet controls the powder bed height, Modern dosator 
nozzle designs are easy to clean and simple in design. Examples of machines 
with intermittent motion are the Zanasi. These can fill between 6,000 and 40,000 
capsules per hour, and the Zanasi plus machines that can fill between 8,000 and 
85,000 capsules per hour. Manufacturers of these are IMA,, Bonapace, Macofar 
(Italy) (Podczeck, 2004a). 
 
The continuous machines are manufacture principally by MG2 and IMA (Italy). 
Examples of MG2 machines are the SUPREMA models that can fill 24,000 or 
48,000 capsules per hour into capsule sizes 00 – 5: the PLANETA models can 
fill  up  to  100,000  capsules  per  hour.  Other  models  include  the  G  series; 
examples include G70, G140, and G250, which can fill up to 70,000, 140,000 
and 200,000 respectively (Jones, 2007; Podczeck., 2004a; MG2 srl, 2009). IMA 
manufacture the IMATIC range of machines and can fill 100,000, 150,000 or 
200,000 capsules per hour (Podczeck, 2004a; IMA, 2009).  
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Figure 1. 7:  Intermittent dosator nozzle filling machine (Taken from   Podczeck; 2004a) 
 
1.4.1.2.2.2  Tamp Filling Machines 
 
On  these  machines  a  plug  is  formed  in  more  than  one  operation  unlike  the 
single action on a dosator machine (Jones, 2001). The powder is contained in a 
powder bowl (dosing hopper) that rotates by indexing and 6 times to complete a 
full  360
o  cycle.  Figure  1.8  shows  a  schematic  drawing  of  the  tamp  filling 
mechanism. The  tamp filling  machines  are  intermittent  in motion.  The  dosing 
disc forms the base of a rotating powder hopper. The disc has sets of accurately 
drilled holes and sets of metal rods form powder plugs in these holes by being 
lowered into them and compressing the powder. The tamping action is repeated 
five times to form an individual powder plug and at the sixth station, the powder 
plug is pushed out into the capsule body (Podczeck, 2004a; Augsburger, 2002). Chapter One                                                                                        Introduction 
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Examples  of  tamp filling  machines  include  the  GKF  400S,  GKF  700S,  GKF 
2000ABS and GKF 2500S produced by Robert Bosch GmbH (Germany). The 
GKF 400S is a small machine for laboratory use and production of clinical trial 
samples. The machine is capable of producing 24,000 capsules per hour, the 
GKF 700S fills 48,000 capsules per hour and the GKF 2000ABS fills 150,000 
capsules per hour (Podczeck, 2004a). The KFM III series produced by Harro 
HÖfliger (Germany) can produce between 9,000 and 24,000 capsules per hour 
depending on the size of the machine. Examples of other machines include the 
IMPRESSA series manufactured by IMA (Italy) that can produce up to 130,000 
capsules  per  hour.  The  Liqfil 
super  40/80  machines  is  produced  by  Qualicaps 
(Japan)  with  a  modified  tamping  mechanism  and  the  In cap  bench top  tamp 
filling  machines    from  Dott.Bonapace  (Italy)  has  a  maximum  output  of  3,000 
capsules per hour, which makes it ideal for early formulation development and 
phase  I/IIa  clinical  supplies  manufacture  (Augsburger,  2002;  Nair,  2004; 
Podczeck, 2004a; CapPlus technologies, 2007) 
 
 
 
Figure 1. 8: Tamp filling machine (dosing disc) (Taken from – Podczeck, 2004a) 
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1.4.2  Filling of Pellets into Capsules 
 
Filling of pellets into capsules requires separate devices from those used for 
powders,  because  pellets  are  usually  larger  in  size  (800  –  1400   m),  they 
cannot  be  compressed,  and  are  usually  coated  with  a  film  to  control  drug 
release. The method for encapsulating pellets into hard gelatin capsules varies 
according to the equipment manufacturer. Capsule machines manufactured by 
Bosch GmbH (Germany) provide two types of filling mechanisms for pellets. The 
most  used  method  is  the  double  slide  method  (Podczeck,  2004a).  The 
apparatus  has  dosing  chambers  of  easily  changed  geometry  into  which  the 
pellets flow from a supply container. A multiple slide arrangement closes the 
inlet  apertures  of  the  dosing  chambers  before  opening  the  outlet  apertures, 
temporarily  enlarges  the  volumes  of  the  dosing  chambers  to  permit  easy 
dispensing into the capsules (Rebmann, 1974). A dosing disc method is used for 
pellets with delicate film coating. Tamping pins are removed and a blocking slide 
is installed between transfer station and the capsule segments. Pellets fill the 
dosing  bores  of  the  dosing  disk  during  indexing  rotation  of  the  dosing  disc 
controlled only by flow. The blocking slide opens to release the pellets into the 
capsule body. Other machines are those that are manufactured by IMA (Italy) 
and  Harro  Höfliger  (Germany).  The method  is  based on  the  use  of  vacuum 
assisted dosator nozzles (Podczeck, 2004a).  
 
1.4.3   Filling of Liquids and Semisolids into Hard Capsules 
 
Bioavailability of poorly water soluble drugs can be improved by liquid or semi 
solid  capsule  formulations.  Advantages  of  liquid  fill  hard  capsules  include  i) 
simple manufacture and in house scale up, ii) higher filling temperature (Smith, 
2001; Rowley, 2004; Mei, 2006), and iii) liquid filling process reduce problems of 
cross contamination (Smith, 2001; Rowley, 2004). Liquids and semi solids can 
be accurately filled into hard capsules provided that the formulation rheology is 
compatible with the liquid pumping capacity of the filling machinery (Kattige and 
Rowley, 2006). 
Semi automatic  and  automatic  filling  machines  are  available  for  all  scales  of 
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machines. The only difference is that they have a heater hopper with a stirrer, to 
maintain  a  homogenous  mixture  and  to  liquefy  thermosofening  formulations, 
which can be dispensed into the capsules via a volumetric pump. After filling, 
they cool and solidify or go back to their resting state in the capsule, forming a 
solid plug (Jones, 2007). Liquid filling improves the uniformity of fill weight and 
content for potent drugs (Jones et al., 1999a). Handling of these capsule bodies 
that are filled with liquids of low viscosity requires great care to prevent spillage 
(Smith, 2001).  
 
Another difference between liquid and powder filling machines is in their speed 
of output. For an equivalent size machine the output of a liquid filling machine is 
about 50 60% that of the same machine used for powders. The reason for this is 
that the liquid is transferred to the capsule body through a small orifice to ensure 
uniformity of the fill. On a powder filling machine the same volume of powder 
passes through an orifice that is only just smaller in diameter than the capsule 
body and it can therefore be done faster (Rowley, 2004). 
1.5  Formulation Properties for Filling Materials into Hard Capsules 
 
In general terms, all formulations for filling into capsules have to meet the same 
basic criteria: i) they must be capable of being filled uniformly to give a stable 
product, ii) they must release their active contents in a form that is available for 
absorption by the patient, and iii) they must comply with the requirements of the 
pharmacopoeia and regulatory authorities e.g.  dissolution tests (Jones, 2007). 
 
Two of the most important factors that should be considered when designing 
formulations  for  hard  capsules  are  good  machine  performance  and  release 
properties (Jones et al., 1999a). The requirements imposed on the formulation 
by the filling process, such as lubricity, and fluidity can vary between machine 
types.  In  addition,  the  interplay  between  formulation  variables  and  process 
variables may be expected to influence drug release (Augsburger, 2002). 
 
When  developing  a  capsule  formulation,  it  is  essential  to  ensure  that  each 
capsule provides the required dose of drug and that it is reproducibly released Chapter One                                                                                        Introduction 
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from  the  capsule  to  ensure  drug  bioavailability.  The  type  and  quantity  of 
ingredients  including  diluents,  lubricants,  disintegrants,  glidants  and  wetting 
agents to be incorporated in to the capsule can influence drug release and is all 
part of the formulation process, and depends on the dose of the drug and on its 
physical and chemical properties (Hogan et al., 1996). The dose of the drug and 
its solubility are important considerations in the design of the formulation. Drugs 
with high water solubility exhibit few formulation problems. However, drugs with 
low water solubility have a slow dissolution rate, and the absorption efficiency 
may then suffer.  Drug stability in the gastrointestinal fluids is another concern 
for  slowly  dissolving  drugs,  which  can  affect  their  bioavailability  (Augsburger, 
2002). 
 
1.5.1  Effect  of  Formulation  Properties  for  Filling  Dry  Solids  into  Hard 
Capsules 
 
Relatively  few  workers  have  studied  the  pharmaceutics  of  powder  filling  into 
capsules. This is partly because capsules are only used in pharmaceutical and 
nutraceutical  fields,  unlike  tablets  that  are  used  in  many  fields  (Podczeck, 
2004a). In dry formulations, powder mixtures for filling into capsules must be 
homogeneous  blends  of  particles,  which  do  not  segregate  during  machine 
handling Care in blending is especially important for low dose drugs, since lack 
of  homogeneity  may  result  in  significant  therapeutic  consequences. 
Preformulation  studies  therefore  need  to  be  performed  in  order  to  determine 
whether all the particles in the formulation are homogenous and whether the 
particle size needs to be modified (either decreased or increased) (Ansel et al., 
2005). 
 
The  factors  that  contributes  most  to  the  uniform  filling  of  capsules  is  good 
powder flow and no adhesion, this ensures that the powder bed depth in the 
powder bowl of the filling machine remains constant and that the structure of the 
powder  bed  is  even,  and  the  holes  are  refilled  before  subsequent  dosing.  If 
powders flow too well the mechanical systems are unable to control them, which 
can result in fill weight variations when using the tamp filling machine (Podczeck Chapter One                                                                                        Introduction 
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and Newton, 1999), or poor powder plug formation when using a dosator nozzle 
filling machine (Jolliffe and Newton, 1982).  
 
Poor powder flow is often the result of small sized particles. By decreasing the 
particle size, the electrostatic charge increases. This may lead to the formation 
of agglomerates while leaving the hopper, which might hinder the flow during the 
filling  process  resulting  in  wide  weight  variation  within  the  final  product.  It  is 
therefore essential to improve the flow properties of the mix (Stegemann, 2002).  
 
Powder packing properties are important because the powder may densify in the 
hopper over time leading to a powder with a greater density been fed into the 
powder bowl. This can results in capsules with a higher fill weight (Podczeck, 
2004b).  An  increase  in  packing  density  (i.e.  a  decrease  in  porosity)  of  the 
encapsulated mass will also probably result in a decrease in liquid permeability 
and dissolution rate, particularly if the drug is hydrophobic, or if a hydrophilic 
drug  is  mixed  with  a  hydrophobic  lubricant  such  as  magnesium  stearate 
(Ashford, 2007). Particle size of the active drug is therefore critically important to 
the homogeneity and flowability of the powder. Powders with different particle 
size  and  shape  have  different  flow  and  packing  properties,  which  alter  the 
volume of powders during encapsulation. Therefore, it is necessary to define the 
particle size and shape during formulation to avoid such problems (Staniforth 
and Aulton, 2007).  The reduction in particle size increases the surface area 
available from which dissolution can occur. Bastami and Groves (1978) show 
that a decrease in particle size of sodium phenytoin improved the dissolution 
rate  from  capsules  containing  100mg  of  active  drug  and  150mg  of  lactose. 
Nevertheless, there must be some limitations to particle size reduction because 
this can cause aggregation. Lee et al. (2000) found that an increase in particle 
size increases powder flow and makes the powder bulk behave less cohesively. 
Therefore, it is essential that the particles be of a size that flows freely and at the 
same  time  have  an  improved  dissolution  rate,  which  is  why  granulation  is 
sometimes used.  Granulation can prevent segregation of fine particles leading 
to  improved  homogeneity  of  the  powder  mix  and  will  provide  better  flow 
properties  than  powder  (Podczeck,  1996).  Podczeck  et  al  (1999)  compared 
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their relation to capsule filling on tamp filling and dosator machines. They found 
that the plug formed using the dosator nozzle machine was always denser than 
the  maximum  bulk  density  of  the  granulation,  whereas  on  the  tamp  filling 
machine  for  smaller  granule  sizes  the  maximum  bulk  density  was  reached 
easily. It was suggested that when low plug density is needed, for example, for 
low bioavailability drugs, the tamp filling machine is favourable. However, if a 
greater extent of compression is required, for example, for high dose drugs, the 
dosator nozzle principle should be used. 
 
Chopra et al (2002) studied the influence of pellet shape and film coating on the 
filling of pellets into hard shell capsules. They demonstrated that pellets do not 
have to be ideally spherical in order for them to be filled reproducibly into hard 
shell  capsules.  They  also  found  that  film  coating  could  result  in  pronounced 
electrostatic charges, which is one of the main problems when filling pellets into 
capsules. Hence, there are problems with agglomeration, bridge formation and 
blockage of the filling mechanism. They concluded that the surface roughness of 
pellets needs to be monitored because pronounced surface roughness hinders 
the filling.  
 
In  another  study,  Rowe  et  al  (2005)  used  a  computer  simulation  based  on 
Monte Carlo  technique  to  investigate  the  influence  of  pellet  size,  shape, 
distribution and aggregation on the filling of hard shell capsules. They found that 
filling  is  a  function  of  pellet  shape.  They  also  found  that  the  inclusion  of  an 
aggregate consisting of five spherical pellets at a concentration of 10% (v/v) did 
not have any effect on fill weight or variability for all capsule sizes. However, if 
this aggregate was replaced by a 10% (v/v) of a larger type consisting of seven 
spherical pellets, under filling occurred. Similarly, Ali et al (2009) studied the 
influence of pellet aggregate populations on the variability of pellet filling into 
hard  capsules  using  computer  simulation  studies,  and  found  that  filling  of 
pellet/aggregate mixtures is dependent on the size and shape of aggregates as 
well as the method of filling. Small sized aggregates with simple shape caused 
little variation in the consistency of the fill weight. As the complexity of shape 
and size increased, the variability of fill weight increased.  
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1.5.2  Effect of the Addition of Excipients in  Capsule Formulations 
 
A  study  by  Hogan  et  al,  (1996)  investigating  the  relationship  between  drug 
properties, filling and the release of drug from hard capsules using multivariate 
statistical  analysis.  Five  fillers  were  chosen  for  their  relative  solubility,  which 
increased in the following order: calcium phosphate < microcrystalline cellulose 
< maize starch < starch 1500 < lactose monohydrate. Five disintegrants were 
chosen  (Explotab,  AcDiSol,  Amberlite,  Polyplasdone  and  maize  starch).  The 
main factors influencing  drug solubility were, particle size and concentration, 
type and concentration of standard lubricant (magnesium stearate) and glidant 
(Aerosil), in both cases levels of 0.0, 0.5, 1.0, 1.5 and 2.0% w/w were used, the 
midpoint of the experimental design was set to 1.0%. They found that the filling 
properties are related to the formulations in a complex manner. In particular, the 
mean particle size of the drug and the drug concentration dominate the filling 
performance. However, the type of filler and the glidant concentration are also 
important influencing factors.  
 
The inclusion of excipients (e.g. diluents, lubricants and surfactants) in a capsule 
formulation  can  have  a  significant  effect  on  the  rate  of  dissolution  of  drugs, 
particularly  those  that  are  poorly  soluble  and  hydrophobic.  The  more  water 
soluble the formulation, the quicker it disintegrates and releases the substance 
(Stegemann,  2002).  A  hydrophilic  diluent  serves  to  increase  the  rate  of 
penetration  of  the  aqueous  gastrointestinal  fluids  into  the  contents  of  the 
capsule, and to aid the dispersion and subsequent dissolution of the drug in 
these  fluids.  However,  the  diluent  should  exhibit  no  tendency  to  adsorb  or 
complex with the drug, as this can impair absorption from the gastrointestinal 
tract (Ashford, 2007). The Properties of fillers (or diluents), and how well they 
function  is  vital  to  the  efficiency,  safety,  potency,  purity,  and  quality  of  the 
formulation. They are usually added to increase the volume of the mixture to a 
more manageable quantity (Jones et al., 1999a). Low dose actives are made to 
flow well by mixing them with free flowing diluents, e.g. spray dried lactose. The 
diluent is also chosen for its plug forming properties. The most frequently used 
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Granulated powdered cellulose is recommended for capsule filling as a diluent 
and flow agent. Its comparatively large particle size results in overall acceptable 
flow properties, and due to its rough surface texture it should be useful for the 
manufacture of interactive powder mixtures used in capsule filling of low dose 
drugs (Podczeck and Newton, 2000). Lactose monohydrate is widely used as 
filler in hard capsules. It may also be the major ingredient in the capsule fill when 
handling  potent  drugs  (Tattawasart  and  Armstrong,  1997),  and  has  many 
advantages some of which are water solubility, excellent physical and chemical 
stability, compatibility with many active ingredients and excipients and its low 
hygroscopicity.  
 
Glidants are used to improve powder flow properties. They do this is a number 
of  ways  such  as:  i)  reducing  the  roughness  of  the  particles  by  filling  any 
irregularities  in  their  surfaces,  ii)  reducing  attractive  forces  by  physically 
separating  the  bulk  powder  particles,  iii)  modifying  electrostatic  charge  and 
reducing interparticulate friction which reduces powder to powder adhesion, iv) 
by acting as moisture scavengers. Examples of glidants include colloidal silica, 
maize starch, talc, and magnesium stearate (Augsburger, 2002). 
The same lubricants that are used in tablets are also used in capsules. It is 
essential  that  the  plug  in  capsule  filling  machines  can  be  ejected  without 
difficulty  from  a  dosator  (Augsburger,  2002).  Lubricants  ease  the  ejection  of 
plugs from the dosing machines. They reduce adhesion of the powders on to 
metal surfaces and reduce filming on pistons. The friction between the sliding 
surfaces that are in contact with the powder can also be reduced by the addition 
of lubricants to the formulation, and can have an effect on drug release. The 
most  popular  and  effective  lubricants  are  the  hydrophobic  stearates,  e.g. 
magnesium stearate (Augsburger, 2002; Rao et al., 2005; Jones, 2007). Their 
hydrophobic nature often retards liquid penetration into capsule ingredients so 
that  after  the  shell  has  dissolved  into  the  gastrointestinal  fluids,  a  capsule 
shaped plug often remains (Ashford, 2007). Simmones et al (1972) studied the 
effect of three levels of magnesium stearate (0%, 1% and 5%) on the dissolution 
rate of chlordiazipoxide, and found that the dissolution rate was reduced at 5% 
magnesium  stearate.  Augsburger  (1988)  studied  the  effect  of  the  lubricant 
magnesium  stearate  on  the  in  vitro  release  of  hydrochlorothiazide  using  an Chapter One                                                                                        Introduction 
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instrumented  filling  machine.,  It  was  found  that  as  the  concentration  of 
magnesium stearate increased to a maximum of 1%, the drug dissolution rate 
improved. When  the  amount  of  lubricant  was  increased  above  1%,  the  plug 
became too hydrophobic, this is because plugs become softer with the initial 
increase in magnesium stearate thus fall apart better in the test medium but 
after  1%  the  plugs  are  too  hydrophobic  for  the  softening  to  have  an  effect. 
Podczeck and Newton (2000) studied the powder and capsule filling properties 
of  lubricated  granulated  cellulose  powder  on  a  tamp filling  machine  with  and 
without  the  addition  of  various  concentrations  of  magnesium  stearate.  They 
found that the filling properties are better at lower magnesium stearate levels 
(0.2%).  Heda  et  al  (2002)  carried  out  a  study,  to  provide  semi  quantitative 
definitions  of  the  fluidity,  lubricity,  and  compactibility  requirements  of 
formulations for dosator and dosing disc machines. It was found that a lower 
level  of  lubricant  may  be  sufficient  on  a  tamp filling  machine  compared  to  a 
dosator machine. 
 
The wetting properties of the formulation are of critical importance to the release 
of the drug substance (Buckton et al., 1987; Stegemann, 2002). Surfactants may 
be included in capsule formulations to increase the wetting of the powder mass 
and  to  enhance  drug  dissolution.  The  most  commonly  used  surfactants  in 
capsule formulations are 0.1 0.5% of sodium lauryl sulphate (SLS) and sodium 
docusate  sometimes  used  to  alleviate  the  hydrophobic  effect  of  magnesium 
stearate  on  dissolution  from  capsule  (Mahato,  2007).  Although  sodium  lauryl 
sulphate is commonly used in dissolution media for poor water soluble drugs, it 
has  been  observed  that  SLS  negatively  impacts  on  the  dissolution  of  drug 
products from gelatin capsules. Zhao et al. (2004) studied the effect of sodium 
lauryl sulphate on the dissolution of hard gelatin capsule shells in commonly 
used  dissolution media.  It  was  found  that  SLS  significantly  slowed  down  the 
dissolution  of  gelatin  shells  at  pH  <  5,  and  it  was  suggested  that  other 
surfactants  should  be  investigated  as  an  alternative  to  SLS  in  dissolution 
method development of gelatin capsule products if a low pH is used. 
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1.6  Gelatin 
1.6.1  Gelatin Properties 
 
Gelatin (Figure 1.9) comes from the Latin word ‘gelatus’ which means stiff or 
frozen  (Jones,  2004b).  Gelatin  is  used  pharmaceutically  in  two piece  hard 
capsules, soft elastic capsules, granulation, encapsulation, micro encapsulation 
and  tablet  coating.  It  is  also  used  in  the  preparation  of  pastes,  pastilles, 
pessaries, and suppositories, and as a viscosity increasing agent for solutions 
and semisolids (Podczeck., 2009). It has wide spread use in pharmacy and has 
been used as a material of choice for hard capsules mainly due to the relative 
simplicity of its manufacturing (Missaghi and Fassihi, 2006).  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. 9: Gelatin structure (Taken from   Chaplin, 2006) 
 
Gelatin is a self gelling agent, and when a solution above a minimum critical 
concentration is cooled below 40
oC, a three dimensional gel network is formed 
(Cole  et  al,  2004;  Jones  R.T.,  2004).  Gelatin  is  a  heterogeneous  mixture  of 
water soluble proteins of high molecular weight. On a dry weight basis gelatin 
consist  of  98  –  99%  protein,  with  molecular  weights  (MW)  ranging  between 
20,000 and 250,000 Da (NOSB, 2002).  
 
Gelatin is practically insoluble in acetone, chloroform, ethanol (95%), ether, and 
methanol. It is soluble in glycerine, acids, and alkalis. In water, gelatin swells 
and softens, gradually absorbing between five and 10 times its own weight of Chapter One                                                                                        Introduction 
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water. It is soluble in hot water, forming a jelly, or gel, on cooling to 35 40
oC 
(Podczeck, 2009). 
 
Gelatin possesses some important features. Some of these include its non toxic 
nature,  is  widely  used  in  foods,  is  soluble  in  biological  fluids  at  body 
temperature, and only requires temperatures a few degrees above ambient to 
undergo reversible phase change from sol   gel (Jones, 2007) which has made it 
the material of choice for the manufacture of hard capsules up until this present 
time. Gelatin produces strong, clear, flexible and high gloss films, which can 
dissolve readily under the conditions existing in the stomach. (Jones RT, 2004). 
Is  derived  from  collagen  which  is  an  insoluble  fibrous  protein  isolated  from 
animal skin and bones, mainly cattle bones, split cattle hides, pork and pork 
skins by thermal denaturation (Usta et al., 2003; Gomez Guillen, 2005;  Jones, 
2007; karim et al., 2008). The source and type of collagen will influence the 
properties of the resulting gelatins (Gilsenan, 2000).  
 
Gelatin  is  amphoteric  in  nature,  i.e.  neither  acidic  nor  alkaline,  however 
possesses both properties depending on the nature of the solution, and its pH 
usually ranges between 4.8 and 9.4. There are several varieties of gelatin and 
its composition depends on the source of collagen and the hydrolytic treatment 
used. Type A gelatins are acid pre treated (pH is between 3.8 and 6) and are 
extracted from soft bone ossein, sinew, pigskin, and fish skin. Type B gelatins 
are alkali treated (pH between 5 and 7) and are extracted mainly from bovine 
bones. Gelatin used In the pharmaceutical industry is a mixture of the two types, 
however, sometimes only type A or type B are used. Other types include type C 
(from alkaline pre treated bovine and cattle hides), and type AB (from acid pre 
treated bovine bones) (NAOB, 2002; Singh, 2002; Bosch and Gielens, 2003; 
Jones RT, 2004). The isoelectric point for type A gelatin is between pH 6 – 9.5, 
and that for type B between pH 4.7 – 5.6 (BP, 2009). 
 
Gel strength and viscosity are the most important physical properties of gelatin. 
Bloom strength is an empirical gel strength measure and gives an indication to 
the quality and firmness of the gel, including low (<150 g), medium (150 220 g) 
to high Bloom (220 300 g). A higher molecular weight gelatin is known to have a Chapter One                                                                                        Introduction 
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higher  Bloom  value  than  a  low  molecular  weight  gelatin  (Badii  and  Howell, 
2006).  Generally,  Bloom  strength  in  the  range  of  150   280  g are  considered 
suitable for capsules. The unit is in ‘grams’ because it is the weight required to 
depress by 4 mm the surface of a 6.67% w/w gelatin gel that has been matured 
and prepared as defined in the relevant British Standard (BS 757, 1975).   For 
any  given  gelatin,  gel  strength  is  dependent  on  the  pH,  concentration, 
temperature and maturing time. However not all gelatins form a gel under the 
conditions of the Bloom test. Cold water fish gelatins have zero Bloom, even 
when they have comparable average molecular weights and viscosities to high 
Bloom mammalian gelatins, this makes them unsuitable for capsule production 
(Jones RT, 2004). 
 
 
1.6.2  Gelatin Drawbacks for Use in Hard Capsules  
1.6.2.1  Gelatin Moisture Content 
 
The use of gelatin in the pharmaceutical industry has certain drawbacks. One of 
these is that gelatin has a moisture content between 13 and 16%. The water in 
its composition operates as a plasticizer for the film, when the moisture content 
falls, the capsules become brittle and break (Kontny and Mulski, 1989; Liebowitz 
et  al.,  1990;  Ogura,  1998;  Jones,  2004d;  Yakimets  et  al.,  2005;  Ciper  and 
Bodmiere,  2006).  The  water  content  may  make  the  capsules  unsuitable  for 
water unstable  drugs  (Honkanen,  2004). Too  much  sorbed moisture  (>  18%) 
can also cause the capsules to become sticky, soft, distorted, which will effect 
the capsule filling, and will be subjected to microbial decomposition, and adhere 
to one another, therefore, it is essential for the capsules to have an intermediate 
moisture content range to provide best possible handling properties (Kontny and 
Mulski., 1989; Jones 2004d).  
Exposure  to  high  humidity  has  shown  to  affect  the  in vitro  dissolution  of  the 
gelatin  capsules.  For  example  when  exposed  to  severe  storing  conditions 
(40
oC/75%RH)  for  about  6  months,<ICH>accelerated  storage  conditions>, 
gelatin  capsules  undergo  a  cross  linking  reaction  which  further  reduces  the 
solubility of the capsule  shells and the dissolution rate of the active drug within 
them (Digenis et al., 1994; Sakaeda et al., 2002;  Marachais et al., 2003).  Chapter One                                                                                        Introduction 
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1.6.2.2  Gelatin Cross Linking 
 
Two  stress  conditions  are  commonly  known  in  connection  with  gelatin  films. 
Firstly  under  certain  storage  conditions  (Elevated  temperature  and  /  or  high 
humidity) some drugs may react with the amino groups of the gelatin protein, 
causing the gelatin to cross link (Digenis et al., 1994). Secondly, the exposure of 
gelatin to aldehyde groups in the filling material can cause cross linking between 
the  gelatin  films.  This  cross linking  leads  to  the  formation  of  a  rubbery 
translucent film around the inside of the capsule shell reducing its solubility, and 
therefore reducing the dissolution rate of the products filled into the capsules 
(Marchais, 2003; Jones, 2004d). It has been suggested that gelatin reacts with 
formaldehyde  through  the  initial  formation  of  amine  methylols  on  lysine  and 
arginine  residues  and  subsequently  forming  methylene  bridges  or  cross links 
between lysine and arginine (Gold et al., 1997). 
 
Digenis  et  al  (1994)  found  that  the  cross  linking  occurring  in  stressed  hard 
gelatin capsules can cause changes in the in vitro dissolution performance of 
drugs and that significant attention should be paid to the purity and chemical 
reactivity  of  all  the  inactive  ingredients  that  are  to  be  encapsulated  into  the 
capsule.  Digenis  et  al.  (1994)  suggested  that  dissolution  studies  with  hard 
gelatin  capsules  should  be  conducted  in  two  stages,  first  in  a  dissolution 
medium without enzymes and secondly in a media containing enzymes (pepsin 
at pH 1.2, or pancreatin at pH 7.2) that represent the gastrointestinal media. 
Such in vitro tests may constitute a better indication of the in vivo behaviour of 
gelatin encapsulated formulations. Since then, this has now been adopted by 
the USP/NF.  
 
Brown et al (1998) studied the effects of gelatin cross linking on in vivo capsule 
disintegration using gamma scintigraphy and found that the moderately stressed 
capsules failed the USP dissolution specifications for acetaminophen capsule 
when tested in water and simulated gastric fluid without enzyme but passed with 
addition of pepsin. Moderately stressed capsules started to disintegrate at 10 ± 
6 minutes (range 6 to 24 minutes) compared to 8 ± 2 minutes (range 5 to 11 
minutes) for the unstressed capsule. Meyer et al. (2000) studied the effect of Chapter One                                                                                        Introduction 
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gelatin  cross linking  on  the  in vitro  dissolution  of  hard  and  soft  gelatin 
acetaminophen  capsules  and  found  that  the  rate  of  dissolution  dramatically 
decreased  as  the  degree  of  cross linking  increased,  and  that  the  capsules 
stressed to the greatest extent were not bioequivalent to the unstressed control 
capsules. Han et al (2009) investigated the impact of cross linked hard gelatin 
capsules  on  drug  release  using  fibre optic  dissolution  testing,  and  found  a 
delayed opening time for cross linked capsules as compared to controls, and the 
cross linked capsules showed significantly slower drug release. 
 
1.6.2.3  Gelatin and Bovine Spongiform Encephalopathy (BSE) 
 
Bovine  Spongiform  Encephalopathy  or  Transmissible  Spongiform 
Encephalopathy (BSE Or TSE) is a neurological disorder in cattle that can be 
transmitted to humans causing Creutzfeldt   Jakob disease (CJD) which is a 
rapid progressive degenerative condition of the brain (Peters, 2002). This has 
led  to  increasing  concerns  about  the  use  of  gelatin  derived  possibly  from 
infected animal parts, and the possibility of it containing the prions that cause 
CJD  (Karim  and  Bhat,  2008).  One  study  demonstrated  that  the  process  of 
gelatin production destroys most of the BSE prions that may be present in the 
raw  material  (Grobben  et  al.,  2004).  The  European  Safety  Authority  (EFSA) 
stated that the residual BSE risk in bone derived gelatin is regarded as being 
very small compared to the consumption of meat or meat products in the UK 
(Schrieber and Gareis, 2007; Karim and Bhat, 2008). However, it is fair to say 
that the concerns do exist due to the severity of the disease and the known 
stability  of  the  prion  (Chaplin,  2006).  Another  important  concern  is  that 
vegetarians  and  certain  religions  will  not  accept  the  administration  of  gelatin 
capsules. This has encouraged a serious search for other alternatives (Pranoto, 
2007; Rahman et al., 2008). 
Today, the European Directorate issues a general certificate of conformity for 
Safety of Medicines to the gelatin manufacturer as prescribed in the European 
Pharmacopoeia. This certificate is issued based on a detailed dossier submitted 
by the manufacturer on all aspects of gelatin manufacture relative to the TSE, 
and also requires a quality system such as  ISO 9000 to comply with all required 
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1.6.3  Alternative Gelatin Capsules 
1.6.3.1  Gelatin/PEG Capsules 
 
These capsules are one of the outcomes of the development work undertaken 
by Qualicaps (Shionogi) in the 1990s. The objective of this work was to try to 
make a hard capsule whose physical properties are not so dependent on its 
moisture  content  (Jones,  2004d).  The  addition  of  polyethylene  glycol  (PEG), 
usually  5%,  with  a  molecular  weight  of  4000  Da  to  gelatin,  improves  the 
mechanical strength of a capsule and reduces the brittleness that is often seen 
when standard gelatin capsules are exposed to low moisture conditions. This 
makes these capsules more compatible for moisture sensitive and hygroscopic 
formulations. Gelatin/ PEG capsules at moisture content reduced to 8%   12% 
have  a  mechanical  strength  that  is  similar  to  standard  gelatin  capsules  with 
moisture  content  between  13  –  16%,  the  latter  are  very  brittle  at  moisture 
content less than 10% (Ogura et al., 1998; Jones, 2004d).  
 
Chiwele  et  al  (2000)  compared  the  shell  dissolution  of  various  empty  hard 
capsules using the ball bearing method. Experiments were carried out between 
10
o  and  55
oC,  these  temperatures  were  chosen  because  they  represent  the 
normal range of temperatures for hot and cold drinks. Gelatin and gelatin/PEG 
capsule shells did not dissolve at temperatures below 30
oC. It was suggested 
that gelatin and gelatin/PEG capsules should be taken with a warm drink, and 
cold drinks should be avoided. Podczeck and Jones (2002) compared the in 
vitro dissolution of theophylline from different types of capsules. There appeared 
to be no difference between gelatin and gelatin/PEG capsules in their dissolution 
rates,  and  no  difference  was  seen  in  the  shell  dissolution  time  of  the  two 
capsules in water at 37
oC. Ciper and Bodmeier (2005) prepared novel based 
fast disintegrating dosage forms (Fastcap) for the oral cavity and compared the 
mechanical and disintegration properties with gelatin and gelatin/PEG capsules. 
They found that a decrease in moisture content <10% w/w resulted in a sharp 
increase in broken gelatin, gelatin/PEG and Fastcaps. However, these are only 
an academic idea, there are no capsules on the market using them. 
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1.6.3.2   Capsule Shells from Fish Gelatin 
 
Gelatin can be made from different collagen sources than bovine and porcine, 
such as fish and chicken bone. Due to the increase in demand for non bovine 
and  non porcine  gelatin, fish  gelatin has  gained  some  importance  (Badii  and 
Howell, 2006; Arnesen and Gildberg, 2007). Fish derived collagen is used in 
foods, in the manufacture of glues, and in a number of industrial applications.  
Fish gelatin is useful for providing an additional source of gelatin especially for 
religious and social reasons (Badii and Howell, 2006).   
Roxlor  have  manufactured  Aquacaps  (capsules  made  from  fish  skin  gelatin) 
since 2001 (Roxlor LLC, 2010). 
 
Collagens  present  in  fish  skins  have  a  wider  range  of  amino  acids  than  
mammalian collagens. The melting and gelling temperature of gelatin has been 
found  to  show  a  relationship  with  the  proportion  of  imino  acids  proline  and 
hydroxyproline in the original collagen. This is ~ 24% for mammals and 16  18% 
for most fish species (Gilsenan and Murphy, 2000). It can therefore be seen that 
the total imino acid content is significantly lower. Consequently, the fish collagen 
has a notably lower melting temperature (Olsen, 2003). Generally, collagen and 
gelatin,  prepared from  low  temperature fish  species  (e.g.  Cod)  contain  lower 
amounts of proline and hydroxyproline, lower number of hydrogen bonds, and 
have a lower melting point than species from a higher temperature environment 
such as the mammalian collagens and warm water fish (e.g. tuna)  (Baddi and 
Howell,  2006).  The  low  gelling  and  melting  temperature,  and  the  low  gel 
modulus  of  cold  fish  gelatins,  makes  these  gelatins  unsuited  as  mammalian 
gelatin  replacements  (Haug,  2004;  Pranoto,  2007).  For  this  reason  the  main 
drawbacks of fish gelatins are that they have poorer rheological properties than 
mammalian gelatins, and their decrease in the thermal stability could affect the 
performance at body temperature. It should not be forgotten that fish is also one 
of the most common allergenic foods (Gomez – Guillen, 2002; Olsen, 2003). 
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1.7  Alternatives to Gelatin Capsules 
 
Capsules  can  be  made  from  materials  other  than  gelatin.    The  search  for 
alternatives to gelatin capsules began in the 1830s to find ways to overcome 
Mothes’s original patent. In the 19
th century capsules were made from a variety 
of materials such as starch, gluten, animal membranes and a vegetable gelatin 
prepared from carragheen moss. However, gelatin has been the only material 
that  has  stood  to  this  time  (Jones,  2004e).  Since  then,  the  stimulus  to  find 
gelatin alternatives has been the demand for materials from non animal sources 
to  overcome  religious  and  dietary  restriction  and  to  overcome  the  problems 
associated with its high moisture content and instability on storage (Tuleu et al., 
2007). Many companies in recent years have developed alternatives to the use 
of  gelatin  (Ogura  et  al.,  1998;  Olsen,  2003).  The  most  appropriate  material 
would be one that is a good film former, that dissolves rapidly in biological fluids 
at 37
o C (Jones., 2004e), and must have a gelation property so that a capsule 
film can be cast or dipped, which would allow the present industrialized shell 
manufacturing process to be used (Nagata, 2000; Jones. 2004e). 
 
The  most  popular  alternative  to  gelatin  capsules  are  hypromellose 
(hydroxypropyl  methylcellulose,  HPMC)  capsules.  Other  alternatives  include 
Pullulan and modified starches (Jones, 2004e). 
 
1.7.1   Pullulan 
 
Pullulan  is  a  water soluble  polysaccharide  extracellulary  produced,  e.g.  by 
growing certain yeasts on starch syrups (Scott et al., 2005; Rekha and Sharma, 
2007). It has been used widely in Japan and has been in commercial production 
for over 25 years (Capsugel, 2010). It is also currently been used in cosmetics 
and pharmaceuticals. Pullulan can be used in the production of capsule shells 
(NPcaps). Its film forming properties are similar to those of the gelatin shells 
(EFSA, 2004; Sakata and Otsuka, 2009).  
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Pullulan is easily soluble in hot and cold water, has low oxygen permeability, 
and a moisture content at 50% RH of about 12% (Scott et al., 2005; Rekha and 
Sharma, 2007). In terms of its physical strength, like gelatin, it is dependent on 
water to act as a film plasticizer (Sakata and Otsuka, 2009). However, Pullulan 
is unsuitable for multinational use as it is only produced as yet by one supplier. It 
is not any cheaper than other capsule shells and overall carries no advantages 
over the hypromellose capsule. 
 
1.7.2  Modified Starches 
 
Starch  is  an  abundant  polysaccharide  that  occurs  naturally  in  many  plants 
including wheat, corn, potato, tapioca and rice. It is renewable, biodegradable 
and of low cost (Robert et al, 1999). When starch is mixed with hot water at a 
temperature  above  or  equal  to  65
oC,  irreversible  gelatinization  can  occur 
(Dennis and James, 1999). 
Modification of edible starches can improve their film forming characteristics and 
produce a flexible capsule that has properties similar to that of gelatin capsules. 
Generally, they have poor mechanical properties. Therefore, the success in this 
field  is  limited.  Modified  starches  have  thicker  shell  walls  than  the  standard 
gelatin  capsule  shells.  They  also  have  different  shape,  which  makes  the 
standard filling machines unsuitable as they will also need specific filling and 
closing equipment. Another drawback is that their aqueous solubility  is lower 
than the gelatin capsules. (Dennis and James, 1999;  Scott et al., 2003). 
 
Scott et al (2003) patented “modified starch film composition”. They claimed to 
have  found  that  the  addition  of  a  very  small  amount  of  a  setting  system, 
preferably  hydrocolloids  and  most  preferably  polysaccharides,  results  in  an 
appropriate setting ability with the result that the modified starch capsules can 
be  manufactured  by  the  same  dip  moulding  process  used  for  hard  gelatin 
capsules. They also found that the addition of a plasticizer in the formulation 
could improve the flexibility of the hard capsule shells. These capsules are made 
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with powders, any loose material on the edge of the body or cap prevents the 
sealing so they are not used for powder formulations 
 
Bae et al (2008), in an article entitled ‘pharmaceutical hard capsule formation 
properties  of  mungbean,  waterchestnut,  and  sweet  potato  starches  ‘ 
investigated  the  solubility  of  starch  capsules  in  neutral  and  slightly  acidic 
solutions  at  37
oC,  following  the  Korea  Pharmacopoeia  (2002)  method.    The 
results indicated that the developed starch capsules only partly dissolved within 
10 minutes in 50 ml water or in 50 ml HCl (pH 1.2), with small fragments of 
capsule remaining.  
 
Nevertheless, although studies are being conducted to find solutions to some of 
the disadvantages associated with modified starch capsules, there is still, no 
capsules available for use however an increasing need for more research. 
 
 
1.7.3  Hydroxypropyl methylcellulose 
 
 
 
 
 
 
 
Figure 1. 10: Structural formula of hypromellose, formally known as hydroxypropyl 
methylcellulose (HPMC).R= H,  CH3 or  CH2CH(CH3)OH  (Taken from   Honkanen, 2004). 
 
HPMC  has  many  pharmaceutical  uses.  It  can  be  used  as  a  drug  carrier,  a 
coating agent, tabletting agent, rate controlling polymer for sustained release, 
can also be used as an emulsifier in ointments, in ophthalmic solutions and as a 
thickening agent and foam stabilizer (Kokubo, 2003; Harwood., 2006). 
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Hypromellose  browns  at  temperatures  between  190 200
o,  chars  at  225 230
o, 
and has a glass transition temperature ranging between 170 180
oC. It is soluble 
in water, forming a viscous colloidal solution: practically insoluble in chloroform, 
ethanol  (95%),  and  ether,  but  soluble  in  mixtures  of  ethanol  and 
dichloromethane, mixtures of methanol and dichloromethane, and mixtures of 
water and alcohol. Certain grades of hypromellose are also soluble in aqueous 
acetone  solutions,  mixtures  of  dichloromethane  and  propan 2 ol,  and  other 
organic solvents. It is incompatible with some oxidizing agents and as it is non 
ionic  will  not  complex  with  metallic  salts  or  organics  to  form  insoluble 
precipitates (Harwood., 2006). 
 
Figure  1.10  shows  the  structural  formula  of  hypromellose.  It  is  a  partly  O 
methylated and O (2 hydroxypropylated) cellulose.  Hypromellose is available in 
several  grades  that  vary  in  viscosity  and  the  extent  of  substitution.  The 
molecular weight of HPMC is approximately 10,000 1 500 000 Da (Harwood., 
2006).  The  physicochemical  properties  of  the  HPMC  polymer  are  strongly 
affected by i) the methoxy group content, ii) the hydroxypropoxy group content, 
and iii) the molecular weight (Siepmann and Peppas, 2001). 
Hypromellose  capsules  are  a  new  type  of  hard  two piece  capsule  that  were 
developed as an alternative to the two piece gelatin capsules in an attempt to 
overcome some of the drawbacks that are associated with the gelatin capsules. 
 
Hydroxypropyl methylcellulose is an odourless, tasteless and inert hydrophilic 
polymer with no ionic charge. It is made from plant derived materials, is Halal 
certified and can be used when dietary concerns or religious beliefs require an 
alternative to gelatin or when the characteristics of gelatin present a challenge to 
the drug formulation (Cole, 2004).  
 
HPMC is manufactured and prepared from purified cellulose, which is obtained 
from  cotton  linters  or  wood  pulp  by  chemical  processing  (Harwood,  2006).  
Swollen  alkali  cellulose,  which  is  more  reactive  than  untreated  cellulose,  is 
produced  by  treating  the  cellulose  with  sodium  hydroxide  then  using 
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hydroxypropyl ethers of cellulose. This is then purified and made into powder or 
granules (Honkanen, 2004). 
 
In  order  to  be  able  to  manufacture  HPMC  capsules  using  the  conventional 
dipping process, a gelling agent is required to be added to a solution of HPMC 
to produce an equivalent network. Currently, either carrageenan (HPMC carr) 
(0.35 ~ 1.00%) or gel gum (HPMC gellan) are used in commercially available 
capsules (Nagata and Jones, 2000; Cole et al, 2004). Gellan gum is insoluble at 
pH < 4.0, whereas Carrageenan is readily soluble at pH 1.2 (Tuleu et al., 2007). 
The  same  dipping  and  forming  method  used  in  the  manufacture  of  gelatin 
capsules  is  used  in  the  manufacture  of  HPMC  capsules  (Yamamoto,  1998), 
where mould pins are dipped into a solution of HPMC. The pins are raised up 
from the HPMC solution. HPMC films are then gelled and dried by controlled 
temperature and humidity air, then trimmed and removed from the pins after 
which the cap and the body are joined together. Small amounts of the natural 
gelling agent Carrageenan, and a gelling promoter such as potassium chloride 
(0.35 ~ 0.50%) are added (Ogura, 1998; Nagata, 2002).  
Hypromellose hard capsules have been developed by Qualicaps (Shionogi) S.A. 
(Quali V
®  capsule),  Capsugel  Division  of  Pfizer  Inc.  (Vcaps  TM),  Natural 
Capsules Ltd. (Cellulose capsule), and Associated Capsules Ltd. (Naturecaps) 
(Honkanen, 2004). However, several patents were first granted to the Japanese 
company, Qualicaps (Shionogi) on a HPMC gelling system using hypromellose 
solutions to which carrageenan was added as a network former and potassium 
chloride as a gelation promoter (Yamamoto et al, 1993, 1995, 1998; Matsuura 
and Tanjoh, 2003).   
 
1.7.3.1  Characteristics of HPMC Capsules 
 
HPMC capsules are flexible and odourless. The appearance of HPMC capsules 
is  similar  to  gelatin  capsules  except  that  the  surface  of  gelatin  capsules  is 
lustrous, whereas the surface of the HPMC capsules is matt (Honkanen, 2004).  
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1.7.3.1.1  Moisture Content 
 
The main difference in the capsule properties between HPMC and gelatin is the 
moisture  content:  Qualicaps  Quali V  capsules  contain  4 6%  and  Capsugel 
Vcaps contain 5 7% whereas gelatin contain 13 16% (Ogura et al, 1998; Jones, 
2004d). Nagata (2002) measured the equilibrium water content of both gelatin 
and  HPMC  capsules  using  a  Microbalance  system  at  25  and  40
oC.  Ten 
milligrams of capsule shell fragments were placed on a dish in the microbalance. 
The pieces were dried until there was 0% water content. The data showed that 
the equilibrium water content of HPMC capsules was lower at 25
oC and 40
oC 
than that of gelatin capsules and that the water contents of HPMC capsules 
measured by Karl Fisher titration were 4 – 6% opposed to the gelatin capsules 
that contained higher moisture content (13 15%) when stored at 20 25
oC and 
40 60%RH.  This  difference  in  moisture  content  between  HPMC  and  gelatin 
capsules  could  be  of  significance  if  the  drug  filled  in  the  capsule  is  strongly 
hygroscopic  attracting  water  molecules  from  the  capsule  shells  (Honkanen, 
2004). Bond et al (1970) found this, where moisture was transferred to cefalexin, 
and by Bell et al (1973), with moisture transfer to a sodium cromoglycate lactose 
blend even after previous equilibrated at the same RH. 
The moisture content of HPMC capsules is 30 – 50% lower than that of the 
gelatin capsules. Moreover, the chemically reactive groups that are present in 
gelatin  are  not  contained  in  HPMC,  which  potentially  decreases  reactions 
between the drug and the capsule shell (Honkanen et al., 2002). 
 
When  the  moisture  content  of  the  gelatin  capsule  shell  is  decreased,  the 
capsules tend to become brittle and are subject to breakage on handling. Kontny 
(1989) studied gelatin brittleness as a function of relative humidity and found 
that  capsules  stored  at  relative  humidities  less  than  about  40%  exhibited 
brittleness. 
 
Matsuura  and  Yamamoto  (1993)  found  that  HPMC  capsules  had  sufficient 
mechanical strength even at low moisture content (~ 1%) in both the impact and 
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Similarly, (Ogura et al; 1998) observed that the percentage of broken gelatin 
capsules  sharply  increases  as  the  moisture  content  of  the  hard  gelatin  shell 
drops below 10%. In contrast, no brittleness was observed in HPMC capsule 
shells even at moisture levels of only 2%.  
 
Nagata  (2002)  stored  HPMC  and  gelatin  capsules  under  various  humidity 
conditions to alter their moisture contents. The brittleness of the capsules was 
evaluated using two methods. One method reproduced a situation where the 
filled capsule was taken out of its blister package by pressing it through the 
aluminium foil. A capsule filled with corn starch was placed on a plate and a 5kg 
force applied. The other reproduced the forces applied during manufacturing or 
transporting: a 50g weight was dropped on an empty capsule from 10cm height. 
It was found that gelatin capsules became brittle below 10% water content in 
both experiments. However, HPMC capsules were not broken even at 1% water 
content.  
 
Podczeck  (2002)  compared  gelatin,  gelatin/PEG  and  HPMC  capsules  by 
measuring  indentation  forces  after  storing  the  capsules  at  different  relative 
humidity conditions for up to four weeks. HPMC capsules were found to be less 
resistant to indentation. However, they maintained their mechanical properties at 
both low and high relative humidity conditions whereas gelatin and gelatin/PEG 
capsules did not.   
 
Missaghi  and  Fassihi  (2006)  determined  the  weight  reduction  of  gelatin  and 
hypromellose capsule shells at different time points by placing in an oven at 
45oC and comparing to their initial weight. They found that moisture loss had a 
more marked effect on the gelatin shells, which could reduce their plasticity and 
become brittle.  
 
Ciper  and  Bodmeier  (2006)  found  that  that  vacuum drying  of  hard  gelatin 
capsules resulted in brittle capsules. The brittleness of the hard gelatin capsules 
correlated  well  with  their  moisture  content.  The  critical  value  for  sufficient 
brittleness  of  the  gelatin  capsules  was  <4%  w/w.  However,  HPMC  capsules 
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1.7.3.1.2  Permeability to Gases 
 
Filled hard capsules are not gas tight unless they have been banded and gases 
can readily reach the contents by passage through the space between the cap 
and the body in the region of the overlap (Jones, 2004d). HPMC capsules are 
slightly more permeable to the diffusion of gases than gelatin capsules. This is 
thought to be due to the structure of the shell wall, which is looser for the HPMC 
capsules.  
 
Nagata (2001) investigated the permeability of oxygen and water vapour through 
HPMC and gelatin films. A diaphragmatic electrode was set on the one open 
side of a square stainless steel tube. The opposite side was sealed by a cast 
film, which was 100 microns thick, the tube was place in a container and oxygen 
flushed over its surface.. The oxygen concentration, inside the tube, after three 
days was found to be 0.1% and 0.3% for gelatin and HPMC respectively. It was 
therefore suggested that when oxygen sensitive products are filled into HPMC 
capsules, either an anti oxidant should be formulated with the dosage, or the 
filled capsule could be packaged in aluminium foil blister packaging (Nagata, 
2002). 
 
Bae  et  al  (2008)  used  an  OX Tran  ®  2/60  oxygen  transmission  tester  to 
measure oxygen permeability of gelatin, HPMC and starch capsules. On one 
side of the film, 100% oxygen was flowing, and on the other side nitrogen gas 
(98% nitrogen and 2% hydrogen). Samples were exposed to 0% RH at 30
oC. 
The oxygen permeabilities were found to be 0.117 and 2.098 fl m/m
2. s Pa for 
gelatin and HPMC respectively.  
 
1.7.3.1.3       Compatibility between Capsule Fill and Capsule Shell 
 
Some  substances  are  considered  not  suitable  for  filling  into  hard  gelatin 
capsules.  As  discussed  previously,  the  presence  of  aldehyde  groups  in 
formulations  can  promote  cross linking  between  gelatin  proteins,  as  a  result 
form a thin insoluble membrane called a pellicle, which can lead to slow and 
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demonstrated when gelatin and HPMC capsules were filled with the macrolide 
antibiotic spiramycin, which is known to cause problems in gelatin capsules. The 
filled  capsules  were  stored  for  10  days  at  60
oC  and  75%  RH.  The  HPMC 
capsules remained unaffected (initial disintegration time = 4.6min; after 10 days 
= 4.5min) opposed to gelatin capsules that were changed, the capsules did not 
disintegrate after storage (initial disintegration time = 3.3 min; after 10 days > 
30min) (Ogura et al, 1998).  
 
Substances containing aldehyde groups tend to discolour when stored under 
stress conditions. HPMC capsules do not contain reactive groups, therefore this 
minimises  discolouration  problems  that  can  occur  because  of  interactions 
between the drug and capsule shell. HPMC and gelatin capsules were filled with 
ascorbic acid (which contain aldehyde groups) packed in polyethylene bottles 
without  any  desiccant,  and  stored  at  40
oC  and  RH  75%  for  2  months.  After 
storage  the  gelatin  capsules  changed  from  white  to  brown,  and  the  HPMC 
capsule did not change colour (Ogura et al., 1998). 
 
1.7.3.1.4  Dissolution Properties 
 
An important property of Qualicaps HPMC capsules is that they are soluble at 
temperatures  as  low  as  10
oC  as  opposed  to  gelatin  capsules  that  become 
insoluble at temperatures below 25
oC (Nagata and Jones, 2000).  
 
The disintegration time of capsules is influenced by the composition and the 
structure of the shell. The shell structure of gelatin and the way in which gelatin 
capsules disintegrate and dissolve has been studied by Ludwig et. al., (1979); 
Ludwig  and  Ooteghem,  (1980a,  1980b,  1980c,  1981).    capsules  must  first 
become hydrated, the capsules then split at  the shoulders of the shell, where 
the wall is thinnest. It takes longer for hypromellose capsules to start to dissolve 
because of the slower passage of moisture through their walls (Jones, 2009). 
The solubility of gelatin and HPMC capsules differ in different aqueous media 
and  this  affects  the  way  in  which  capsules  disintegrate  and  dissolve  (Jones, 
2004e).  The  gelling  agent  used  in  HPMC  capsule  shells  can  also  greatly Chapter One                                                                                        Introduction 
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influence the shell dissolution time (Cole et al., 2004). As mentioned previously 
either carrageenan or gellan gum are used as the gelling agent in commercially 
available capsules. Gellan gum is a microbial polysaccharide (Grasdalen and 
Smidsrod,  1987)  produced  by  the  organism  Sphingomonas  elodea  in  a 
fermentation process. It has a linear tetrasaccharide repeating sequence with 
one  carboxyl  group  per  repeat  unit.  Carrageenans  are  algal  polysaccharides 
consisting of high molecular weight linear sulphated galactan chains. In solution, 
both gelling agents exist as disordered coils. However, on cooling the chains 
associate  by  the  formation  of  double  helices.    Gelation  then  occurs  by 
aggregation of these helices to form a continuous, three dimensional network 
(Cole  et  al.,  2004).    Both  polysaccharides  are  negatively  charged,  therefore, 
gelation  is  promoted  by  cations  that  suppress  the  electrostatic  repulsion 
between the helices and allow aggregation to occur. Gelation is dependent on 
both ionic strength and the identity of the cation, where divalent metal ions are 
particularly effective in inducing the gelation of gellan gum and carrageenan with 
a correlation between ion binding and gel formation (Grasdalen and Smidsord, 
1987; Cole et al, 2004). The  strongest gels of k carrageenan are formed with K
+ 
rather than Li
+, Na
+, Mg
2+, Ca
2+ or S
2+ (Kara et al., 2006). 
  
In the case of HPMC gellan capsules if water is used as the dissolution medium, 
gellan gels dissociate because of the diffusion of cations out of the network, which 
results in rapid film disruption and consequently drug release (Cole et al., 2004). 
This effect has also been observed for HPMC carr. (Ogura et al., 1998; Nagata and 
Jones,  2000;  Cole  et  al.,  2004).  However,  in  acid  conditions,  the  carrageenan 
behaves in the same way as in water because of the sulphate groups which have 
very low pKa retain their negative charge. This causes disruption to the helix helix 
aggregates by electrostatic repulsion when the gel forming cations diffuse into the 
surrounding acidic solution. On the other hand, the carboxyl groups of the gellan 
gum have a much higher pKa, and will therefore convert into the uncharged ( 
COOH) form at low pH, which then leads to elimination of electrostatic repulsion 
between the helices (Grasdalen and Smidsord, 1987; Cole et al, 2004). 
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1.7.3.1.4.1  Dissolution of Capsule Shells  
 
A study by Chiwele et al (2000) compared the shell dissolution properties of 
three different types of empty hard shell capsules, standard gelatin capsules, 
gelatin/PEG, and HPMC capsules, in different dissolution media and at different 
temperature.  
The results demonstrated that in any dissolution medium with a pH below or 
equal  to 5.8,  HPMC  capsules dissolved  rapidly.  The pH  of  mixed  phosphate 
buffers  significantly  altered  the  shell  dissolution  properties  of  gelatin  and 
gelatin/PEG capsules at temperatures below 37
oC. It was also found that neither 
type of capsule should be taken with carbonated drinks such as cola as the 
combination  may  slow  down  the  dissolution  of  the  capsule  shell.  More 
importantly, it was found that cold drinks should be avoided when taking gelatin 
or gelatin/PEG capsules as this could slow down drug release. However, the 
drug  release  from  HPMC  capsules  was  not  affected.  It  was  concluded  that 
HPMC  capsules  dissolve  rapidly  and  the  shell  dissolution  is  independent  of 
temperature between 10
o and 55
 o C at a pH ≤ 5.8. However, gelatin capsules 
do not dissolve at temperatures below 30
  o C and their dissolution times are 
actually dependent on temperature. 
 
El Malah et al (2007) investigated the rupture times hypromellose capsules as a 
function of capsule size, capsule grade, and dissolution medium. A real time dip 
type  fiberoptic  system  was  used  to  measure  the  increase  in  absorbance 
associated with the labrosol released from the capsules. The authors believe 
that this method is capable of differentiating the rupture time of the capsules of 
different materials under different testing conditions. The results demonstrated 
that the size of hypromellose capsules had insignificant effect on rupture time. 
However, rupture time was significantly lower in simulated gastric fluid (pH 1.2) 
than  simulated  intestinal  fluid  (pH  7.2).  The  primary  factors  effecting 
hypromellose rupture time were believed to be the composition of the dissolution 
medium and ionic strength. 
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1.7.3.1.4.2  Dissolution of Filled Capsules  
 
In  study  by  Sakaeda  et  al  (2002),  dissolution  tests  were  performed  using 
paracetamol as the drug of choice and filling it into gelatin capsules and HPMC. 
The capsules were stored at 30 
o C /60% RH for one year and 40 
o C / 75% RH 
for 6 months, and tested in acetic acid (pH 4.0) and purified water dissolution 
media.  The  dissolution  profiles  changed  significantly  for  the  gelatin  capsules 
between  the  different  storage  conditions.  However,  no  change  or  delay  in 
dissolution  was  observed  for  the  HPMC  capsules  and  it  was  found  that  the 
dissolution  profiles  for  HPMC  capsules  are  independent  of  the  dissolution 
medium  opposed  to  the  gelatin  capsules  that  behaved  differently  in  different 
dissolution media. Further dissolution tests using three commercially available 
HPMC  capsules  (Qualicaps,  Capsugel  and  SuHeung)  showed  that  the 
dissolution  of  HPMC  capsules  from  Qualicaps  was  independent  of  the 
dissolution  media,  however,  the  others  showed  different  dissolution  profiles 
depending on the dissolution medium used. 
 
In  another  study,  Podczeck  and  Jones  (2002)  investigated  the  in–vitro 
dissolution of the moderately water soluble drug theophylline from different types 
of  hard  shell  capsules  (HPMC  capsules,  standard  gelatin,  and  gelatin/PEG 
capsules). Three different formulations were used: i) drug alone, ii) drug and 
lactose monohydrate, and iii) drug + microfine cellulose. The dissolution tests 
were  performed using  1000ml distilled  water  at  37
oC  and  a paddle  speed  of 
50rpm. The results showed that the dissolution for all formulations of the HPMC 
capsules after 60 minutes was greater than for the other capsule types.  No 
difference  was  observed  between  the  gelatin  capsules  and  gelatin/PEG 
capsules.  
 
The gelatin, gelatin / PEG and HPMC capsules dissolve at the shoulders of the 
capsule, however, once the HPMC capsules split, they release their contents 
faster,  because  they  dissolve  evenly  proceeding  simultaneously  across  the 
whole shell  (Chiwele et al, 2000; Podczeck and Jones, 2002; Jones, 2009). 
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could be advantageous for low solubility drugs, and that the change from using 
gelatin  capsules  to  HPMC  would  not  pose  problems  with  respect  to  drug 
absorption and bioavailability. 
 
Cole et al. (2004) carried out in vitro/in vivo studies to compare HPMC capsules, 
prepared using a gellan gum and potassium gelling system, with standard hard 
gelatin  capsules.  The  in  vitro  dissolution  of  ibuprofen  filled  into  gelatin  and 
HPMC  capsules  was  determined  using  potassium  phosphate  and  tris 
(hydroxymethyl) aminomethane (TRIS) buffers (pH 7.2). The effect of pH and 
composition of the media was determined using paracetamol as the model drug, 
which  is  soluble  throughout  the  pH  range  1.2  to  7.2.  Therefore,  the  in vitro 
release of the capsules can be assessed over the whole range of pH values, 
dissolution media used were water, 0.1 M HCL, sodium acetate buffer (pH 7.2) 
and TRIS buffer pH 7.2. In vivo  performance was evaluated using scintigraphy 
and  pharmacokinetics.  They  explained  that  alternatives  to  gelatin  require  the 
addition  of  a  gelling  system  such  as polysaccharides.  These  gelling  systems 
require  metal  cations  to  promote  the  formation  of  a  gel  structure.  It  was 
observed that the presence of K
+ cations, from the potassium phosphate buffer, 
and acid conditions hindered the opening of HPMC capsules and drug release 
was delayed. However, when the cation present was sodium at pH 4.5 and 7.2, 
the  release  of  paracetamol  was  less  delayed,  and  the  dissolution  of  HPMC 
capsules in water was found to be identical to that of gelatin. The in vivo studies 
demonstrated that disintegration from the gelatin capsules in both fasted and fed 
state was faster than from HPMCgellan (14 hr vs 41 in fasted) and (73 hr vs 97 hr 
in fed state). It was concluded that new bio relevant dissolution media would 
need to be developed for non gelatin capsules. 
 
 In a study by Ogura et al. (1998), dissolution testing using cephalexin as the 
model drug and solutions of various pHs using the paddle method showed that 
in  the  first  test  fluid  (pH  1.2)  and  a  solution  of  pH4  both  gelatin  and  HPMC 
capsules behaved more or less the same with no significant difference in their 
dissolution.  In the second test fluid (pH 6.8) both the capsules were found to 
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began to split 5 minutes later than the gelatin capsules. This was said to be 
related  to  the  presence  of  potassium  in  the  second  test  fluid  that  promotes 
carrageenan  gelation  and  hence  is  causative  of  membrane  formation.  This 
suggestion or hypothesis was supported by further tests that were performed in 
various  buffer  solutions  that  did  not  contain  potassium,  which  showed  no 
difference in the dissolution times.  
 
Tuleu et al (2007) compared the disintegration of HPMC and gelatin capsules in 
fasted human subjects using the technique of gamma scintigraphy. The HPMC 
capsules, containing carrageenan as a gelling agent, and gelatin capsules of 
size 0 were filled with a lactose based mixture. The capsules were separately 
radiolabelled  with  indium 111  and  technetium 99m.  Both  capsules  were 
administered simultaneously with 180 ml water to eight healthy male subjects 
following an overnight fast. No difference in the oesophageal transit of the two 
types  of  capsules  were  noted.  The  mean  disintegration  time  for  the  HPMC 
capsules  was  9  ±  2min  (range  6 11  min).  The  corresponding  mean  time  for 
gelatin  capsules  was  7  ±  4  min  (range  3 13  min).  They  conclude  that 
disintegration times were not significantly different (P = 0.108, paired t test). 
 
 
1.7.3.1.5     Oesophageal Sticking of Capsule Shells 
 
Oesophageal  adhesion  by  dosage  forms  was  recognized  as  early  as  1970, 
when  it  was  reported  that  tablets  containing  potassium  chloride  caused 
oesophageal injury. More than 70 drugs in common use have been reported to 
be associated with oesophageal injury (Sakkinen et al., 2003). This is of serious 
concern, if the drug has a corrosive effect on the oesophagus. The volume of 
water swallowed and the position of the body when swallowing are important 
determinants of the oesophageal transit time of capsules. Otherwise, i) delayed 
oesophageal  transit  of  the  dosage  form  may  delay  drug  absorption,  and  ii) 
oesophageal  disorders  may  develop  (Marvola,  1982;  Channer  and  Roberts, 
1984; Bailey et al., 1987; Honkanen et al., 2002; Honkanen, 2004) 
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A number of in vitro and in vivo studies have demonstrated that gelatin capsules 
have a high tendency to stick to the oesophagus (Swisher et al., 1984; Bailey et 
al., 1987; Perkins et al., 1999). Honkanen and co workers (2002) studied the 
biopharmaceutical  behaviour  of  HPMC  (carrageenan)  capsules  by  comparing 
them  with  the  properties  of  the  hard  gelatin  capsules.  The  tendency  of  the 
HPMC  capsules  to  stick  to  isolated  porcine  oesophageal  preparations  was 
evaluated.  The  results  showed  that  the  force  required  to  detach  the  gelatin 
capsules  from  the  oesophagus  is  2.5  times  greater  than  that  for  HPMC 
capsules. It was also observed that hard gelatin capsules were adhered to the 
oesophagus  so  firmly  that  they  broke  while  detaching.  In  another  study  by 
Honkanen et al (2004), the rate of dissolution of HPMC capsules in the human 
GI tract was investigated using a gamma scintigraphic imaging method. Two 
different prolonged release formulations without an active ingredient were used. 
The capsules had been made from different viscosity grades of HPMC (HPMC 
K100 and HPMC K4M). The first observation was that the HPMC capsules had 
a tendency to attach to the oesophagus, therefore it was recommended that the 
HPMC capsules and the gelatin capsules should both be taken with sufficient 
amount of water (150 200 ml) in an upright position.  It was also found that the 
viscosity grade of the HPMC did not affect the transit times of the capsules in 
the gastrointestinal tract. 
 
 
1.7.3.1.6  HPMC Capsules and Dry Powder Inhalers 
 
When  considering  capsules for  dry  powder  inhalers  (DPIs),  there  are  certain 
properties that their shells must meet. They should be able to be punctured or 
cut cleanly without shedding any particles from the shell. However when gelatin 
capsules loose water after storage under certain conditions and tend to become 
brittle. Hence, capsule puncturing becomes irregular leading to the generation of 
particles.  This  problem  can  be  overcome  by  the  use  of  QUALI V® I 
(Hypromellose  capsules)  which  do  not  shed  particles  from  the  capsule  shell 
when punctured, as water content is not as essential as it is in gelatin shells as 
discussed previously.  Another important factor is that the powder should be 
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emptying test involving filling capsules with either starch or lactose, and shaking 
them in a plastic bottle and then emptying them out indicated that there was 
significantly  less  retention  in  hypromellose  capsules  compared  to  gelatin 
capsules (Nagata, 2002; Jones, 2003b). This is not seen with gelatin capsules 
due to the static charge that is generated between the fill and the capsule shell. 
In a study conducted by Nagata (2002), the static electricity of the capsules was 
measured  by  placing  100  empty  capsules  into  an  acrylic  vat  container  of  a 
friability tester, and rotated for one minute at 26rpm and an angle of 50
o then the 
static  electricity  was  measured  with  STATIRON  M2  electrostatic  tester.  The 
results showed that the static electricity of  the HPMC capsules was one tenth of 
gelatin capsules regardless of the capsule size HPMC: (0.17± 0.29 kV, capsule 
size 1 and 0.25 ± 0.29kV capsule size 3) Gelatin: (3.33 ± 0.58 kV, capsule size 1 
and 3.67 ± 0.58 kV capsule  size  3).  
Capsules  for  inhalation  should  also  have  undetectable  levels  of  bacterial 
endotoxins, and low microbial count. This is very important to avoid the patient 
inhaling bacteria into their lungs. Quali V I capsules can be manufactured with a 
limit of <10 colony forming units per gram (cfu/g) as oppose to <10
3 cfu/g for 
standard  oral  capsules,  i.e.  100  times  less  than  standard  gelatin  capsules 
(Jones, 2003b; Jones, 2004a).   
 
Bichall and Jones (2008) investigated and compared the puncturing properties 
of gelatin and hypromellose capsules, stored at 11 and 33% RH, to simulate low 
humidity  conditions  known  to  affect  gelatin  capsules>  for  use  in  dry  power 
inhalers. The capsules were punctured using a pin from a Fordail® inhaler, with 
insertion force measurements via an instron tester. It was demonstrated that the 
amount of pin movement required to puncture the gelatin shell wall was slightly 
higher than for the hypromellose capsules, and that the HPMC capsules were 
less effected than the gelatin over a range of lower moisture contents.  
 
The  Quali V I  capsules  possess  essential  characteristics  for  their  use  in  dry 
powder  inhalers.  They  have  appropriate  mechanical  strength,  undetectable 
levels  of  bacteria,  the  powder  can  be  emptied  cleanly  from  the  shell  with 
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particles. Hypromellose capsules can be considered as suitable alternatives to 
gelatin  capsules,  with  possibility  for  greater  acceptability  by  manufacturers, 
regulatory authorities and consumers (Missaghi and Fassihi, 2006). 
 
1.8   Dissolution Test Modelling  
 
Drug  dissolution  from  a  dosage  form  plays  an  important  role  in  drug 
development and quality assessment (Podczeck, 1993; Costa et al., 2003). The 
drug release is a function of time involving a series of processes, which can 
exist in a dosage form (Podczeck, 1993).  
The rate of dissolution of a solid drug in liquid can be described by the Noyes 
Whitney equation (Equation 1.1) shown below. 
 
dm/dt = kA (Cs – C) (Equation 1.1) 
where dm/dt represents the rate of dissolution, A is the surface area of the un 
dissolved  drug  in  contact  with  the  solvent,  Cs  is  the  concentration  of  solute 
required  to  saturate  the  solvent  at  the  experimental  temperature,  C  is  the 
concentration  of  solute  in  the  solution  at  time  t  and  k  is  the  dissolution  rate 
constant (Proudfoot, 1999). Dissolution tests should be carried out under sink 
conditions as stated in Chapter 2, Section 2.2.5.2 and 2.2.5.3. i.e. this is when 
equation 1 becomes: dm/dt = kACs. If the volume of the dissolution medium is so 
large that C does not exceed 10% of the value of Cs  sink conditions are also 
maintained (Proudfoot, 1999).  
 
Not only is the maximum dissolution of drug from a dosage form in a certain time 
an important parameter to be determined, but also is the release rate, i.e. the 
amount of drug released per unit time. This is often the rate limiting process for 
drug absorption (Pinto el al., 1997; Podcezk and Jones, 2002).  The mechanism 
of drug release from a dosage form is therefore of great importance in order to 
calculate  the  dissolution  rate  (Podczeck  and  Jones,  2002).  However,  the 
processes mentioned above depend on the type, quantity, and on properties of 
the ingredients and on the unit operations of the manufacturing. As a result, the Chapter One                                                                                        Introduction 
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drug dissolution curves from different dosage forms show very different shapes 
(Loth et al., 2007).  
 
The methods for the comparison of in vitro dissolution profiles can be classified 
into three groups:  
 
i.  Methods based on analysis of variance (ANOVA) (Mauger et al., 1986;  
Polli et al., 1997; Yuksel et al., 2000),  
ii.  Model dependent methods  
iii.  Model independent methods. 
 
Most of the models which have been developed to describe the drug release 
process are based on Fickian diffusion. Fickian (Case I) diffusion is where the 
rate of drug diffusion is much less than that of polymer relaxation and can be 
defined  by  an  initial  t1/2  time  dependence  of  the  fractional  release  for  slabs, 
cylinders, and spheres. Case II diffusion, is the other extreme in which diffusion 
is very rapid compared with the relaxation process and be defined by an initial 
linear time dependence of the fractional release for all geometries. Anomalous 
(Non Fickian) release behaviour is intermediate between Fickian and Case II 
transport, i.e. corresponds to coupled diffusion/polymer relaxation. (Ritger and 
Peppas, 1987a; Ritger and Peppas, 1987b; Crank, 1979) 
 
Earlier work by Higuchi (1963) described the release of drugs from insoluble 
matrix as a square root of time dependent process based on Fickian diffusion. 
Equation 1.2 is the simple version of the Higuchi model which is used by most 
studies.  
 
 
Q = Kt
1/2 (Equation 1.2) 
Where K is the dissolution rate constant of the drug (Higuchi, 1963; Shoaib et 
al., 2006). 
 
Fickian diffusional release from a thin polymer film under perfect sink conditions 
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released.  The  short  time  approximation  is  valid  for  the  first  60%  of  the  total 
released drug (Mt/M∞ ≤ 0.60) (Ritger and Peppas, 1987a, 1987b) 
 
Mt/M∞ = 4 [Dt/πl
2]
1/2   (Equation 1.3) 
Where Mt is defined as the mass of drug released at time t, and M∞ is the mass 
of drug released as time approaches infinity, D is the drug diffusion coefficient , l 
is the thickness of the thin polymer slab. 
 
Kosmeyer et al (1983) introduced an exponential equation (Equation 1.4) to  
describe drug release from a polymeric system 
 
Mt/M∞ = Kt
n    (Equation 1.4) 
Where K is the constant related to the charachteristics of the system and the 
drug and n is the diffusional exponent which is used to characterise the different 
release mechanisms of drug release. 
 
Ritger and Peppas found that Equation 1.4 could be used to analyse data of 
Fickian and non Fickan diffusional release from non swellable polymeric delivery 
systems. It was shown that in the case of pure Fickian release n has the values 
of  0.5,  0.45  and  0.43  for  the  release  from  thin  films  cylinders  and  spheres 
respectively.  non fickian  diffusion  is  defined  by  n  values  between  0.5  which 
increase until the drug transport is said to be of Case II transport, n = 0.89 or 
0.85  for  release  from  cylinders  and  spheres  respctively  (Ritger  and  Peppas, 
1987a,  1987b,  Shoaib  et  al.,  2006;  Sriamornsak  and  Sungthongjeen,  2007). 
Occasionally  values  of  n  >  0.89  or  n  >  0.85  for  release  from  cylinders  and 
spheres have been observed and considered to be super case II kinetics. This 
mechanism could result from increased plasticization at the relaxing boundary 
(gel layer) (Sriamornsak and Sungthongjeen, 2007). 
 
Peppas and Sahlin (1989) produced a modified version of Equation 2 which was 
written  in  terms  of  the  release  mechanism’s  diffusional  and  relaxational 
contributions (Equation 1.5) 
 
Mt/M∞ = K1t
m + K2t
2m  (Equation 1.5) Chapter One                                                                                        Introduction 
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K1  and  K2  are  constants  related  to  the  diffusion  and  relaxation  process 
respectively. M is the fickian diffusion exponent for a controlled release device of 
any shape.  
 
Other release models include the zero order rate (Equation 1.6) which describes 
the systems where the drug release rate is independent of its concentration. The 
first  order  (Equation  1.7)  describes the  release  rate from  systems  where  the 
release rate is concentration dependent (Costa el al., 2003; Shoaib et al., 2006). 
The  Hixson crowell  cube  root  law  which  describes  the  release  from  systems 
where there is a change in the surface area of the particles or tablets (Hixson 
and  Crowell,  1931;  Shoaib  et  al.,  2006;  Raslan  and  Maswadeh,  2006).  The 
Weibull  release model which is a very flexible life time distribution function, and 
the Logistic release model which is an S shaped model (Costa  et al., 2003). 
 
C = Kot (Equation 1.6) 
Where  Ko  is  the  zero  order  rate  constant  expressed  in  units  of 
concentration/time and t is the time.  
 
LnC = LnCo – kt (Equation 1.7) 
Where Co is the initial concentration of the drug and k is the first order constant.  
 
Some of the limitations of analysing the results by fitting them to a curve of one 
of  the  pre established  model  dependent  approaches  discussed  above  is  that 
they are based only on a limited portion of drug release and the rest of the drug 
released  is  ignored  (Pinto  et  al.,  1997).  Therefore,  using  standard  reaction 
kinetics,  equations  rarely  results  in  an  adequate  quantification  of  the  total 
dissolution profile (Podczeck, 1993; Loth et al., 2007). Moreover, burst effects 
could  occur providing a larger amount of drug to the patient than predicted by 
the models. Another marked drawback is when several release profiles of a drug 
need  to  be  compared,  as  it  is  statistically  incorrect  to  compare  two  or  more 
curves based on the analysis of the individual points in a graph (Pinto et al., 
1997).  
The model independent methods are the second main group for comparison of 
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do not rely in the choice of model functions that sometimes may prove artificial 
(Costa et al., 2003). Model independent approaches (pragmatic plane geometry, 
prospective  area,  transit  curves)  (Podczeck,  1993)  encompass  statistical 
moment analysis which have the advantage of providing estimates of in vivo 
dissolution  and  absorption  rates.  Statistical  moments  theory  is  based  on  the 
preliminary  assumption  that  the  movement  of  the  individual  drug  molecules 
through  the  dosage  form  is  goverened  by  laws  of  probability  and  that  drug 
concentration in the dissolution medium at a certain time can be regarded as a 
statistical distribution curve (Pinto et al 1997). 
 
The statistical moments such as the mean dissolution time (MDT), its variance 
(VDT), and the relative dispersion of the concentration time profile (RD), have 
been used by many authors to characterise dissolution profiles (Sousa et al., 
1996; Lundqvist el al., 1998; Pinto el al., 1997; Sousa et al., 2002; Chopra et al., 
2002; Costa et al., 2003; Tunon et al., 2003; Sriamornsak and Sunthongjeen, 
2007). 
 
The  mean  dissolution  time  (MDT)  can  be  described  as  the  arithmetic  mean 
value of any dissolution profile. If the content of the drug substance which is still 
in  the  dosage  form  is  plotted  as  a  function  of  time,  the  mean  value  of  the 
residence profile is the mean residence time (MRT) (Podczeck, 1993). 
 
The  pragmatic  plane  geometry  is  a  simple  method  to  determine  the  MDT 
(Equation 1.8) using trapezoidal rules as suggested by Podczeck (1993). The 
drug release profile is needed and the maximal amount of the drug substance 
that is dissolved (αtmax) are required.  
 
MDT = ABC/ αtmax  (Equation 1.8) 
Where ABC is the area between the drug dissolution curve and the asymptote. 
 
The prospective area method to determine the MDT is based on the cumulative 
dissolution curve and is thought to be more complicated however, is useful for 
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The  variance  of  dissolution  time  (VDT)  has  been  defined  as  the  difference 
between the second common moment and the squared mean (Equation 1.9) 
(Voegele et al., 1988; Sousa et al., 1996) 
 
m2 – MDT
2 = VDT (Equation 1.9) 
 
The relative dispersion coefficient (RDC) (Equation 1.10) is used to describe the 
model which would describe the dissolution curve best.  
 
RDC = VDT/ MDT
2 (Equation 1.10) 
The most common release mechanisms which can be defined using the RDC 
are zero order (RD: 0.333), first order (RD: 1.0), square root (RD: 0.8) and cube 
root (RD: 0.6).  If the data fails to fit any of the models, then the values of MDT, 
VR and RD can be used to describe the curve (Sousa et al., 1996; Pinto et al., 
1997) 
 
1.9   Dynamic Mechanical Analysis 
1.9.1  Rheology – Brief Introduction 
 
Rheology  can  be  defined  as  the  science  of  deformation  and  flow.  It  is  well 
known that the rheological properties of biomaterials directly affect their clinical 
performance.  It  is  therefore  essential  to  accurately  and  usefully  characterise 
their  rheological  properties  to  ensure  optimisation  of  their  design  and 
performance (Barnes, 1993; Jones et al, 1997; Jones, 1999). 
 
There  are  a  number  of  techniques  that  allow  rheological  characterisation  of 
polymeric systems (Craig and Johnson, 1995; Jones, 1999). These include i) 
Thermo mechanical analysis,  where a non oscillatory stress is applied to the 
sample and the resulting deformation is measured as a function of temperature, 
ii) Thermo dilatometry, where the changes in sample dimensions are recorded 
after  having  been  exposed  to  a  range  of  temperatures.  For  this  study,  the 
rheological technique chosen was Dynamic Mechanical Analysis (DMA), which 
is a novel method for determining the mechanical properties of capsule shells. Chapter One                                                                                        Introduction 
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The methods employed were stress strain curves, creep testing and dynamic 
testing. 
 
1.9.2  Applications of Dynamic Mechanical Analysis 
 
Dynamic  Mechanical  Analysis  (DMA)  is  a  versatile  technique,  which  can  be 
used to simultaneously characterise both the rheological and thermal properties 
of a wide range of sample types ranging from soft samples, such as elastomers, 
thin  films  and  single  filament  fibres,  to  hard  samples,  like  composites  and 
ceramics (Perkin Elmer, 1996; Jones D, 1999). DMA measures properties such 
as the Modulus of elasticity and viscosity (tendency to flow) as a function of 
time, temperature, frequency, stress or a combination of these (Perkin Elmer, 
1996). Dynamic mechanical analysis also provides information such as, glass 
transition  temperatures,  rate  and  extent  of  polymeric  curing,  quantification  of 
gelation, e.g. sol – gel transitions, damping properties (the ability of a material to 
dissipate  applied  mechanical  energy  as  heat),  polymer 
morphology/compatibility,  and  interactions  between  polymeric  components,  or 
between  drug  molecules  and  polymeric  constituents  of  pharmaceutical  and 
biomedical systems.   
 
In simple terms, DMA can be described as an analytical technique in which an 
oscillatory force is applied to a sample and the material’s response to that force 
is analyzed (Menard, 1999; Jones, 1999).  
 
1.9.3  Relationship between Stress and Strain 
 
Material properties can be regarded as being between two limiting extremes, i.e. 
the limits of elastic or Hookean behaviour and the limits of viscous or Newtonian 
behaviour  (Menard,  1999).  However  many  polymers  are  viscoelastic  in  their 
behaviour  i.e.  exhibiting  both  elastic  (solid)  and  viscous  (liquid)  properties 
(Jones D, 1999).  Stress (σ) is described as the force per unit area (Pa) required 
to deform a sample. Strain (γ) is the measurement of deformation relative to a 
reference configuration of length, area or volume. The ratio of stress to strain is 
called  the  modulus  (E),  which  is  the  material’s  stiffness  or  its  resistance  to Chapter One                                                                                        Introduction 
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deformation (Menard, 1999; Barnes, 1993). The rheological behaviour of ideal 
solids described by Hooke’s law, states that the strain of a sample is directly 
proportional to the applied stress whereby the modulus of elasticity or Young’s 
modulus is the proportionality constant. (Jones D, 1999). The above description 
is represented in a stress – strain curve shown in Figure 1.11. 
 
 
  
Figure 1. 11: Stress – strain curve (Adapted from Menard, 1999) 
 
 
The calculation of stress (Equation 1.11) and strain (Equation 1.12) is as follows:
      
σ  = F / A (Equation 1.11) 
F = the force applied to the sample 
A = the initial cross sectional area through which the force is applied. 
 
γ γ γ γ =        L /L (Equation 1.12) 
 L = Change in length of the material 
L   = Original length of the material 
 
The proportional limit is the point on a stress – strain curve at which it begins to 
deviate from the straight line relationship between stress and strain. The elastic 
limit is the maximum stress a sample may be subjected to and from which it can Chapter One                                                                                        Introduction 
  86 
still return to its original length upon release of the load. Whenever the elastic 
limit of the solid material is exceeded, irreversible sample deformation occurs 
(Jones D.S, 1999). 
 
Newton proposed that applied stress is proportional to the rate of strain. The 
proportionality constant in this case being viscosity (Jones D, 1999) 
Polymers that have a high modulus are elastic. This applies to both amorphous 
polymers below the glass transition and to crystalline polymers. Those polymers 
with a low modulus are viscous, this occurs in amorphous polymers above the 
glass transition temperature (Lenk, 1978). 
 
 
1.9.4.  Viscoelasticity 
 
The word ‘viscoelastic’ means the simultaneous existence of viscous and elastic 
properties in a material. There are two different methods to determine the linear 
viscoelastic  behaviour  of  materials:  i)  static,  such  as  creep  recovery  and  ii) 
dynamic.  
Static tests involve the imposition of a step change in stress (or strain) and the 
observation  in  the  subsequent  development  in  time  of  the  strain  (or  stress). 
Dynamic tests involve the application of a harmonically varying strain (Barnes et 
al, 1993). 
 
Creep recovery  testing  is  a  very  powerful  analytical  tool,  which  allows  the 
examination of a material’s response to a constant load and its behaviour on 
removal of that load. It allows the study of material behavior under certain stress 
conditions and is used to generate modulus, E, and viscosity, η, values over 
prolonged periods. It involves the application and removal of a set load to a 
sample for a set time and measuring the resultant sample displacement. The 
time  and  stress dependent  behaviour  are  characterized  by  monitoring  the 
change in strain (Menard, 1999).  A typical Creep Recovery curve is shown in 
Figure 1.12. 
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Figure 1. 12: A typical creep recovery curve (Adapted from, Menard, 1999; Marriott, 2002; 
Njintang, etal., 2007) 
 
 
In the creep mode, a static stress is instantaneously applied and held constant 
for a set time. The sample’s response is then measured. In the recovery mode, 
the sample is allowed to recover from a continuous stress that was applied and 
is then removed. The sample’s response can then be measured. 
 
The following variables can be calculated from the creep recovery curve; 
The Compliance, J, which is the reciprocal of the static modulus or the ratio of 
static stress to static strain. Instantaneous Compliance, J0, that is related to the 
elastic character of the material; Retarded Compliance, JR, which is related to 
the  delayed  reaction  of  the  material  when  the  applied  stress  is  released; 
Newtonian Compliance, JN, which is associated with the viscous element of the 
material (Lefebvre and Mahmoudi, 2007; Njintang et al., 2007; Stathopoulos et 
al., 2007;). The equations for three variables are shown below in Table 1.2. 
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Table 1. 2: Important Variables that can be calculated from the Creep Recovery 
Curve (refer to Figure 1.14 for description of region). 
 
Region  Equation  Brief Explanation 
 
A ￿ ￿ ￿ ￿ B 
 
J0 = 1 / E0 
 
Where E0 : Young’s Modulus 
An initial elastic jump is observed  
 
 
 
 
B ￿ ￿ ￿ ￿ C 
 
JR = 1 / ER 
 
Where ER : Retarded Elasticity 
Here the material is attempting to 
flow  as  a  viscous  fluid  but  is 
however  being  retarded  by  its 
solid characteristics 
 
 
 C ￿ ￿ ￿ ￿ D 
 
JN = t / η η η ηN 
 
t: time 
ηN: Newtonian Viscosity 
 
Viscous  flow  will  eventually 
predominate  and  the  curve  will 
become linear. 
 
D ￿ E 
  This  region  represents  the 
recovery  period  and  is  a  mirror 
image of region C ￿ D 
 
Viscoelastic materials can also be evaluated by means of dynamic experiments 
whereby the sample is exposed to an oscillatory force and the transmitted stress 
is  measured  (Marriott,  2002).    In  a  Hookean  solid,  the  maximum  strain  is 
observed  at  the  same  instant  as  the  maximum  applied  stress.  A  Newtonian 
liquid  will  exhibit  a  90
o  phase  lag  to  an  applied  stress  (Figure  1.13)  (Jones, 
1999). 
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Figure 1. 13: Stress and strain waveforms (Adapted from Jones, 1999) 
 
 
The angle, δ, is the measured phase lag between the applied stimulus and the 
response. I.e. it is the phase difference between the dynamic stress and the 
dynamic  strain  in  a  viscoelastic  material  that  is  subjected  to  a  sinusoidal 
oscillation.  Viscoelastic  materials  exhibit  phase  angles  between  0  –  90
o.  A 
perfectly elastic material exhibits a phase angle of 0
o. However, a perfect fluid 
exhibits a phase angle of 90
o. Tan δ (this is the tangent of the phase angle), also 
called  ‘damping’  and  indicates  how  efficiently  the  material  loses  energy  to 
molecular rearrangements and internal friction. Tan δ is given by the ratio of the 
loss modulus (imaginary or viscous) denoted by G˝ to the storage modulus (real 
or elastic) denoted by G’ (tan δ = G˝ / G’). A high tan δ value is indicative of a 
material that has a high non elastic strain component. A low value indicates one 
that is more elastic (Jones, 1999; Menard, 1999; Marriot, 2002; Podczeck and 
Almeida, 2002). 
 
1.9.5  Dynamic Mechanical Analysis in Literature  
 
There is an extensive amount of research using dynamic mechanical analysis as 
a rheological technique. However, this section will concentrate on the application 
of DMA for materials used in the pharmaceutical industry. 
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 A number of studies have looked into pellet properties. For example Podczeck 
and Almeida (2002) studied the elastic and viscoelastic properties of pellets and 
film coated pellets using DMA, and in particular static scans to obtain values for 
the elastic modulus, and dynamic scans to evaluate the viscoelastic properties 
of the pellets and the film coating. The authors choose DMA to determine the 
elastic  and  viscoelastic  properties  of  pellets  because  it  is  a  non destructive 
technique with a high sensitivity. The modulus of elasticity of the pellets was 
obtained from the slope of the stress strain curve. They were able to measure 
from the dynamic scans, the storage modulus and the phase angle as a function 
of the dynamic force. The authors concluded in their study that DMA has the 
potential  to  aid  the  development  of  film  coatings  for  pellets  to  be  used  in 
tabletting to produce controlled release dosage forms. In another study, Lafferty 
et  al.,  (2002)  used  DMA  (creep  testing)  to  characterize  the  mechanical 
properties  of  polymer  films  formed  from  aqueous  polymer  dispersions,  two 
aqueous film coating preparations were studied. The first was Eudragit NE30D 
(polymethylmethacrylate) and the second was Aquacoat ECD30 (ethylcellulose). 
Films were prepared using a casting procedure for both Eudragit and a mixture 
of Eudragit and Aquacoat at a ratio of 60%: 40%. In the region of linear creep, 
the  film  prepared  from  100%  Eudragit  was  far  less  elastic  than  when  60% 
Aquacoat was present. It was also found in the region of linear creep that the 
strain response was doubled when the applied stress was doubled. The non 
linear region showed that the mixed film is more elastic than the film containing 
only  Eudragit.  The  results  indicated  that  it  is  possible  to  measure  the  visco 
elastic  behaviour  of  films,  quantitatively  by  creep  testing  using  dynamic 
mechanical analysis.   
 
Another study by Bashaiwoldu et al., 2004a used conventional methods as well 
as  dynamic  mechanical  analysis  to  determine  the  mechanical  properties  of 
pellets. A range of mechanical properties were obtained when the pellets were 
subjected  to  diametral  compression  testing  and  beds  of  pellets  were  also 
compacted. Such conventional techniques resulted in irreversible damage to the 
structure of the pellets and the authors found that it was impossible to establish 
the viscoelastic properties of the pellets. However, DMA choice allowed for the 
determination of an accurate Young’s Modulus and the presence of a reversible Chapter One                                                                                        Introduction 
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elastic deformation even after the yield point in terms of the storage modulus 
had been exceeded.  The same authors determined the mechanical properties 
of  pellets  coated  with  an  aqueous  dispersion  of  ethyl  cellulose,  using 
conventional  techniques  as  well  as  DMA  (Bashaiwoldu  et  al.,  2004b).  They 
demonstrated the advantages of DMA in determining the reversible or dissipated 
energy by means of the storage modulus or phase angle when compared with 
the irreversible structural destruction of the pellets by conventional techniques. 
 
Mano  and  Reis  (2004)  used  DMA  to  investigate  the  solid state  rheological 
behaviour in starch based thermoplastic materials made to be used in different 
biomedical  applications.  They  monitored  these  in  simulated  physiological 
conditions  and  found  that  the  viscoelastic  properties  of  this  series  of  starch 
based biomaterials could be studied using DMA under in vitro conditions. 
 
1.10  Modulated Differential Scanning Calorimetry (MDSC) 
1.10.1   Brief Introduction in to Thermal Analysis  
 
Thermal analysis, as described by Ford and Timmins (1989) has long been one 
of the vital instrumental techniques available to the pharmaceutical researcher. It 
is  one  of  the  most  widely  used,  yet  very  often misunderstood  methodologies 
called  upon  to  resolve  problems  created  during  the  use  of  other  techniques. 
Thermal  analysis  is  one  of  the  most  commonly  used  techniques  in  the 
preformulation and development of medicines. 
 
Normally  in  thermal  analysis,  a  steadily  rising  temperature  is  imposed  on  a 
system.  Particularly  with  regard  to  (phase  transitions),  however,  it  is 
recommended that a cooling curve is examined. This differentiates a reversible 
process from an irreversible transition. A reversible transition from a solid to a 
liquid will be endothermic in the rising temperature mode and exothermic during 
the cooling cycle (Chen and Dollimore, 1996). 
 
A variety of instrumentation is available for carrying out thermal analysis in its 
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calorimetry  (DSC),  modulated  DSC  (MDSC),  dynamic  mechanical  analysis 
(DMA), hot stage microscopy (HSM), and others.   
` 
1.10.2   Differential Scanning Calorimetry – DSC 
 
The term differential scanning calorimetry was first used by Watson et al., (1964) 
to describe the instrumental technique developed in 1963 by the Perkin Elmer 
Corporation.  The  technique  maintains  the  sample  and  reference  materials 
isothermal  to  each  other  by  the  application  of  electrical  energy  as  they  are 
heated or cooled at a linear rate. The curve obtained is a recording of heat flow, 
dH/dt, in mcal/sec, as a function of temperature (Wendlandt, 1974). 
 
DSC has been a highly successful analytical tool for over 4 decades. Before 
then,  material  scientists  used  the  non quantitative  DTA  technique  to  study 
changes  in  structure  for  a  broad  range  of  materials  such  as  polymers, 
chemicals, food products, composites and drugs (Thomas, 2005a). Differential 
scanning calorimetry is a well established method of thermal analysis within the 
pharmaceutical sciences, and has found a wide range of applications within the 
pharmaceutical field. In particular, the following are frequently undertaken; the 
detection  of  polymorphism,  measurement  of  reaction  and  decomposition 
kinetics,  assessment  of  the  compatibility  of  dosage  from  constituents,  purity 
determination and glass transition temperature studies. This technique may be 
used to characterise physical and chemical changes in either enthalpy or heat 
capacity of a sample (Coleman et al., 1996). The commercial success of DSC is 
owed  to  its  many  good  features  including  i)  is  a  relatively  fast  technique,  ii) 
Sample  preparation  is  easy,  where  the  sample  of  choice  is  encapsulated  in 
metal  pans  and  placed  into  a  temperature  and  atmosphere  controlled 
environment,  iii)  DSC  has  a  wide  temperature  operational  range  of   180  to 
+725
oC,
 iv) Sophisticated software permits quantitative analysis of transitions as 
a function of temperature and time (Thomas, 2005a). 
 
With standard DSC, the difference in heat flow rate between a sample and an 
inert  reference  is  measured,  as  the  sample  is  heated,  cooled  or  held  at  an 
isothermal temperature. The resulting differential heat flow rate signal is plotted Chapter One                                                                                        Introduction 
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as milliwatts (equivalent to mJ/s) versus temperature or time. With conventional 
DSC, the temperature is always changed linearly and the operator must specify 
the rate in degrees per minute (
oC/min). With a single heating rate, a single heat 
flow rate is produced, which is the sum of all heat flows occurring at any point in 
temperature or time (Thomas, 2005a). 
 
Thermal events, which are detectable by traditional or standard DSC, may be: a) 
endothermic, e.g. melting or dehydration, b) exothermic, e.g. crystallisation, or 
may involve c) a change in the heat capacity of a sample, for example glass 
transition phenomena. These events are illustrated in Figure 1.14, for a sample 
of polyethylene terephthalate (PET), for which all three major types of thermal 
events occur (Coleman and Craig, 1996). 
 
 
 
Figure 1. 14:  Traditional DSC curve of PET showing a) glass transition, b) cold crystallisation 
exotherm, and c) melting endotherm. (Source   Thomas, 2005a; Coleman and Craig, 1996.)  
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1.10.2.1   Differential Scanning Calorimetry – Disadvantages 
 
The DSC has some well known restrictions that can complicate the analysis of 
the results and reduce measurement accuracy and precision. Some of these 
limitations are:  
i.  DSC only measures the sum or average value of the heat flow rate from 
overlapping processes which makes quantitative analysis of the individual 
process impossible.  
ii.  Interpretation of the results can be difficult in some cases, because most 
commercial  materials  are  made  from  blends  of  different  components, 
hence  may  have  different  transitions  at  ranging  temperatures.  These 
transitions often overlap, and experience is required to create methods to 
interpret the results.  
iii.  The only way to improve sensitivity for detecting low energy transitions is 
to increase the sample size or the heating rate or both. However, this will 
decrease the resolution. 
iv.  Flat,  straight  baselines  are  required  for  detection  of  small  transitions, 
especially glass transitions. However, the absolute value of the DSC heat 
flow  signal  is  affected  by  instability  in  the  instrument  electronics  and 
cooling systems, and is also affected by environmental changes such as 
temperature and humidity (Thomas, 2005a).  
 
1.10.3   Modulated Differential Scanning Calorimetry   MDSC   
 
The MDSC technique was commercialised by TA Instruments in 1992 (Thomas, 
2001). It applies simultaneous two different heating rates, linear and modulated. 
The  linear  or  average  heating  rate  provides  the  same  information  (total  heat 
flow)  as  the  standard  DSC  (Thomas,  2005b).  The  basic  principle  is  to 
superimpose  upon  the  constant  linear  heating  rate  of  conventional  DSC  a 
periodically  varying  modulation,  (in  practice  sinusoidally)  in  order  to 
automatically separate the heat capacity baseline from the total heat flow signal. 
This  means  that  it  is  possible  to  identify,  measure,  and  quantify  kinetic 
processes such as crystallisation and crystal perfection in a single experiment 
(Hutchinson and Montserrat, 1996; Reading, 1997; Thomas, 2001). The signal Chapter One                                                                                        Introduction 
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from the instrument is separated into two components shown in Figure 1.15:  i) a 
thermally “reversing” heat flow that is a function of temperature and heating rate, 
and ii) a “non reversing” heat flow that is a function of temperature and time.  
Reversing  heat  flow  is  most  readily  identified  with  the  heat  capacity  of  the 
sample. It provides information on a) glass transition temperature Tg which can 
simply be defined as the temperature at which the material undergoes transition 
from a glassy state to a rubbery state, and b) melting. However, non reversing 
heat  flow  includes  contributions  from  irreversible  processes  such  as 
crystallisation, chemical reactions and loss of volatile components (Price, 1998; 
Thomas, 2005a). 
Figure 1. 15:  MDSC curve showing the total (green), reversing (blue), and non reversing (red) 
heat flow signals (Source Thomas, 2005a).  
 
1.10.4   Calculation of MDSC Signals 
 
In order to perform an MDSC experiment, the operator must specify both the 
average and modulated rates of temperature change. This is done by selecting: 
i) a heating rate that is typically in the range of 1 to 5
oC/min compared with the 
10 to 20
oC/min employed in conventional DSC. This heating rate gives rise to 
the total heat flow signal. The average heating rate must be slow enough to 
provide a sufficient number of modulation cycles over transitions of interest. A Chapter One                                                                                        Introduction 
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minimum of 4 modulation cycles at half height of the melting peak should be 
obtained  (Thomas,  2005c).  ii)  a  temperature  modulation  period  (which  is  the 
time, in seconds, to complete one cycle) typically between 30 and 100 seconds, 
to  allow  sufficient  time  for  heat  flow  to  and  from  the  sample  during  the 
temperature cycles. iii) a temperature modulation amplitude, which is typically in 
the  range  of  ±  0.1  to  ±  2.0
oC.  The  temperature  modulation  amplitude  is  the 
sinusoidal  temperature  change  superimposed  on  the  average  temperature 
change.  With  standard  DSC,  large  modulation  amplitudes  produce  large 
instantaneous  heating  rates  and  hence  give  rise  to  increased  heat  flow 
sensitivity. Since the underlying heating rate of an MDSC experiment is equal to 
the  heating  rate  of  conventional  DSC,  low  underlying  heating  rates  are 
associated  with  increased  resolution.  The  combination  of  large  modulation 
amplitude  and  low  underlying  heating  rates  allows  an  increase  in  sensitivity 
without  the  need  to  sacrifice  resolution  (Coleman  and  Craig,  1996;  Thomas, 
2005b; Thomas, 2005c). 
 
Measurement of the glass transition temperature is probably one of the most 
common measurements made with DSC and MDSC techniques. Selection of 
experimental conditions can significantly affect measurement sensitivity. It may 
be said that sensitivity increases with use of slower heating rates, and larger 
modulation amplitudes and periods (Thomas, 2005c; Thomas 2005e). The glass 
transition is usually detected as a step transition (see Figure 1.16) 
 
Figure 1. 16:  Representation of a glass transition 
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1.10.5 Advantages of MDSC over DSC 
 
Modulated DSC has significant advantages over conventional DSC. It provides 
all the benefits of DSC but has none, or fewer of its limitations. MDSC has the 
following  advantages,  i)  separation  of  overlapping  transitions,  ii)  the  high 
instantaneous heating rate supplied by the sine wave modulation resulting in 
superior  sensitivity.  This  improved  sensitivity  permits  the  detection  of  weak 
transitions,  which  are  not  detectable  by  conventional  DSC,  iii)  improved 
sensitivity and resolution in a single experiment, iv) more accurate measurement 
of  polymer  initial  crystallinity,  v)  detection  and  measurement  of  the  glass 
transition temperature using conventional DSC often requires pre conditioning of 
the sample to reduce the accompanying volume relaxation endotherm.  
This is not required with the MDSC since it separates the glass transition  and 
the relaxation endotherm, which is very important especially when investigating 
thermoset  polymer  systems  because  heating  above  the  glass  transition  may 
advance the cure and affect the results; vi) direct measurement of heat capacity. 
The measurement of heat capacity by conventional DSC requires three scans 
and a certain amount of operator expertise to produce accurate results, whereas 
the  MDSC  requires  only  a  single  sample  run  (Coleman  and  Craig,  1996; 
Thomas, 2005a). 
 
1. 11 Analysis of Variance (ANOVA) 
 
Analysis of variance (ANOVA) is a statistical method used to determine whether 
differences in mean values exist between two or more groups.  
 
The “null hypothesis”, H0, states that all samples tested represent one and the 
same population. The “alternative hypothesis”, H1, assumes that at least one or 
all samples are from different populations. The ANOVA results typically include 
degrees  of  freedom,  F values  and  the  P values.  ANOVA  allows  the 
experimenter  to  test  the  null  hypothesis.  It  does  this  by  comparing  three 
estimates  of  the  variance,  i)  the  total  variance,  which  is  the  estimate  of  the 
variance of the population on the basis of all available data without consideration Chapter One                                                                                        Introduction 
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of  the  split  into  different  samples,  ii)  variance  within  samples,  which  is  an 
estimate  of  the  variance  of  the  population  on  the  bases  of  deviations  of  all 
individual data of one sample from the related sample mean, and iii) variance 
between samples, which is the estimate of the variance of the population on the 
basis of the sample mean values. The ratio of the between and within group 
variances provide the F value, with which the null hypothesis can be evaluated. 
The larger variance is always divided by the smaller variance and consequently 
the F distribution consists only of values ≥ 1.  To decide whether to reject the 
null hypothesis and accept the alternative hypothesis, the calculated F value is 
compared with a table of critical F values using the degrees of freedom for both 
the numerator and denominator (Podczeck, 2007). 
 
The probability value P indicates the level of statistically significant difference 
among the means. This is based on a standard that no more than 5% (0.05) of 
the difference is due to chance or sampling error. The smaller the P value, the 
stronger the evidence is to reject the null hypothesis.  
 
The F value gives a reliable test for the null hypothesis, but it cannot indicate 
which  of  the  means  is  responsible  for  a  significantly  low  probability.  To 
investigate  the  cause  of  rejection  of  the  null  hypothesis  post hoc  or  multiple 
comparison tests can be used. The Scheffé test is used. This test examines or 
compares more than one pair of means simultaneously and it determines which 
variable among several independent variables is statistically the most different. 
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1.12  Critical Summary, Aims and Objectives  
 
An extensive literature review was undertaken to assess the knowledge relating 
to the properties of HPMCcarr (Hydroxypropyl methyl cellulose) hard capsules. 
Hard capsules manufactured from HPMC with carrageenan as a gelling agent 
(Quali V  capsules)  have  demonstrated  rapid  and  comparable  in vivo 
disintigration times to gelatin and overcome some of the disadvantages gelatin 
present.  However,  few  studies  have  investigated  the  physico chemical 
properties  of  hypromellose  capsule.  The  investigations  carried  out  in  this 
research will support work which has previously been reported concerning the 
properties  of  Quali V  capsules,  and  provide  new  information  in  terms  of 
viscoelasticity  (using  the  DMA  which  is  a  novel  method),  interactions  with 
various ions present in different dissolution mediums, drug dissolution behaviour 
when  stored  for  short  and  prolonged  periods,  and  the  mechanisms  of  drug 
release.  
 
This information is not only vital for the development of the new capsules on an 
industrial scale, but also for their efficacy, safety and acceptability to patients 
worldwide.  
 
 
Aims  
 
To determine the physical and mechanical properties of gelatin and a new type 
of  hypromellose  hard  capsule  and  to  investigate  the  influence  of  dissolution 
media  composition,  ionic  strength,  pH  and  storage  conditions  on  the  shell 
dissolution time of the capsules (both filled and empty). 
 
Objectives 
 
a)  To  characterise  the  physical  and  mechanical  properties  of  the  hard 
capsules  using  (i)  moisture  uptake  and  loss  studies  to  investigate  the 
influence  of  changes  in  relative  humidity  and  moisture  content  on  the 
physical  characteristics  of  the  capsules,  (ii)  modulated  differential 
scanning  calorimetry  to  study  the  thermal  behaviour  (in  particular  Tg Chapter One                                                                                        Introduction 
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temperature)  of  the  capsules,  (iii)  dynamic  mechanical  analysis  to 
investigate  the  rheological  properties  of  the  capsules  (elasticity, 
viscoelasticity). 
 
b)  To undertake capsule shell dissolution studies to investigate the influence 
of  storage  RH,  time,  dissolution  media  composition,  pH  and    ionic 
strength on the shell dissolution properties of HPMC (of different batches 
and sizes), gelatin and gelatin/PEG capsules. 
 
c)  To perform drug dissolution studies (using theophylline as a model drug), 
to  investigate  the  influence  of  storage  time,  dissolution  media 
composition, and ionic strength on the in vitro drug dissolution from the 
capsules,  and  to  determine  the  mechanisms  of  dug  release  from  the 
capsules.  
 
 
•  it is important to determine the moisture uptake and loss of the capsules 
because it has been shown that physical characteristics of gelatin hard 
capsules are affected by moisture changes. These could also aid with the 
explanation  of  the  effect  of  storage  conditions  on  the  shell  dissolution 
properties of the different capsules. Rheological studies were undertaken 
to  investigate  and  compare  the  different  viscoelastic  properties  of  the 
capsules. This is important during manufacture, handling and transport. 
And could also provide information on the dissolution behaviour of the 
capsules. For example, the more elastic the capsules are the longer it will 
take for them to rupture, and the harder and more brittle, the faster they 
will  rupture.  Glass  transition  temperatures  were  determined  to 
characterise  physical  properties  of  capsule  shells.  The  glass  transition 
temperature  of  a  material  is  also  an  important  characteristic  for  drug 
delivery, since changes in Tg reflect the materials molecular structure, 
which can influence chemical stability, physical stability, and viscoelastic 
properties. Below the Tg temperature, the material is in the glassy state, 
and  the  mobility  of  the  polymer  chains  is  very  low,  resulting  in  small Chapter One                                                                                        Introduction 
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diffusion  rates.  Hence  the  material  will  have    little  elasticity  and  shell 
dissolution will be small.  
 
•  Capsule shell dissolution was undertaken prior to drug dissolution studies 
to remove the influence of the fill material, since, the determination of the 
endpoint of capsule disintegration as described in the BP is problematic 
because of the shell’s adhesive nature, which can lead to agglomeration 
of shell pieces forming a larger mass. Thus it is not possible to separate 
the  disintegration  time  of  the  powder  plug  and  the  capsule  shell 
separately.  
. Chapter Two                                                                Materials and Methods 
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2  Materials and Methods 
2.1   Materials  
2.1.1  Capsule Shell Type and Composition   
 
A number of different Quali V® capsules were obtained from Qualicaps 
(QUALICAPS EUROPE S.A. Alcobendas, Madrid). The capsule shells obtained 
including their size and composition are listed in Table 2.1.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                                                        
 
9
8
1
0
 
 
 
1
0
4
 
Table 2. 1: Capsule shells tested 
1
Capsule shell type  Colour/ date of manufacture  Size  Capsule Composition 
(Cap/Body) 
Gelatin  White Opaque (2002)  0  Gelatin (83.5% /83.5%) 
Titanium dioxide (2% /2%),  
Water (14.5% /14.5%) 
Gelatin/PEG  White Opaque (2002)  0  Gelatin (78.5% /78.5%) 
Titanium dioxide (2% /2%), 
PEG (5% /5%)  
Water (14.5% /14.5%) 
Old HPMC  
(hydroxypropyl methylcellulose) 
White Opaque (2002) 
 
0  Carrageenan (0.32% /0.31%),  
Potassium chloride (0.43% /0.45%), 
Titanium dioxide (6% /6%),  
Hypromellose (88.25% /88.24%),  
Water (5% /5%) 
New HPMC 
B.N. E0404671 
Green Opaque cap/ White Opaque body (2005).  0  Carrageenan (0.33% /0.31%),  
Potassium chloride (0.44% /0.44%), 
Titanium dioxide (5.44% /6%),  
Hypromellose (88.25% /88.24%),  
Water (5% /5%) 
Yellow Iron Oxide (0.55%) 
FDC Blue 2 (0.25%) 
HPMC B.N. E0504193  Quali V Pharma 
White Opaque (2005) 
0  Titanium dioxide (6% /6%),  
Potassium chloride (0.43% /0.45%), 
Titanium dioxide (6% /6%),  
Hypromellose (88.25% /88.24%),  
Water (5% /5%) 
HPMC B.N  E0403692  Quali V Pharma 
White Opaque (2004) 
00  Titanium dioxide (6% /6%),  
Potassium chloride (0.43% /0.45%), 
Titanium dioxide (6% /6%),  
Hypromellose (88.25% /88.24%),  
Water (5% /5%) 
 
HPMC B.N  E0403095  Quali V Pharma 
White Opaque (2004) 
1  Carrageenan (0.32% /0.31%),  
Potassium chloride (0.43% /0.45%), 
Titanium dioxide (6% /6%),  
Hypromellose (88.25% /88.24%),  
Water (5% /5%) 
HPMC B.N. E0404494  Quali V Pharma 
White Opaque (2004) 
4  Carrageenan (0.33% /0.31%),  
Potassium chloride (0.46% /0.44%) 
Titanium dioxide (6% /6%), 
Hypromellose (88.22% /88.25%),  
Water (5% /5%) Chapter Two                                                                            Materials and Methods                                                          
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2.1.1.1.  Carrageenan. 
 
Carrageenans are members of the class Rhodophycea (red seaweed), which are 
linear  high  molecular  weight  sulphated  polysaccharides  that  consist  mainly  of 
potassium,  sodium,  calcium,  magnesium  and  ammonium  sulphate  esters  of 
galactose and 3,6 – anhydrogalagtose copolymers with alternating units at α – 1,3 
and β – 1,4 (Campo et al., 2009; Singh, 2006; Cole et al., 2004;  Makino et al., 
2001; Ridout et al., 1996). 
 
Carrageenan  can  be  used  in  a  diversity  of  dosage  forms  such  as  creams, 
emulsions, lotions, eye drops, suppositories, tablets and capsules (Singh, 2006). 
Carrageenan is the gel forming agent for the hypromellose capsules used in this 
research study. 
 
Carrageenans  are  obtained  from  different  species  of  Rhodophyta:  Gigartina, 
Chondrus  Crispus,  Eucheuma  and  Hypnea  (Campo  et  al.,  2009)  and  can  be 
devided into three commercially most important types depending on the position of 
the sulphate groups and on whether anyhdrogalactose is present. These include λ 
(lambda) Carrageenan (nongelling polymer), ι (iota) Carrageenan (gelling polymer) 
and  κ  (kappa) carrageenan  (strong  gelling  polymer).  The  λ Carrageenan  is 
characterized only as a thickening agent (Singh, 2006; Ridout et al., 1996; Campo 
et al., 2009).  The ι Carrageenan and the κ Carrageenan contain 32% and 25% of 
the ester sulphate by weight respectively and contain 30% and 35% of the 3,6 
anhydrogalactose. However the λ carrageenan contains no 3,6 anhydrogalactose 
and 35% of ester sulphate. In terms of gelation and solubility in water, the K
+ ions of 
the k carrageenan are required for gelation to occur (Singh, 2006; Kara et al., 2006; 
Campo  et  al.,  2009)  and  the  Ca
2+  ions  of  the  I carrageenan  are  necessary  for 
gelation to occur. At 20
oC, only the sodium salts of the K  and I carrageenan are 
soluble in water (Singh, 2006). Other forms include Mu (l) , Nu (m)  and Theta (h)  
carrageenan. Macroscopic properties of the Carrageenan gels are affected by the Chapter Two                                                                            Materials and Methods                                                          
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concentration  and  species  of  cations  in  solution  (Mangione  et  al.,  2003;  Singh, 
2006). 
 
2.1.1.2.  Potassium Chloride  
 
Potassium  chloride  (KCl)  occurs  as  odorless,  colourless  crystals  or  a  white 
crystalline powder with an unpleasant saline taste. It can be used as a therapeutic 
agent or a tonicity agent (Owen, 2006), and for HPMC capsule shells, KCl is used 
as a gelling promoter (Tuleu et al., 2007; Jones, 2004e, Shionogi Qualicaps, 2002; 
Ogura et al 1998) 
 
2.1.1.3.  Titanium Dioxide  
 
Titanium dioxide (TIO2) is a naturally occurring oxide of titanium and occurs as the 
accessory minerals rutile, anatase and brookite (Gorsy et al., 2001). The anatase 
form is the one used in food and pharmaceuticals (Jones, 2004e).  TIO2 is most 
extensively used as a white pigment (opacifying agent) in film coated tablets, sugar 
coated tablets and capsules. The number code for food additives is  E171 and its 
colour index number is 77891 (Phillips, 1997; Jones, 2004e).  
 
2.1.2   Capsule Filling Materials 
 
2.1.2.1   Theophylline Anhydrous 
 
Theophylline  anhydrous  C7H8N4O2  (1,3–Dimethylxanthine,  MW  180.2  g/mol) 
(Figure. 2.1) is a white crystalline powder (mp 270–274°C), which is slightly soluble 
in water (1 in 120), ethanol (1 in 80) and chloroform (1 in 110) and dissolves in 
solutions of alkali hydroxides, in ammonia and in mineral acids  (Clarke, 2004). 
Theophylline is a non selective phosphodiesterase inhibitor used for the treatment 
of reversible airways obstruction. The pKa is 8.6 at 25
oC Chapter Two                                                                            Materials and Methods                                                          
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Figure 2. 1: Chemical structure of theophylline (BP, 2008a) 
 
 
Moisture  content:  0.15%  ±  0.1%  (determined  using  a  HG53  halogen  moisture 
analyser, Mettler Toldeo, Switzerland). In this work, the theophylline was supplied 
by: BASF AG, Ludwigshafen, Germany with batch number 128521AX10. 
 
2.1.2.2.   Caffeine Anhydrous 
 
Caffeine anhydrous, C8H10N4O2 (1,3,5 Trimethylxanthine, MW 194.2 g/mol) (Figure 
2.2)  is  a  white  crystalline  powder  (mp  238°C)  or  silky,  white  crystals,  sublimes 
readily at 178°C, soluble in water (1 in 46), freely soluble in boiling water (1 in 1.5), 
soluble in ethanol (1 in 66) and acetone (1 in 50), and freely soluble in chloroform 
(1 in 5.5). It dissolves in concentrated solutions of alkali benzoates or salicylates 
(Clarke, 2004). Caffeine anhydrous is a central nervous stimulant. The pKa is 14.0 
at 25°C and 10.4 at 40°C. 
 
Figure 2. 2: Chemical structure of caffeine anhydrous (BP, 2008a). 
 
In this work, the caffeine used was supplied by: SIGMA Chemical Co. USA., with 
batch number 79F0469. Chapter Two                                                                            Materials and Methods                                                          
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2.1.2.3   Magnesium Stearate 
 
Magnesium stearate (C36H70MgO4), MW 591.34 g/mol, is a very fine, light powder, 
practically  insoluble  in  water  and  in  ethanol  (BP,  2009).  Its  chemical  name  is 
octadecanoic  acid  magnesium  salt.  Magnesium  stearate  is  widely  used  in 
cosmetics,  foods,  and  pharmaceutical  formulations.  It  is  primarily  used  as  a 
lubricant in  capsule filling formulations and tablet manufacture at concentrations 
between 0.25 5.0% w/w (Allen and Luner, 2006). 
 
The structural formula is [CH3(CH2)16COO]2Mg. 
 
In  this  work,  magnesium  stearate  was  supplied  by:  BDH  Chemicals  Ltd,  Poole, 
England. Batch number: 4335770J. Chapter Two                                                                            Materials and Methods                                                          
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2.1.3   List of Chemicals Used For Buffer Preparation 
 
•  Anhydrous  potassium  dihydrogen  orthophosphate,  KH2PO4,  MW  136.09 
g/mol  (BDH  ANALAR,  VWR  international  Ltd.  England.  BN:  A651725). 
Anhydrous  potassium  dihydrogen  orthophosphate  is  a  white  crystalline 
powder or colourless crystals, freely soluble in water, practically insoluble in 
alcohol (BP, 2008g). 
 
•  Anhydrous  di potassium  hydrogen  orthophosphate,  K2HPO4,  MW  178.18 
g/mol  (Merck  KGaA,  Germany.  BN:  A853701).  Anhydrous  di potassium 
hydrogen  orthophosphate  is  a  white  powder  or  colourless  crystals,  very 
hygroscopic,  very  soluble  in  water,  very  slightly  soluble  in  alcohol  (BP, 
2008f). 
 
•  Sodium dihydrogen orthophosphate dihydrate, NaH2PO4. 2H2O, MW 156.01 
g/mol  (Analytical  reagent,  Fisher  Scientific,  UK  Limited.  BN:  0767241). 
Sodium dihydrogen orthophosphate characteristics are colourless crystals or 
a white powder. Is very soluble in water and very slightly soluble in ethanol 
(96%) (BP, 2008g). 
 
•  Anhydrous disodium hydrogen orthophosphate, Na2HPO4, MW 141.96 g/mol. 
(Fisher Scientific, UK limited. BN: 0876220). Anhydrous disodium hydrogen 
orthophosphate is a white powder which is hygroscopic, soluble in water, 
practically insoluble in alcohol (BP, 2008f). 
 
•  Sodium  acetate,  NaCH3COO,  MW  82.03  g/mol  (anhydrous)  (laboratory 
reagent grade. Fisher Scientific, UK Limited. BN: 0757453). Sodium acetate 
occurs  as  colourless,  transparent  crystals  or  granular  crystalline  powders 
with a slight acetic acid odour. It is soluble 1 in 0.8 in water and reacts with 
both acidic and basic components (Chambliss, 2006).  
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•  Ammonium acetate, CH3COONH4, MW 77.0825 g/mol (Analytical Reagent 
Grade, Fisher Scientific, UK Limited. BN: 0765176).  
 
•  Anhydrous  disodium  tetraborate  also  called  Borax,  Na2B4O7,  MW  201.21 
g/mol  (Laboratory  Reagent  Grade,  Fisher  Scientific,  UK  Limited.  BN: 
0741318).  Disodium  tetraborate  is  a  white  crystalline  powder,  colourless 
crystals or crystalline masses, efflorescent, soluble in water, very soluble in 
boiling water, freely soluble in glycerol (BP, 2008f). 
 
•  Boric acid, B(OH)3, MW 61.833 g/mol (Aldrich Chemicals Co. Ltd. Gillingham, 
Dorset,  England.  BN:  53382).  Boric  acid  is  a  white  crystalline  powder, 
colourless, shiny plates, greasy to the touch, or white crystals, soluble in 
water and in alcohol, freely soluble in boiling water and in glycerol (85%) 
(BP, 2008f). 
 
•  Citric acid, C6H8O7, MW 192.123 g/mol (anhydrous) (Fisher Scientific, UK 
limited, BN: 0755285). Citric acid is a white crystalline powder, colourless 
crystals  or  granules,  very  soluble  in  water,  freely  soluble  in  alcohol  (BP, 
2008f). 
 
•  Glacial acetic acid, CH3COOH, MW 60.05 g/mol (Analytical Reagent Grade, 
Fisher Scientific, UK Limited, BN: 0762543). Glacial acetic acid is a clear 
colourless liquid which is miscible with water, with ethanol (96%) and with 
glycerol (BP, 2008f). 
 
•  Hydrochloric acid, HCl, MW 36.46 g/mol (Riedel de Haen. SIGMA – Aldrich, 
LaborChemiKallen  GmbH,  BN:  80460).  Hydrochloric  acid  is  clear  and 
colourless (BP, 2008f). 
 
•  Potassium  chloride,  KCl  (See  Section  2.1.1.2)  MW  74.551  g/mol  (BDH 
laboratory  reagents,  BHH  Chemicals  Ltd,  Poole,  England,  BN:  6676570). Chapter Two                                                                            Materials and Methods                                                          
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Potassium  Chloride  is  a  white  or  almost  white,  crystalline  powder  or 
colourless crystals, freely soluble in water, practically insoluble in anhydrous 
ethanol (BP, 2008g). 
 
•  Sodium  chloride,  NaCl,  MW  58.44  g/mol  (Laboratory  Reagents,  Fisher 
Scientific,  UK  Limited,  BN:  0436075).  Sodium  chloride  occurs  as  a  white 
crystalline powder or colourless crystals or white pearls and has a saline 
taste. Is soluble 1 in 2.8 in water at 20
oC, slightly soluble in ethanol and in 
ethanol (95%) is soluble (1 in 250) (Cable, 2006; BP, 2008g). 
 
•  Sodium Hydroxide, NaOH, MW 39.997 g/mol. (BDH Laboratory Reagents, 
BHH Chemicals Ltd, Poole, England, BN: B857248 621). NaOH is a white, 
crystalline mass, supplied as pellets, sticks or slabs, deliquescent, readily 
absorbing carbon dioxide. Is very soluble in water, freely soluble in alcohol 
(BP, 2008g). 
 
 
2.2  List of Equipment  
 
•  Dynamic Mechanical Analyzer, DMA7, connected to Perkin Elmer Thermal 
Analysis Controller, TAC7/DX and to Perkin Elmer Intracooler 1 (Perkin 
Elmer Corp., High Wycombe, UK). 
•  Desiccator vessels containing appropriate saturated salt solutions Mg(NO3)2 
. 6H2O and CaCl2 . 6H2O 
•  Modulated Differential scanning calorimeter (TA Instruments – Waters LCC, 
Delaware USA, Q1000). 
•  Metller Toledo weighing balance, AT460, Delta Range (Switzerland)  
•  Hitachi S 3000N Scanning Electron Microscope (Hitachi High Technologies 
Corporation, Tokyo, Japan) 
•  Electrical  Oven  (LTE,  Laboratory  thermal  equipment  Ltd.  Greenfield.  NR 
Oldham). Chapter Two                                                                            Materials and Methods                                                          
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•  Steel  ball  bearings,  size  2.36  –  6.32  mm  (Skefko  ball  bearings,  Co.  Ltd. 
Luton). 
•  Heidolph Laboratory Stirrer, type RZR 2021 (Germany). 
•  Ultrasonic bath (Model FRM 100, Hilsonic, Brombourough, UK). 
•  UV  spectrophotometer  (M501  Single  Beam  Scanning  UV/Visible 
Spectrophotometer, Camspec, Spectrosonic analytical instruments, Garforth, 
Leeds, England) 
•  Aquatron  water  bath  shaker  (HT,  INFORS  AG,  CH  –  4103,  Bottmingen, 
Switzerland) 
•  Malvern MasterSizer – Particle size analyzer (Malvern Instruments SB.0B, 
Spring Lane South, UK). 
•  AxioVision image analyser (AxioVision Release 4.3, Carl Zeiss, Germany). 
Attached to a microscope (Olympus BH 2, Tokyo, Japan, serial No. 229682) 
and a camera (Axiocam MCR, Carl Zeis to a microscope (Olympus BH 2, 
Tokyo, Japan, serial No. 229682). 
•  Analytical balance (Precisa 125A, Switzerland) 
•  Powder plug rig tester with a transfer plunger (Provided by B.E. Jones and 
manufactured by the Technical Services Department, Eli Lilly & Co. Ltd, UK). 
•  CALEVA 8ST Dissolution tester (G.B.CALEVA Ltd, Dorset, England) 
•  Degasser unit (Copley, Nottingham, UK, S/N 600851) 
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2.3   Methods 
2.3.1  Moisture Uptake and Loss for Hard Capsule Shells 
 
2.3.1.1  Moisture Uptake 
Five  size  zero  capsules  from  each  of  old  HPMC,  new  HPMC,  gelatin,  and 
gelatin/PEG  capsules  were  weighed  (Precisa125  A,  Precisa  balances  ltd. 
Switzerland) and placed into individual airtight containers (one container for each 
type of capsule shells). Initially the containers were weighed while empty with their 
screw caps closed, and then reweighed after placing the capsules into them. The 
capsules were transferred into desiccator vessels containing appropriate saturated 
salt solutions (Mg(NO3)2 . 6H2O and CaCl2 . 6H2O) at 22
oC ± 0.5 to give humidity 
values of 35% and 53%, respectively, and the screw caps were removed to allow 
contact of capsules with atmosphere. After 24 hours, the capsules were removed 
from  the  desiccators,  and  the  screw  caps  were  replaced  immediately  onto  the 
containers to prevent moisture loss. The containers were then reweighed (with and 
without the capsules) and the % moisture uptake calculated as follows: 
 
%  moisture  uptake  =  [(wt  of  capsules  after  storage  –  wt  of  capsules  before 
storage)/wt of capsules before storage)] x 100.  
 
 
2.3.1.2   Moisture Loss 
 
The  empty  containers  were  placed  in  a  heated  oven  (LTE,  Laboratory  thermal 
equipment Ltd. Greenfield. NR Oldham) with the screw cap removed at 100
oC for 
30 minutes in order to remove all moisture, then the containers were removed with 
their screw caps closed and placed in a desiccator containing silica gel and left for 
30  minutes  to  allow  the  containers  to  return  to  room  temperature.  The  empty 
containers were then weighed with their screw caps, and the weight recorded. 1 g 
of capsules was dispensed (after storage at 35% and 53% RH for both 24 hours 
and 3 days at 22
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the container handling carefully with gloves. The container was placed into a pre 
heated oven at 105
oC with the lid removed. After 2 hours the container containing 
the  capsules  was  removed  from  the  oven  and  transferred  to  the  dessicator 
containing  the  silica  gel  for  30  minutes  to  allow  to  return  to  room  temperature 
(Qualicaps Europe SA, 2006). The container with the dry capsules was weighed 
and the %LOD was calculated as follows: 
 
%LOD = ((wt of empty container + wt of capsules) – (wt of container and dry capsules) / wt 
of capsules)) x 100. 
 
Both tests were repeated three times and the mean and standard deviation of the 
results calculated. 
 
 
2.3.2    Modulated Differential Scanning Calorimetry (MDSC) 
 
A  modulated  differential  scanning  calorimeter  (TA  Instruments  –  Waters  LCC, 
Delaware  USA,  Q1000)  was  used  to  determine  the  physical  properties  of  the 
different  capsule  shells.  Tests  were  performed  on  the  old  HPMC,  new  HPMC, 
gelatin, and gelatin/PEG capsule shells. The capsules were stored in desiccators 
containing appropriate salt solutions under two different relative humidity conditions 
(53%RH and 35%RH) at 22
oC for 24 hr and 3 days.  
 
Before carrying out the above MDSC experiments, cell conditioning was required. 
This was necessary to eradicate moisture from the cell. The empty cell was heated 
to a temperature of 75
oC, and held isothermal for 120 minutes. After completing the 
conditioning step, it was necessary to calibrate the equipment.  The calibrations for 
the MDSC in DSC Q1000 included the Tzero (improved baseline over the DSC). 
Both  (i)  cell  resistance  and  capacitance  and  (ii)  cell  constant  and  temperature 
calibration  were  carried  out  using  the  calibration  wizard  in  the  software  (TA 
Instruments Universal Analysis 2000 for windows 2000/XP, version 4.4A, Waters Chapter Two                                                                            Materials and Methods                                                          
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LLC).    The  cell  resistance  and  capacitance  involved  two  tests;  an  empty  cell 
dataset (baseline) carried out without the sample pans, and the determination of the 
sensor resistances and the capacitances between the sample sensor and furnace 
using two equal mass sapphire disks on both the sample and reference positions. 
Both  these  tests  used  a  cell  preheat  followed  by  equilibrium  at  an  initial 
temperature, holding isothermal for five minutes, and heating at a constant rate to a 
final temperature and holding isothermal for 5 minutes. The cell constant calibration 
was based on a run in which a standard metal (indium) was heated through its 
melting transition. The calculated heat of fusion was compared to the theoretical 
value, and the cell constant was the ratio between these two values. Temperature 
calibration was based on a run in which the temperature standard (indium) was 
heated  through  its  melting  transition.  The  extrapolated  onset  of  the  recorded 
melting point of this standard was compared to the known melting point, and the 
difference calculated for temperature calibration. 
 
The gelatin and gelatin/PEG capsule shells were cut into small pieces and 1.7 ± 0.2 
mg samples were individually crimped into hermetically sealed aluminum pans (TA 
instruments, Delware, USA). The HPMC capsules were cut into small pieces, and 
3.3 ± 0.2 mg samples individually crimped into non hermetically sealed aluminum 
pans (TA instruments, Delaware, USA).  
 
The amount of sample in each case was sufficient to completely cover the base of 
the  pan  to  ensure  uniformity,  reduce  thermal  gradients  and  avoid  dead  volume 
inside  the  pans.  The  reason  for  using  non hermetically  sealed  pans  for  HPMC 
arose after finding that the glass transition temperature (Tg) for the HPMC capsule 
shells was not always detected using hermetically sealed pans, but was very much 
pronounced when using the non hermetic pans (See Appendix 1, Section 1.3). For 
gelatin  and  gelatin/PEG  shells,  the  glass  transition  was  detected  using  the 
hermetically sealed pans. The quality of crimping after sealing was observed before 
starting the experiments to ensure that there was no obvious breakage. The sample Chapter Two                                                                            Materials and Methods                                                          
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pans (pan + lid) were weighed carefully to 0.1mg (Metller Toledo, AT460, Delta 
Range, Switzerland) before and after introducing the sample. 
 In  order  to  obtain  reliable  results  from  MDSC  experiments  it  was  important  to 
choose  optimum  values for  the  average  and modulated  heating  rates  (Thomas, 
2005c). The modulation period was long enough so that there was enough time for 
heat flow between the sensor and the sample. The modulation amplitude (±
oC) was 
large enough to provide good sensitivity, and the average heating rate (
oC/min) was 
slow enough to provide a sufficient number of modulation cycles over transitions of 
interest (Thomas, 2005c). The method employed for the gelatin and gelatin/PEG 
capsule shells included a modulation temperature amplitude ± 1.00
oC, a modulation 
time of 60 seconds, and a ramp rate of 3.00
oC/min. The sample was run from a 
starting temperature of 10.00
oC to a final temperature of 200.0
oC. With respect to 
the HPMC capsule shells, the modulation temperature amplitude employed was ± 
2.00
oC,  the  modulation  time  was  60  seconds,  the  ramp  rate  employed  was 
2.00
oC/min, and the sample was run from a starting temperature of 10.00
oC to a 
final temperature of 240.00
oC. The gas supply used was nitrogen, with a flow rate 
of 50 ml min
 1. The Tg was obtained as shown in Figure 2.3. The automatic mode in 
the Universal Analysis 2000 program, calculates three tangent lines between the 
two data limits that are selected. The onset point is the intersection of the first and 
second tangents. Inflection point is the portion of the curve between the first and 
third tangents with the steepest slope. The end is the intersection of the second and 
third tangents.   
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Figure 2. 3: Determination of glass transition 
 
Refer to Appendix 1, Section 1.1 for a description of the MDSC method 
development for both gelatin and HPMC capsules.    
 
2.3.3    Dynamic Mechanical Analysis (DMA) 
 
DMA experiments were performed to test the mechanical properties of the capsule 
shells  using  a Dynamic  Mechanical  Analyzer, DMA7,  (Perkin Elmer  Corp., High 
Wycombe,  UK)  with  parallel  plate  geometry  (diameter  of  plate  5  mm)  and  a 
personal computer (DELL, Optiplex GX1) which was attached to the DMA7 via a 
Perkin Elmer Thermal Analysis Controller, TAC7/DX and Perkin Elmer Intracooler 
1. The whole system was controlled by Pyris software version 4 for windows. A 
photograph and an illustrative diagram of the Perkin Elmer DMA7 are shown in 
Figures 2.4 and 2.5 respectively. 
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 Figure 2. 4: A photograph of the  
Perkin Elmer Dynamic Mechanical 
 Analyzer (Instrument Open).    
Figure 2.5: Illustrative diagram of the 
Perkin Elmer DMA7 (Perkin Elmer, 1996).  
(A) MetraDyne Stress Control System; this 
allows  the  sample  to  strain  naturally, (B) 
Suspension, (C) Test Frame, (D)  HiMetric 
Detection  Circuit,  (E)  LVDT  Core,  (F)  
LVDT  Heater,  (G)  UniMount  Measuring 
Systems, (H) IsoSink Temperature Control 
System,  (I)  Furnace,  (J)  Purge  Gas,  (K) 
Heat Sink, (L) Cooling. 
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A number of different tests were performed on the capsule shells using the DMA: a) 
Static scans to obtain a value for the elastic modulus, b) Dynamic scans to evaluate 
the  viscoelastic  properties  of  the  material,  and  c)  Linear  Creep  to  analyze  the 
materials recovery from an applied stress.  
 
In  order  to  control  the  moisture  content  of  the  capsules,  they  were  placed  in 
desiccator vessels containing appropriate saturated salt solutions i.e.  Mg(NO3)2 . 
6H2O and CaCl2 . 6H2O to provide two different relative humidity conditions (i.e. 
53%RH  and  35%RH,  respectively)  with  a  defined  storage  temperature  (22
oC). 
Capsules  were  stored  in  the  desiccators  for  24  hours,  and  after  removal  were 
immediately placed in the DMA apparatus and handled carefully with gloves and 
stainless  steel  tweezers.  The  above  was  repeated  for  capsules  stored  in 
desiccators for 72 hours and the two sets of results were compared. A photograph 
of  the  parallel  plate  measuring  system  used  is  shown  in  Figure  2.6,  and  an 
illustrative diagram of the parallel plate is shown in Figure 2.7.  
 
 
 
 
 
 
 
 
 
 
 
 
 
    
 
Figure 2. 4            Figure 2. 5   
Parallel plate measuring device                           Illustrative diagram of the parallel plate  
system with a sample mounted                                               measuring system (Perkin Elmer, 1989) 
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In all DMA methods, the furnace was carefully lowered and locked into position at 
the base of the DMA7, the split diffusion cap was placed over the furnace opening 
to  prevent  dropping  the  sample  into  it  and  to  maintain  the  furnace  equilibrium. 
Before  starting  any  method,  the  probe  was  raised and  lowered  to  auto tare  the 
probe mass. The probe was then raised and a single cap or body was placed in the 
centre of the bottom parallel plate. The probe was then lowered to hold the capsule 
in position, making sure that the sample was positioned at the centre of the top 
plate and the middle of the bottom plate. The furnace was then raised and locked 
into place. Throughout the various scans, the samples were equilibrated at 20 ± 
0.100°C and purged with Helium gas at a rate of  20 ml min
 1.   
 
Tests were repeated five times and the mean and standard deviation of the results 
calculated. 
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2.3.3.1   DMA – Static Scan  
 
Using the Pyris software for control, the Static Scan method started with a static 
force scan from 0.00 mN increasing to 2500.00 mN at a rate of 200.0 mN min
 1 and 
a frequency of 1 Hz. Static Scans where carried out to study the material’s elastic 
modulus, denoted by the letter E (also called Young’s Modulus). Figure 2.8 shows 
an example of the static scan curve obtained for the capsules tested. This was 
plotted as stress, σ (Pa) against static strain, γ (%). The probe position, shown by 
the blue line, was also included as part of the graph, which allowed monitoring of 
the position of the capsule with respect to the probe. The modulus of elasticity, 
shown by the red line, was calculated for all tested capsule shells from the slope of 
the linear portion of the stress strain curve.  
 
 
Refer to Appendix 1, Section 1.2.1 for a description of the Dynamic Scan method 
development.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
1
2
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Figure 2. 6:  A typical curve of stress versus strain.Chapter Two                                                                            Materials and Methods                                                          
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2.3.3.2   DMA – Linear Creep 
An example of a creep recovery curve for the capsules tested is shown in Figure 
2.9. The graph is a plot of static compliance (1/Pa) versus time (min), the static 
compliance, shown by the red line, and the static strain, as the Green line. The 
probe position is shown as the blue line. The method for all the capsule samples 
was  as  follows:  In  the  creep  mode, a  static  force  of 40.0  mN was applied and 
continued for 15 minutes. In the recovery  mode, a static force of 20.0 mN was 
applied  for  3  minutes.  Both  the  retarded  compliance  (elastic  element  of  the 
capsule), JR, and the Newtonian compliance (viscous element of the capsule), JN, 
were calculated from the creep recovery curve. Taking Figure 2.8 as an example: 
JN was calculated by subtracting the recovered static compliance, from the static 
compliance at the end of the creep period (i.e. 9.565 x 10
 3 – 4.783 x 10
 3). JR was 
calculated by subtracting the initial static compliance from the final recovered static 
compliance (i.e. 9.628 x 10
 2 – 9.565x10
 3). 
 
Refer to Appendix 1, Section 1.2.2 for a description of the Linear Creep method 
development.   
1
2
4
 
 
 
Figure 2. 7: Creep recovery curve showing static compliance and strain versus timeChapter Two                                                                            Materials and Methods                                                          
  125 
2.3.3.3   DMA – Dynamic Scan 
Dynamic scans were undertaken from 0.00mN to 700mN with a loading rate of 30.0 
mN min
 1, a frequency of 1 Hz and using a static force of 900 mN. An example of 
the dynamic scan obtained with a capsule sample is shown in Figure 2.10. The 
graph was plotted as storage modulus (Pa) versus dynamic force (mN). A number 
of different measurements could be determined from the dynamic scans. In this 
case, the storage modulus seen as the red line, the phase angle (θ) seen as the 
green line (a phase angle of zero indicates that the material is fully elastic and a 
phase  angle  of  90
o  indicates  the  material  behaves  fully  viscous),  and  tan  delta 
represented as the blue line. The slope of the linear portion of the storage modulus 
dynamic force curve was determined to ensure all samples were reproducible with 
similar values.  
  
Refer to Appendix 1, Section 1.2.3 for a description of the Dynamic Scan method 
development.   
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Figure 2. 8: A typical dynamic scan of modulus, phase angle and tan delta versus dynamic force (mN)Chapter Two                                                                       Materials and Methods                                                                                      
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2.3.4   Capsule Shell Dissolution Studies 
 
The hard capsule shell dissolution time was determined following a method first 
described  by  Boymond  et  al  (1966)  and  later  modified  by  Jones  and  Cole 
(1971).  A  steel  ball  bearing  was  placed  in  each  capsule;  the  capsules  were 
closed  to  their  specified  closed  joined  length  and  placed  in  a  stainless  steel 
metal holder which was suspended across a 1L beaker as shown in Figure 2.11. 
The diameters of the ball bearings used for each capsule are shown in Table 
2.2. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. 9: A photograph of special metal holder suspended across a 1L beaker 
 
 
Table 2. 2: Diameter of ball bearings used  
Capsule Size  Diameter of ball bearing (mm) 
 
Weight of Ball bearings (mg) 
(mean = 4) 
00  6.32  1.02 
 0  4.99  0.52 
 1  4.99  0.52 
 4  2.36  0.048 
 
For each buffer type, ten of each type of capsule were tested. The metal holder 
contained holes spaced about 5mm apart, which allowed for the capsule body to 
go through but not the cap. 
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The glass beaker was placed in a water bath maintained at a temperature of 
37
oC ± 0.5
oC. Once in position, the buffer level touched the lower surface of the 
metal holders but did not cover the top surface, i.e. only the capsule bodies were 
immersed in the liquid. The buffer was stirred at 37 rpm (Heidolph Laboratory 
Stirrer, type RZR 2021, Germany) keeping the paddle 1cm above the base of 
the beaker and about 5 mm from the metal holders. The end point of capsule 
shell dissolution was defined as the time when the steel ball bearing hit the base 
of the glass beaker following release from the capsule body. Results obtained 
are  the  mean  and  standard  deviation  of  ten  capsules.  Analysis  of  Variance 
(ANOVA) was performed using SPSS 15.0 (SPSS, Working, U.K.) 
 
 
The shell dissolution properties of empty Gelatin, Gelatin/PEG, Old HPMC and 
New HPMC two piece capsules were studied using the ball bearing test as a 
function  of  dissolution  medium,  pH,  ionic  strength  and  storage  conditions. 
Details of the capsule sizes and composition are in Section 2.1.1. In order to 
control the moisture content, the capsules were stored in desiccators containing 
appropriate saturated salt solutions (Section 2.3.3) and were stored at 35%RH 
and 53%RH with a defined storage temperature (22
oC) for 24 hours and 3 days. 
 
2.3.4.1   Effect of Dissolution Media and pH  
 
The effect of dissolution media composition and pH on all types of capsules 
presented in Table 2.1 was investigated in a number of dissolution mediausing 
the ball bearing method described in Section 2.3.4.  
 
The  following  dissolution  media  were  prepared  according  to  the  methods 
published in the British Pharmacopeia (Appendix ID, 2008d) these include:  
 
1)  Sörensen phosphate buffer  (pH 5 – 8)  
2)  Citro phosphate buffer (pH 5 – 7): 
3)  Phosphate borax buffer (pH 7, 8)  
4)  Borate buffer (pH 8)  
5)  Acetate buffer (pH 5, 6)  Chapter Two                                                                       Materials and Methods                                                                                      
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6)  Distilled water (glass distillery, Sanyo, Gallenkamp PLC)  
7)  Artificial gastric juice (pH 1.2) (BP, Appendix IA, 2008e) 
 
The pH of the buffers was checked using a pH meter (Jenway 3505, Essex, UK) 
Full  preparation  details  of  the  dissolution  media  are  shown  in  Appendix  2, 
Section 2.1 
 
2.3.4.2   Effect of Ionic Strength 
 
The  effect  of  ionic  strength  present  of  the  dissolution  media  on  the  shell 
dissolution of empty size 0 new HPMC and gelatin capsules previously stored at 
35%  and  53%RH  for  both  24  hours  and  3  days  was  carried  out  using  the 
method described in section 2.3.4. The dissolution media used for this test were: 
•  Potassium phosphate buffer pH 7.4 which was prepared using K2HPO4 
(dipotassium  hydrogen  orthophosphate)  and  KH2PO4  (potassium 
dihydrogen  orthophosphate)  in  varying  concentrations  of  K
+ 
  (0.1M  – 
0.5M) see Appendix 2, Table 2.1. 
 
•  Sodium phosphate buffer pH 7.4, which was prepared using Na2HPO4 
(disodium hydrogen orthophosphate) and NaH2PO4 (sodium dihydrogen 
orthophosphate)  in  varying  concentration  of  Na
+  (0.1M  –  0.5M),  see 
Appendix 2, Table 2.2. 
 
•  0.1M hydrochloric acid (HCl) containing either sodium chloride (NaCl) or 
potassium chloride (KCl) with different concentration of Na+ or K+ to give 
the same ionic strengths of that of the 0.1M   0.5M potassium and sodium 
phosphate buffers. See Appendix 2, Table 2.3. 
 
In all cases, the results are the mean and standard deviation of 10 capsules. 
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2.3.5   Effect of Ionic Strength on the Dissolution of Theophylline 
from Hard Capsules 
 
Wavelength scans were performed with the highest (15 mgL
 1) and lowest (1.5 
mgL
 1)  dilutions  using  UV  spectrophotometry  M501  Single  Beam  Scanning 
UV/Visible Spectrophotometer (Camspec, Spectrosonic analytical instruments, 
Garforth  Leeds,  England).  The  solutions  were  scanned  through  a  range  of 
190nm – 400nm with medium speed settings. The wavelength scan generated a 
graph  of  absorbance  vs  wavelength  (nm)  which  is  illustrated  in  Figure  2.12 
giving a suitable λmax value of 272 nm. 
 
Figure 2. 10: Illustrative diagram of wavelength scan for theophylline 
 
 
 
2.3.5.1   Calibration Plot for Theophylline  
 
A  stock  solution  containing  150  mgL
 1  of  theophylline  was  prepared  by 
accurately weighing theophylline anhydrous powder (BASF AG, Ludwigshafen, 
Germany, BN: 128521AX10) and transferring it to a 1 L volumetric flask. The 
flask  was  filled  with  approximately  750  ml  of  degassed    0.1  M  or  0.5  M 
phosphate buffer pH 7.4, sonicated for 15   20 minutes In an ultrasonic bath 
(Model FRM 100, Hilsonic, Brombourough, UK) then made up to one litre with 
the phosphate buffer. Chapter Two                                                                       Materials and Methods                                                                                      
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Dilutions were prepared in the range 1.5 mgL
 1, 3 mgL
 1, 6 mgL
 1, 9 mgL
 1, 12 
mgL
 1  and  15  mgL
 1  and  absorbances  determined  at  272  nm  using  UV 
spectrophotometry  (M501  Single  Beam  Scanning  UV/Visible 
Spectrophotometer,  Camspec,  Spectrosonic  analytical  instruments,  Garforth 
Leeds, England).  Two stock solutions and two sets of dilutions were prepared 
for each buffer type and the average of these two replicates was used to plot the 
calibration curve (absorbance vs concentration mgL
 1). 
 
2.3.5.2   Saturation Solubility 
 
Excess  theophylline  was  weighed  into  a  100ml  round  flask  containing  either 
0.1M phosphate buffer or 0.5M phosphate buffer at pH 7.4 and was sonicated 
for 10 – 15 minutes to aid dissolution of the drug. The flask was then transferred 
to  an  Aquatron  water  bath  shaker  (HT  Infors  AG,  CH  –  4103,  Bottmingen, 
Switzerland) and was stirred continuously for a 24 hour period at a temperature 
of 37
oC and at 50 rpm i.e. employing conditions similar to the dissolution test 
conditions.  The  test  was  repeated  for  each  buffer.  10ml  samples  were  then 
extracted,  filtered  through  0.2  micrometer  cellulose  nitrate  membrane  filters 
(Whatman,  Schleicher  &  Schuell,  Maidstone,  England)  and  diluted.  The 
absorbance of the diluted samples was measured using the M501 single beam 
UV/Visible  spectrophotometer  at  272  nm  (Camspec,  Spectronic  Analytical 
Instruments, Garforth Leeds, England).  
 
2.3.5.3   Preparation of Powder Formulations for Capsules 
 
The formulation consisted of theophylline anhydrous powder (99.5%w/w) and 
magnesium stearate (0.5%w/w). Magnesium stearate was used as a lubricating 
agent to reduce the sticking of the powder from the plugs to the die and tamping 
pin.  
 
The powder mixture was prepared and filled into capsules using the method 
described by Podczeck and Jones (2002) where sufficient theophylline to fill 40 
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the  powder  was  scraped  off  the  sides  of  the  mortar  at  1  minute  intervals. 
Sufficient magnesium stearate was then added to the mortar and mixed for a 
further 2 minutes to ensure a uniform distribution. Three batches of 40 capsules 
were prepared. 
 
2.3.5.4   Particle Size Analysis 
2.3.5.4.1   Laser Light Scattering  
 
Particle size analysis of theophylline powder mix was determined by laser light 
scattering using the Malvern MasterSizer (Malvern Instruments SB.0B, Model 
MSS, 1997, Spring Lane South, UK). The powder mix was dispersed in propan 
2 ol (Analytical reagent Fischer scientific, U.K. Ltd. BN: 9889914 358) within a 
sample  unit  (MS1S  small  volume  sample  unit).  The  solution  was  kept  in 
suspension by magnetically rotating a stirrer bead within the sample unit and 
measuring the distribution of the powder mix with a low angle laser beam. Three 
powder mix batches were tested taken 5 samples from each of the 3 batches. 
The particles which pass through the laser bean scatter light, the optical unit 
captures  the  scattering  pattern  which  is  measured  based  on  the  Fraunhofer 
theory, which assumes that the particle is spherical and that the light that has 
penetrated  the  particle  does  not  contribute  to  the  scattering  pattern  (i.e.  the 
particles are opaque) so that all sizes scatter with equal efficiency (Washington, 
1992). 
 
2.3.5.4.2   Image Analysis  
 
Particle size analysis of the three powder mix batches was determined by image 
analysis. The samples were prepared on a microscope slide and dispersed in 2 
drops of dispersion fluid with a refractive index of 1.40 (Certified refractive index 
liquids, Calligen, USA) to achieve maximum particle dispersion and prevent the 
occurrence of agglomerates.  
 
The sample slide was placed on a light microscope (Olympus BH 2, Olympus 
Optical Co., Tokyo, Japan) an objective lens with a 10 X magnification power 
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x  0.01  =  1mm  graticule  (Graticules  Ltd,  Tonbridge,  U.K.,  CS  809).  The 
microscope was connected with a digital camera (Axiocam MCR, Carl Zeiss, 
Germany)  and  images  were  taken  and  processed  using  AxioVison  image 
analyzer  software  (AxioVision  Release  4.3,  Carl  Zeiss,  Germany).  For  each 
batch, the Feret diameter of 30 particles was determined (total = 90 particles) 
and the average value recorded. 
 
2.3.5.5   Determination of Theophylline Water Content  
 
Powder  moisture  content  of  theophylline  was  determined  using  a  Halogen 
Moisture Analyser (HG53, Mettler Toledo, Switzerland). This method was a fast 
and precise method for moisture determination in comparison with conventional 
drying methods. A powder sample was placed in a flat aluminium sample pan, 
which was prior positioned into the automatic sample chamber ensuring that the 
base of the aluminium pan was fully covered.  The sample was introduced into 
the heating chamber and the drying process began by means of the halogen 
radiator. The moisture was determined from the weight loss of the sample dried, 
which was measured simultaneously by a precision balance. The samples were 
dried at 100
oC and the weight was measured at 30 seconds intervals until the 
reduction in sample weight loss did not exceed 1 mg for more than 140 seconds. 
The  procedure  was  repeated  three  times  and  the  mean  %  moisture  content 
recorded.  
 
2.3.5.6   Capsule Filling  
 
Individual  amounts  of  powder  mixture  were  weighed  accurately  to  0.450g  ± 
0.005g using an analytical balance (Precisa 125A, Switzerland) and transferred 
to the die of the powder plug  rig tester (instrumented with a load cell and an 
electronic micrometer) with a diameter corresponding to the diameter of a plug 
that would fit into a size 0 body. The powder plug rig tester forms a plug by 
applying a force gradually in a controlled manner (Jones, 1998).  A photograph 
of the rig tester is shown in Figure 2.13. The tamping finger was lowered into the 
hole of the die and the powder mass compressed using a force of 72N. The 
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‘plug  transfer  unit’  (Figure  2.14),  whereby  the  die  containing  the  plug  was 
accurately centred above the capsule body allowing transfer of the plug. The 
latter was placed in a metal holder which allowed the replacement of the cap 
and closing of the capsules to the correct joined length.   
 
Figure 2. 11: A photograph of the powder plug testing rig. 
 
 
 
Figure 2. 12: Plug transfer unit, LHS transfer of powder plug to body, RHS rejoining of cap and 
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2.3.5.7   Drug Dissolution Tests  
 
Dissolution studies were carried out using the theophylline formulation prepared 
as described in Section 2.2.5.2. and filled into capsules. Drug dissolution was 
studied in a Caleva 8ST Dissolution tester (G.B.Caleva Ltd, Dorset, England), 
shown in Figure 2.15, equipped with seven 1L clear glass dissolution vessels 
filled to 900 ml with dissolution media, which was degassed using a dissolution 
media degasser unit (Copley, Nottingham, UK, S/N 600851) and maintained at a 
temperature of 37 ± 0.5
 oC. The paddle speed was 50 rpm. The dissolution tests 
were carried out using the BP paddle method (Appendix XII B. Dissolution tests 
for Tablets and Capsules (Dissolution test for Solid Dosage Forms) (BP, 2008c). 
The capsules tested were placed into sinkers to prevent floating. 
 
 
Figure 2. 13: Dissolution tester (G.B.Caleva Ltd, Dorset, England) 
 
Size 0 new HPMC capsules and size 0 gelatin capsule shells were filled with  
450 mg of the theophylline formulation, and tested in the following media (media 
preparation described in Section 2.3.4.2): 
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2)  0.1 M – 0.5 M sodium phosphate buffer pH 7.4  
3)  0.1 M HCl pH 1.2 
4)  0.1M  HCl  pH1.2  prepared  with  either  NaCl  or  KCl  to  give  different 
concentrations of Na
+ and K
+ ions to give the same ionic strengths of that 
of the 0.1 M and 0.5 M potassium and sodium phosphate buffers. 
Dissolution tests were also carried out in dissolution media2 and 4 after storing 
the theophylline filled capsules for 6 months at 35%RH. 
Samples  of  10ml  were  extracted  through  10  ml  syringes  attached  to  bent 
stainless steel cannula and filters with a pore size of 20  m (Supplied by Copley 
Scientific,  Nottingham,  UK)  every  3  minutes  up  to  30  minutes,  then  every  5 
minutes up to 60 minutes, then at 75, 90 and 120 minutes and every hour until 5 
hours had elapsed. Each 10 ml sample extracted from the dissolution vessel 
was  replaced  by  an  equal  amount  of  buffer.  The  saturation  solubility  of 
theophylline in 0.1 M and 0.5 M phosphate buffer pH 7.4 as discussed in section 
2.2.5.1.2  was  found  to  be  5.8  gL
 1  (0.1  M)  and  4.5  gL
 1  (0.5  M)  hence  sink 
conditions  were  maintained  at  a  dose  of  450mg.  The  absorbance  for  each 
sample  withdrawn  was  determined  using  the  UV  spectrophotometer  at  a 
wavelength of 272 nm. 
 
The  amount  of  drug  replaced  at each time  interval  was  calculated  using  the 
following equation: 
 
An = ((Cn x 900) + (Cn 1 x 10) + (Cn  2 x 10) + (Cn 3 x 10))/1000 ...etc 
 
Where An is the amount of drug released (mg) at a specified time, and Cn is the 
concentration in mg/L.  
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2.3.6  Effect of Dissolution Media on Capsule Shell Wall Thickness 
 
The work investigated the effect of ionic strength and buffer type used during the 
dissolution  studies  (Section  3.6.2)  on  the  initial  stages  of  capsule  shell 
dissolution (i.e. before the shells begin to split, from 0.5 min – 3 min). Changes 
in  the  shell  thickness  of  size  0  HPMC  and  gelatin  hard  capsules  were 
determined at the initial stages of dissolution (i.e. before the shells begin to split, 
from 0.5 min – 3 min).  Empty capsule shells were stored at 35%RH/24 hr and 
placed in the following buffers using the apparatus for capsule shell dissolution 
(Section 2.2.4.1.1) without the addition of the ball bearings to the capsule shell 
body: 
 
1) 0.1 M and 0.5 M potassium phosphate buffer (KPB) pH 7.4 
2) 0.1 M and 0.5 M sodium phosphate buffer (NaPB) pH 7.4 
3) 0.1 M HCl pH 1.2 prepared with different concentrations of Na
+ and K
+ ions 
using NaCl and KCl to give the same ionic strengths of that of 0.1 M and 0.5 M 
KPB and NaPB.   
 
Media preparation described in Section 2.3.4.2 
 
The empty capsule bodies were immersed in buffer which was kept at a 
temperature of 37 ± 0.5
oC and was stirred at 37 rpm (Heidolph Laboratory 
stirrer, Type RZR 2021, Germany). The capsule shell bodies were removed from 
the dissolution media at different times (30 seconds and 2 minutes) and left to 
dry on filter paper for 24 hours under ambient conditions. 
 
For each buffer type and time, ten capsule shells were tested. Cross sections 
from each of the capsule shell bodies were sliced with a sharp knife above the 
shoulder  of  the  shell  body  and  the  thickness  measured  using  a  Mitutoyo 
micrometer 0 25 mm, 0.01 mm (Figure 2.16)  
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Figure 2. 14: Photograph of the Mitutoyo micrometer (0 25 mm, 0.01 mm), with sample shell 
 
The sample was placed between the spindle face and the Anvil face, the ratchet 
was turned until the sample shell was trapped between the two faces. Three 
measurements were taken around the circumference of each cross section and 
the  results  obtained  were  the  mean  and  standard  deviation  of  10  capsules. 
Measurements of the thickness of dry capsule shell bodies were also taken after 
storage at 35%RH and 53%RH for both 24 hours and 3 days in order to see the 
effect  of  storage  humidity  on  the  change  in  shell  thickness,  and  to  enable 
comparison between the dry and treated capsules. To observe the changes in 
capsule  shell  thickness,  images  of  the  shell  bodies  were  taken  using  image 
analysis  AxioVision  image  analyser  (AxioVision  Release  4.3,  Carl  Zeiss, 
Germany). The equipment was calibrated with a 100 x 0.01 = 1mm graticule 
(Graticules Ltd, Tonbridge, U.K., CS 809).  
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2.3.7  Statistical Analysis  
 
Statistical  analysis  was  performed  using  SPSS  v15.0  software  package  for 
windows (SPSS Inc., Chicago, Illinois, USA). The statistical method used was 
Analysis of Variance (ANOVA). When more than two groups were present a 
Post hoc  Scheffe’  test  was  performed  to  determine  which  variable  among 
several independent variables was statistically the most different.  
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3  Physical and Mechanical Properties of Capsule Shells – Results and 
Discussion 
 
3.1   Background 
It has been shown that the physical characteristics of gelatin hard capsule shells 
are affected by moisture changes (Berntsson et al., 1997; Ciper and Bodmiere, 
2005; Yakimets et al., 2005; Ciper and Bodmiere, 2006), causing the capsules 
to become brittle if moisture content is less than 10% w/w. On the other hand, 
become soft, distorted and sticky at high moisture content (above 18% w/w) and 
may  render  the  shell  prone  to  microbial  decomposition  (Kontny  and  Mulski., 
1989; Jones, 2004d). Problems also occur if the drug filled in the capsule is 
strongly hygroscopic attracting water molecules from the capsule shells, this in 
turn would affect drug release rate and shelf life (Czyzewski, 2007). Therefore, 
moisture uptake and loss from the different capsule shells (gelatin, gelatin/PEG, 
and 3 different batches of HPMC) was determined as described in Chapter 2, 
Section 2.3.1.  
 
The  glass  transition  temperature  (Tg)  of  a  material  is  also  an  important 
characteristic  for  drug  delivery,  since  changes  in  Tg  reflect  the  materials’ 
molecular structure, which can influence chemical stability, physical stability, and 
viscoelastic properties. Below the Tg temperature, the material is in its glassy 
state,  and  the  mobility  of  the  polymer  chains  is  very  low,  resulting  in  small 
diffusion rates. Above the Tg temperature, the polymer is in its rubbery state, 
leading to higher mass transfer rates of water and drug (Hancock and Zografi, 
1994. Siepmann and Peppas, 2001). The mechanical properties of a material 
can also be affected by the Tg, where a decrease in material resistance could be 
a result of a decrease in the material’s Tg (Vanin et al., 2005). Therefore, thermal 
analysis  was  undertaken,  to  determine  and  compare  the  glass  transition 
temperatures (Tg) of the different capsule shells, which would provide an insight 
into their fundamental physico chemical properties. 
 
Rheological  studies  to  determine  the  mechanical  properties  of  the  capsules 
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previously  used  for  capsule  shells.  This  would  provide  useful  information  to 
explain differences in behaviour between the gelatin and HPMC capsules. 
 
3.2  Physical Characteristics of Capsule Shells 
3.2.1  Determination of Moisture Uptake for Capsule Shells 
 
Water present in gelatin films is chemically bound to varying extents. Gelatin 
forms a three dimensional network with zones of intermolecular microcrystalline 
junctions.  The  dehydration  of  this  system  may  produce  brittle  films  (Slade  & 
Levine,  1987;  Vanin  et  al.,  2005).  Under  normal  ambient  conditions,  gelatin 
capsules cannot be dried to less than 4% w/w of water. This residual water is 
strongly bound to the gelatin molecule, and if it is removed down to a level of 
0.3% w/w, the gelatin will not reconstitute to the same physicochemical state 
(Yannas and Tobolsky, 1967; Jones, 2004d). As a consequence of this, and due 
to the brittleness associated with the gelatin capsules at moisture levels below 
10% w/w, all the capsules in this work were stored in airtight containers, and 
tested as received i.e. at or close to their equilibrium moisture content (~ 12 – 
14%). 
 
The  moisture  uptake  of  the  different  samples  of  capsules  stored  at  different 
humidity conditions is shown in Table 3.1: the values are the mean and standard 
deviation of three replicates. These results are represented graphically in Figure 
3.1.  
 
 
 
 
 
 
 
 
 
 
 Chapter Three                   Physical and Mechanical Properties of Capsule Shells 
                                                                                      
  143 
Table 3. 1: % w/w Moisture uptake for capsule shells stored at different 
conditions at a temperature of  22
oC. 
 
Capsule 
type  
Storage 
Conditions 
Wt before 
storage 
(mg) 
Wt after 
storage (mg) 
%  w/w 
Moisture 
Uptake 
STD 
35%RH/24hr  97.83  97.89  0.06  0.01 
53%RH/24hr  96.10  97.71  1.61  0.14 
35%RH/3 d   96.14  97.74  1.66  0.26 
Old HPMC 
53%RH/3 d  96.21  98.23  2.10  0.71 
35%RH/24hr  87.14  87.68  0.62  0.05 
53%RH/24hr  88.02  89.62  1.79  0.11 
35%RH/3 d   89.09  89.70  2.90  0.55 
New HPMC 
53%RH/3 d  87.36  89.78  2.77  0.19 
35%RH/24hr  90.72  91.16  0.48  0.04 
53%RH/24hr  88.67  90.26  1.76  0.18 
35%RH/3 d   89.54  92.08  2.87  0.09 
E0504193 
HPMC  
53%RH/3 d  88.84  91.46  2.86  0.05 
35%RH/24hr  102.49  102.76  0.26  0.04 
53%RH/24hr  102.52  103.28  0.75  0.06 
35%RH/3 d   101.91  103.50  1.54  0.19 
Gelatin 
53%RH/3 d  102.12  104.35  2.19  0.06 
35%RH/24hr  101.42  101.68  0.26  0.02 
53%RH/24hr  101.79  102.52  0.71  0.09 
35%RH/3 d   101.56  103.10  1.49  0.05 
Gelatin/PEG 
 
 
 
53%RH/3 d  101.53  103.46  1.87  0.33 
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Figure 3. 1: % w/w Moisture uptake of capsule shells stored at different RH conditions 
(Temperature: 22
oC)  
 
The  results  generally  show  that  a  greater  amount  of  moisture  is  sorbed  by 
HPMC capsule shells at each storage condition (apart from old HPMC capsules 
at 35%RH/24 hrs) when compared with the gelatin and gelatin/PEG capsules. 
For  example:  0.62  ±  0.05  %  (new  HPMC)  vs  0.26  ±  0.04  %  (gelatin)  after 
storage at 35%RH for 24 hours, and 2.77 ± 0.19 % (new HPMC) vs 2.19 ± 0.06 
% (gelatin) after storage at 53% RH for 3 days. 
 
The results show that an increase in storage humidity and time leads to greater 
moisture  sorption  by  all  capsule  shells.  For  example  for  old  HPMC,  the  % 
moisture uptake increased from 0.06 ± 0.01 % (35%RH/24 h) to 2.1 ± 0.71 % 
(53%RH/3 days), similarly, for gelatin, the % moisture uptake increased from 
0.26 ± 0.04 % to 2.19 ± 0.06 %. However, for the new HPMC and E0504193 
HPMC capsules shells, the % moisture uptake was almost the same at 35%RH 
and 53%RH after 3 days with 2.9 ± 0.55 % vs 2.77 ± 0.19 % for new HPMC) and 
2.87 ± 0.09 % vs 2.86 ± 0.05 % for E0504193 HPMC.  
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Statistical analysis using one way ANOVA indicated that storing the capsules 
under  different  relative  humidity  conditions  had  a  significant  effect  on  the 
moisture uptake into the shells (p < 0.001). Post – hoc Scheffé tests for the Old 
HPMC    capsules  (Appendix  3,  Table  3.1)  show  that  although  there  was  a 
tendency for more moisture to be taken up by the capsule shells as the storage 
conditions  were  increased,  this  slight  increase  between  the  three  storage 
conditions (53%RH/24 hr, 35%RH and 53%RH for 3 days) was insignificant.  
 
Post hoc Scheffé tests (Appendix 3, Table 3.2) showed that the moisture uptake 
into the New HPMC capsules shells when stored at 35%RH and 53%RH for 3 
days is statistically insignificant. This implied that for these shells the relative 
humidity  level  is  less  important,  because  the  moisture  uptake  reached  a 
maximum  value,  since  no  further  uptake  was  found  (See  Table  3.1).  Similar 
observations were made for the E0504193 HPMC capsules (Appendix 3, Table 
3.3) where the % moisture uptake into the capsule shells was similar at 35% and 
53%RH when stored for 3 days.  
 
Post hoc  Scheffe’  tests  for  gelatin  capsule  shells  (Appendix  3,  Table  3.4) 
indicated  that  the  moisture  uptake  was  significantly  different  at  each  of  the 
different  storage  conditions.  The  results  for  gelatin/PEG  capsule  shells  are 
similar to those obtained for gelatin. It was found that longer storage times (3 
days) for both relative humidities 35% and 53% led to a significantly greater 
moisture uptake when compared with 24 hours storage time. Thus, the storage 
conditions  have  a  significant  effect  on  moisture  uptake  for  the  gelatin/PEG 
capsule shells (Appendix 3, Table 3.5). These results are similar to those found 
by Podczeck (2002) who studied the strength and brittleness of hard capsules 
made  from  different  materials  (gelatin,  gelatin/PEG  and  HPMC  capsules) 
by  measuring  indentation forces after storing the capsules at different relative 
humidities  (5     94%  w/w)  for  up  to  four  weeks.  Hard  shell  capsules  gelatin 
capsules  made  with  PEG  4000  did  not  have  a  change  in  their  affinity  for 
moisture when stored at higher RH. HPMC capsules had an increased affinity 
for moisture above 75% and their equilibrium moisture isotherms were shallower 
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different to the results obtained in this study (Table 3.1) where more moisture 
was sorbed by the HPMC shells at each relative humidity. All the capsules were 
tested as received, therefore they were at or close to their equilibrium moisture 
content (EMC). However, in the study carried out by Podczeck (2002), capsules 
were  dried  for  one  week  over  silica  gel,  and  therefore  had  moisture  content 
close to 0%. This would have led to a steep rise in the moisture sorption for 
gelatin (EMC 14%) compared to HPMC (EMC 4%) and could account for this 
difference. 
 
3.2.2    Determination of Moisture Content for Capsule Shells After Storage  
 
Data  presented  in  Table  3.2  shows  the  %  moisture  contents  of  the  various 
capsule shells after storage. The results are the mean and standard deviation of 
three replicates. 
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Table 3. 2: % Moisture loss for capsule shells at different storage conditions and 
temperature 22 ± 1
oC.  
 
Capsule type   Storage RH  % Moisture 
Content 
35%RH/24hr  3.02  (0.12) 
53%RH/24hr  4.29  (0.07) 
35%RH/3 days   4.76  (0.12) 
Old HPMC 
53%RH/3 days  5.35  (0.09) 
35%RH/24hr  3.41  (0.05) 
53%RH/24hr  4.36  (0.06) 
35%RH/3 days  5.55  (0.12) 
New HPMC 
53%RH/3 days  5.53  (0.03) 
35%RH/24hr  3.38  (0.14) 
53%RH/24hr  4.35  (0.06) 
35%RH/3 days  5.51  (0.09) 
E0504193 HPMC 
53%RH/3 days  5.52  (0.09) 
35%RH/24hr  12.45  (0.72) 
53%RH/24hr  13.78  (0.49) 
35%RH/3 days  16.52  (0.85) 
Gelatin 
53%RH/3 days  16.58  (2.12) 
35%RH/24hr  12.87  (0.60) 
53%RH/24hr  13.73  (0.22) 
35%RH/3 days  16.37  (0.31) 
Gelatin/PEG 
 
53%RH/3 days  16.53  (1.15) 
     The results are the mean and (standard deviation) of 3 replicates 
 
The  results  generally  show  that  the  gelatin  and  gelatin/PEG  have  higher 
moisture contents when compared with the HPMC capsules at similar storage 
conditions. The results show that there is a tendency for more moisture to be 
lost  from  the  gelatin  and  gelatin/PEG  shells  when  stored  at  higher  relative 
humidity and longer storage periods (12.87% vs 16.53% for gelatin/PEG shells, 
and 12.45% vs 16.58% for gelatin capsules) both at 35%RH/24 hr and 53%RH/3 
days  respectively.  Statistical  analysis  using  one  way  ANOVA,  shows  the 
differences in moisture loss at each condition for both gelatin and  gelatin/PEG 
capsules to be statistically significant, F (3,8) = 50.687 and 197.39 for gelatin 
and gelatin/PEG respectively, with p < 0.001. Post  hoc scheffe tests for the 
gelatin (Appendix 3, Table 3.6) show that these differences lie between the short 
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and  53%RH/3days.  For  gelatin/PEG  (Appendix  3,  Table  3.7)  differences  lie 
between 35%RH/24 hr and the two storage conditions 53%RH/24 hr and 3 days.  
 
The results presented in Tale 3.2 show that, for old HPMC shells the % moisture 
loss was significantly different at each storage condition (one way ANOVA: p < 
0.001).  For  E0504193  and  new  HPMC  capsules,  moisture  loss  at  the  two 
storage conditions (35% and 53% RH/ 3days) was similar. For example, for the 
E0504193 HPMC shells the moisture loss at 35% and 53%RH/3 days was 5.51 
± 0.09% vs 5.52 ± 0.09% respectively, and for new HPMC was 5.55 ± 0.12% 
and 5.53 ± 0.03%. These results are in agreement with the post hoc Scheffe’ 
tests  (Appendix  3,  Tables  3.8  –  3.10),  showing  that  for  E0504193  and  new 
HPMC  capsules,  the  %  moisture  loss  from  those  storage  conditions  are 
significantly  similar,  and  in  both  cases  are  significantly  different  to  the  % 
moisture loss at 35% and 53%RH for 24 hr (one way ANOVA: p < 0.001). It was 
found that the gelatin capsules became brittle only after one hour of drying if 
handled, whereas the HPMC capsules remained flexible.  
Ciper and Bodmeier (2005), measured the moisture content of size 0 gelatin and 
HPMC and fastcaps capsule shells gravimetrically by reweighing the capsules 
after drying in an oven at 105
oC untill know further weight loss was obtained. 
The capsules were stored for 3 days in dessicators to give relative humidities 
27%, 44 51%, 68% and 75% at room temperature. They found that the lower the 
moisture content, the more brittle the capsule shells became and could break 
during  processing  and  handling.  The  percentage  of  broken  gelatin  capsules 
increased when the moisture content of hard gelatin capsules, and gelatin/PEG 
capsules dropped below 10% w/w. This is because water acts as a plastisizer in 
gelatn  capsules.  The  HPMC  capsules  were  not  brittle,  even  at  2%  w/w  RH. 
Further work (Ciper and Bodmeier, 2006) found that gelatin capsules became 
brittle at a moisture content of between 5.6 and 3.9% w/w after drying for 1 and 
2.5h. Furthur decrease in moisture content to <3.9% w/w (3 h vacuum drying) 
resulted  in  highly  brittle  capsules.  HPMC  capsules  did  not  break,  but  only 
deformed even at the lowest moisture content.  
. 
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HPMC capsules have a lower moisture content to gelatin capsules, and the films 
are  less  permeable  to  water  vapour.  Water  can  be  removed  from  HPMC 
capsules without loss in their physical properties (Jones, 2003a), and this makes 
HPMC  suitable  for  hygroscopic  and  deliquescent  drugs  that  cannot  be 
encapsulated in hard gelatin capsules (Nair el al., 2004). Moisture here plays a 
different role to that in gelatin (Jones, 2004d). Polymers with hydrophilic groups 
such as hydroxyl groups, have various strengths of interaction with water. The 
mechanical  properties  of  cellulose  ethers  are  affected  by  this  interaction 
(Nokhodchi et al., 1997; Ford, 1999). Water can plasticize the polymer or form 
stable bridges, through hydrogen bonding. Nokhodchi et al (1997) studied  the 
interaction between water and HPMC, and suggested that there would be no 
partition between the absorbed water and the monolayer moisture, since water 
would bind to the hydrophilic groups of HPMC, and would be present as bound 
water  (not  necessarily  a  monolayer),  multilayered  water,  and  inter particulate 
water. Therefore, the initial absorption of water would turn into bound water and 
the innermost water would be very tightly bound to the polymer and difficult to 
remove.  
 
3.2.3  Modulated Differential Scanning Calorimetry 
3.2.3.1  Glass Transition Temperature (Tg) of Gelatin Capsules 
 
The  glass  transition  temperatures  of  gelatin  and  gelatin/PEG  capsules  after 
storage at 35 and 53%RH for 24 hours and 3 days are tabulated below in Table 
3.3 and 3.4 respectively. 
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Table 3. 3: Glass transition temperatures (
oC) and melting (
oC) of gelatin 
capsule shells stored under different conditions. 
 
   Note: Tgi, Tgm, Tge: initial, mid and end of glass transition temperature, Tm: melting temperature 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Storage 
Condition 
Gelatin 
Capsules  
Tgi  Tgm  Tge  Tm 
1  67.56  69.44  71.87  80.44 
2  67.68  69.44  71.81  80.11 
3  67.88  69.44  71.26  79.86 
Mean  67.71  69.44  71.65  80.14 
35%RH/24 
hr 
STD  0.16  0.00  0.34  0.29 
1  65.09  66.68  67.65  79.56 
2  66.19  67.41  69.20  79.74 
3  64.73  66.45  67.58  78.85 
Mean  65.34  66.85  68.14  79.38 
53%RH/24 
hr 
STD  0.76  0.50  0.92  0.47 
1  65.25  66.19  68.63  78.75 
2  65.27  66.45  67.99  78.85 
3  65.06  66.19  68.30  78.31 
Mean  65.19  66.28  68.31  78.64 
35%RH/3 
days 
STD  0.12  0.15  0.32  0.29 
1  63.11  64.67  66.02  77.66 
2  61.52  63.16  64.07  76.21 
3  62.40  64.34  66.13  77.13 
Mean  62.34  64.06  65.41  77.00 
53%RH/3 
days  
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Table 3. 4: Glass transition temperatures (
oC) and melting (
oC) of gelatin/PEG 
capsule shells stored under different conditions. 
 
Storage 
Condition 
Gelatin/PEG 
Capsules  
Tgi  Tgm  Tge  Tm 
1  65.38  67.24  70.68  83.59 
2  66.66  67.55  70.58  81.38 
3  65.50  66.74  69.20  81.13 
Mean  65.85  67.18  70.15  82.03 
35%RH/24 
hr 
STD  0.71  0.41  0.83  1.35 
1  64.76  66.21  67.58  80.37 
2  64.66  66.40  67.58  79.18 
3  64.84  66.40  67.84  79.27 
Mean  64.75  66.34  67.67  79.61 
53%RH/24 
hr 
STD  0.09  0.11  0.15  0.66 
1  64.53  65.94  67.45  79.96 
2  64.67  65.58  68.03  79.18 
3  64.63  65.59  67.28  78.82 
Mean  64.61  65.70  67.59  79.32 
35%RH/3 
days 
STD  0.07  0.21  0.39  0.58 
1  60.94  62.88  66.36  78.78 
2  61.96  63.81  66.14  77.83 
3  61.92  63.72  66.20  77.80 
Mean  61.61  63.47  66.23  78.14 
53%RH/3 
days  
STD  0.58  0.51  0.11  0.56 
Note: Tgi, Tgm, Tge: initial, mid and end of glass transition temperature, Tm: melting temperature.  
 
Tables 3.3 and 3.4 clearly show that relative humidity and storage time had a 
pronounced  effect  on  the  glass  transition  temperature  of  both  gelatin  and 
gelatin/PEG  shells.  As  RH  and  storage  time  increase,  the  Tg  decreased 
significantly, for both the gelatin (69.43
oC to 64.06
oC), and gelatin/PEG (67.18
oC 
to  63.47
oC)  for  (35%RH  /24  hr)  and  (53%RH/3  days)  respectively  (one way 
ANOVA p < 0.001) (see Appendix 3, Tables 3.11 and 3.12 for post hoc Scheffe’ 
tests).  The  addition  of  PEG  to  gelatin  reduced  the  Tg  slightly  at  all  storage 
conditions when compared with gelatin alone. However, the reduction in Tg was 
only  significant  at  35%RH/24  hr  (Appendix  3,  Table  3.13).  Examples  of  the 
profiles obtained for the gelatin capsule shells, pure gelatin granules and the 
gelatin/PEG  capsule  shells  are  shown  in  Figures  3.2a  and  3.2b     3.4 
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Figure 3. 2a: MDSC thermogram of the gelatin capsule shells after storage at 35%RH for 24 
hours (modulation temperature amplitude ± 1.00
oC, modulation time of 60 seconds, ramp rate of 
3.00
oC/min). 
 
In MDSC, the total heat flow is separated into the reversing and non reversing 
(kinetic)  components.  Heat  capacity  (Cp)  and  changes  in  heat  capacity  are 
contained  in  the  reversing  signal,  whereas,  the  kinetic  processes  such  as 
decomposition, evaporation, molecular  relaxation,  crystallization  and  chemical 
reactions  are  found  in  the  non reversing  signal  (Coleman  and  Craig.,  1996; 
Thomas, 2005c). The glass transition temperature is analysed in the reversing 
signal, since other factors are separated from it (Rahman et al., 2008).  
  
The Tg seen in the reversing heat flow signal (blue) in Figure 3.2a, was 69.44
oC, 
and is characterised by a step transition with Tgi of 67.88
oC and Tge of 71.26
oC. 
Figure 3.2a shows the glass transition to be followed by an exothermic peak. 
This exothermic peak was similar to that found by Rahman et al (2008) in a 
study looking at thermal characterisation of gelatin extracted from yellowfin tuna 
skin and commercial mammalian gelatin, using both standard and modulated 
DSC. The peak was described as an “unusual” exothermic peak which may be 
due  to  other  structural  changes  occurring  after  the  glass  transition.  The  first 
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67.28 
oC, and was a possible endothermic event indicating a kinetic process as 
a consequence of the glass transition. The frequency effect of the MDSC causes 
an endothermic peak, the area of which is superimposed on the endothermic 
peak caused by Enthalpic Recovery. Enthalpic relaxation or physical ageing is a 
thermoreversible phenomenon, and results in a decrease in the energy content 
of a material. Enthalpic recovery is the recovery of the energy that the sample 
gave up as it relaxed towards an equilibrium over time (Thiewes and Steeneken, 
1997; Thomas, 2005e). Figure 3.2b shows an example of the enthalpic recovery 
endotherms in the non reversing signal, where there is a shift of the endotherm 
to lower temperature coinciding with the decrease in glass transition (see Table 
3.3) with increasing water content.  
 
 
 
Figure 3.2b: Example of enthalpic recovery thermograms for gelatin capsule shells after storage 
at different relative humidities. 
 
This phenomena was also reported for gelatin by Badii et al (2005) in a study 
looking at the enthalpy relaxation of gelatin containing different water contents (~ 
7, 11 and 14%) in the glassy state using a Perkin Elmer Pyris Diamond DSC. 
The gelatin stored in the glassy state showed physical ageing, whether it was 
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mobility  by  increasing  storage  temperature,  or  by  plasticization  by  water, 
increased  the  rate  and  extent  of  the  enthalpy  relaxation.  This  finding  is 
significant to the stability of the gelatin capsules, which could lead to changes in 
the mechanical and diffusional properties of the capsule shells (Borde et al., 
2002;  Badii  et  al.,  2005).  Yakimets  et  al  (2005)  measured  four  thermal 
characteristics of gelatin films in the glassy state (Tg, Tm, enthalpy of melting and 
relaxation  enthalpy)  using  a  Perkin Elmer  DSC  7  instrument.  An  enthalpy  of 
relaxation  around  the  Tg  for  the  gelatin  films  equilibrated  at  different  RH 
indicated the existence of physical ageing. The enthalpy relaxation phenomenon 
was  found  in  other  studies,  such  as  that  by  Borde  et  al  (2002)  for  hydrated 
polysaccaharides  using  DSC,  where  it  was  found  that  structural  relaxation 
during storage yielded either sub – Tg enthalpy recovery peaks or overshoots in 
the glass transition region. The kinetics of physical ageing were found to depend 
on the molecular mobility of the glassy state, e.g. the storage temperature, and 
to a lesser extent due to the chemical structure and degree of advancement of 
structural  relaxation.  The  sub  –Tg  endothermic  peak  found  by  Rahman  et  al 
(2008)  was  thought  to  represent  hydrogen  bond  disruption  within  the  gelatin 
protein, which was also described by Bell and Touma 1996. 
 
The second peak seen in the non reversing signal was most likely to be the 
melting (Badii et al., 2005) of the gelatin shell sample, with Tm onset of 74.80
oC 
and a Tm peak = 79.86
oC. This is also described as the helix coil (sol – gel) 
transition  (Bigi  et  al.,  1998;  Sorbal  et  al.,  2001a;  vanin  et  al.,  2005).  This  is 
thought  to  occur,  mainly,  as  a  consequence  of  hydrogen  bond  interactions 
(Achet and He., 1995; Bigi et al., 1998), and is similar to the helix coil transition 
of  collagen,  which  involves  the  breakage  of  hydrogen  bonds  endothermically 
between adjacent polypeptide chains of collagen molecules in the denaturation 
process (Bigi et al., 2004; Zhang et al., 2006).  
 
There are usually two simultaneous changes in heat capacity. One is the result 
of  loss  of  water  due  to  evaporation.  When  this  occurs,  there  is  a  1  –  5% 
decrease in sample mass, which in turn results in a 5 10% decrease in heat 
capacity. The second change in heat capacity is due to dehydration/desolvation 
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causes an increase in heat capacity (Thomas, 2005d). In this study during the 
third  largest  peak  seen  in  the  non reversing  signal,  a  reduction  in  the  heat 
capacity is observed (see Figure 3.2a). This suggests that the main peak is a 
result of evaporation of water at around 130
oC. This is well above the boiling 
point of water, presumably due to strong bonds between water molecules and 
gelatin helix.   
 
Only a fraction of the gelatin macromolecules comprises the crystalline network. 
The  space  between  the  fibrils  is  composed  of  disordered  amorphous 
polypeptide  chains,  and  water  provides  the  elasticity  to  the  gelatin  capsules 
(Nazzal and Wang, 2001).  
 
Table 3.3 shows a decrease in melting temperature and Tg with an increase in 
storage RH and time, with a Tm decrease from 80.14
oC (35%RH/24 hr) to 77
oC 
(53%RH/3 days) and a Tg decrease from 67.18
oC (35%RH/24 hr) to 63.47
oC 
(53%RH/3 days).  Other studies, including Rahman et al (2008) using standard 
DSC, where samples were cooled to  90
oC at a heating rate of 5
oC/min, followed 
by scanning from  90
oC to 300
oC at a heating rate of 5 or 10
oC/min, found much 
higher Tm values when samples were stored at 11.3% RH (135, 151 and 149
oC 
for bovine, porcine and tuna gelatin respectively) which could be attributed to the 
higher  heating  rate  used.  However,  an  increase  in  the  RH  did  not  cause  a 
significant change in the Tm. An increase in RH caused a significant decrease in 
Tg for all gelatin types tested, with a decrease from 76
oC (11.3% RH) to 45
oC 
(75.3%RH) for bovine gelatin using standard DSC, and a decrease in Tg from 
77
oC to 53
oC again for bovine gelatin using MDSC. Tm values obtained by Baddi 
et al (2005) using Perkin Elmer Pyris Diamond DSC on bovine skin gelatin with 
11% water, had Tm onset ~ 97 – 98
oC, Tm peak ~ 107 – 108
oC. As the water 
content increased to 14%, the Tm peak decreased to 90
oC and the Tg shifted to 
lower  temperatures.  Similarly  Yakimets  et  al  (2005)  using  standard  DSC, 
measured  the  Tm  of  type  B  bovine  gelatin  samples,  with  first  heating  at 
10 °C/min, then rapidly cooling down (50 °C/min) and reheated at the same rate 
of  10 °C/min,  found  Tm  values  of  100
oC  (10%  w/w  water  content)  which 
decreased to 90
oC (15% w/w water content). Sorbal et al (2001a) tested pigskin 
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10
oC/min.  The  samples  conditioned  over  silica  gel  presented  a  classical 
behaviour: a Tg followed by a helix coil transition ~ 150
oC, which decreased 
when the samples were conditioned over saturated saline solutions to as low as 
80
oC when the water activity was 0.75. The Tm values reported in the various 
literature were found to be higher than those obtained for the gelatin capsules 
studied here. MDSC was therefore conducted on bovine gelatin powder (See 
Figure 3.3), to enable comparison with the gelatin capsules and to investigate 
whether other components affected the Tg or the Tm. 
 
Figure 3. 3: Glass Transition of bovine gelatin powder stored at 35%RH for 24 hours.  
Modulation temperature amplitude ± 1.00
oC, modulation time of 60 seconds, ramp rate of 
3.00
oC/min. Mean Tg = 75.79 (0.07), mean Tm = 103.54 (0.86). n = 2 
 
 
Figure  3.3  and  Table  3.3,  clearly  show  that  the  Tg  of  bovine  gelatin  powder 
(75.84
oC)  was  higher  than  that  of  the  gelatin  capsules  (69.43
oC)  stored  at 
35%RH/24 hr, and occurred with wider temperature range (~14
oC) compared 
with  ~  5
oC  for  gelatin  capsules.  Similarly,  the  Tm  of  bovine  gelatin  is  higher 
(103.54
oC) and closer to values reported in the literature than that of the gelatin 
capsules  (82.03
oC)  stored  under  the  same  conditions.  The  Tg  temperature 
obtained in the study by Badii el al (2005) for bovine gelatin with 11% water 
content,  using  standard  DSC  was  72 73
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Rahman et al (2008) for bovine gelatin at 11.3% RH (77 
oC) was very similar to 
the Tg obtained in this study for bovine gelatin stored at 35%RH / 24 hr (76
oC). 
Gelatin  is  a  complex  molecule,  and  the  differences  in  Tg  could  be  due  to  a 
number of reasons, such as the thermal history of the material, the molecular 
weight  of  the  polymer  chains,  the  presence  of  plasticizer,  the  degree  of 
crystallinity of the sample and its composition (Thiewes and Steeneken, 1997; 
Rahman et al., 2008).  Differences could also be due to heating rates applied, 
the heating rate used in this study was much slower (3
oC/min) to the heating 
rates applied by the various studies described above (10
oC/min). 
 
The Tg and Tm data for gelatin/PEG capsule shells are reported in Table 3.4, and 
an example of a typical profile obtained for these capsules is shown below in 
Figure 3.4. 
 
 
Figure 3. 4: MDSC Thermogram of the gelatin/PEG capsule shells after storage at 53%RH for 
24 hours (modulation temperature amplitude ± 1.00
oC, modulation time of 60 seconds, ramp rate 
of 3.00
oC/min).  
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The  gelatin/PEG  capsules  contain  4%  polyethylene  glycol  4000,  which  is 
thought  to  make  the  gelatin  capsules  more  flexible  at  lower  than  normal 
moisture contents, and less dependent on moisture (Jones, 2004d). 
 
The gelatin and gelatin/PEG profiles are similar to one another, with a clear Tg in 
the reversing signal, a sub Tg endothermic peak, a Tm peak and a large water 
evaporation peak occurring in the non reversing signal. Tables 3.3 and 3.4 also 
show slight plasticization effect, with decreases in Tg when PEG is added to the 
gelatin  capsules.  For  example  the  Tgm  of  gelatin  was  69.43 
oC  and  of 
gelatin/PEG 67.18
oC when stored at 35%RH/24 hr. In addition, it was observed 
that the addition of PEG to gelatin capsules does not influence the helix coil 
transition temperature (Tm).  
 
Sorbal et al (2001b) found that the Tg depression caused by sorbitol plasticizer 
in gelatin films was small. This is similar to that seen in this study, where no Tg 
depression was seen for PEG. It was found in their study that for bovine hide 
gelatin films the Tg dropped from 56.5
oC at 15 g sorbital/100 g gelatin, to 37.3
oC 
at 65 g sorbital/100 g gelatin, and for porcine gelatin films the drop was from 
50.3
oC at 15 g sorbital/100g gelatin to 26.3
oC at 45 g sorbital/100 g gelatin. 
Although the two studies described used gelatin from different origins, however 
similar patterns were observed, where slight decreases in Tg temperature were 
found in this study when PEG 4000 was added to gelatin capsules, the greatest 
drop  in  Tg  was  observed  for  the  capsules  stored  at  35%RH/  24  hr  (69.43  – 
66.76
oC for gelatin and gelatin/PEG respectively). 
 
Vanin el al (2005) studied the effects of plasticizers and their concentrations on 
thermal  and functional  properties  of  gelatin  (pig skin  origin)  based  films. The 
glass transition (Tg) and helix coil transition temperature (melting temperature) 
was calculated (Tm). It was shown that the Tg of gelatin films ranged from 13.4
oC 
to  98.5
oC  depending  on  the  plasticizer  used  and  its  concentration,  and  that 
lower values of Tg and Tm were observed with DTG (diethylene glycol) followed 
by  PPG  (polypropylene  glycol)  and  GLY  (glycerol). With  DTG  the  Tg  ranged 
between 13.4
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gelatin), with PPG the Tg ranged between 61.9
oC and 69.9
oC, and with GLY 
ranged between 41.4
oC and 82.5
oC. Another study by Sothornvit et al (2002) 
demonstrated that the concentration of plasticizer (PEG 200 and 400) did not 
influence the Tg of beta lactoglobulin films.  
Cao et al (2009) used PEG with different molecular weights (300 – 20 000) to 
plasticize gelatin films, and found that PEG of lower molecular weights exhibited 
a better plasticizing effect, since the increase in MW of PEG results in its polarity 
and solubility decrease. PEG with MW 300 – 600 is in liquid state, MW 800 is a 
soft wax, and those with MW 1500, 4000, 10 000 and 20 000 are a sheet solid at 
ambient temperature. This could explain the small plasticization effects of PEG 
(4000) on gelatin capsules in this study; PEG with a MW of 4000 is suitable and 
does not interfere with hard capsule manufacture.  
It has been suggested that polar groups (  OH) along plasticizer chains develop 
polymer  –  plasticizer  hydrogen  bonds  replacing  the  polymer  –  polymer 
interactions in biopolymer films. The hydrogen bonding ability of PEG is affected 
by  factors  such  as  the  number  of  hydroxyl  groups  per  mole, molecular  size, 
solubility and polarity (Yang and Paulson, 2000; Cao et al., 2009). 
 
3.2.3.2  Glass Transition Temperature (Tg) of Hypromellose (HPMC) 
Capsules 
 
The  glass  transition  temperatures  for  the  various  HPMC  capsule  shells  are 
shown below in Table 3.5: the results are the mean and standard deviation of 
three replicates. 
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Table 3. 5:  The glass transition temperature of different HPMC capsules after 
storage, effect of time & RH 
 
 
Glass Transition (
oC) 
Capsule Shell 
  
Storage Condition 
  
1  2  3 
Mean 
  
STD 
  
35%RH/24 hr  157.99  157.87  157.34  157.74  0.34 
53%RH/24 hr  157.36  159.37  159.14  158.62  1.1 
35%RH/3 days  157.36  158.12  158.12  157.86  0.43 
Old HPMC 
  
53%RH/3 days  158.28  158.16  157.79  158.07  0.25 
35%RH/24 hr  152.29  152.28  152.48  152.35  0.11 
53%RH/24 hr  152.02  152.28  152.28  152.19  0.15 
35%RH/3 days  151.26  151.27  151.27  151.26  0.005 
New HPMC 
  
53%RH/3 days  150.6  150.51  150.51  150.54  0.05 
35%RH/24 hr  151.78  151.78  151.52  151.69  0.15 
53%RH/24 hr  151.96  151.61  151.98   151.79  0.25 
35%RH/3 days  151.22  151.52  151.52  151.42  0.17 
E0501493 
  
53%RH/3 days  151.25  151.52  151.27  151.34  0.15 
 
The scans for the HPMC capsule shells were performed through a temperature 
range from 10.00 to 240.00
oC at a ramp rate of 2.00 
oC/min and a modulation 
period  of  60s.  The  profiles  obtained  for  the  Old  HPMC,  New  HPMC  and 
E0501493 HPMC are shown below in Figure 3.5, 3.6 and 3.7 respectively.  
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Figure 3. 5: MDSC Thermogram sample of the old HPMC capsule shells after storage at 
35%RH for 24 hours (modulation temperature amplitude ± 2.00
oC, modulation time of 60 
seconds, ramp rate of 2.00
oC/min). 
 
Figure 3. 6: MDSC Thermogram sample of the New HPMC capsule shells after storage at 
35%RH for 24 hours (modulation temperature amplitude ± 2.00
oC, modulation time of 60 
seconds, ramp rate of 2.00
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Figure 3. 7: MDSC Thermogram sample of the E0504193 HPMC capsule shells after storage at 
35%RH/24 hr (modulation temperature amplitude ± 2.00
oC, modulation time of 60 seconds, 
ramp rate of 2.00
oC/min). 
 
The results generally show that the new and E0504194 HPMC capsules had a 
lower Tg temperature when compared with the Old HPMC, and generally had 
smaller  standard  deviation  values.  For  example:  152.35  ±0.11
oC  vs  157.74 
±0.34
 oC for new and Old HPMC capsules respectively. The results also show 
that RH and storage time did not influence the Tg for the Old HPMC capsules, 
since the values were very similar at all storage conditions (p > 0.05). However, 
relative humidity and time were influential factors affecting the Tg for both the 
E0504193  and  New  HPMC  capsules  (p  <  0.001)  with  significant  differences 
between the 24 hr and 3 days storage at both relative humidities  (Appendix 3, 
Tables 3.14 and 3.15). 
 
Ford (1999) described HPMC as being a non homogenous polymer. Therefore, 
its Tg is not a sharp transition even in fully optimised systems, and can occur 
over a wide temperature range possibly as large as 30
oC. The glass transition 
seen here in the reversing signal for the HPMC capsule shells is one that is 
broad and occurs over a wide temperature range with an onset from ~ 142 to 
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HPMC  used.  No  indication  of  any  crystallinty  was  observed  in  the  MDSC 
thermograms and therefore the polymers were considered to be amorphous.  
The profiles obtained for the three HPMC types in this study are similar, with a 
broad endotherm at the initial portion of the total heat flow and non reversing 
signal, which is a characteristic of the evaporation of moisture, and occurs at a 
temperature  of  about  63
oC.  According  to  Ford  (1999),  the  glass  transition 
temperature is dependent upon the amount of moisture in a sample, as moisture 
not only lowers the temperature at which the transition occurs but also broadens 
the range over which it is seen. 
 
The E0501493 HPMC capsule shells, at 35% and 53%RH/24 hr storage have 
the  lowest  glass  transition  (151.69
oC  and  151.79
oC  respectively)  when 
compared with the New HPMC (152.35
oC and 152.19
oC respectively), and old 
HPMC (157.74
oC and 158.62
oC respectively) capsule shells. However, at 35% 
and 53%RH/3 days, the Tg of the new HPMC shells decreases slightly, and the 
values become closer to those obtained for the E0501493 HPMC batch (151.26 
oC and 150.54 
oC) vs (151.42
oC and 151.34 
oC) for New HPMC and E0504193 
respectively. These values are similar to those reported in a study by Sakellariou 
et  al  (1985)  in  which  the  thermomechanical  properties  and  glass  transition 
temperatures of a number of cellulose derivatives used in the film coating of oral 
dosage  forms  were  studied  using  DSC,  differential  thermal  analysis  and  the 
torisional braid pendulum. The powdered samples of HPMC had a Tg of 180
oC. 
However, when a cast film was used that had been made from a solvent mixture 
of equal parts by volume of dichloromethane and methanol, the Tg was reduced 
to 157
oC. The thermomechanical spectra of two grades of HPMC showed slight 
but significant differences, HPMC (b) with a value of 158.5
oC, and HPMC (a) 
with a  value of 153.5
oC. This difference was due to differences in molecular 
weight distributions of the two batches, with HPMC (a) containing a considerable 
fraction  of  low  molecular  weight  species  and  HPMC  (b)  containing  a 
considerable fraction of high molecular weight species. The shorter chains in 
HPMC (a) will result in additional free volume and mobility due to the increased 
number of chain ends causing a reduction in its glass transition temperature. 
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McPhillips et al (1999), used MDSC with a HPMC powder sample in pin hole 
pans with a scan rate of 2
oC/min, a modulation amplitude of 0.212 
oC, and a 
modulation  period  of  40s.  The  profile  showed  a  broad  low  temperature 
endotherm in the total heat flow, similar to the one obtained in this study. In 
addition,  a  corresponding  Tg  value  of  167.2
oC  in  the  reversing  signal.  Using 
HPMC films, the glass transitions were found to be 165.8
oC (scan rate 2
oC/min) 
and 165.2
oC (scan rate 5
oC/min). Joshi and Wilson (1993) also determined the 
glass transition of HPMC E5 from aqueous cast films in DSC pans showing it to 
be 154
oC. With a 1% moisture level, this value decreased to 152
oC and no glass 
transition  was  observed  for  samples  containing  greater  than  1%  water. 
However, this finding was not seen for the HPMC capsule shells studied here, 
as it was found that storage at a higher relative humidity did not influence the Tg 
of the HPMC capsules and only shifted the glass transition of the new HPMC by 
a small fraction.  
 
3.3  Mechanical Properties of Capsule Shells 
3.3.1  Dynamic Mechanical Analysis 
3.3.1.1  Static Scans 
 
The modulus of elasticity of the capsule shells were calculated from the slope of 
the linear portion of the stress strain curve (See Chapter 2, Fig. 2.8). The values 
obtained for Young’s modulus at storage conditions of 35% RH and 53% RH for 
24 hours and 3 days are reported in Table 3.6. These are also represented in 
Figures 3.8 and 3.9 respectively.  
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Table 3. 6: Young’s modulus (MPa) of the various capsule cap shells, effect of 
RH and time. 
 
Storage Modulus (MPa)   
Capsule Shell 
Type   35% RH/24 
hr 
35%RH /3 
days 
53%RH /24 hr  53%RH /3 
days 
Gelatin  1.102 (0.04)  1.046 (0.47)  0.98 (0.09)  1.092 (0.07) 
Gelatin/peg  1.182 (0.12)  1.173 (0.06)  1.257 (0.11)  1.051 (0.04) 
Old HPMC  1.251 (0.12)  1.094 (0.07)  1.166 (0.05)  0.885 (0.01) 
New HPMC   1.274 (0.23)  1.077 (0.06)  0.748 (0.02)  0.728 (0.03) 
HPMC 
(E0504193) 
0.862 (0.42)  0.816 (0.07)  0.799 (0.06)  0.762 (0.03) 
Cap  1.28 (0.05)  1.13 (0.07)  0.923 (0.023)  0.883 (0.03)  S4 
Body  0.938 (0.05)  0.933 (0.02)  0.787 (0.05)  0.882 (0.04) 
Cap  0.822 (0.05)  0.83 (0.02)  0.776 (0.03)  0.778 (0.08)  S1 
Body  0.730 (0.04)  0.741 (0.04)  0.793 (0.06)  0.753 (0.02) 
S00  0.864 (0.02)  0.933 (0.06)  0.762 (0.02)  0.928 (0.04) 
S4, S1 and S00 refer to the different sizes of the capsules 
The results are the mean and (standard deviation) of 5 replicates 
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Figure 3. 8: Young’s modulus of elasticity of hard shell capsule caps stored at 35%RH 
 
 
 
Figure 3. 9: Young’s modulus of elasticity of hard shell capsule caps stored at 53%RH 
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The results generally show that the gelatin and gelatin/PEG capsule shells had 
higher  Young’s  modulus  values  when  compared  with  HPMC  capsules, 
especially New, E0504193, S1,S4 and S00 HPMC. For example 1.102 MPa vs 
0.862 MPa for gelatin and E0504193 HPMC respectively stored at 35%RH/24 
hr, and 1.092 MPa vs 0.762 MPa for gelatin and E0504193 HPMC respectively 
stored at 53%RH/3 days.  
 
Table 3.6 and Figure 3.8 show that all size 0 capsules apart from E0504193 
HPMC had a similar Young’s modulus when stored at 35%RH/ 24 hours and 3 
days (one way ANOVA p > 0.05) (see Appendix 3, Tables 3.16, and 3.17 for 
post hoc scheffe tests). Initially when the capsules were stored at 35%RH for 24 
hours,  the  Old  and  New  HPMC  capsule  caps  had  slightly  higher  Young’s 
modulus values than gelatin and gelatin/PEG. This could be due to the lower 
moisture content associated with the HPMC capsule shells. However, when the 
capsules  were  stored  at  35%RH  for  3  days  the  Young’s  modulus  values 
decreased, which is most likely a result of the sorption of moisture as was found 
in Table 3.1 (Section 3.2.1).  
 
The  Young’s  modulus  of  gelatin  capsules  stored  at  35%  RH  decreased  with 
time,  after  24  hr  it  was  1.102  MPa  and  after  3  days  1.046,  similarly  for 
gelatin/PEG  capsules  that  decreased  from  1.182  MPa  to  1.173.  Statistical 
analysis using one way ANOVA shows these drops in values for both capsules 
to be statistically insignificant (p> 0.05).  
 
For Old HPMC the Young’s modulus decreased from 1.251 to 1.094 MPa, New 
HPMC decreased from 1.274 to 1.077
 MPa, and E0504193 HPMC from 0.862 to 
0.816 MPa all after storage at 35%RH/24 hr and 3 days respectively. However, 
this decrease in Young’s modulus between 35%RH/24 hr and 35%RH/3 days for 
all HPMC capsules was not significant (p> 0.05).
 At 35%RH for 3 days all size 0 
capsules apart from E0504193 HPMC were statistically similar (p > 0.05). This 
possibly indicates that the HPMC capsules had absorbed enough moisture to 
give them mechanical properties similar to that of the corresponding gelatin and 
gelatin/PEG capsule shells.  
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As the relative humidity increased further to 53%RH, a similar pattern was seen 
(Table  3.6  and  Figure  3.9)  especially  for  the  HPMC  shells,  with  further 
decreases in the Young’s modulus values when stored at 53%RH/24 hr and 3 
days  respectively.  For  Gelatin/PEG  capsule  caps,  the  Young’s  modulus 
decreased from 1.257MPa (53% RH/24 hr) to 1.051 MPa (53% RH/3 days). No 
decrease  was  found  for  the  gelatin  capsules,  and  comparing  gelatin  and 
gelatin/PEG  shells  using  statistical  analysis  (one way  ANOVA)  at  35%  and 
53%RH/24 hr and 3 days gave statistically insignificant results (p = 0.063) and 
(p  =  0.079)  respectively.  Therefore,  storage  RH  and  time  had  no  significant 
effect on the behaviour of these shells.  
 
The Young’s modulus for Old HPMC stored at 53%RG significantly decreased 
with time (p < 0.001). After 24 hours, it was 1.166 MPa, and after 3 days, it was 
0.885 MPa. Similarly for New HPMC caps with a decrease from 0.748 MPa to 
0.728  MPa,  and  for  E0501493  HPMC  cap  shells  the  young’s  modulus 
decreased from 0.799 MPa to 0.762 MPa. The decreases seen for the New and 
E0504193 HPMC are statistically insignificant (p > 0,05) between 53%RH/24 hr 
and 3 days.  
 
 At 53%RH/24 and 3 days all HPMC capsule shell caps (apart from Old HPMC 
stored for 24 hours) had a significantly smaller Young’s modulus than the gelatin 
and gelatin/PEG capsules (p < 0.001) (See Appendix 3, Tables 3.18    3.19). 
This could be due to the tendency to absorb more moisture at higher storage 
conditions (Podczeck, 2002). This was also seen in Table 3.1, Section 3.2.1, 
which shows the moisture uptake for the different capsule shells. For example 
the moisture uptake of New HPMC, E0504193 HPMC and gelatin after storage 
at  53%RH/3  days  was  2.77%  ±  0.19,  2.86%  ±  0.05  and  2.19%  ±  0.06 
respectively. Statistical analysis using one way ANOVA for Old and New HPMC 
shells indicated that storage conditions (35% and 53%RH/24 hr and 3 days) had 
a significant effect on changes in their elastic properties (p < 0.001) (For post 
hoc  scheffe  tests  see  Appendix  3,  Table  3.20  and  3.21)  however  was 
statistically insignificant for the E0504193 HPMC (p > 0.05). 
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Yakimets el al (2005) investigated the mechanical properties of gelatin films in 
the glassy state. Uniaxial tension tests were performed in order to characterize 
the mechanical behaviour with respect to water content. It was demonstrated 
that at water content above 14%, the elasticity modulus of the films showed a 
significant  decrease.  This  effect  was  explained  by  the  appearance  of 
polymolecular water. It was also observed that at water content up to 7% and 
from 14 to 22% the glassy gelatin films exhibited a typical brittle behaviour and 
the fracture occurred in the area of viscoelastic deformation. 
 
Lee  and  Jones  (2007)  studied  the  effects  of  moisture  content  on  puncturing 
properties of hard hypromellose capsules for inhalation. The moisture content 
was measured by loss on drying after 2 hours in an oven set at 100
oC (± 5
o). 
Capsules were stored at 11%, 33% and 55% RH, and the moisture contents of 
the capsules after conditioning were 2.0%, 3.8% and 6.2% respectively. It was 
found that as the capsule shells became more hydrated they were more elastic 
and deformable. In this study, capsules stored at 35% and 53%RH for 24 hours 
and 3 days showed moisture contents of 3.02%, 4.29%, 4.76% and 5.35% for 
Old HPMC, and similar values for New and E0504193 HPMC (See Table 3.2). 
Hence, higher relative humidity and longer storage periods led to decreases in 
Young’s  modulus  for  HPMC  capsule  shells,  therefore  increasing  their  elastic 
properties.  Birchall and Jones (2008) compared the puncturing properties of 
gelatin  and hypromellose  capsules  stored at  11 and 33%  RH  and found the 
puncturing properties of hypromellose capsules to be less affected than gelatin 
over a range of lower moisture contents.  
 
The results presented in this study indicate that under low RH storage conditions 
(35%RH  for  24  hr  and  3  days),  all  capsules  exhibit  similar  deformation 
properties, however, at higher humidity and a longer storage period (53%RH for 
24  hr  and  3  days);  the  capsules  begin  to  behave  differently,  due  to  greater 
differences in moisture uptake. Hence, moisture content plays an important role 
in the determination of the stiffness of capsule shell materials. In general, the 
values for Young’s modulus at 53%RH for all capsule types are lower than those 
at 35%RH. In addition, the results generally showed that the Young’s modulus of 
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time and are similar to the values obtained for the New and E0504193 HPMC, 
especially at 53%RH.  
 
 
3.3.1.1.1  Further Investigations of Young’s Modulus Values for the 
Capsule Shells 
 
Since the capsule shells are round at contact (shoulder), it could be argued that 
the size of the contact is small in relation to the dimensions of the capsule cap 
(See Figure 3.10).  
 
Figure 3. 10: Area of contact between a capsule cap and a flat surface 
 
To determine the contact area between the capsule cap and the DMA probe, a 
method first developed by Podczeck et al. (1996) to determine the contact area 
between small particles and a surface was adapted. This method was chosen 
because the DMA exerts only small loadings (in the low Newton range) and it is 
assumed  that  the  deformation  caused  is  not  permanent.  Therefore,  further 
calculations were made to obtain flattened contact areas between capsule shell 
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to calculate the corrected Young’s modulus of the different shells as obtained 
from  the  static  scans  accordingly.  One  of  the  important  factors,  which  were 
determined, was the reduced Young’s modulus E*: when two materials are in 
close  contact,  for  example  during  indentation,  the  elastic  properties  of  the 
contacting  surfaces  at  the  contact  point  change  (Timoshenko  and  Goodier, 
1970) compared to the bulk properties of the materials. The reduced Young’s 
modulus can be calculated from equation 3.1: 
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1 ν ν   (Equation 3.1) 
E1 and E2 are the Young’s modulus for brass and the capsule shells (gelatin or 
HPMC) respectively. These maybe taken as 7 x 10
8 N/m
2 (0.7 GPa) for gelatin 
(Fukae et al., 2005), 1.30 x 10
9 N/m
2 (1.3 GPa) for HPMC (Rowe and Roberts, 
1995) and 1 x 10
11 N/m
2 (100 GPa) for Brass (Lide, 2005), ν
2
1 and ν
2
2are the 
Poisson’s ratios for the materials in contact. The Poisson’s ratio is the ratio of 
the  transverse  strain  to  the  axial  strain.  This  ratio  is  not  reported  for  the 
individual  materials  but  is  usually  in  the  range  of  0.28  to  0.35,  therefore  an 
average of 0.3 has been used here (Benham, 1998). 
 
The radius of the flattened part of the capsule shell shoulder a0 can be estimated 
using  simple  Hertz  theory  (Hertz,  1896)  and  is  represented  by  equation  3.2, 
where the assumption of full elastic behaviour of the capsules is made: 
 
( )
* 4
3 3
0 Ε
=
RP
α  (Equation 3.2) 
     
Where  R  is  the  radius  of  the  capsule  shoulder  and  is  calculated  from  the 
diameter of the capsule shells that were available in the capsule specification 
manual and are also reported by Jones (2004d). P is the maximum force applied 
by the DMA during the test (2.5 N was used for static scans), and E* is the 
reduced Young’s modulus which was calculated as 0.764 GPa for gelatin and 
1.41 GPa for HPMC. The contact area can then simply be calculated using the 
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2
0 πα = A   (Equation 3.3) 
 
 Conversion factors for the capsule shells were then calculated. This was done 
by  dividing  the  area  of  the  DMA  plate  that  comes  into  contact  with  the  cap 
shoulder (19.625 mm
2) by the contact areas (mm
2) of the capsule shells.  
The parameters described above for the different capsules were calculated and 
are tabulated below in Table 3.7 
 
Table 3. 7: Contact areas and reduced Young’s modulus parameters for the 
different capsule shells 
 
Capsule Type  Radius  Reduced 
Young's 
Modulus 
(GPa) 
Flattening 
radius   
Hertz 
theory 
(mm) 
Contact 
area 
(mm
2) 
Conversion 
Factor  
Gelatin Size 0   3.84  0.764  0.211  0.140  140.1 
HPMC Size 0  3.84  1.410  0.172  0.093  210.8 
Cap   
      2.67 
 
1.410 
 
0.153 
 
0.073  268.6 
HPMC 
Size 4  
Body  2.54 
 
1.410  0.150  0.071  277.6 
 
Cap   
3.46  
 
1.410 
 
0.166  
 
0.087 
 
226.0  
HPMC 
Size1  
Body  3.33  1.410  0.164  0.085  231.8 
HPMC Size 00  4.28   1.410  0.179  0.100  196.1 
 
The new Young’s modulus values for the different capsule shells based on the 
theory  described  above  were  calculated  by  multiplying  the  original  obtained 
values for the Young’s modulus (Table 3.6) by the conversion factors (Table 
3.9). The results are presented below in Table 3.8. 
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Table 3. 8: New Young’s modulus (MPa) of the various capsule cap shells, 
effect of RH and storage time  
  The results are the mean and (Standard Deviation) of 5 replicates 
 
The results presented in Table 3.8 generally show a similar trend to the original 
Young’s  modulus  values  presented  in  Table  3.6.  Where  it  was  found  that 
storage humidity and time had no significant effect on the behaviour of gelatin (P 
= 0.063), gelatin/PEG (p = 0.056) and E050 HPMC (p = 0.125) capsules. 
 
Table  3.6  shows  that  gelatin  and  gelatin/PEG  capsules  when  stored  at 
35%RH/24  hr  and  3  days  were  more  elastic  than  the  old  and  New  HPMC 
capsules  stored  at  the  same  conditions,  which  was  attributed  to  their  higher 
moisture  content.    This  can  also  be  seen  in  Table  3.8  where  gelatin  and 
gelatin/PEG  shells  had  a  significantly  smaller  Young’s  modulus  than  old and 
New  HPMC  stored  at  those  conditions  (one  way  ANOVA  p  <  0.001).  For 
example 314.11 MPa vs 154.41 MPa for old HPMC and gelatin respectively, and 
319.86 MPa vs 154.41 MPa for New HPMC and gelatin capsules respectively 
both stored at 35%RH/24 hr (P < 0.001) (See Appendix 3 Tables 3.22 and 3.23 
for Post hoc Scheffe tests).  
 
Young’s  modulus  values,  in  general,  for  all  HPMC  capsules  (Table  3.8)  are 
higher than the values obtained for gelatin and gelatin/PEG shells. However, the 
Young’s Modulus (MPa)   
Capsule Shell 
Type  
35%Rh/24 hr  35%RH/3 
days 
53%RH/24 
hr 
53%RH/3 
days 
Gelatin  154.41 (6.0)  146.57 (7.4)  137.23 (14.0)  152.94 (12.0) 
Gelatin/peg  165.53 (19.0)  170.30 (18.0)  176.12 (18.0)  147.21 (6.0) 
Old HPMC  314.11 (33.1)  231.00 (16.0)  245.79 (11.5)  186.59 (3.4) 
New HPMC   319.86 (78.0)  227.05 (13.5)  153.48 (4.1)  157.67 (7.3) 
HPMC 
(E0504193) 
181.63 (10.0)  172.00 (17.5)  168.39 (15.1)  160.55 (7.5) 
cap  342.48 (15.0)  303.99 (18.5)  247.81 (6.4)  237.23 (8.5)  S4 
  body  260.51 (15.0)  259.01 (15.2)  218.58 (11.0)  244.72 (17.1) 
cap  185.98 (10.2)  187.60 (5.0)  175.46 (6.6)  175.90 (17.4)  S1 
  body  295.56 (12.2)  171.71 (8.4)  183.91 (10.0)  174.53 (5.6) 
S00  cap  169.60 (3.0)  177.07 (12.0)  119.42 (14.0)  182.07 (9.5) Chapter Three                   Physical and Mechanical Properties of Capsule Shells 
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results  show  a  significant  decrease  in  stiffness  for  HPMC  capsules  with  an 
increase in RH and storage time (p < 0.001). At 53%RH/3 days differences seen 
between size 0 HPMC (apart from Old HPMC), and gelatin and between S1, 
S00 HPMC and gelatin are statistically insignificant (P > 0.05) (see Appendix 3, 
Tables 3.24 – 3.32 for Post hoc Scheffé tests).  
 
These results indicate that with increase in RH and storage time (i.e 53%RH and 
3 days) HPMC shells  will have a tendency to become more elastic than the 
gelatin  shells  due  to  uptake  of  more  moisture  and  possibly  the  presence  of 
loosely bound water, which was described by Kuentz et al (2006). 
 
Kuentz et al (2006) characterized the softening of empty hard gelatin and HPMC 
capsules by means of mechanical tests, a Bareiss hardness test, and a stiffness 
test using a texture analysis method. A benchtop time domain NMR method was 
applied to characterize the physico chemical state of water in the capsule shells 
and  to  correlate  this with  the  results  of  the  mechanical tests. Three different 
water  populations  were  identified  in  the  capsule  shells  that  differ  in  their 
molecular mobility. These were described as: tightly bound (M3), Bound (M2), 
and loosely bound (M1). The most loosely bound water fraction dominated in the 
capsule  shells  in  the  range  beyond  60%  relative  humidity,  and  at  humidities 
between  10  and  35%,  water  is  present  in  all  the  three  forms  and  in  similar 
proportions. A decline of stiffness in HPMC capsules as a function of the M1 
water subsystem was found, and was lower than the corresponding values for 
gelatin. They also found that the tightly bound water (M3) for HPMC capsules 
increased slightly under very dry conditions and showed the most noticeable 
difference  in  comparison  with  gelatin.  This  could  explain  the  significant 
differences, which were seen in this study at 35%RH/24 hr between the gelatin 
and  HPMC  capsules.  Kuentz  et  al  (2006)  added  that  the  amount  of  loosely 
bound water in the sample could be held as a marker for mechanical stiffness of 
gelatin and HPMC capsules. 
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3.3.1.2  Linear Creep 
Creep tests measure the time dependent changes in the observed strain under 
defined  stress.  The  results  obtained  from  the  creep recovery  tests  of  the 
different capsule shells are presented in Table 3.9 and Figure 3.11 showing the 
retarded  compliance,  JR,  which  is  the  elastic  element  of  the  material;  this  is 
related to the delayed reaction of the shell when an applied stress is removed. 
Figure 3.12 shows the Newtonian compliance, JN, which is associated with the 
viscous element of the material. For the calculation of JR and JN, refer to Chapter 
2, Section 2.3.3.1.2. 
 
Table 3. 9: Percentage Retarded (JR) and Newtonian (JN) Compliance of the 
various capsule shell caps after storage under different conditions  
 
%JR  %JN  %JR   %JN  %JR   %JN  %JR  %JN 
  
  
Capsule Type  
35%RH / 24hr 
Storage 
35%RH / 3day 
storage 
53%RH / 24hr 
Storage 
53%RH / 3day 
storage 
Gelatin  98.47 
(0.12) 
1.58 
(0.12) 
98.42 
(0.1) 
1.57 
(0.1) 
98.35 
(0.09) 
1.65 
(0.09) 
98.26 
(0.07) 
1.69 
(0.07) 
Gelatin/PEG  98.57 
(0.06) 
1.43 
(0.06) 
98.47 
(0.07) 
1.51 
(0.07) 
98.44 
(0.32) 
1.56 
(0.32) 
98.42 
(0.74) 
1.53 
(0.74) 
Old HPMC  99.13 
(0.08) 
0.87 
(0.08) 
98.66 
(0.1) 
0.89 
(0.1) 
98.95 
(0.05) 
1.06 
(0.05) 
99.22 
(0.11) 
1.11 
(0.11) 
New HPMC  99.26 
(0.05) 
0.74 
(0.05) 
99.21 
(0.03) 
0.81 
(0.03) 
98.67 
(0.03) 
1.33 
(0.03) 
98.68 
(0.06) 
1.32 
(0.06) 
E0501493 
HPMC 
99.32 
(0.6) 
0.75 
 (0.6) 
98.99 
(0.11) 
1.04 
(0.11) 
98.74 
(0.06) 
1.26 
(0.06) 
98.75 
(0.1) 
1.28 
(0.1) 
Cap      98.93 
(0.1) 
1.07 
(0.1) 
    98.51 
(0.08) 
1.49 
(0.08) 
HPMC 
S4 
Body      99.12 
(0.1) 
0.88 
(0.1) 
    98.83 
(0.1) 
1.17 
(0.1) 
Cap      99.00 
(0.03) 
1.00 
(0.03) 
    98.64 
(0.07) 
1.36 
(0.07) 
HPMC 
S1 
Body      99.19 
(0.06) 
0.81 
(0.06) 
    98.92 
(0.06) 
1.08 
(0.06) 
HPMC 
S00 
Cap      99.29 
(0.08) 
0.79 
(008) 
    98.83 
(0.15) 
1.17 
(0.15) 
The results are the mean and (Standard Deviation) of 5 replicates 
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Figure 3. 11: Percentage Retarded compliance of the various capsule shell caps after storage 
under different conditions 
 
Figure 3. 12: Percentage Newtonian Compliance of the various capsule shell caps after storage 
under different conditions 
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Table  3.9  generally  shows  a  decrease  in  %  JR  with  an  increase  in  RH  and 
storage time for all capsules. For example, % JR for gelatin caps decreased from 
98.47% ± 0.12 (35%RH/24 hr) to 98.26% ± 0.07 (53%RH/3 days), and for the 
New HPMC caps decreased from 99.26% ± 0.05 (35%RH/24 hr) to 98.68% ± 
0.06  (53%RH/3  days).  The  results  also  show  that  the  %  JR  for  all  HPMC 
capsules was higher than that of the gelatin and the gelatin/PEG at all storage 
conditions. For example at 35%RH/24 hr the % JR for old HPMC and gelatin was 
99.13% ± 0.08  and 98.47% ± 0.12 respectively. Similarly for S00 HPMC and 
gelatin  stored  at  35%RH/3  days  was  99.29%  ±  0.08  and  98.42%  ±  0.1 
respectively. 
 
The % JR results presented in Table 3.9 were assessed using one way ANOVA. 
It was found that differences seen between gelatin and all HPMC capsules at all 
storage conditions (apart from 53%RH/3 days) were statistically significant (p < 
0.05). Post hoc (Scheffé) tests were applied to evaluate differences between the 
means (Appendix 3, Tables 3.33 – 3.36).  
 
At 35%RH/24 hr (Table 3.9 and Figure 3.11) gelatin and gelatin/PEG caps had a 
statistically similar % JR (98.47 % vs 98.57 %  respectively) (p > 0.05), also, the 
small differences seen between size 0 HPMC caps (Table 3.9) were insignificant 
(Appendix 3, Table 3.33). Comparing the gelatin and size 0 HPMC capsules 
stored at 35%RH/24 hr, it is clear that the % JR of the gelatin/PEG, and gelatin 
capsule shell caps is significantly lower (p < 0.05) than the retarded compliance 
of the corresponding HPMC capsules, indicating that the shells are less elastic 
and do not fully recover from an applied stress, or may take longer to recover 
from an applied stress when compared with the HPMC capsule shells which 
show almost complete recovery.  
 
The same observations were found for capsules stored at 35%RH/3 days and at 
53%RH/24 hr, where gelatin and gelatin/PEG caps had statistically similar %JR 
values  (98.42%  vs  98.47%  respectively)  for  gelatin  caps    and  (98.35%  vs 
98.44% respectively) for gelatin/PEG. Results presented in Table 3.9 and Post 
hoc (Scheffé) tests (See Appendix 3, Table 3.34 and 3.35) show that size 0 
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storage  conditions.  For  example,   for  Old,  New  and  E0504193 HPMC  shells 
stored  at  35%RH/3  days,  the  results  were  (98.66%,  99.21%,  and  98.99%). 
Scheffé tests also showed that sizes 4, 1, and 00 HPMC caps were statistically 
similar to size 0 HPMC caps (p > 0.05).  
 
Further increase in storage time from 24 hours to 3 days at 53%RH showed no 
further change in % JR for HPMC capsules, (98.95% vs 99.2%) for Old HPMC, 
(98.67% vs 98.68%) for New HPMC, and (98.74% vs 98.75%) for E0504193 
HPMC all stored at 53%RH for 24 hours and 3 days respectively. Significant 
differences  were  found  between  sample  means    of  all  capsules  tested  after 
storage  at  53%RH/3  days  (p  <  0.001),  however,  Post hoc  (Scheffé)  tests 
(Appendix  3,  Table  3.36)  show  that  those  difference  were  only  between 
gelatin/PEG capsules and Old HPMC plus S00 HPMC caps. 
 
Further  statistical  analysis  on  the  individual  capsules  showed  that  the  small 
decreases  in  %  JR  for  gelatin  and  gelatin/PEG  shells  from  35%RH/24  hr  to 
53%RH/3 days was insignificant (p = 0.107 and 0.179 respectively). For HPMC 
capsules, RH and time lead to significant decreases in the %JR. These changes 
were  especially  seen  between  the  two  storage  conditions  35%RH/24  hr  and 
53%RH/3 days (Appendix 3, Tables 3.37 – 3.39). This finding agrees with that 
described by Kuentz el al (2006), where it found that the behaviour of tightly 
bound  water  showed  the  most  noticeable  difference  for  HPMC  polymer  in 
comparison with gelatin. This could then explain the significant differences that 
were seen in most cases between 35%RH/24 hr and 53%RH/3 days for the 
HPMC capsules.  
 
The  results  presented  above  indicate  that  higher  RH  and  increased  storage 
times  reduce  the  elasticity  of  all  capsule  types,  and  reduce  their  recovery 
properties  to  an  applied  stress.  However,  the  HPMC  capsules  are  the  most 
elastic type of shells with better recovery in comparison to gelatin that showed 
lower  %  JR  at  all  storage  conditions.  These  results  are  in  agreement  with 
Podczeck (2002) who compared the elasticity of gelatin and HPMC after storage 
at  various  humidities,  and  found  that  HPMC  capsules  are  more  elastic  than 
gelatin. The results also agree with Missaghi and Fassihi (2006) investigating Chapter Three                   Physical and Mechanical Properties of Capsule Shells 
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the mechanical properties of the two types of capsules using a texture analyzer 
TA.XT2i, equipped with Texture Exceed Software and employing a 5 Kg load 
cell, and found that gelatin capsules are harder and less elastic than HPMC 
capsules. 
 
Table 3.9 and Figure 3.12 show the percentage Newtonian compliance of the 
various  capsule  shell  caps  after  storage  under  different  conditions.  The 
Newtonian  compliance  represents  the  viscous  element  of  the  material.  It 
represents the energy loss after the applied stress is removed, and the material 
is allowed to return to its original shape (Stathopoulos, et al., 2007). Figure 3.12 
and Table 3.9 show differences in Newtonian compliance between the different 
capsule shells, with higher values as expected for the gelatin and gelatin/PEG 
shells when compared with the HPMC capsules. Statistical analysis (one way 
ANOVA) showed significant differences between the different capsules shells (p 
< 0.001) when stored at 35%RH/24 hr. By applying Post hoc (Scheffé) tests, 
those differences were found to be between the gelatin and all size 0 HPMC 
capsules (Appendix 3, Table 3.40) 
 
The same findings were obtained when the capsules were stored at 35%RH/3 
days  and  53%RH/24  hr  (one  way  ANOVA,  p  <  0.001),  where  gelatin  and 
gelatin/PEG shells had % JN values higher than all HPMC capsules (Appendix 3, 
Tables 3.41 and 3.42 respectively). For example, at 35%RH/ 3 days % JN for 
gelatin  and  New  HPMC  caps  were  1.58%  and  0.81%  respectively,  and  at 
53%RH/ 24 hr were 1.65% and 1.40%. 
 
Differences seen in % JN for all capsules stored at 53%RH/ 3 days (Figure 3.12) 
was found to be significant (one way ANOVA, p < 0.01). However, Scheffé tests 
(Appendix 3, Table 3.43) showed those differences are only between the Old 
HPMC shells (1.11%) and the gelatin/PEG shells (1.96%).  
 
Statistical analysis of the individual capsules at each storage condition, showed 
that RH and storage time had an insignificant effect on the % JN of the gelatin 
and gelatin/PEG shells (p = 0.107 and 0.179 respectively), and that the %JN of Chapter Three                   Physical and Mechanical Properties of Capsule Shells 
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the  HPMC  capsules  significantly  increased  between  RHs  35%  and  53% 
(Appendix 3, Tables 3.44 – 3.46). 
 
3.3.1.3  Dynamic Scans 
 
Dynamic scans were performed to evaluate the viscoelastic properties of the 
capsule shells. The storage modulus and phase angle as a function of dynamic 
force were recorded.  
 
The storage modulus was initially observed to change as a function of dynamic 
force applied. At low dynamic force values the storage modulus reduced rapidly 
in a non linear fashion and at high dynamic forces, this function became linear 
and continued to decrease for all the capsule types after they had been stored at 
35%RH (Figure 3.13a). However, at high dynamic forces, the storage modulus 
increased in a linear fashion with an increase in dynamic force for the HPMC 
capsules when stored at 53%RH for 24 hours and 53%RH for 3 days (Figure 
3.14b). The change in storage modulus with increasing dynamic force is a result 
of increasing elastic deformation (Podczeck and Almeida, 2002). The storage 
modulus at the maximum dynamic force (700mN) and the slope of the linear 
portion of the storage modulus dynamic force curve were obtained. The phase 
angle as a function of the dynamic force employed increased in some cases with 
increasing dynamic force and in some cases decreased. The phase angle at the 
onset of the linear portion of the storage modulus dynamic force curve and at 
the maximum or end of the linear portion of the modulus dynamic force curve 
was determined and the difference between the two measured phase angles 
was calculated. (For full description of the method, please refer to Chapter 2. 
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Figure 3. 13a: An example of a typical dynamic scan for capsules stored at 35%RH showing a 
decrease in storage modulus (red) at high dynamic forces  
 
 
Figure 3.13b: An example of a dynamic scan for HPMC capsules stored at 53%RH showing an 
increase in storage modulus at high dynamic forces  
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3.3.1.3.1  Effect of Storage Modulus  
The effect of storage conditions and capsule type on the storage modulus of the 
various capsule shells is shown below in Table 3.10 and Figure 3.14. 
 
Table 3. 10: Storage Modulus (MPa), of the various capsule shells, determined 
either at the maximum dynamic force (700 mN), or at the end of the linear 
portion of the storage modulus dynamic force curve  
 
Capsule 
Type  
35%RH/24 
hours 
53%RH/24 
hours 
35%RH/3 
days 
53%RH/3 
days 
Gelatin   26.61  (4.9)  25.32 (1.9)  25.61 (2.5)  24.76 (1.8) 
Gelatin/PEG  27.22  (3.1)  35.61 (7.8)  24.74 (1.8)  32.78 (3.0) 
Old HPMC  23.33  (2.9)  24.57 (3.3)  24.63 (1.8)  22.15 (3.0) 
New HPMC  21.62  (4.6)  23.24 (6.0)  20.37 (2.2)  20.14 (2.1) 
E050 HPMC  17.89  (1.4)  20.86 (2.5)  16.83 (1.2)  16.35 (1.5) 
Cap  17.25  (2.0)  15.92 (2.5)  16.78 (1.5)  16.23 (2.2)  S4 
HPMC  Bod  23.02  (1.0)  25.28 (2.1)  18.27 (10.4)   
Cap  15.78  (1.6)  16.82 (2.4)    14.556 (0.7)  S1 
HPMC  Bod  21.94  (2.0)  25.61 (1.4)  23.26 (5.8)   
S00 
HPMC 
Cap  19.01  (4.1)  21.63 (5.7)  21.08 (5.1)  22.44 (5.1) 
The results are the mean and (Standard Deviation) of 5 replicates 
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Figure 3. 14: The influence of storage conditions and type of capsule on the storage modulus of 
the different capsule shells. The storage modulus, determined at the maximum dynamic force 
(700mN) or at the end of the linear portion of the storage modulus dynamic force curve. 
 
In general, it was found that the storage modulus or elasticity at a dynamic force 
of 700 mN was affected by the storage conditions and was different depending 
on  the  capsule  shell  type.  The  storage  modulus  of  all  capsule  shells  tested, 
apart from gelatin/PEG and size 00 HPMC decreased with an increase in RH 
and storage time (Figure 3.14). However, this was mostly observed between the 
two  storage  conditions  35%RH/24  hr  and  53%RH/3  days.  For  example,  the 
storage modulus of gelatin caps decreased from 26.61 MPa to 24.76 MPa, for 
Old HPMC from 23.33 MPa to 22.15 MPa, and for New HPMC caps decreased 
from 21.62 MPa to 20.14 MPa.  
 
Statistical  analysis  using  one way  ANOVA  showed  these  decreases  to  be 
insignificant (p > 0.05) for all capsule shell types. On the other hand, it was 
found that the two storage conditions 35%RH/3 days and 53%RH/24 hr to be 
significantly different for the gelatin/PEG shells, and the two storage conditions 
53%RH/3 days and 53%RH/24 hr to be significantly different for the E0504193 
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they may only represent the larger variability of the storage modulus for those 
two capsules. 
 
Comparing  the  capsules  shells  to  one  another,  it  was  found  that  the  HPMC 
capsules had a lower storage modulus than the gelatin and gelatin/PEG shells 
at all storage conditions. At 35%RH/ 24  hr and 3 days (one way ANOVA, p < 
0.001),  Post hoc  Scheffé  tests  showed  a  significant  difference  between  the 
E0504193 HPMC (17.88 MPa and 16.83 MPa respectively), and the two capsule 
types  gelatin  (26.61 MPa  and  25.61  MPa)  and  gelatin/PEG  (27.22  MPa  and 
24.74 MPa) capsule shells (Appendix 3, Table 3.47 and 3.48). At 53%RH for 24 
hours  (p  <  0.001)  a  significant  difference  was  seen  between  the  gelatin, 
gelatin/PEG  capsules  and  all  HPMC  capsule  shells  apart  from  Old  HPMC 
(Appendix 3, Table 3.49). 
 
At 53%RH/3 days, differences seen in storage modulus between the Old HPMC 
(22.15  MPa),  E0501493  HPMC  (20.93  MPa),  New  HPMC  (20.14  MPa)  and 
gelatin (24.77 MPa) capsules were insignificant (Appendix 3, Table 3.50). The 
pattern seen for the storage modulus is similar to that observed for the Young’s 
modulus, showing that the HPMC capsules are more elastic than the gelatin 
capsules.  
 
Similar observations were made for sizes 4,1 and 00 HPMC capsules, where 
they  were  found  to  be  statistically  similar  to  size  0  HPMC  capsules  at  the 
different  RH  and  storage  times,  and  statistically  significantly  different  from 
gelatin and gelatin/PEG shells at all storage conditions. However, at 53%RH/3 
days they were only significantly different to the gelatin/PEG shells (Appendix 
3h, Tables 3.47 – 3.50). 
 
3.3.1.3.1.1  Further Investigations of Storage Modulus Values for the 
Capsule Shells 
 
The storage modulus values presented in Table 3.10 were further investigated 
using  the  process  discussed  in  section  3.3.1.1.1.  The  results  obtained  are 
presented below in Table 3.11 Chapter Three                   Physical and Mechanical Properties of Capsule Shells 
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Table 3. 11: New Storage Modulus (MPa), of the various capsule shells, 
determined either at the maximum dynamic force (700 mN), or at the end of the 
linear portion of the storage modulus dynamic force  
 
Capsule Type  35%RH for 24 
hours 
53%RH for 24 
hours 
35%RH for 3 
days 
53%RH for  3 
days 
Gelatin  3727.22 (697.7)  3546.74 (262.9)  3588.21 (355.8)  3469.30 (254.6) 
Gelatin/PEG  3813.24(426.9)  4989.19 (1085.4)  3466.52 (246.3)  4592.53 (649.7) 
Old HPMC  4916.74 (607.0)  5179.15 (692.7)  5191.50 (384.3)  4668.71 (635.8) 
New HPMC  4557.83 (968.9)  4899.24 (1240.8)  4293.03 (464.2)  4245.55 (446.1) 
E0504193 
HPMC  3770.83 (293.8)  4396.57 (527.7)  3548.23 (243.5)  3445.82 (310.6) 
 
Cap 
 
4643.72 (496.0)  4276.11 (534.3) 
 
4508.67 (403.7) 
 
4359.49 (584.5) 
 
S4 
HPMC   
Bod 
 
6389.24 (279.0)  7017.73 (465.2) 
 
6341.70 (555.5) 
 
 
Cap 
 
3567.32 (362.1)  3810.36 (512.4) 
   
3289.66 (157.6) 
 
S1 
HPMC   
Bod 
 
5086.76 (461.2)  5936.40 (294.1) 
 
5391.76 (1358.0) 
 
S00 
HPMC 
 
Cap  3727.23 (809.4)  4241.64 (1009.1) 
 
4134.22 (994.8)  4400.84 (992.5) 
The results are the mean and (Standard Deviation) of 5 replicates 
 
 
The storage modulus results obtained using the process discussed in Section 
3.3.1.1.1  were  similar  to  the  values  found  in  Table  3.10,  with  a  decrease  in 
storage  modulus  for  all  capsule  shells,  apart  from  gelatin/PEG  and  size  00 
HPMC as the RH and storage time increased. This was observed between the 
two storage conditions 35%RH/24 hr and 53%RH/3 days. The results in Table 
3.10 showed that all HPMC capsules had a lower storage modulus than the 
gelatin and gelatin/PEG capsules. However, the results obtained in Table 3.11 
using the flattening radius theory did not show this, instead,  all HPMC capsules, 
apart  from  E050  and  S1  HPMC  caps,  were  found  to  have  higher  storage 
modulus  values  at  all  storage  conditions  when  compared  to  gelatin  and 
gelatin/PEG. 
 
The results obtained from one way ANOVA statistical analysis on the data in 
Table 3.11, and post hoc scheffe tests showed significant differences between 
the gelatin and Old HPMC capsules at all storage conditions (p < 0.005), where 
Old  HPMC  had  significantly  higher  storage  modulus  values.  However,  no Chapter Three                   Physical and Mechanical Properties of Capsule Shells 
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statistical  differences  were  found  between  the  Old  HPMC  and  gelatin/PEG 
shells at 53%RH/24 hr and 3 days. 
Storage modulus values for the New HPMC and size 4 capsules, on the other 
hand were found to be similar to the gelatin and gelatin/PEG shells at all storage 
conditions (p> 0.005), apart from 35%RH/3 days, where the New HPMC and 
size 4 capsules had significantly higher storage modulus values than both the 
gelatin and gelatin/PEG shells (p = 0.008 and 0.001 for New HPMC and S4 
capsules respectively). 
 
Similarly, the storage modulus values for the E0504193 HPMC capsules were 
statistically  similar  to  both  the  gelatin  and  gelatin/PEG  shells  at  all  storage 
conditions (p > 0.05), apart from 53%RH/3 days, where the E0504193 HPMC 
capsules  were  found  to  have  a  significantly  lower  storage  modulus  when 
compared with the gelatin/PEG, p = 0.002, 3445.82 MPa vs 4592.53 MPa for 
E0504193 HPMC and gelatin/PEG capsules respectively.  
 
Size1 HPMC capsules had similar storage modulus values to both gelatin and 
gelatin/PEG shells at all storage conditions (p > 0.005), and had significantly 
lower  values  compared  with  the  gelatin/PEG  shells  at  53%RH/  3  days,  p  = 
0.001, (3289.65 MPa vs 4592.53 MPa) for S1 HPMC and gelatin/PEG shells 
respectively.  
Size 00 HPMC capsules were similar to both gelatin and gelatin/PEG shells at 
all storage conditions (p > 0.05). 
 
Generally, these results indicate that the differences seen between the gelatin 
and all the HPMC capsules are in most cases insignificant, and that the HPMC 
capsules  in  some  cases  had  storage  modulus  values  that  were  significantly 
smaller than the gelatin/PEG shells.  
 
3.3.1.3.2  Effect of Phase Angle  
 
The  phase  angle  of  the  different  capsule  shell  types  was  measured  at  two 
positions (i.e. at a dynamic force of 700mN and at the start of the linear position 
of the storage modulus dynamic force curve), See Figure 3.15. The phase angle Chapter Three                   Physical and Mechanical Properties of Capsule Shells 
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will be zero if the material behaves fully elastically during deformation, whereas 
a value of 90
o is found for a fully viscous behaviour and any phase angle in 
between the two threshold values indicates the degree of viscoelasticity of the 
material being tested under load (Podczeck and Almeida, 2002).  
 
 
 
 
 
 
 
 
 
Figure 3. 15: The phase angle determined at the beginning of the linear portion of the storage 
modulus dynamic force curve  
 
 
Figure  3.15  shows  that  gelatin  and  gelatin/PEG  capsules  had  a  very  similar 
phase angle when stored at the various conditions. HPMC capsule shells had a 
slightly  higher  phase  angle  than  the  gelatin  and  gelatin/PEG  capsule  shells 
when  stored  at  the  same  storage  conditions.  The  results  also  show  that  the 
phase  angle  for  the  HPMC  capsule  shells  increased  when  stored  at  higher 
relative humidity conditions. For example, the phase angle for the Old HPMC 
capsule shells was 3.68
o when stored at 35%RH for 24 hours, this value then 
increased to 3.86
o when stored at 53%RH for 24 hours and the value increased 
further to 4.32
o after storage at 53%RH for 3 days. The same was seen for the 
New HPMC capsules, where the phase angle was 4.03
o when stored at 35%RH 
for 24 hours, this value increased to 4.19
o when stored at 53%RH for 24 hours, 
and increased further to 4.44
o when stored at 53%RH for 3 days. E0504193 
HPMC initially started with a value of 3.91
o which increased to a phase angle 
value of 4.07
o when stored at 53%RH for 24 hours and then to 4.68
o at 53%RH Chapter Three                   Physical and Mechanical Properties of Capsule Shells 
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for  3  days.  This  pattern  was  not  seen  for  the  gelatin,  and  the  gelatin/PEG 
capsules, where they appeared to have a similar or a very slight difference in 
their  phase  angle  regardless  of  the  storage  conditions.  The  phase  angle  for 
gelatin was 3.14
o at 35%RH/24 hrs and after storage for 3 days at 53%RH was 
3.12
o, and for gelatin/peg was 3.08
o at 35%RH/24 hr and after storage for 3 
days at 53%RH was 3.06
o. Figure 3.16 below shows the phase angle of the 
various capsule shells taken at a dynamic force of 700mN. 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. 16: The phase angle determined at a dynamic force of 700mN of the linear portion of 
the storage modulus dynamic force curve  
 
Generally,  the  phase angle for  both the  gelatin  and  the  gelatin/PEG  capsule 
shells increased with an increase in dynamic force. The same was observed for 
all the HPMC capsule shell types when stored at 35%RH for 24 hours and for 3 
days. However, contrary to the gelatin and gelatin/PEG capsule shells, it was 
observed  that  the  phase  angle  for  the  HPMC  capsules  decreased  with  an 
increase in dynamic force after the capsules had been stored at 53%RH for 24 
hours  and  53%RH  for  3  days.  For  example:  after  storing  the  capsules  at 
53%RH/24 hours, the Old HPMC  shells at a dynamic force of 360 mN had a 
phase angle of 3.86
o, which decreased to 3.80
o, the New HPMC capsule shells Chapter Three                   Physical and Mechanical Properties of Capsule Shells 
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at 437 mN had a phase angle of 4.19
o, which decreased to 4.10
o. Similarly, the 
phase angle for E0504193 HPMC decreased from 4.07
o at 313 mN to 4.03
o.  
When the capsules were stored at 53% RH for 3 days, the phase angle for the 
Old HPMC decreased from 4.32
o to 4.08
o, New HPMC from 4.44
o to 4.28
o, and 
for the E0501493 HPMC capsule shells the phase angle decreased from 4.68
o 
to 4.34
o. 
 
The difference between the phase angle at the start of the linear portion of the 
storage modulus dynamic force curve and at a fixed dynamic force of 700mN is 
shown below in Figure 3.17. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. 17: The difference in phase angle determined between the onset of the linear portion 
of the storage modulus dynamic force and a dynamic force of 700mN.  
 
 
The increase in storage modulus and the continuing decrease in phase angle of 
the  HPMC  capsule  shells  with  an  increase  in  humidity  and  elapse  of  time, 
indicates an  increase  in  the  viscoelastic  nature of  the  HPMC  capsule  shells. 
However,  the  decrease  of  storage  modulus  and  tendency  of  phase  angle  to 
increase for the gelatin and gelatin/PEG capsule shells could lead to a decrease 
in their viscoelasticity. 
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3.4  Conclusions  
 
The  physical  properties  of  the  gelatin  capsules  differ  to  those  of  the  HPMC 
capsules, where it was found during the loss on drying studies that the gelatin 
capsules became brittle when moisture had been removed from them; however, 
this  was  not  the  case  with  the  HPMC  capsules,  which  remained  flexible. 
Furthermore, the DSC profiles for the gelatin capsules showed some degree of 
physical aging, again this was not observed for the HPMC shells. The DMA test 
demonstrated that the HPMC capsules were more elastic than the gelatin and 
gelatin/PEG shells with a greater degree of recovery to an applied stress. The 
results  also  demonstrated  that  the  gelatin  and  gelatin/PEG  shells  had  the 
greatest  viscous  element  in  comparison  to  HPMC  capsules,  however,  the 
viscous element of the HPMC capsules increased gradually with an increase in 
RH and time until it reached constant values at 53%RH for 24 hours and 3 days.  
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4.  Capsule Shell Dissolution Studies – Results and Discussion  
 
4.1 Background 
 
When capsules disintegrate, they hydrate, swell, split at the shoulders where the 
walls are thinnest, and allow the contents to escape, leaving the empty capsule 
shell (Jones, 2009). The BP has a disintegration test for capsules but this only 
applies to filled products, thus the purpose of the disintegration test in the British 
Pharmacopoeia is only to check whether the release of the contents happens 
within the time limit required (BP, 2008b). The determination of the endpoint of 
capsule  disintegration  as  described  in  the  BP  is  problematic  because  of  the 
shell’s adhesive nature, which can lead to agglomeration of shell pieces forming 
a larger mass. Thus, it is not possible to separate the disintegration time of the 
powder  plug  and  the  capsule  shell  separately  (Jones,  2004c;  Chiwele  et.al. 
2000). In addition, some materials can cause swelling of the powder plug on 
contact with moisture and some parts of the plug may get trapped at the ends of 
the capsule shell, which may influence the opening time of the capsule shell 
(Jones,  1972;  Chiewele  et.al.,  2000).  A  study  by  Nazzal  et  al  (2002) 
demonstrated that an increase in Chremphor EL concentration in the fill material 
of  hypromellose  capsules  delayed  the  release  of  the  formulation  into  the 
dissolution  medium.  The  delayed  release  was  attributed  to  the  formation  of 
viscous  gel  at  the  lipid water  interface.  Similarly  the  exposure  of  gelatin  to 
aldehyde  groups  in  the  filling  material  can  cause  cross  linking  between  the 
gelatin films, this reduces the solubility of the capsule shell (Marachais, 2003).  
 
The method described by Boymond et al (1966) and modified by Jones and Cole 
(1971) removed the influence of filling material on capsule shell dissolution by 
using steel ball bearings as the fill material because they are chemically inert, 
insoluble and do not absorb, react, or interfere with the capsule being examined. 
The  size  of  the  ball  bearing  was  chosen  to  match  approximately  the  inner 
diameter of the capsule body (Chiewele et.al., 2000).  Jones and Cole (1971) 
found that there was approximately 30% change in solubility of gelatin capsules 
when tested over the permitted temperature range of ± 2.0°C in the BP 1968 test, 
and at 30
oC, the gelatin shells become insoluble. For these reasons the tighter 
temperature range of 37
oC ± 1
oC was adopted in the BP in 1973 (Jones, 2004d).Chapter Four                                                                  Capsule Shell Dissolution  
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The solubility of gelatin and HPMC capsules differ in different aqueous media 
and  this  affects  the  way  in  which  capsules  disintegrate  and  dissolve  (Jones, 
2004e).  The  gelling  agent  used  in  HPMC  capsule  shells  can  also  greatly 
influence the shell dissolution time (Cole et al., 2004). 
 
In this work, the shell dissolution properties of the various capsule shells were 
studied  using  the  ball  bearing  method  as  a  function  of  storage  conditions, 
dissolution  medium,  pH  and  ionic  strength.  The  results  of  these  tests  are 
described below. 
 
 
4.2   Dissolution of Capsule Shells in Deionised Water 
 
The effect of storage conditions and time (35%RH/24 hr, 53%RH/24hr, 35%RH/3 
days and 53%RH/3 days) on the shell dissolution times for the various capsule 
shells in deionised water are presented below in Figure 4.1.  
 
 
Figure 4. 1: Ball bearing release time from capsules in deionised water, effect of storage    
conditions (RH) and time (Bars represent std.dev.) 
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The  shell  dissolution  times  of  the  two piece  hard  shells  after  storage  under 
different conditions are compared in Figure 4.1. The results show that the HPMC 
capsule shells generally gave higher values for dissolution time in water when 
compared with the gelatin and gelatin/PEG capsule shells. 
 
The shell dissolution times of the gelatin/PEG capsules after storage for 24 hours 
at 35% and 53%RH were higher than those obtained with the gelatin capsules, 
i.e.  1.85  min  vs  1.53  min  and  1.80  min  vs  1.34  min  respectively.  The  shell 
dissolution  times  for  the  gelatin/PEG  capsules  were  reduced  for  both  storage 
humidities when the storage time was increased from 24 hours to 3 days. This 
was not seen for the gelatin capsules shells. Differences were also seen with the 
HPMC capsules with the Old HPMC capsule shells having a significantly higher 
mean dissolution time than any of the other HPMC capsules, e.g. 6.46 min vs 
3.29 min and 6.13 min vs 3.94 min for Old HPMC and New HPMC capsules after 
storage at 35% and 53%RH for 24 hours respectively. 
 
The shell dissolution for the New HPMC capsule shells decreased as the RH 
increased,  from  3.94  min  (35%RH/24hrs)  to  2.76  min  (53%RH/24hrs).  The 
HPMC capsules (E0504193) showed a decrease in shell dissolution time with 
both  an  increase  in  storage  time  and  humidity,  for  example  from  4.74  min 
(35%RH/24hr) to 3.63 min (53%RH/3 days). Similar patterns were seen for the 
S1 and S4 capsules shells with a general decrease in dissolution time as the 
storage  time  increased  at  the  higher  humidities.  For  gelatin  and  old  HPMC 
capsule  shells,  some  differences  were  seen  in  the  shell  dissolution  times  at 
different storage conditions but this was not systematic or in any direction. 
 
The  Old  HPMC  capsules  gave  the  longest  dissolution  times,  and  was  almost 
twice as long as the dissolution time for the New HPMC shells at all storage 
conditions. For example; 6.13 min vs 3.39 min at 35%RH/24 hr. 
 
A three way between groups analysis of variance was conducted to explore the 
impact of storage humidity, storage time and capsule type on the ball bearing 
release time from the capsule shells. The results show a significant difference 
between the different capsule shells F (7, 288) = 277.087, P < 0.001, they also Chapter Four                                                                  Capsule Shell Dissolution                                                                      
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show that RH significantly effects shell dissolution time F (1, 288) = 4.303, P = 
0.039. However, storage time (24 hr and 3 days) had an insignificant effect on 
capsule dissolution time F (1, 288) = 0.191, P = 0.663. The results also indicate a 
significant interaction between the two factors (humidity and capsule type) F (7, 
288) = 2.666, P = 0.011, and between (storage time and capsule type) F (7, 288) 
= 5.245, P < 0.001. To see where the differences lie a post hoc (Scheffé) test 
was  performed  (Table  4.1).    Differences  in  the  shell  dissolution  times  of  the 
empty  capsules  are  clearly  seen  for  all  capsule  types,  with  gelatin  and 
gelatin/peg (subset 1) being significantly different to the HPMC shells and the old 
HPMC (subset 4) are significantly different to all other shells. 
Table 4. 1:  Post hoc (Scheffe’) test for shell dissolution data in deionised water  
Subset 
Capsule type  N  1  2  3  4 
Gelatin  40  1.542      
Gelatin/peg  40  1.707      
S1  40   3.187    
S00  40   3.311    
New HPMC  40   3.339    
S4  40     3.917  
E0501493  40     4.051  
Old HPMC  40       6.703 
Sig.    .983  .989  .995  1.000 
Means for groups in homogeneous subsets are displayed.  
 
The standard deviation (SD) and the percentage coefficient of variation (%CV) 
values for the results obtained from the ball bearing test in deionised water are 
shown in Table 4.2.   
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Table 4. 2: Percentage coefficient of variation (%CV) and standard deviation 
(STD)  for  the  shell  dissolution  time  in  deionised  water  after  storage  under 
different conditions  
 
35%RH/24hr 
 
53%RH/24hr  35%RH/3days  53%RH/3days    
Capsule type 
%CV  STD  %CV  STD  %CV  STD  %CV  STD 
Old HPMC  6.0  0.4  13.8  0.9  21.4  1.5  16.0  1.1 
New HPMC   10.2  0.4  4.9  0.2  15.8  0.5  17.4  0.5 
E0504193  17.7  0.8  11.7  0.5  18.1  0.7  26.4  1.0 
Gelatin   5.2  0.1  18.3  0.3  17.0  0.3  17.0  0.3 
Gelatin/PEG  23.3  0.4  14.6  0.3  20.0  0.3  15.8  0.3 
S00 HPMC  4.0  0.1  13.7  0.4  16.1  0.6  15.6  0.5 
S1 HPMC  18.7  0.6  18.1  0.6  26.4  0.9  19.6  0.6 
S4 HPMC  14.2  0.6  12.2  0.5  11.6  0.5  13.4  0.5 
 
When  stored  at  35%RH/24  hr  to  53%RH/3  days,  the  %  CV  for  the  shell 
dissolution  of  the  old  HPMC  shells  increased  from  6.0%  to  16.0%,  for  New 
HPMC  capsules  increased  from  10.2%  to  17.4%,  for  HPMC  capsule  shells 
E0504193  from  17.7%  26.4%.  Similarly,  for  gelatin  increased  from  5.2%  to 
17.0%. This indicates more variation in dissolution time when stored at higher 
relative humidities and for longer storage periods. 
 
 
4.3  Dissolution of Empty Capsule Shells in Sörensen Phosphate Buffer 
(SPB)  (pH 5, 6, 7 and 8) 
 
The effect of storage conditions on the shell dissolution times for the various 
capsule shells in SPB are presented below in Figure 4.2 – 4.5 
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     Figure 4. 2: Capsule shell dissolution in SPB pH 5 buffer, effect of storage conditions. 
 
 
 
    Figure 4. 3: Capsule shell dissolution in SPB pH 6 buffer, effect of storage conditions. 
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     Figure 4. 4: Capsule shell dissolution in SPB pH 7 buffer, effect of storage conditions. 
 
 
 
 
 
   Figure 4. 5: Capsule shell dissolution in SPB pH 8 buffer, effect of storage conditions. 
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The  effect  of  storage  conditions  on  the  shell  dissolution  time  of  the  different 
capsule shells in SPB pH 5 – pH 8 are presented in Figures 4.2 – 4.5. The 
results  showed  that  the  HPMC  capsules  generally  gave  higher  values  for 
dissolution time than the gelatin and gelatin/PEG capsules in SPB pH 5 – pH 8.  
 
Dissolution  time  values  for  the  gelatin/PEG  capsules  were  higher  than  the 
gelatin capsules in all storage conditions. This was especially seen in SPB (pH 6 
– pH 8). 
 
The old HPMC capsule shells showed a significantly higher mean dissolution 
time in deionised water, than any other capsule (apart from S4 at pH 5   7) and 
took almost twice as long to dissolve when comparing with New HPMC capsule 
shells i.e. 9.07 min vs 5.07 min for old HPMC and New HPMC at 35%RH/24hr 
respectively. 
 
At pH 5 (Figure 4.2) the shell dissolution time of the gelatin and gelatin/PEG was 
influenced by the storage conditions: for gelatin decreasing from 2.50 min at 
35%RH/24hr to 1.59 min at 53%RH/3 days, and for gelatin/PEG from 2.35 min 
at 35%RH/24hr to 1.82 min at 53%RH/3 days. Similarly, the shell dissolution 
time for Old HPMC decreased from 9.07 min to 8.53 min, for New HPMC from 
5.07 min to 4.69 min, and for E050 HPMC from 6.06 min to 4.58 min. Decrease 
in shell dissolution time was also seen for sizes 00 and 4 HPMC capsules after 
storage at the higher humidity for 3 days.  
 
The  results  were  subjected  to  three way  ANOVA  (univariate  ANOVA). 
Dissolution  times  were  selected  as  the  dependent  variable,  whilst  storage 
humidity, storage time and capsule type were classified as fixed factors in the 
analysis.  The  test  of  between  subject  effects    showed  that  relative  humidity 
(35% RH and 53% RH) had an insignificant effect on capsule shell dissolution. 
However, the decrease in shell dissolution time with an increase in storage time 
(24 hours and 3 days) was statistically significant F (1, 288) = 9.466, P = 0.002. 
Statistical  analysis  also  showed  that  the  differences  seen  between  the  all 
capsules tested  in SPB pH 5 were statistically significant F (7, 288) = 161.48, P 
< 0.001. Furthur statistical analysis using Post hoc (sheffe’) tests for the capsule Chapter Four                                                                  Capsule Shell Dissolution                                                                      
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shell  types  was  undertaken  (Table  4.3)  and  showed  gelatin/PEG and  gelatin 
(subset 1) to be significantly different to all other HPMC capsules and old HPMC 
and S4 HPMC capsules (subset 3) to different to all other HPMC shells. Capsule 
shell  dissolution  in  SPB  pH  5  showed  differences  in  shell  dissolution  time 
between  the  different  sizes,  00,  1  &  4.  The  shell  dissolution  time  of  the  S4 
capsule shells taking almost twice as long as S00 and S1 (8.92 min vs 4.47 min 
and 4.75 min respectively). 
 
Table 4. 3: Post hoc (Scheffe’) tests for shell dissolution in SPB pH 5  
Subset 
Capsule type   N  1  2  3 
Gelatin/Peg  40  2.144    
Gelatin  40  2.229    
S00  40   4.474  
S1  40   4.755  
New HPMC  40   4.886  
E0501493  40   5.352  
Old HPMC  40     8.921 
S4  40     9.078 
Sig.    1.000  .250  1.000 
Means for groups in homogeneous subsets are displayed.  
Similar patterns were observed in SPB pH 6 (Figure 4.3) with a decrease in the 
capsule shell dissolution time for gelatin capsules from 1.79 min (35%RH/24hr) 
to 1.43 min (53%RH/3 days) and for gelatin/PEG from 1.94 min (35%RH/24hr) 
to 1.80 min (53%RH/3 days). similarly, the HPMC capsules showed a decrease 
in shell dissolution time at higher relative humidity and storage period In pH 7 
and  pH  8  of  the  phsophate  buffer  (Figures  4.4  and  4.5).  Again  the  shell 
dissolution time was influenced by the storage conditions with a decrease in 
shell dissolution time for the HPMC capsule shells after storage for 3 days at 
53%RH. However, this was not seen for gelatin and gelatin/PEG capsule shells 
at pH 7.  
 
SPB  pH  6  statistical  comparision  using  three way  ANOVA  showed  that  both 
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and  25.901  respectively)  with  p values  of  <  0.001.  statistical  analysis  also 
showed that the differences seen between the differnet capsules in SPB pH 6 
were statistically significant F (7, 288) = 257.052, p < 0.001. Post hoc scheffe 
test (Appendix 4, Table 4.1) again showed that gelatin and gelatin/peg had the 
shortest  shell  dissolution  time  which  was  significantly  different  to  all  other 
capsule shell types and that S4 capsules were significantly different to all other 
HPMC capsules as was old HPMC.  
 
SPB pH 7 the findings were the same as those found in SPB pH 5 where the 
effect  of  storage  humidity  on  capsules  shell  dissolution  was  insignificant. 
However, the effect of storage time and capsule type were siginificant (F values 
of 15.995 and 381.025 respectively) and p values of < 0.001. Post hoc scheffe 
test (Appendix 4, Table 4.2) again showed that gelatin and gelatin/peg had the 
shortest  shell  dissolution  time  which  was  significantly  different  to  all  other 
capsule shell types and that S4 capsules were significantly different to all other 
HPMC  capsules  as  was  old  HPMC.  Finally  in  SPB  pH  8  tests  of  between 
subjects effects showed that the times for the release of the ball bearing from 
the difference capsules to be statistically significantly F (7, 288) = 435.876, p < 
0.001,  however,  the  effect  of  the  other  two  independent  factors  (storage 
humidity and storage time were statistically insignificant). Post hoc scheffe test 
(Appendix 4, Table 4.3) showed that gelatin and gelatin/peg had the smallest 
shell dissolution time which was significantly different to all other capsule shell 
types. Unlike other pH’s S4 capsules were significantly similar to S00 and New 
HPMC shells. However, the time taken for the release of the ball bearings from 
the old HPMC capsules remained to be statistically significantly higher than all 
other capsule types. 
 
The  standard  deviations  (STD)  and  the  percentage  coefficient  of  variation 
(%CV) of the results obtained from the ball bearing test in SPB pH 5 – pH 8 at 
35%RH and 53%RH for 24 hours are presented in Table 4.4. 
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Table 4. 4: Percentage coefficient of variation (%CV) and standard deviation 
(STD) for shell dissolution in SPB pH 5   pH 8 after storage at 35%RH and 
53%RH.  
 
 35%RH/ 24hr storage   
pH 5     pH 6     pH 7     pH 8       
Capsule type  STD  %CV  STD  %CV  STD  %CV  STD  %CV 
Old HPMC  1.18  13.01  1.34  14.00  1.17  12.73  1.58  20.28 
New HPMC   0.66  13.02  0.47  8.64  0.70  13.83  0.47  10.61 
E0504193  1.12  18.48  0.88  13.52  1.17  20.45  1.15  24.06 
Gelatin   0.25  10.00  0.60  33.52  0.23  14.47  0.08  3.70 
Gelatin/PEG  0.96  40.85  0.34  17.53  0.31  15.05  0.49  21.97 
S00 HPMC  0.63  13.15  1.00  19.01  0.62  14.12  0.69  18.15 
S1 HPMC  0.82  17.05  0.57  9.81  1.52  30.58  0.68  16.35 
S4 HPMC  2.60  27.89  1.57  17.05  1.03  13.12  0.43  9.95 
53%RH/24 hr storage 
Old HPMC  1.66  18.32  1.37  14.07  8.13  12.30  0.88  9.79 
New HPMC   0.65  12.85  0.36  6.64  4.74  24.68  0.41  10.37 
E0504193  1.10  20.22  0.82  16.07  6.52  13.04  0.85  18.90 
Gelatin   0.63  23.68  0.33  18.54  1.80  18.33  0.34  17.44 
Gelatin/PEG  0.75  29.18  0.34  17.62  2.25  14.67  0.14  6.31 
S00 HPMC  1.21  26.13  0.83  19.95  4.26  19.25  0.78  21.67 
S1 HPMC  1.46  29.80  0.91  20.54  4.43  17.83  0.62  13.90 
S4 HPMC  0.84  9.33  0.78  10.91  7.67  14.60  0.42  10.82 
35%RH/3 days 
Old HPMC  2.05  22.70  2.73  31.9  0.89  10.70  0.64  7.51 
New HPMC   0.64  13.53  0.50  10.48  0.64  13.66  0.40  9.78 
E0504193  1.01  18.95  1.41  29.07  0.43  7.67  0.52  11.51 
Gelatin   0.26  11.93  0.25  15.53  0.28  16.49  0.29  15.29 
Gelatin/PEG  0.41  22.29  0.39  21.31  0.22  10.15  0.15  6.60 
S00 HPMC  0.66  14.90  0.61  14.84  0.41  10.74  0.46  12.53 
S1 HPMC  1.17  26.29  1.38  26.54  0.69  16.35  0.40  9.50 
S4 HPMC  2.25  24.94  1.82  22.64  1.08  14.46  0.45  11.85 
53%RH/3 days 
Old HPMC  3.01  35.29  0.92  11.02  1.00  12.46  0.55  6.50 
New HPMC   0.44  9.38  0.55  11.93  0.36  7.94  0.35  8.52 
E0504193  1.74  37.99  0.89  18.89  0.37  6.82  0.64  14.15 
Gelatin   0.26  16.35  0.22  15.38  0.27  16.72  0.34  18.12 
Gelatin/PEG  0.42  23.08  0.39  21.67  0.11  4.96  0.25  11.41 
S00 HPMC  1.04  25.68  0.46  13.86  0.38  9.73  0.48  13.30 
S1 HPMC  1.21  24.89  0.69  16.75  0.74  17.77  0.48  11.38 
S4 HPMC  2.22  24.72  2.02  24.54  0.76  10.32  0.40  10.49 
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The results generally show that the variations (% CV) are higher for pH 5 at 
53%RH/24 hr when compared to other pHs, however, this effect is not shown 
with 35%RH/24 hr and no clear trend is seen between the different capsules 
with changes in storage conditions and pH.  
The effect of pH on the shell dissolution of the various capsule shells in SPB are 
summarised  in  Figures  4.6  and  4.7  for  35%RH/24hr  and  53%RH/24hr 
respectively. 
 
 
 
Figure 4. 6: Shell dissolution in SPB, after storage at 35% RH for 24 hours, the effect of pH. 
 
 
 
 
Figure 4. 7: Shell dissolution in SPB, after storage at 53% RH for 24 hours, the effect of pH. Chapter Four                                                                  Capsule Shell Dissolution                                                                      
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The mean shell dissolution time of the HPMC capsule shells decreased as the 
pH of the SPB increased from pH 5 – pH 8 whereas the gelatin and gelatin/PEG 
capsules  remained  unaffected.  For  example,  the  Old  HPMC  capsule  shell 
dissolution time at 35%RH/24hr, fell from 9.06 min to 7.78 min at pH 5 and pH 8 
respectively. Similarly, the New HPMC capsule shell dissolution time decreased 
from 5.07 min to 4.43 min at pH 5 and pH 8 respectively, the same was seen for 
E0504193 HPMC with a drop from 6.06 min to 4.78 min at pH 5 and pH 8. There 
was also a considerable decrease in capsule shell dissolution time for the size 4 
capsule  shells  with  a  drop  from  9.32  min  to  4.32  min  from  pH  5  to  pH  8 
respectively after storage at 35%RH for 24 hours. The effects of pH on shell 
dissolution time appeared less pronounced after storage at 53%RH for 24 hours. 
However, the size 4 capsule shells still showed a sharp decrease in dissolution 
time from pH 5 to pH 8.  
 
Statistical  analysis  using  two way  ANOVA  was  performed,  and  the  tests  of 
between  subject  effects  showed  that  both  the  capsule  type  and  pH  were 
statistically significant factors (F values 233.200 and 35.107 respectively) with p  
values of < 0.001. The interaction between the two factors was also found to be 
statistically significant (F value 6.296 and p < 0.001). Further statistical analysis 
in  the  form  of  post hoc  (Scheffe’)  test  was  undertaken  for  the  capsule  shell 
dissolution time in respect of capsule type (Appendix 4, Table 4.4) where it was 
found that gelatin and gelatin/peg shells had the shortest mean shell dissolution 
time when compared with the HPMC capsules and that the old HPMC and S4 
HPMC shells had the longest mean shell dissolution time. The second post hoc 
data looked at shell dissolution time data with respect to pH (Appendix 4, Table 
4.5), and was found that the shell dissolution time was shortest in SPB pH 8 and 
longest in pH’s 5 and 6.  
 
 
4.4  Dissolution of  Capsule Shells in Citro Phosphate Buffer (CPB)  (pH 5, 
6, and 7) 
 
The effect of storage conditions on the shell dissolution times for the various 
capsule shells in CPB (pH 5 – pH 7) are presented below in Figures 4.8 – 4.10 Chapter Four                                                                  Capsule Shell Dissolution                                                                      
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    Figure 4. 8: Capsule shell dissolution in CPB pH 5, effect of storage conditions  
 
 
 
Figure 4. 9: Capsule shell dissolution in CPB pH 6, effect of storage conditions  
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   Figure 4. 10: Capsule shell dissolution in CPB pH 7, effect of storage conditions  
 
 
The results in deionised water and SPB (see Figures 4.8 – 4.10) show that the 
HPMC capsule shells generally gave higher values for capsule dissolution times 
in  CPB  compared  with  the  gelatin  and  gelatin/PEG  capsules  at  all  storage 
conditions. 
 
There was no significant difference between the gelatin and gelatin/PEG capsule 
dissolution time in CPB buffer pH 5   pH 7 at all storage conditions. Differences 
can be seen between the different samples of HPMC capsules with Old HPMC 
having a higher mean dissolution time compared to other HPMC capsules in pH 
5  –  pH  7  CPB.  The  old  HPMC  capsule  shells  took  nearly  twice  as  long  to 
dissolve when compared to the New HPMC capsules as was seen previously in 
deionised water, and SPB. For example, the shell dissolution times for Old and 
New  HPMC  stored  at  35%RH/24  hr  at  pH  5  was  8.53  min  and  5.29  min 
respectively. At pH 6 was 9.01 min and 5.46 min, and at pH 7 was 10.17 min and 
6.28 min. The shell dissolution times of sizes 00, 1 and 4 HPMC capsules at all 
pHs are similar to the shells dissolution times of the New HPMC and E0504193 
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The results showed small differences, in some cases, in dissolution time with 
with  an  increase  in  the  RH  storage  conditions,  see  Figures  4.8  –  4.10.  For 
example, the mean dissolution time of the old HPMC capsule shells after storage 
for 24 hours at 35%RH was 8.53 min, which decreased to 7.82 min after storage 
for 3 days in citro phosphate buffer pH 5. The shell dissolution time of the New 
HPMC capsules also decreased from 5.29 min at 35%RH/24hr to 4.58 min at 
53%RH/3  days  and  for  E0501493  HPMC  decreased  from  5.87  min  at 
35%RH/24hr to 5.03 min at 53%RH/3 days. The same observations were made 
in pH 6 and pH 7 for the New HPMC capsule shells with a decrease in shell 
dissolution time at higher relative humidity and storage time. 
 
Statistical analysis using three way ANOVA (univariate ANOVA) was conducted, 
as before, treating the shell dissolution time as the dependent factor, and  storage 
humidity, storage time and capsule type as the fixed factors. The test of between 
subject effects showed that in CPB pH 5 both storage humidity and storage time 
were statistically significant factors (F values of 7.298 (p = 0.007) and 10.218 (p = 
0.002) respectively). However, out of the two factors, storage time was found to be 
of greater importance to the shell dissolution time than the storage humidity, as 
the F factor was greater than the storage humidity. In CPB pH 6, only the fixed 
factor storage humidity had a significant effect on capsule shell dissolution time (F 
= 7.810, p = 0.006), and in CPB pH 7, neither storage humidity nor storage time 
had a significant effect on capsule shell dissolution time (p > 0.05). Therefore, the 
changes seen in shell dissolution time with an increase in relative humidity and 
storage time appear to be not systematic in any direction. As expected, the third 
fixed factor, capsule type, influenced shell dissolution time at all pHs: In pH 5 (F = 
211.429, p < 0.001); in pH 6 (F= 235.841, p < 0.001) and in pH 7 (F = 219.929, p 
< 0.001). At all pHs gelatin and gelatin/peg had the shortest mean shell dissolution 
time (1.97 min and 2.05 min in pH 5 respectively) when compared with HPMC 
capsules  (e.g.  in  pH  5:  4.874  min  (New  HPMC),  8.339  min  (old  HPMC).  Old 
HPMC  capsules  had  the  longest  shell  dissolution  time  and  the  mean  shell 
dissolution  times  of  S4,  S1,  S00  and  New  HPMC  were  significantly  similar 
(Appendix 4, Tables 4.6 – 4.8). 
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The standard deviation (STD) and the percentage coefficient of variation (%CV) 
of the results obtained from the ball bearing test in citro phosphate buffer pH 5 – 
pH 7 after storage for 24 hours at 35% and 53%RH are presented in Table 4.5. 
 
Table 4. 5: Percentage coefficient of variation (%CV) and standard deviation 
(STD) of all capsules in CPB pH 5 – pH 7 after storage under for 24hours at 
35%RH and 53%RH. 
 
pH 5 
  
pH 6 
  
pH 7 
  
  
Capsule type 
STD  %CV  STD  %CV  STD  %CV 
35%RH/24 hr 
Old HPMC  1.20  14.06  1.45  16.09  1.81  17.16 
New HPMC   0.70  13.23  0.76  13.92  1.46  23.25 
E0504193  0.37  6.30  1.35  20.24  1.21  16.03 
Gelatin   0.30  15.07  0.34  16.59  0.39  18.22 
Gelatin/PEG  0.06  2.67  0.39  19.69  0.34  16.50 
S00 HPMC  0.96  22.09  1.39  24.34  1.69  26.49 
S1 HPMC  1.08  17.85  1.00  17.12  1.47  19.22 
S4 HPMC  1.03  20.81  1.06  18.96  1.58  23.06 
53%RH/24 hr  
Old HPMC  1.00  11.36  1.30  15.48  2.25  21.49 
New HPMC   0.47  9.71  0.86  16.28  0.54  8.86 
E0504193  1.49  27.34  1.07  18.26  1.88  23.74 
Gelatin   0.33  17.09  0.08  3.66  0.22  10.73 
Gelatin/PEG  0.37  18.05  0.31  15.42  0.26  12.21 
S00 HPMC  0.73  16.15  1.44  27.96  0.74  11.69 
S1 HPMC  0.73  17.51  1.11  19.68  1.23  16.12 
S4 HPMC  0.93  20.08  1.05  22.58  1.61  25.56 
35%RH/3 days 
Old HPMC  1.58  19.24  1.19  11.13  1.14  10.85 
New HPMC   0.50  10.44  0.87  16.11  0.84  13.57 
E0504193  0.86  0.17  1.09  18.57  1.56  18.55 
Gelatin   0.30  15.23  0.08  3.74  0.42  21.54 
Gelatin/PEG  0.37  19.27  0.35  16.91  0.36  18.09 
S00 HPMC  0.41  8.12  1.15  23.05  1.35  21.76 
S1 HPMC  0.62  13.90  0.72  13.58  1.21  16.26 
S4 HPMC  0.99  22.45  0.77  14.26  0.80  11.61 
53%RH/3 days 
Old HPMC  1.35  17.26  1.16  11.63  1.39  13.31 
New HPMC   0.75  16.38  0.66  13.28  0.55  9.08 
E0504193  1.70  33.79  1.52  30.95  1.56  20.05 
Gelatin   0.32  16.16  0.20  9.56  0.34  17.26 
Gelatin/PEG  0.60  30.00  0.67  29.26  0.50  24.88 
S00 HPMC  0.81  17.50  1.04  20.43  1.19  18.25 
S1 HPMC  0.67  15.09  0.69  11.90  0.81  12.22 
S4 HPMC  1.14  27.21  0.86  16.96  1.91  30.76 
 
The results generally show that at 35%RH/24 hr, the variations are higher at 
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and HPMC shells were similar and did not considerably change with a change in 
pH or storage conditions.  
 
The effect of pH on the shell dissolution of the various capsule shells in CPB are 
presented in Figures 4.11 and 4.12. 
 
 
Figure 4. 11: Shell dissolution in CPB, after storage at 35% RH for 24 hours, the effect of pH. 
 
 
 
 
Figure 4. 12: Shell dissolution in CPB, after storage at 53% RH for 24 hours, the effect of pH. Chapter Four                                                                  Capsule Shell Dissolution                                                                      
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Figure 4. 11 and  
Figure  4.  12,  show  the  effect  of  pH  on  the  shell  dissolution  of  the  various 
capsules  in CPB. The HPMC shell dissolution time increased with an increase 
in  pH  from  pH  5  –  pH  7.  The  old  HPMC  capsules  shells  gave  a  significant 
increase from 8.53 min (pH 5) to 10.55 min (pH 7) after storage for 24 hours at 
35%RH (one way ANOVA p = 0.015). Small but insignificant (one way ANOVA 
p>  0.05)  increases  were  also  seen  for  New  HPMC  capsules  where  the 
dissolution time increased from 5.29 min (pH 5) to 6.28 min (pH 7) after storage 
for 24 hours at 35%RH. For E0504193 HPMC a significant increase in shells 
dissolution time was seen from 5.87 min (pH 5) to 7.55 min (pH 7) after storage 
for 24 hours at 35%RH (one way ANOVA P = 0.006). The same patterns were 
seen  for  S00,  S1  and  S4  capsules  with  an  significant  increase  in  shell 
dissolution time as the pH increases. The pH of the CPB did not seem to have a 
significant  effect  on  the  shell  dissolution  time  of  the  gelatin  and  gelatin/PEG 
capsules.    Two way  ANOVA  (univariate  ANOVA)  demonstrated  that  the  two 
fixed factors pH and capsule type were statistically significant factors on shell 
dissolution time (F = 28.455 and 146.082 respectively) with p values < 0.001. 
The  interaction  between  the  two  factors  was  also  found  to  be  statistically 
significant (F = 2.021, p = 0.018). Post hoc Scheffé’ tests were carried out to see 
where  ther  difference  lie.  The  post   hoc  Scheffé’  tests  for  capsule  type 
(Appendix 4, Table 4.9) showed the mean shell dissolution time for gelatin and 
gelatin/PEG in all pHs to be significantly shorter than any other capsule type, 
and that the mean shell dissolution time of old HPMC was significantly longer 
than any other capsule type in all pHs. The second post hoc data looked at the 
shell dissolution time with respect to pH (Appendix 4, Table 4.10), the results 
were distributed into two subsets. The capsules immeresed in the lower pHs (pH 
5  and  pH  6)  had  a  mean  shell  dissolution  time  of  4.91  min  and  5.29  min 
respectively which was significantly different to the capsules immersed in pH 7 
with a mean shell dissolution time of 6.18 min.   
 
4.5  Dissolution of Capsule Shells in Phosphate Borax Buffer (PBB) (pH 7 
and pH 8) 
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The effect of different storage conditions on the shell dissolution of various 
empty capsule shells are presented below in Figures 4.13 and 4.14. 
 
 
 
    Figure 4. 13: Capsule shell dissolution in PBB pH 7, effect of storage conditions  
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   Figure 4. 14: Capsule shell dissolution in PBB pH 8, effect of strorage conditions  
 
Figure 4.13 and 4.14 show the HPMC capsules, giving higher values for capsule 
shell dissolution time than the gelatin and gelatin/PEG capsules stored under all 
conditions in PBB. This was the case for these capsules in deionised water, 
SPB and CPB previously.   
 
Differences were seen with the HPMC capsules, with the old HPMC capsule 
shells having a higher mean dissolution time than any other capsule e.g. 9.86 
min vs 4.65 min (pH 7) and 10.15 min vs 4.76 min (pH 8) for old HPMC and New 
HPMC  capsules  respectively  after  storage  for  24  hours  at  35%RH.  The  S4 
HPMC capsules gave higher mean dissolution times than S00 and S1 at both 
pHs under all conditions. 
 
The results showed, in some cases, differences in dissolution time with storage 
conditions, see Figures 4.13 and 4.14. The mean dissolution time for gelatin in 
PBB  pH  7  was  1.82  min  at  35%RH/24hr  which  decreased  to  1.55  min  at 
53%RH/3 days, and for pH 8, a decrease from 1.73 min at  35%RH/24hr to 1.66 
min at 53%RH/3 days was observed. However, storage conditions did not affect 
the shell dissolution of gelatin/PEG capsules in PBB pH 7 and pH 8. For all 
HPMC  capsules  with  an  increase  in  RH  and  storage  time,  the  mean  shell 
dissolution time tended to decrease, for example, with old HPMC, a decrease in 
shell  dissolution  time  from  9.86  min  at  35%RH/24hr  to  7.95  min  at 
53%RH/3days was seen with PBB pH 7. For HPMC sizes 00, 1 & 4, differences 
in dissolution time with an increase in relative humidity and storage time were 
seen in both pH 7 and pH 8 with a decrease in the mean shell dissolution time 
for S00 HPMC from 4.58 min (35%RH/24hr) to 3.61 min (53%RH/3 days) at pH 
7 and for S4 HPMC from 11.18 min (35%RH/24hr) to 7.76 min at 53%RH/3 
days) at pH 7. However, the mean dissolution time for S1 HPMC capsule shells 
was not affected by storage conditions at pH 7, but was affected by changes in 
storage  at pH  8  with  a  decrease from 4.96  min  at  35%RH/24hr to  4.69 min 
53%RH/3  days.  These  findings  show  that  storage  conditions  can,  in  some 
cases, influence the shell dissolution time of the capsules. Three way ANOVA 
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storage time in PBB pH 7 had a significant effect on capsule shell dissolution 
time (F = 6.114, P = 0.014). However, in PBB pH 8 neither storage time nor 
storage  humidity  had  an  effect  on  capsule  shell  dissolution  time.  The  most 
significant factor on capsule shell dissolution time was capsule type in both pH 7 
and pH 8 (F  factors of 99.202 and 275.174 respectively) p < 0.001. Post hoc 
tests  of  the  effect  of  capsule  type  on  capsule  shell  dissolution  (Appendix  4, 
Tables 4.11 and 4.12 ) showed that gelatin and gelatin/peg capsules had the 
shortest capsule shell dissolution time when compared with HPMC, and that old 
HPMC and S4 capsules had the longest shell dissolution time. The post hoc 
tables  also  showed  that  S1,  S00,  New  HPMC  and  E0504193  HPMC  were 
similar at pH 7 and pH 8. However, in pH 8 S00 and E0504193 HPMC were 
significantly different.  In PBB  pH 7 the interaction between capsule type and 
storage time is significant (F = 3.734, p = 0.001) and in pH 8 the interaction 
between  the  three  factors  was  significant  (F  =  2.280,  p  =  0.028),  providing 
evidence that the different factors have an interactive influence on capsule shell 
dissolution time. However, in both cases this was of little significance as the F 
factor was significantly smaller than capsule type alone.  
 
The standard deviation (STD) and percentage coefficient of variation (%CV) for 
capsule shell dissolution data in PBB pH 7   pH 8  after storage for 24 hr and 3 
days at  35%RH and 53%RH are presented in Table 3.6.4. 
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Table 4. 6: Percentage coefficient of variation (%CV) and standard deviation 
(STD) for shell dissolution in PBB pH 7 –  pH 8 after storage for 24 hours and 3 
days  at 35%RH and 53%RH. 
 
pH 7 
  
pH 8 
  
  
Capsule type 
%CV  STD  %CV  STD 
  35%RH/24 hr 
Old HPMC  23.23  2.29  15.86  1.61 
New HPMC   17.85  0.83  14.71  0.70 
E0504193  11.91  0.68  14.39  0.80 
Gelatin   17.58  0.32  20.23  0.35 
Gelatin/PEG  19.25  0.36  16.93  0.32 
S00 HPMC  29.91  1.37  21.93  0.84 
S1 HPMC  18.73  0.94  21.17  1.05 
S4 HPMC  48.66  5.44  15.37  1.42 
  53%RH/24 hr 
Old HPMC  18.51  1.82  13.79  1.55 
New HPMC   13.58  0.63  10.97  0.52 
E0504193  18.66  0.95  17.66  0.98 
Gelatin   18.13  0.33  17.46  0.33 
Gelatin/PEG  22.02  0.37  19.39  0.32 
S00 HPMC  20.63  0.79  30.81  1.14 
S1 HPMC  27.78  1.25  36.63  1.74 
S4 HPMC  49.08  5.38  32.93  2.48 
  35%RH/3 days  
Old HPMC  22.38  2.16  14.87  1.69 
New HPMC   18.32  0.83  16.11  0.73 
E0504193  9.42  0.55  16.60  0.87 
Gelatin   16.37  0.28  16.67  0.31 
Gelatin/PEG  19.79  0.37  20.00  0.35 
S00 HPMC  31.97  1.48  9.95  0.41 
S1 HPMC  14.79  0.75  28.96  1.37 
S4 HPMC  41.26  3.33  20.79  1.73 
  53%RH/3 days  
Old HPMC  35.97  2.86  19.66  1.96 
New HPMC   21.68  0.98  16.11  0.73 
E0504193  20.47  1.04  21.88  0.98 
Gelatin   17.42  0.27  16.87  0.28 
Gelatin/PEG  20.83  0.40  16.58  0.32 
S00 HPMC  24.38  0.88  23.16  0.85 
S1 HPMC  15.64  0.79  28.36  1.33 
S4 HPMC  28.22  2.19  23.91  1.92 
 Chapter Four                                                                  Capsule Shell Dissolution                                                                      
  215 
The results presented in Table 4.6 generally show that at all storage conditions, 
old  HPMC,  New  HPMC  and  S4  capsules  have  a  greater  variation  at  pH  7 
compared to pH 8. This effect is not systematic for other capsules.   
The effect of pH on the the dissolution time of the empty capsule shells using 
the ball bearing method in PBB after storage for 24 hours at 35% and 53%RH 
are shown below In Figures 4.15 and 4.16. 
 
 
Figure 4. 15: Shell dissolution in PBB, after storage at 35% RH for 24 hours, the effect of pH. 
 
 
 
 
 
Figure 4. 16:  Shell dissolution in PBB, after storage at 53% RH for 24 hours, the effect of pH. Chapter Four                                                                  Capsule Shell Dissolution                                                                      
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In phosphate borax buffer (Fig. 4.15 & 4.16), a change in pH did not have a 
significant effect  on  the  shell  dissolution  time of  HPMC  and  gelatin  capsules 
(one way ANOVA p > 0.05) apart from the old HPMC and S4 HPMC capsules. 
Old  HPMC  capsule  shells  showed  an  increase  in  the  mean  capsule  shell 
dissolution time from 9.86 min (pH 7) to 10.15 min (pH 8) at 35%RH/24hr and 
9.83 min (pH 7) to 11.24 min (pH 8) at 53%RH/24hr. As the pH increases from 
pH 7 to pH 8 the size 4 HPMC capsule shells showed a sharp decrease in shell 
dissolution  time  from  11.18  min  (pH  7)  to  9.24  min  (pH  8)  after  storage  at 
35%RH/24hr, and from 10.96 min (pH 7) to 7.53 min (pH 8) after storage at 
53%RH/24hr. 
 
4.6  Dissolution of Capsule Shells in Borate Buffer (BB) (pH 8) 
 
The effect of different storage conditions on the shell dissolution of various 
empty shells in BB pH8 are presented below in Figure 4.17. 
 
 
Figure 4. 17: Capsule shell dissolution in BB pH 8, effect of storage conditions 
   Chapter Four                                                                  Capsule Shell Dissolution                                                                      
  217 
   
 
Figure  4.17  shows  HPMC  capsules  generally  giving  higher  values    for  shell 
dissolution  time  in  borate  buffer  when  compared  to  gelatin  and  gelatin/PEG 
capsules  stored  under  all  conditions.  Differences  can  be  seen  between  the 
HPMC capsules, with the old HPMC capsules having a higher mean dissolution 
time than any other capsule, apart from S4 HPMC capsules which have higher 
mean  dissolution  times  when  compared  with  New,  E0504193,  S00  and  S1 
HPMC  capsules  at  all  storage  conditions.  For  example  the  shell  dissolution 
times for S4 and New HPMC are 7.42 min vs 4.01 min respectivly, for S4 and 
E0504193 the shell dissolution times are  7.42 min vs 3.85 min respectively, 
similarly  for S4 and S00 are 7.42 min vs 3.85 min respectively and the shell 
dissolution times for S4 and S1 are 7.42 min vs 4.60 min  respectively all after 
storage at 53%RH for 24 hours. 
 
Between subject  effects  using  three way  ANOVA  show  that  storage  humidity 
has a significant effect on shell dissolution time (F = 6.128, p = 0.014), however, 
the  effect  of  storage  time  is  very  small  (F  =  3.940,  p  =  0.048).  The  data 
presented in Figure 4.17 it is clear that no conclusive evidence can be seen for 
the  effect  of  storage  on  shell  dissolution  time,  since  in  some  cases  the 
dissolution time decreased with an increase in storage humidity and time and in 
other cases it did not. For example: for old HPMC (9.07 min vs 10.78 min) at 
35% RH/24 and 53%RH/3 days, however, for S1 capsules (5.00 min vs 3.59 
min) and for S00 (4.08 min vs 4.19 min) both at 35% RH/24 hr and 53% RH/3 
days.  Therefore  the  effect  of  storage  on  the  shell  dissolution  time  is  not 
systematic in any direction.  
Statistical analysis shows that the type of capsule significantly influences shell 
dissolution (F = 201.220, p < 0.001). The post hoc (Scheffe’) test for the shell 
dissolution time with respect to capsule type was distributed into four subsets, 
showing  gelatin  and  gelatin/peg  (subset  1)  as  in  all  other  dissolution  media 
having the shortest shell dissolution time. The New HPMC, E0504193, S00 and 
S1 (subset 2), S4 HPMC (subset 3) and old HPMC (subset 4). The S4 and old 
HPMC capsules took the longest mean shell dissolution time (8.426 min and 
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The standard deviation (STD) and percentage coeffiecient of variance (%CV) for 
the results obtained from the ball beaing test in borate buffer pH8 after storage 
for 24 hours at 35% and 53%RH are presented in Table 4.7. 
 
Table 4. 7: Percentage coefficient of variation (%CV) and standard deviation 
(SD) for shell dissolution in BB pH 8 after storage under different conditions 
 
35%RH/24hr  53%RH/24hr  35%RH/3days  53%RH/3day
s 
  
Capsule type 
%CV  STD  %CV  STD  %CV  STD  %CV  STD 
Old HPMC  24.59  2.23  38.35  3.46  17.49  1.74  15.49  1.67 
New HPMC   9.51  0.39  20.69  0.83  21.55  0.86  9.61  0.42 
E0504193  27.57  1.26  19.48  0.75  20.62  0.93  24.36  1.04 
Gelatin   18.29  0.30  17.34  0.30  17.51  0.31  18.48  0.34 
Gelatin/PEG  17.71  0.31  17.79  0.29  15.38  0.32  26.77  0.53 
S00 HPMC  20.83  0.85  28.49  1.10  20.04  0.85  9.79  0.41 
S1 HPMC  23.60  1.18  20.65  0.95  17.84  0.81  32.31  1.16 
S4 HPMC  10.48  0.92  20.49  1.52  27.13  2.74  27.13  2.01 
 
The results in Table 4.7 show that variation in values are generally similar in all 
storage conditions. And no considerable differences in %CV were found with a 
change in storage conditions.  
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4.7 Dissolution of  Capsule Shells in Acetate Buffer (AB)  pH5 and pH6 
 
The effect of different storage conditions on the shell dissolution of various 
empty shells in AB pH 5 and pH 6 are presented below in Figure 4.18 and 4.19 
 
 
Figure 4. 18. Capsule shell dissolution in AB pH 5, effect of storage conditions 
 
 
Figure 4. 19: Capsule shell dissolution in AB pH 6, effect of storage conditions  
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HPMC capsules have a generally higher mean dissolution time in acetate buffer 
pH 5 when compared to gelatin and gelatin/PEG capsules e.g. 3.26 min vs 2.06 
min  for  New  HPMC  and  gelatin  respectively  after  storage  for  24  hours  at 
53%RH,  see  Figure  4.18.  The  results  are  similar  to  those  seen  in  other 
dissolution  media  and  show  that  the  old  HPMC  capsule  shells  have  a 
significantly higher mean dissolution time. This is nearly twice that of the other 
HPMC capsule shells e.g. for Old and New HPMC capsules was 8.28 min and 
3.26 min respectively, and for Old and E050 HPMC was 8.28 min and 4.14 min 
respectively. The shell dissolution of all HPMC capsules was hindered in acetate 
buffer pH6, see Figure 4.19, and the capsules did not split even after > 1 hour in 
the test medium.  The mean shell dissolution time of the gelatin and gelatin/PEG 
capsules shells was increased also from 2.02 min to 3.20 min, and from 2.01 
min to 3.84 min at 35%RH/24 hr respectively. Similarly, the shell dissolution time 
of gelatin and gelatin/PEG  increased at the higher pH from 2.06 min to 3.36 
min, and from 2.14 min to 3.68 min for respectively. The same was seen for 
storage at 35% and 53%RH for 3 hours.  
 
The results show that storage conditions do not appear to have an effect on 
capsule shell dissolution time in AB for all capsules apart from the old HPMC 
capsule shells, which showed a decrease from 8.05 min at 35%RH/24hr to 7.88 
min  at  53%RH/3  day  storage.  Statistical  analysis  using  three way  ANOVA 
shows  that  the  effect  of  storage  humidity  and  storage  time  on  capsule  shell 
dissolution time  were  found  to  be  insignificant  (p  >  0.05).  Statistical  analysis 
showed that the difference in shell dissolution time seen between the different 
capsules on to be statistically significant F (7, 288) = 137.579, p < 0.001. Post 
hoc (Scheffe’) tests distributed the shell dissolution time data for the different 
capsules  into four  subsets  (Appendix  4,  Table  4.13).  Gelatin  and  gelatin/peg 
(subset 1) had the shortest mean shell dissolution time, Old HPMC (subset 4) 
had the longest mean shell dissolution time and the rest of the HPMC shells 
were distributed between subsets 2 (New HPMC, S1, S4, S00) and subset 3 
(S00, S1, E0504193).  
 
Table 4.8 shows the standard deviation (STD) and percentage coeffiecient of 
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buffer pH5 after storage at 35% and 53%RH for 24 hours and 3 days  
 
Table 4. 8: Percentage coefficient of variation (%CV) and standard deviation 
(STD) for shell dissolution in AB pH 5 after storage under different conditions 
 
 
 
The variation in the results for gelatin and HPMC shells are similar and do not 
show any changes due to the storage conditions. 
 
The  shell  dissolution  properties  of  the  various  capsule  shell  types  are  very 
different  in  acetate  buffer  pH5  and  pH6  (Table  4.9)  with  no  capsule  shell 
dissolution  occuring  at  pH6  for  any  of  the  HPMC  capsule  types  even  after 
leaving the capsules suspended in the buffer for > 1hr. The shell dissolution 
properties of the gelatin and gelatin/PEG capsules are also effected by a change 
in pH with a marked increase in the shell dissolution time at pH6 (Fig. 4.20 & 
4.21). For example, the shell dissolution time of gelatin increases from 2.02 min 
(pH5) to 3.2 min (pH6) and for the gelatin/PEG capsules it increases from 2.01 
min (pH5) to 3.84 min (pH6) after storage at 35%RH for 24 hours. Similarly the 
shell dissolution time of gelatin increases from 2.06 min (pH5) to 3.36 min (pH6) 
and for the gelatin/PEG capsules from 2.14 min (pH5) to 3.68 min (pH6) after 
storage at 53%RH for 24 hours. 
 
4.8 Dissolution of  Capsule Shells in Artificial Gastric Juice (AGJ) pH1.2 
 
The effect of different storage conditions on the shell dissolution of various 
empty shells in artificial gastric juice pH 1.2 are presented below in Figure 4.22  
35%RH/24hr  53%RH/24hr   35%RH/3days  53%RH/3days     
Capsule type  %CV  STD  %CV  STD  %CV  STD  %CV  STD 
Old HPMC  9.57  0.77  12.32  1.02  17.43  1.34  12.82  1.01 
New HPMC   19.64  0.66  17.48  0.57  16.39  0.59  13.65  0.52 
E0504193  9.43  0.38  22.95  0.95  22.44  1.01  18.54  0.79 
Gelatin   16.34  0.33  31.07  0.64  12.74  0.27  16.49  0.31 
Gelatin/PEG  18.91  0.38  19.16  0.41  17.82  0.36  20.86  0.39 
S00 HPMC  21.59  0.76  16.16  0.64  13.51  0.57  14.90  0.52 
S1 HPMC  11.49  0.44  18.89  0.68  21.77  0.86  34.38  1.32 
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      Figure 4. 20: Capsule shell dissolution AGJ pH 1.2, effect of storage conditions  
 
The shell dissolution times for HPMC compared to gelatin and gelatin/PEG were 
similar to those obtained in all dissolution media described above. All the HPMC 
capsules tested had the longer capsule shell dissolution times when compared 
with gelatin and gelatin/PEG shells. The old HPMC capsules had the highest 
shell dissolution time when compared with all other capsule shells.  The results 
presented in Figure 4.20 also show, in some cases, differences in dissolution 
time  with  storage  conditions.  For  example,  the  mean  dissolution  time  of  the 
HPMC  capsules,  decreased  from  35%RH/24  hr  to  53%RH/  3  days.  For  Old 
HPMC they decreased from 6.19 min to 5.93 min, for New HPMC from 3.18 min 
to 3.10 min, and for E050 HPMC from 3.55 min to 3.37 min. Decreases in mean 
dissolution  time  are  similarly  seen  for  S00,  S1,  S4  HPMC  capsules  and  for 
gelatin/PEG  capsules.  However,  the  differences  seen  in  the  mean  shell 
dissolution  times  with  a  change  in  the  storage  conditions  were  insignificant 
(Three way  ANOVA,  p  >  0.05).  Statistical  analysis  using  three  way  ANOVA 
showed  that  the  differences  between  the  capsule  shells  to  be  significantly 
different  (p  <  0.001).  The  post hoc  (Scheffe’)  test  (Appendix  4  Table  4.14) 
showed gelatin and gelatin/peg (subset 1) to be significantly different to HPMC 
shells, and have the shortest mean shell dissolution time (1.60 min and 1.62 min 
respectively).  As  with  all  other  buffers,  old  HPMC  (subset  3)  is  significantly Chapter Four                                                                  Capsule Shell Dissolution                                                                      
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different to the New HPMC shells and have the longest mean shell dissolution 
time (6.22 min and 3.09 min respectively).  
 
The standard deviation (SD) and percentage coeffiecient of variance (%CV) for 
the  results  obtained  in  AGJ  pH1.2  after  storage  at  different  conditions  are 
presnted below in Table 4.9. 
 
Table 4. 9: Percentage coefficient of variation (%CV) and standard deviation 
(STD) for shell dissolution in AGJ pH 1.2 after storage under different conditions 
 
35%RH/24hr  53%RH/24hr  35%RH/3days  53%RH/3day
s 
 
Capsule type 
%CV  STD  %CV  STD  %CV  STD  %CV  ST
D 
Old HPMC  18.09  1.12  17.10  1.05  14.20  0.94  15.35  0.91 
New HPMC   16.04  0.51  13.62  0.41  17.04  0.53  11.29  0.35 
E0504193  15.77  0.56  14.94  0.52  18.01  0.65  15.43  0.52 
Gelatin   16.97  0.28  16.96  0.29  20.13  0.31  21.76  0.37 
Gelatin/PEG  14.37  0.24  16.98  0.27  13.42  0.20  17.19  0.27 
S00 HPMC  12.01  0.40  18.84  0.62  19.02  0.62  19.94  0.64 
S1 HPMC  23.67  0.76  16.17  0.54  16.77  0.55  15.78  0.48 
S4 HPMC  16.61  0.53  21.10  0.65  16.72  0.51  16.23  0.49 
 
Table 4.9 shows that the variations for both HPMC and gelatin capsules were 
generally  similar  at  all  storage  conditions  and  were  not  systematic  in  any 
direction.  
 
 
4.9  Effect of Ionic Strength on Capsule Shell Dissolution  
 
To explore the effect of ionic strength, the ball bearing test was carried out in 
potassium phosphate buffer (KPB), sodium phosphate buffer (NaPB) keeping 
the pH constant (pH 7.4) and increasing the molar concentration (0.1 M – 0.5 
M), and in HCl  pH 1.2 with increasing concentrations of either NaCl or KCl  (0.1 
M – 0.5 M). Chapter Four                                                                  Capsule Shell Dissolution                                                                      
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4.9.1  Capsule Shell Dissolution in Potassium Phosphate Buffer (KPB) 
 
The shell dissolution times for gelatin and New HPMC capsules in 0.1 M to 0.5 
M KPB pH 7.4 after storage at 35% and 53%RH for 24 hours and 3 days are 
shown below in Figure 4.21 and 4.22   
 
 
Figure 4. 21: Dissolution times of gelatin and New HPMC capsule shells in potassium 
phosphate buffer (KPB) with increasing molarity (0.1M – 0.5M) after storage at 35% and 53%RH 
for 24 hours. 
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Figure 4. 22:  Dissolution times of gelatin and New HPMC capsule shells in potassium 
phosphate buffer (KPB) with increasing molarity (0.1M – 0.5M) after storage at 35% and 53%RH 
for 3 days. 
 
 
Figures 4.21 and 4.22 show, that the mean shell dissolution times for gelatin in 
0.1 M – 0.5 M, were much shorter to those of the HPMC capsule shells. With the 
New HPMC capsules, time to the release of the ball bearing was increased with 
an increase in molarity from 0.1 M – 0.3 M. At 0.4 M and 0.5 M the release of 
the ball bearing did not occur even after a period of 1 hours and 30 minutes. 
Using gelatin capsules the time to the release of the ball bearing was similar 
from 0.1 M – 0.3 M, followed by an increase in shell dissolution time in 0.4 M 
and 0.5 M KPB, this increase was only significant when the gelatin capsules 
were  stored  at  35%  and  53%RH  for  3  days  (one  way  ANOVA,  p  <  0.001).  
Statistical  analysis  (ANOVA)  was  also  used  to  test  the  effect  of  storage 
conditions on the shell dissolution time in the increasing concentrations of KPB. 
For gelatin capsules the results demonstrated that only in 0.1 M and 0.2 M KPB 
significant differences were seen in shell dissolution time between the storage 
conditions (35%, 53%RH/ 24 hr) and (53%RH/3 days) (p < 0.001).  
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4.9.2 Capsule Shell Dissolution in Sodium Phosphate Buffer (NaPB) 
 
The shell dissolution times for gelatin and New HPMC capsules in 0.1 M to 0.5 
M NaPB pH 7.4 after storage at 35% and 53%RH for 24 hours and 3 days are 
presented below in Figure 4.23 and 4.24   
 
 
Figure 4. 23: Dissolution times of gelatin and New HPMC capsule shells in sodium phosphate 
buffer (NaPB) with increasing molarity (0.1M – 0.5M) after storage at 35% and 53%RH for 24 
hours. 
 
 
Figure 4. 24: Dissolution times of gelatin and New HPMC capsule in sodium phosphate buffer 
(NaPB) with increasing molarity (0.1M – 0.5M) after storage at 35% and 53%RH for 3 days. Chapter Four                                                                  Capsule Shell Dissolution                                                                      
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The results generally show that the mean shell dissolution times of gelatin from 
0.1 M – 0.5 M were much smaller than that of the HPMC capsule shells. The 
data for gelatin shell dissolution times at increasing molarities of NaPB (0.1 M – 
0.5 M) were similar. However, when the capsules were stored at 35%RH and 
53%RH/ 3 days, statistical analysis showed that gelatin shell dissolution was 
significantly faster in 0.1 M than in 0.2M   0.5 M NaPB (one way ANOVA, p < 
0.001). Figures 4.23 and 4.24 also show a significant increase in HPMC shell 
dissolution  time  with  an  increase  in  molarity  from  0.1  M  –  0.3  M  (one  way 
ANOVA, p < 0.05). The release of the ball bearings in 0.4 M occurred for some 
capsules in NaPB but was variable, contrary to the observations made in KPB 
where the shell opening was hindered in 0.4 M. In 0.5 M NaPB, the release of 
the  ball  bearings  did  not  occur  even  after  1  hour  and  30  minutes.  Storage 
conditions, in some cases, had a significant effect on capsule shell dissolution 
time, but in other cases did not, and those results were not systematic in any 
direction.  
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4.9.3 Capsule Shell Dissolution in Hydrochloric Acid (HCl) With Increasing 
concentrations of NaCl or KCl 
 
The shell dissolution times for gelatin and New HPMC capsules in HCl with 
increasing concentrations of NaCl and KCl (0.1 M – 0.5 M) after storage at 35% 
and 53%RH for 24 hours and 3 days are shown below in Figures 4.25 and 4.26 
and Figures 4.27 – 4.18 respectively. 
 
Figure 4. 25: Dissolution times of gelatin and New HPMC capsule shells in HCl + NaCl with 
increasing molarity (0.1M – 0.5M) after storage at 35% and 53%RH for 24 hours. 
 
 
 
Figure 4. 26: Dissolution times of gelatin and New HPMC capsule shells in 0.1 M HCl with 
increasing concentrations of NaCl (0.1M – 0.5M) after storage at 35% and 53%RH for 3 days. Chapter Four                                                                  Capsule Shell Dissolution                                                                      
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Shell dissolution time for HPMC capsules showed a significant increase with an 
increase in molar concentration (one way ANOVA p < 0.001). HPMC capsule 
shell  dissolution  was  seen  in  0.4  M  and  0.5  M  dissolution  media,  unlike  the 
observations found with KPB and NaPB where ball bearings were not released. 
The  results  show  a  slight  increase  in  gelatin  shell  dissolution  time  with  an 
increase in molar concentration, this was significant between 0.1 M and 0.5 M, 
the later having higher shell dissolution time at all storage conditions (one way 
ANOVA,  p  <  0.001).  Storage  conditions  did  not  have  a  significant  effect  on 
gelatin shell dissolution time at all molarities (one way ANOVA, p > 0.05) apart 
from 0.2 M, however, those differences were not systematic in one direction.  
 
 
 
Figure 4. 27: Dissolution times of gelatin and New HPMC capsule shells in HCl with increasing 
increasing concentration on KCl (0.1M – 0.5M) after storage at 35% and 53%RH for 24 hours. 
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Figure 4. 28: Dissolution times of gelatin and New HPMC capsule shells in 0.1 M HCl with 
increasing concentrations of KCl (0.1M – 0.5M) after storage at35%  and  53%RH for 3 days. 
 
Similar  observations  were  made  for  the  shell  dissolution  time  in  HCl  with 
increasing concentrations of KCl (Figures 4.27 – 4.28). A significant increase in 
HPMC shell dissolution time occurred as the molarity increased from 0.1 M – 0.5 
M.  However,  the  release  of  the  ball  bearings  did  not  occur  after  storing  the 
capsules  at  35%  and  53%RH  for  3  days.  Changes  in  shell  dissolution  time 
occurred for the gelatin capsules however, the results were not systematic in 
one  direction  and  in  most  cases  changes  seen  were  insignificant.  Storage 
conditions also did not have a significant effect on gelatin shell dissolution time 
in all molarities.  
 
Figures 4.29 and 4.30 compare the shell dissolution times of HPMC and gelatin 
in 0.1 M – 0.5 M of the selected dissolution media. Chapter Four                                                                  Capsule Shell Dissolution                                                                      
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 Figure 4. 29: Comparing HPMC shell dissolution times in the selected dissolution media  
 
 
Figure 4. 30: Comparing Gelatin shell dissolution times in the selected dissolution media 
 
The results generally show that HPMC shell dissolution time was slowest in KPB 
at all tested molarities and had the highest rate in 0.1 M and 0.2 M NaPB and 
(HCl + NaCl). For gelatin, shell dissolution was slowest in 0.1 M NaPB followed 
by 0.1 M KPB. The fastest shell dissolution occurred in 0.1 M and 0.2 M (HCl + 
KCl).  However,  the  shell  dissolution  times  were  very  similar  in  0.5  M  in  all 
dissolution media.  Chapter Four                                                                  Capsule Shell Dissolution                                                                      
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4.10  General Discussion of Capsule Shell Dissolution Results  
4.10.1 Effect of Storage Conditions 
 
The results showed that storage conditions had the greatest effect on the shell 
dissolution time of the gelatin, HPMC (E0504193), S1 and S4 capsule shells in 
deionised  water  especially  between  35%RH/24  hr  and  53%RH/  3  days. 
However, in most cases storage conditions showed no significant effect on the 
capsule  shell  dissolution  time  and  the  results  were  not  systematic  in  one 
direction. In Chapter 3, it was found that moisture uptake and loss by gelatin 
shells was significantly different at different RH and storage times. For New and 
E050 HPMC, differences were mainly found between the storage times 24 hours 
and 3 days, and differences in moisture uptake and loss at 35% and 53%RH for 
3  days  were  insignificant.  The  Glass  transition  temperature  data,  showed 
significant differences between gelatin and gelatin/PEG capsules 35%RH/24 hr 
and  53%RH/  3  days  for,  this  was  similarly  seen  for  New  and  E050  HPMC 
capsules, and for old HPMC capsules those differences were insignificant. DMA 
data showed that storage conditions had an insignificant effect on changes in 
the elasticity of gelatin, gelatin/PEG, and E050 capsules. However, for the old 
and New HPMC capsules, differences were mainly found between the high and 
low storage times (24 hr and 3 days).  
 
Generally, these findings suggest that storage conditions used for the tests on 
the capsule shells did not influence the dissolution properties of capsule shells 
significantly.  However,  in  terms  of  the  physical  and  mechanical  properties  of 
capsules, the storage conditions, in particular the 35%RH/ 24 hr and 53%RH/3 
days, influenced the Tg temperature of both gelatin and HPMC capsules, and 
influenced the elasticity of the HPMC capsule shells to a certain degree.  
 
4.10.2 Effect of pH and Media Composition 
 
There was a decrease in shell dissolution time in SPB with an increase in pH 
from pH5 – pH8, especially seen with the HPMC capsule shells. There was an 
increase in shell dissolution time in CPB with an increase in pH from pH5 – pH7, 
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HPMC shell dissolution in AB pH6 and an increase in shell dissolution time of 
gelatin and gelatin/PEG capsules in this buffer when the pH was increased from 
pH5 to pH6 
 
Changes seen in HPMC capsule shell dissolution are not thought to be an effect 
of  pH  since  it  has  been  reported  that  non ionic  polymers  will  not  ionize  by 
changing the pH (Tochio et al., 2002; El Malah and Nazzal, 2007; Liu et al., 
2008).  Instead, they are thought to be due to the salt concentration and ionic 
strength  of  these  dissolution  media.  Also,  the  difference  seen  between  the 
different HPMC capsules especially the old and New HPMC shells could be due 
to the type of additives or grade and/or molecular weight of the hypromellose 
used to compare the capsules (El Malah and Nazzal, 2007).  
 
The  ionic  strength  of a  solution  is  a function  of  the  concentration  of  all  ions 
present  in  a  solution.  The  ionic  strengths  of  the  dissolution  media  were 
calculated using equation 4.1 and are shown in Table 4.10. 
 
Ic = ½ ∑ ∑ CBZ
2
B  (Equation 4.1) 
CB is the molar concentration of ion B (mol dm
 3);  
Z is the charge number of that ion and the sum is taken over all ions in the 
solution  
 
Table 4. 10:  Ionic strength values for the dissolution media.  
 
  Ionic Strength (M) 
pH  SPB  PBB  CPB  AB  BB  AGJ 
1.2            0.114 
5  0.068    0.608  0.167     
6  0.089    0.963  1.304     
7  0.176  0.171  1.248       
8  0.245  0.200      0.250   
SPB (sörensen phosphate buffer); PBB (phosphate borax buffer); CPB (citro phosphate buffer); 
AB (acetate buffer); BB (borate buffer); AGJ (artificail gastric juice). 
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SPB was composed of two solutions. Solution A: Na2HPO4 (disodium hydrogen 
orthophosphate)  and  solution  B:  KH2PO4  (dihydrogen  potassium 
orthophosphate). Ionization of SPB is as follows: 
 
Na2HPO4 ￿ [Na
+] + [HPO4
 ] 
KH2PO4 ￿ [K
+] + [H2PO4
 ] 
 
Considerably greater amount of solution B was required for preparing pH 5 than 
was  required  for  preparing  pH8  i.e.  less  K
+  ions  were  present  at  higher  pH. 
However,  considerably  greater  amounts  of  the  Na+  were  required  when 
preparing  pH  8  than  was  required  when  preparing  pH  5  i.e.  more  Na
+  were 
present at higher pH.  See Table 4.11 for the calculated molarities of the two 
solutions. 
 
Table  4.  11:  Molar  strengths  of  disodium  hydrogen  orthophosphate  and 
dihydrogen potassium orthophosphate at pH 5 – 8  
 
Molarity (M)   
 pH  Na2HPO4  KH2PO4 
pH5  0.00079  0.066 
pH6  0.0099  0.0057 
pH7  0.05  0.026 
pH8  0.081  0.0021 
 
CPB was composed of 0.1M citric acid (C6H8O7) and 0.2M disodium hydrogen 
orthophosphate (Na2HPO4). The results obtained showed that the greater the 
amount of citric acid required (pH 5), the faster the capsule shell dissolution 
especially  for  HPMC  capsules  and  as  the  amount  of  citirc  acid  required 
decreased (pH 7) the slower became the dissolution. Ionization is as follows: 
 
C6H8O7 ￿ [H
+] + [C6H7O7 
 ] 
Na2HPO4 ￿ [2Na
+] + [HPO4 
 2] 
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The ionic strength of SPB and CPB increased with an increase in pH (Table 
4.11).  In  the  former  case,  the  concentration  of  Na
+  increased  and  the 
concentration  of  K
+  decreased  and  in  the  latter  the  Na
+  increased  and  the 
concentration of H
+ decreased. 
 
Acetate buffer pH5 was composed of sodium acetate (C2H3O2Na) and acetic 
acid, pH6 was composed of ammonium acetate (CH3COONH3) and acetic acid. 
Ionisation of the sodium acetate and ammonium acetate is as follows: 
 
C2H3O2Na ￿ [Na
+]  + [C2H3O2] 
CH3COONH3 ￿ [CH3COO
 ] + [NH3
+] 
 
The  observations  seen  in  acetate  buffer  could  be  due  to  the  difference  in 
composition of the buffer showing that acetate buffer with the sodium salt does 
not effect the shell dissolution properties of the capsules but they are effected 
when the salt is changed to ammonium acetate causing failure in dissolution. 
The  ionic  strength  was  also  increased  considerably  [0.167  (pH5)  and  1.304 
(pH6)]  i.e  the  ionic  strength  was  nearly  eight  times  stronger  at  pH6.  It  has 
previously shown that ammonium sulphate reduced the solubility of gelatin, this 
was thought to be due to both protein and salt competing for water to hydrate 
(Elysee Collen and Lencki, 1996; Sarabia et al., 2000). 
 
To explore the effect of ionic strength further, the ball bearing test was carried 
out  in  potassium  phosphate  buffer,  sodium  phosphate  buffer  keeping  the  pH 
constant (pH7.4) and increasing the molar concentration (0.1 M – 0.5M), and in 
HCl  pH 1.2 with increasing concentrations of either NaCl or KCl  (0.1 M – 0.5 M) 
(Section 4.9, Figures 4.21 – 4.28). The results generally showed that: 
 
1.  The mean shell dissolution times of gelatin shells from 0.1M – 0.5M were 
shorter than that of the HPMC capsule shells. 
2.   Dissolution  time  for  the  HPMC  capsules  increased  with  increase  in 
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3.  Dissolution  times  for  the  gelatin  capsules  were  significantly  different 
between 0.1 M and 0.5 M in all buffers tested.  
Table 4.12 shows the ionic strength of the KPB, NaPB, NaCl and KCl at molar 
concentrations 0.1M – 0.5M.  
 
Table 4. 12: Ionic strengths of potassium phosphate buffer, sodium phosphate 
buffer, NaCl and KCl. 
 
Ionic Strength    
 
Molarity 
Potassium Phosphate  
Buffer  
(K2HPO4 and KH2PO4) 
Sodium Phosphate 
Buffer 
(Na2HPO4 and 
NaH2PO4) 
NaCl  KCl 
0.1M  0.22  0.22  0.12  0.12 
0.2M  0.46  0.46  0.36  0.36 
0.3M  0.73  0.73  0.6  0.6 
0.4M  0.94  0.94  0.84  0.84 
0.5M  1.18  1.18  1.08  1.08 
Ionic strength of HCl = 0.1 
Ionisation of potassium phosphate and sodium phosphate is as follows:   
 
K2HPO4 ￿ [2K
+] + [HPO4 
 2] 
KH2PO4 ￿ [K
+] + [H2PO4 
 1] 
Na2HPO4 ￿ [2Na
+] + [HPO4 
 2] 
NaH2PO4 ￿ [Na
+] + [H2PO4 
 1] 
 
These  findings  showed  that  an  increase  in  ionic  strength  and  especially  an 
increase  in  K
+  concentration  hindered  HPMC  capsule  shell  dissolution  and 
slowed down the dissolution of gelatin capsule shells. For gelatin shells, this 
effect was greatest in NaPB (see Section 4.9).   
 
Tochio  et.  al.  (2002)  studied  the  influence  of  pH  and  the  types  and 
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media  had  a  minimal  effect  on  dissolution  from  both  HPMC  and  gelatin 
capsules, and that the concentration of potassium ions had a significant effect 
on dissolution from HPMC capsules containing carrageenan.  The higher the 
concentration  of  potassium  ions,  the  slower  the  rate  (if  concentration  of 
potassium ions was over 12.5mM and the total ions if over 355 mM). However, 
the  dissolution  profiles  from  HPMC  capsules  were  unchanged  when  low 
concentrations of potassium ions were used. When potassium ions in the test 
solutions were substituted with sodium ions then changes in the dissolution from 
HPMC capsules were not seen. Cole et al (2004) demonstrated that the release 
of  acetaminophen  from  HPMC  capsules  was  delayed  and  variable  in  the 
presence of K
+ cations in potassium phosphate buffer. They also demonstrated 
that  when  the  cation  present  was  Na
+  at  pH  4.5  and  7.2,  the  release  of 
acetaminophen  was  less  delayed.  The  capsules  that  they  tested  contained 
gellan  gum  as  appose  to  the  Carrageenan,  which  are  contained  in  Quali V 
capsules.  In  this  study,  capsule  shell  dissolution  was  also  hindered  by  the 
presence  of  high  Na
+  ion  concentrations  in  the  phosphate  buffers  (0.5M). 
Vazquez et al (1992) attributed differences in release from HPMC matrices to 
high concentrations of phosphate ions being present, rather than the high ionic 
strength.  This  could  be  one  of  the  causes  as  to  why  the  capsule  shell 
dissolution, in this study, occurred when the dissolution media was composed of 
HCl containing high concentrations (0.4 M and 0.5 M) of either KCl or NaCl, but 
did not occur when the dissolution media was composed of potassium or sodium 
phosphate at high concentrations (0.4 M and 0.5 M). Also, Chiewele et al (2000) 
found  that  neither  type  of  capsules  (HPMC,  gelatin,  gelatin/PEG)  should  be 
taken with carbonated cola type drinks to avoid slow down of the capsule shell 
dissolution, as those drinks contain considerable amounts of phosphates.  
Lee et al (2006b) studied the influence of electrolytes in the gastric and intestinal 
fluids  (ionic  strengths  0.01  –  0.2)  on  the  dissolution  of  various  grades  of 
cellulose. Theophylline with lactose was filled into hard capsules and dissolution 
was  carried  out  in  acid  (pH  1.2)  and  basic  buffer  (pH  6.8),  with  adding  the 
following electrolytes (LiCl, NaCl, KCl, CaCl2 and AlCl3). It was found that drug 
release  from  gelatin  capsules  were  slightly  reduced  with  increasing  ionic 
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by electrolytes, and decreased in the following order (0.1 M LiCl, NaCl, KCl, 
CaCl2 and AlCl3).  
 
Kappa carrageenan is characterised by an alternating disaccharide unit of (1 ￿ 
3) linked β – D – galactose – 4 – sulphate and (1 ￿ 4) linked 3,6 – anhydro –α – 
anhydro  –  α  –  D  –  galactose.  This  polysaccharide  undergoes  a  coil  –  helix 
conformational  transition  upon  temperature  reduction  in  the  presence  of  ions 
such as potassium, which affects the solubility of the polymer and thus promotes 
aggregation (Rochas and Rinaudo, 1984; Turquois et al., 1992; Ridout et al., 
1996). When the dissolution medium contains sufficient gel forming potassium 
cations, dissociation of the aggregates is hindered with the result that the gel 
from gellan and carrageenan retains its structure and the solubility is reduced. 
However, when the buffer solution contains sodium cations, disruption of the film 
is faster. This is thought to be due to the binding efficiency with which ions of 
different sizes can fit into potential sites on the helices (Cole et al., 2004).  
Picker (1999) studied the release behaviour from matrix tablet Carrageenans 
and effect of added cations, and found that the addition of potassium chloride 
slowed down the release from the k carrageenan.  
The increase in HPMC shell dissolution time seen as the ionic strength of CPB 
and AB is increased could be attributed to the salting out of the HPMC polymer 
by inorganic ions (Kavanagh and Corrigan., 2004; El Malah and Nazzal, 2007). 
Salting out refers to the reduction in aqueous solubility of neutral solute in the 
presence  of  dissolved  ions  (Turner,  2003).  Salt  solutions  present  in  large 
amounts greatly influence the mass transfer of volatile organic compounds from 
the  liquid  phase  to  the  air.  The  aqueous  solubility  of  the  different  kinds  of 
compounds decrease in the presences of inorganic salts. This could also explain 
the reduced capsule shell solubility in the presence of high concentrations of 
Na
+ ions, where the polymer molecular chains may have lost water of hydration 
due to the ions competing for the available water of hydration.  
 
It  is  widely  accepted  that  the  dominant  phenomenon for  gelation  of  MC  and 
HPMC  is  the  intermolecular  association  of  the  hydrophobic  groups  on  the 
polymer  chains,  leading  to  cross linking  and  gel  formation.  The  behaviour  of 
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additives such as salts. The salts can either reduce the water solubility of the 
solutes  (salting  out  effect)  or  increase  it  (salting  in  effects)  which  is  more 
common for a salt with large partial molar volume (Gorgenyi el al, 2006; Liu et 
al., 2008). The effects of cations are smaller than that of anions. A typical salting 
out anions order is SCN
  < CIO4
  < I
  < NO3
  < Br
  < Cl
  < F
  < HPO4
  < SO4
2  the 
salting out ability is due to the strengths of the interactions between the anions 
and water (liu et al., 2008). This is of great importance, since electrolytes of our 
daily diet, and salts present in our bio systems may affect the performance of 
dosage forms.  
 
Kavanagh and Corrigan (2004) studied the swelling and erosion properties of 
HPMC matrices in di sodium hydrogen phosphate dodecahydrate, di hydrogen 
phosphate di hydrate, in NaCl and HCl 37%, and found a linear decrease in 
erosion rate with increasing ionic strength. The decrease in erosion rate was 
attributed to the salting out of the polymer by the inorganic ions present in the 
dissolution media. As the ionic strength of the medium increased, the polymer 
molecule  chains  lose  water  of  hydration  due  to  the  ions  competing  for  the 
available  water  of  hydration.  Although  HPMC  is  a  non ionic  polymer,  its 
behaviour can be influenced by the ionic composition of the medium 
 A study by liu et al (2008) showed that the simulated intestinal fluid (pH7.4) had 
a stronger salting out effect compared with simulated gastric fluid (pH1.2). This 
was explained by the difference in the salting out capacity of the anions since 
cations have much less effect on the thermogelation compared to anions (the 
effect of the chloride ions, Cl
 ,  is much less that those of the hydroxide ions, 
OH
−, and H2PO4
  which tend to attract water molecules from polymers, water 
cages  and  shells  more  strongly).  They  also  explained  that  lower  methoxyl 
substituted  units  and  less  hydrophobic  substitutions  such  as  hydroxypropyl 
groups  become  more  hydrophobic  in  the  presence  of  simulated  gastric  and 
simulated intestinal fluid due to salting out effects. 
                  
 
In  order  to  further  investigate  differences  in  shell  dissolution  between  the 
different capsules, the effect of buffers with pH 5 on capsule shell dissolution 
time are shown in Figures 4.31 and 4.32 at 35% and 53%RH respectively, and 
compared with the shell dissolution times in water and AGJ (pH 1.2)  Chapter Four                                                                  Capsule Shell Dissolution                                                                      
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Figure 4. 31: Shell dissolution times in SPB, CPB, AB all with pH5, in AGJ (pH 1.2)  and water 
after storage at 35%RH for 24 hours. 
 
 
Figure 4. 32: Shell dissolution times in SPB, CPB, AB  all with pH 5,  in AGJ (pH 1.2), and in 
water after storage at 53%RH for 24 hours. 
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At pH 5, capsule shell dissolution time was highest in both SPB and CPB, with 
simlar dissolution times fot both buffers, apart from S4 HPMC shells, where SPB 
gave  higher  dissolution  time  values.  Shell  dissolution  in  AB  (pH  5)  was 
significantly faster (one way ANOVA, p < 0.001) than SPB and CPB for all the 
HPMC capsules shells apart from old HPMC, and it was found that HPMC shells 
generally dissolved more rapidly in acidic conditions and water.  
 
Post hoc  (Scheffe’)  tests  showed  that  for  old  HPMC  capsules  (Appendix  4, 
Table  4.15),  both  water  and  AGJ  had  a  similar  effect  on  capsule  shell 
dissolution, and the three dissolution media AB, SPB and CPB (pH 5) were also 
significantly similar.  
 
For New and E0504193 HPMC (Appendix 4, Tables 4.16 – 4.17), capsule shell 
dissolution in (AGJ, AB, and water) was found to be significantly faster than the 
shell dissolution in (CPB and SPB).  
 
Gelatin and gelatin/PEG capsules dissolved more rapidly in both water and AGJ, 
for gelatin, these were significantly different to the shell dissolution in CPB, AB 
and SPB (one way ANOVA, p < 0.001) (Appendix 4, Table 4.18). However, for 
gelatin/PEG the differences seen in capsule shell dissolution time were found to 
be  insignificant  (p  >  0.005).  Similar  findings  were  obtained  using  one  way 
ANOVA after storing all capsules at 35% and 53%RH for 3 days.  
 
The effect of different buffers with pH 6 on capsule shell dissolution time are 
shown in Figures 4.33 and 4.34 and compared with the shell dissolution times in 
water and AGJ (pH1.2)  Chapter Four                                                                  Capsule Shell Dissolution                                                                      
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Figure 4. 33: Shell dissolution times in SPB, CPB, AB, all with pH6, in AGJ (pH 1.2), and in 
water, after storage at 35%RH for 24 hours 
 
 
 
 
Figure 4. 34: Shell dissolution times in SPB, CPB, AB all with pH6, in AGJ (pH 1.2), and in water 
after storage at 53%RH for 24 hours 
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Figures 4.33 and 4.34 showed that the highest mean dissolution time occurred 
in  SPB  and  CPB especially  when  the  HPMC  capsule  shells  were  tested.  As 
seen before, the old HPMC capsules had the highest mean dissolution time and 
the size 4 HPMC capsule shells behaved similarly to Old HPMC in SPB with a 
very slow dissolution rate compared with other New HPMC capsule shells.  
 
Gelatin and gelatin/PEG capsules had a smaller mean dissolution time in all 
dissolution media when compared with HPMC. In AB (pH6), the HPMC shell 
dissolution was hindered and the gelatin and gelatin/PEG mean shell dissolution 
time  was  much  higher  than  the  mean  dissolution  times  obtained  in  other 
dissolution media. It was also apparent that in water or in the presence of acidic 
conditions the mean shell dissolution time of all the capsules was much smaller.   
 
Statistical analysis using one way ANOVA showed that the effect of different 
dissolution media at pH 6 excluding AB (for HPMC capsules) was insignificant (p 
> 0.05). However a significant difference was seen when comparing SPB, CPB 
to AGJ and water for all size 0 HPMC capsule shells (p < 0.001).  For gelatin 
and  gelatin/PEG  capsule  shells,  the  mean  dissolution  time  was  significantly 
increased when AB (pH6) was used as the dissoltion media (See Appendix 4 
Tables 4.19  4.23)   
 
The  effect  of  different  buffers  at  pH  7  on  capsule  shell  dissolution  time  are 
shown in Figures 4.35 & 4.36 and compared with the shell dissolution times in 
water and AGJ (pH1.2)  
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Figure 4. 35: Shell dissolution times in SPB, PBB, CPB all with pH 7, in AGJ (pH 1.2), and in 
water after storage at 35%RH for 24 hours 
 
 
 
Figure 4. 36: Shell dissolution times in SPB, PBB, CPB all with pH7, in AGJ (pH 1.2), and in 
water after storage at 53%RH for 24 hours 
 Chapter Four                                                                  Capsule Shell Dissolution                                                                      
  245 
Figures 4.35 and 4.36 showed the shell dissolution times of the capsule shells in 
SPB were smaller when compared with pH5 and pH6, and the shell dissolution 
time in CPB was smaller when compared with pH5 and pH6. 
 
For Old HPMC capsules, the dissolution time was longer than other capsule 
shell  types.  Post hoc  (Scheffe’)  tests  (Appendix  4  Table  4.24),  show  that 
differences  in  shell  dissolution  time  in  SPB,  PBB,  CPB  (pH7)  is  statistically 
insignificant,  but  were  significantly  different  when  compared  with  deionised 
water and AGJ.  For New HPMC and E05034193 capsule shells (Appendix 4 
Table  4.25  and  4.26),  the  shell  dissolution  times  in  CPB  were  significantly 
different  to  that  in  SPB  and  PBB,  and  those  three  buffers  at  pH7  were 
significantly different to AGJ (pH1.2).  For gelatin capsules (Appendix 4 Table 
4.27), shell dissolution was faster in all dissolution media compared with HPMC 
capsules,  significant  differences  in  gelatin  shell  dissolution  time  were  found 
between water and the two mediaCPB, and PBB. For gelatin/PEG capsules, no 
significant  differences  were  seen  in  capsule  shell  dissolution  for  any  of  the 
dissolution media (p > 0.05). 
 
The effect of different buffers with pH 8 on capsule shell dissolution time are 
shown in Figures 4.37 & 4.38 and compared with the shell dissolution times in 
water and AGJ (pH1.2)  
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Figure 4. 37: Shell dissolution times in SPB, PBB, BB all with pH 8,  in AGJ (pH 1.2), and in 
water after storage at 35%RH for 24 hours 
 
 
 
Figure 4. 38: Shell dissolution times in SPB, PBB, BB all with pH8, in AGJ (pH 1.2), and in water 
after storage at 53%RH for 24 hours 
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Figures 4.37 and 4.38 show that the shell dissolution times for the New HPMC, 
E0504193,  S00  and  S1  capsules  in  SPB  (pH8)  were  similar  to  the  shell 
dissolution time in water and to some extent in AGJ. This observation was not 
seen in SPB pH5 and pH6. Statistical analysis performed on HPMC capsules 
(Appendix 4 Tables 4.28 – 4.30) showed that the effect of AGJ, water and SPB 
(pH8) on the rate of capsule shell dissolution was insignificant for both old and 
E0504193 HPMC (p > 0.05), and for New HPMC capsules, the effect of water 
and  SPB  (pH  8)  was  insignificant.  However,  for  gelatin  and  gelatin/PEG 
capsules  (Appendix  4,  Tables  4.31  –  4.32),  both  water  and  AGJ  had  a 
significantly lower shell dissolution time than SPB (pH 8) (p < 0.05).  The shell 
dissolution time in PBB (pH8) was the highest for old HPMC and S4 HPMC 
capsule shells and was similar to the dissolution rate in BB for all capsule shells. 
 
In  summary,  the  results  showed  that  the  highest  dissolution  rate  for  HPMC 
capsule  shells  occurred  in  AGJ  followed  by  water  and  for  the  gelatin  and 
gelatin/PEG capsule shells, dissolution was generally faster in water followed by 
AGJ. However, the shell dissolution of HPMC capsule shells remained slower 
than the gelatin capsules in those two media (AGJ and water). This is supported 
by Chiewele et. al. (2000) who found that, in simple acidic and simulated gastric 
media  using  the  ball  bearing  test,  empty  HPMC  capsule  shells  containing 
carrageenan had a slower dissolution rate than gelatin capsules. The results in 
this study are similar to those found by Chiewele et al (2000)  demonstrating that 
in phosphate buffers (SPB, PBB, CPB) the capsule shell dissolution time for all 
the capsules tested was longer than that in AGJ and water. However, at pH 8, 
SPB and water were statistically similar for old HPMC capsules. However, Cole 
et  al  (2004)  demonstrated  that  in  acid  conditions  HPMC(gellan gum)  capsules 
remain practically intact with very little acetaminophen drug release, this effect is 
related to the fact that gellan gum is insoluble at pH < 4.0, whereas carrageenan 
is readily soluble at pH 1.2. El Malah and Nazzal (2007) studied the rupture time 
of  hard  gelatin  and  hypromellose  capsules  using  a  USP  type  II  dissolution 
apparatus  (VK  7000),  set  at  a  rotating  paddle  speed  of  50  rpm  and  a  bath 
temperature of 37
oC ± 0.5, in 500 ml of either simulated gastric fluid (pH 1.2) or 
phosphate buffer (pH 7.2) as the simulated intestinal fluid. They showed that the 
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reported that the pH of the dissolution medium had a significant effect on the 
rupture  time of  the  hard  gelatin  capsules. Chiwele  et  al  (2000) reported  that 
gelatin capsule shells dissolve at a slower rate in neutral pH media than in acidic 
media. This was attributed to the isoelectric point of gelatin being approximately 
5 – 7 (Wu et al., 2003). However, this would only be true if the gelatin used was 
alkaline treated, since acid processed material (Type A) has a lower IEP. The 
isoelectric point is the pH of a gelatin solution in which no net migration of the 
protein is produced by application of an electric field; the pH value of the solution 
determines the effective (net) charge on the gelatin. It is positive at pH values 
below the isoelectric point (IEP) where gelatin can be considered as a cationic 
polymer due to the –NH3
+ groups. Similarly, at pH values above the IEP, gelatin 
has a net negative charge and can be considered as an anionic polymer due to 
the –COO
  groups (Bele et al., 2002; Jones R.T, 2004). For HPMC capsules, El 
Malah and Nazzal (2007) found that dissolution medium had a significant effect 
on  the  rupture  time  of  the  hypromellose  capsules,  and  that  the  rupture  time 
increased in the simulated intestinal fluid (pH 7.2), which is very similar to the 
results demonstrated in this study.  
 
 
4.11  General Conclusion  
 
Previous knowledge of the viscoelastic properties of gelatin and HPMC capsule 
shells enabled prediction of their dissolution properties, where it was found that 
capsules with greater elasticity, i.e. HPMC capsules took longer to dissolve in all 
dissolution media, whereas shell dissolution of capsules made from gelatin was 
more rapid as expected.  
 
In  general,  it  was  found  that  the  shell  dissolution  times  for  both  gelatin  and 
HPMC capsules differed depending on the dissolution medium tested, and were 
affected  by  changes  in  ionic  strength,  however,  these  effects  were  more 
pronounced  for  the  HPMC  capsules.  Changes  seen  in  HPMC  capsule  shell 
dissolution  were  attributed  to  both  ionic  strength  and  dissolution  media 
composition.  HPMC  capsules  were  mostly  effected  by  the  presence  of  high 
concentrations of K
+ ions, these capsules were also affected by the presence of Chapter Four                                                                  Capsule Shell Dissolution                                                                      
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high concentrations of Na
+ ions but this effect was largest in phosphate buffer 
when compared to the results found when Na
+ or K
+ ions were added to HCl. 
This  suggests  that  phosphate  ions  also  influenced  the  shell  dissolution 
properties of these capsules. The results also show that other changes shown in 
HPMC  capsule  shell  dissolution  are  most  probably  due  to  the  salting  out  of 
HPMC polymer by inorganic ions.  Chapter Five                                                                    Drug Dissolution Studies 
    250 
 
 
 
 
 
 
 
 
 
 
Chapter Five 
Drug Dissolution Studies 
Results and Discussion 
 Chapter Five                                                                    Drug Dissolution Studies 
251 
5   Drug Dissolution Studies – Results and Discussion  
5.1  Background  
 
In vitro dissolution testing is one of the most important tests in monitoring the 
variables associated with design and manufacturing of dosage forms that have 
an influence on the release characteristics of the drug. It plays an important role 
in  the  development  of  new  drug  formulations  (Podczeck,  1993;  Pinto  et  al., 
1997; Costa et al., 2003). The drug release is a function of time involving a 
series  of  simultaneous  and  successive,  primary  and  secondary  processes, 
which can exist in a dosage form, these include, wetting, capillary penetration, 
swelling, disintegration, diffusion and dissolution. An interrelationship between 
these processes can exist, but they are very difficult to identify (Podczeck, 1993; 
Loth et al., 2007).  
 
In vitro  dissolution  of  theophylline  from  both  hard  gelatin  and  New  HPMC 
capsules  was  carried  out  in  a  number  of  dissolution  media  after  storing  the 
capsules at 35%RH for 24 hours and 6 months (see Section for description of 
method). The objective of this was to determine the effect of dissolution media 
and ionic strength on drug release from these capsules and to study the effect of 
storage on the stability of the capsule shells.  Chapter Five                                                                    Drug Dissolution Studies 
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5.2  Effect of Ionic Strength on the Dissolution of Theophylline from 
Hard Capsules after Storage at 35%RH for 24 Hours 
 
For theophylline particle size analysis and calibration data in all dissolution 
mediatested please refer to Appendix 5.  
5.2.1  Drug dissolution   Method Development  
 
The in vitro release profiles of theophylline and caffeine from both gelatin and 
New HPMC capsules in KPB pH 7.4 are shown in Figures 5.1 – 5.3.  
 
 
 
Figure 5. 1: Dissolution of theophylline from gelatin and New HPMC hard capsules in 0.1M and 
0.5M KPB at pH 7.4 
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Figure 5. 2: Dissolution of theophylline from New HPMC hard capsules in 0.1M – 0.5M KPB at 
pH 7.4 
 
 
 
Figure 5. 3: Dissolution of caffeine from New HPMC capsules in 0.1M and 0.5M KPB at pH 7.4. 
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Figures 5.1 and 5.2 show that the maximum drug release in all cases does not 
exceed  65%. This  was found  when  the  theophylline  stock  solution  (prepared 
with either 0.1 M or 0.5 M KPB) was stored for 24 hours. 
 
To explore this effect further, caffeine was selected as a model drug, because of 
its similarities to theophylline in properties and chemical structure (Figure 5.4). 
 
 
    Caffeine        Theophylline 
 
Figure 5. 4: Chemical structures of caffeine and theopylline 
 
 
Where 400 mg of caffeine was filled into New HPMC capsules. Dissolution tests 
were carried out as before in 0.1M and 0.5M KPB under the same conditions 
(37
oC) and 50 rpm. 
 
The in vitro release of caffeine from the New HPMC capsule shells in 0.1M KPB 
pH7.4 gave an initial lag time (0.12% drug release at 3 minutes, 0.29% drug 
release at 6 minutes and 27.27% drug release at 12 minutes) before reaching 
complete (approx. 100% ) release after 45 minutes (see Figure 5.3). This was a 
similar  lag  time  to  that  observed  when  theophylline  was  released  under  the 
same conditions (Figure 5.2). Caffeine gave very low drug release from HPMC 
capsules (19.17%) in 0.5M KPB after 5 hours, which was similar to theophylline 
under the same conditions (Figure 5.1 and 5.2). These results show that the 
differences seen are most likely to be due to an interaction between the buffer 
solution and the theophylline since sink conditions for the drug had been met, 
these were equivalent to a maximum possible dose 5.29 g/900 ml (0.1 M KPB) 
and  4.06  g/900  ml  (0.5  M  KPB).  The  chemical  structure  of  caffeine  and 
theophylline is shown in Figure 5.4, theophylline being a metabolite of caffeine. Chapter Five                                                                    Drug Dissolution Studies  
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The two structures are very similar, the only exception being the presence of 
methylamine (N CH3) group for the caffeine that is substituted by an amine (NH) 
group in theophylline.  
 
To  overcome  this,  further  calibrations  for  theophylline  were  undertaken  (see 
Section 2.3.5.1 for method). However, this time the stock was not left for 24 
hours,  instead  was  used  immediately  after  preparation,  and  the  results  are 
presented in the next sections.  
5.2.2  Drug Dissolution in Potassium Phosphate Buffer (KPB)  
 
Drug release data and profiles of theophylline from gelatin and New HPMC hard 
shells in KPB pH 7.4 (0.1 M and 0.5 M) and from New HPMC in KPB pH 7.4 (0.1 
M – 0.5 M) after storage at 35%RH/24 hr, are reported in Tables 5.1 and 5.2, 
and in Figures 5.5 and 5.6 respectively.  
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Table 5. 1:  Dissolution data of theophylline filled gelatin and New HPMC 
capsule shells using 0.1 M and 0.5 M KPB. 
 
% Drug Release    
Time 
(mins) 
Gelatin 
(0.1M KPB) 
HPMC 
(0.1M KPB) 
Gelatin 
(0.5M KPB) 
HPMC 
(0.5M KPB) 
0  0.00  (0.00)  0.00  (0.00)  0.00  (0.00  0.00  (0.00) 
3  11.10  (4.31)  0.04  (0.06)  7.88  (5.52)  0.00  (0.00) 
6  41.85  (6.49)  0.12  (0.01)  30.30  (12.61)  0.00  (0.00) 
9  55.84  (10.82)  1.01  (1.86)  45.20  (15.29)  0.04  (0.06) 
12  64.04  (8.71)  13.45  (16.09)  50.64  (14.63)  0.19  (0.27) 
15  68.64  (6.70)  40.18  (22.65)  56.55  (13.13)  0.15  (0.17) 
18  71.59  (4.97)  66.60  (33.26)  63.87  (12.93)  0.24  (0.21) 
21  74.62  (3.42)  92.07  (7.67)  67.68  (11.85)  0.34  (0.26) 
24  76.46  (3.35)  96.13  (6.62)  69.70  (11.38)  0.45  (0.31) 
27  78.93  (2.72)  97.31  (4.75)  70.54  (11.39)  0.54  (0.34) 
30  80.34  (2.24)  98.81  (2.60)  72.37  (10.90)  0.64  (0.39) 
35  82.02  (2.40)  100.15  (2.89)  74.28  (10.16)  0.91  (0.44) 
40  84.84  (2.53)  101.62  (1.72)  76.50  (9.91)  0.95  (0.51) 
45  86.43  (2.36)  103.18  (2.36)  78.53  (9.52)  1.12  (0.62) 
50  87.44  (2.40)  102.15  (1.02)  83.77  (4.69)  1.25  (0.64) 
55  89.40  (2.23)  102.10  (1.62)  82.53  (7.89)  1.38  (0.71) 
60  91.73  (2.91)  101.97  (1.72)  86.47  (7.92)  1.51  (0.77) 
75  94.70  (2.37)  101.04  (1.38)  90.11  (7.07)  1.86  (0.99) 
90  97.44  (2.03)  100.56  (1.22)  93.36  (6.97)  2.27  (1.26) 
120  101.07  (2.17)  100.90  (1.22)  97.33  (4.70)  2.84  (1.58) 
180  103.36  (1.62)  100.56  (1.39)  101.30  (1.12)  4.00  (2.59) 
240  103.81  (1.59)  101.32  (1.48)  101.88  (0.80)  5.07  (3.34) 
300  104.62  (1.33)  102.04  (1.37)  102.30  (0.59)  5.92  (4.73) 
The results are the mean and (standard deviation) of 6 capsules 
 
2
5
7
 
Table 5. 2:  Dissolution data of theophylline filled New HPMC capsule shells using 0.1 M – 0.5 M KPB 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The results are the mean and (standard deviation) of 6 capsules.
% Drug Dissolution    
Time 
(mins) 
0.1M KPB  0.2M KPB  0.3M KPB  0.4M KPB  0.5M KPB 
0  0.00  (0.00)  0.00  (0.00)  0.00  (0.00)  0.00  (0.00)  0.00  (0.00) 
3  0.04  (0.06)  0.68  (1.43)  0.00  (0.00)  0.01  (0.02)  0.00  (0.00) 
6  0.12  (0.01)  2.30  (4.97)  0.00  (0.00)  0.01  (0.03)  0.00  (0.00) 
9  1.01  (1.86)  3.30  (7.33)  0.29  (0.07)  0.10  (0.10)  0.04  (0.06) 
12  13.45  (16.09)  4.88  (10.68)  0.39  (0.08)  0.28  (0.13)  0.19  (0.27) 
15  40.18  (22.65)  7.99  (13.82)  0.63  (0.08)  0.51  (0.36)  0.15  (0.17) 
18  66.60  (33.26)  12.12  (18.84)  1.12  (0.44)  0.67  (0.50)  0.24  (0.21) 
21  92.07  (7.67)  16.96  (24.84)  1.42  (0.68)  0.95  (0.69)  0.34  (0.26) 
24  96.13  (6.62)  20.23  (28.22)  1.62  (0.77)  1.16  (0.85)  0.45  (0.31) 
27  97.31  (4.75)  25.64  (32.01)  2.00  (0.86)  1.42  (1.10)  0.54  (0.34) 
30  99.19  (2.60)  30.92  (32.32)  3.08  (3.14)  1.50  (0.92)  0.64  (0.39) 
35  99.79  (2.89)  34.78  (33.33)  4.59  (5.23)  1.87  (1.04)  0.91  (0.44) 
40  101.62  (1.72)  37.85  (32.03)  5.85  (7.36)  2.01  (1.19)  0.95  (0.51) 
45  102.57  (2.36)  44.00  (33.94)  6.74  (8.69)  2.44  (1.48)  1.12  (0.62) 
50  101.81  (1.02)  46.56  (34.08)  7.71  (9.82)  2.75  (1.66)  1.25  (0.64) 
55  102.42  (1.62)  50.78  (33.60)  8.81  (10.24)  3.17  (2.13)  1.38  (0.71) 
60  101.96  (1.72)  53.16  (33.50)  9.73  (11.32)  4.21  (4.08)  1.51  (0.77) 
75  101.03  (1.38)  58.53  (32.14)  11.71  (12.83)  5.12  (5.12)  1.86  (0.99) 
90  100.55  (1.22)  69.85  (29.22)  14.52  (15.49)  6.83  (7.44)  2.27  (1.26) 
120  100.89  (1.22)  76.75  (27.00)  17.88  (18.78)  8.59  (9.53)  2.84  (1.58) 
180  100.55  (1.39)  94.19  (13.29)  26.90  (25.43)  11.36  (11.52)  4.00  (2.59) 
240  101.31  (1.48)  95.48  (19.34)  33.94  (29.23)  13.63  (12.93)  5.07  (3.34) 
300  102.04  (1.37)  103.72  (2.14)  44.11  (29.38)  16.02  (13.86)  5.92  (4.73) Chapter Five                                                                   Drug Dissolution Studies  
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Figure 5. 5: Dissolution of theophylline from gelatin and New HPMC hard capsules in 0.1M and 
0.5M KPB at pH7.4 
 
 
 
Figure 5. 6: Dissolution of theophylline from New HPMC hard capsules in 0.1M – 0.5M KPB at 
pH 7.4 
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In  vitro release data and profiles of theophylline from gelatin and New HPMC 
capsules in 0.1M and 0.5M KPB pH 7.4 are shown in Table 5.1 and Figure 5.5. 
The dissolution of theophylline from gelatin capsules in 0.1M KPB was rapid with 
11.10%  drug  release  after  3  minutes,  41.85%  release  after  6  minutes  and 
64.04%  of  the  theophylline  was  released  after  12  minutes.  In  contrast,  the 
release  from  the  HPMC  capsules  was  slow  (Figure  5.7),  with  0.04%  drug 
release at 3 minutes, 0.12% drug release at 6 minutes and 13.45% drug release 
at  12  minutes.  However,  after  21  minutes  the  mean  %  drug  release  of 
theophylline in 0.1M KPB from HPMC capsules was greater than from gelatin 
capsules (92.07% vs 74.62% respectively). Maximum drug release occurred at 
approximately 35 minutes for the HPMC capsules, whereas it took almost 120 
minutes for maximum drug release to occur from the gelatin capsules. 
 
 
 
Figure 5. 7: Initial stages of dissolution of theophylline from New HPMC hard capsules in 0.1M   
0.5M KPB pH 7.4  
 
 
The  dissolution  of  theophylline  from  gelatin  capsules  in  0.5M  KPB  was  also 
rapid with a similar release profile to that in 0.1M KPB. However, it is apparent 
that the drug dissolution was generally more variable in 0.5 M KPB, see table 
5.1, with high standard deviations for example: (11.10 ± 4.31% vs 7.88 ± 5.52% Chapter Five                                                                   Drug Dissolution Studies  
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at 3 minutes), (41.85 ± 6.49% vs 30.30 ± 12.61% at 6 minutes), (64.04 ± 8.71% 
vs 50.64 ± 14.63% at 12 minutes), and (80.34 ± 2.24% vs 72.37 ± 10.90 at 30 
minutes), in 0.1M and 0.5M KPB respectively. However, the release of drug in 
0.5M KPB from the HPMC capsule shells was very low with only 5.92% drug 
release  after  five  hours.  These  findings  suggest  that  the  presence  of  high 
concentrations  of  potassium  ions  had  a  significant  effect  on  the  release  of 
theophylline from the HPMC capsules and to some extent affected the release 
from gelatin capsule shells. Figure 5.7 shows a clear relationship between ionic 
concentration and drug release, with a significant decrease in drug release from 
HPMC  capsules  as  the  ionic  strength  is  increased  above  0.46  (0.2  M)  (see 
Chapter 4, Table 4.12). It can also be seen that as the molarity is increased from 
0.1 M to 0.2 M, the dissolution becomes more variable from the HPMC capsules 
with high standard deviations: for example 7.67 vs 24.84 at 21 minutes, 2.60 vs 
32.32 at 30 minutes and 1.72 vs 33.50 at 60 minutes for 0.1 M an 0.2 M. These 
results mirror those found in Chapter 4 (Section 4.9.1), where it was found that 
capsule shell dissolution time was similar at 0.1 and 0.2 M KPB (ionic strengths: 
0.22  and  0.46  respectively),  significantly  decreased  at  0.3  M  (Ionic  strength 
0.73), and with no dissolution at 0.4 and 0.5 M (ionic strengths 0.94 and 1.18 
respectively). Similarly, the capsule shell dissolution time for gelatin was found 
to increase in 0.5 M KPB, and was significant at 35% and 53%RH/ 3 days (see 
Section 4.10.2 for discussion).  
The following observations were made during dissolution of theophylline from 
HPMC and gelatin capsule shells in 0.1 M and 0.5 M KPB: 
 
Gelatin capsules when immersed in 0.1 M KPB began to dissolve and the walls 
swell. After 40 to 50 seconds wrinkles appeared at the shoulders of the cap then 
the body, and after 60   70 seconds, the wrinkles disappeared and droplets were 
observed on the inner side of the wall at the shoulders, which was similar to the 
observations of Ludwig and Ooteghem (1979). In 0.1M KPB, the gelatin capsule 
shells were partly dissolved at 3.00 minutes and after about 6.00 minutes the 
shell was fully dissolved with only the theophylline powder plug remaining.  The 
same  was  observed  in  0.5  M  KPB,  however,  the  time  taken  for  the  gelatin 
capsules to fully dissolve increased to 10 minutes.  
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HPMC  capsules,  after  immersion  in  0.1M  KPB  the  capsule  shells  began  to 
dissolve  (observed  by  the  fading  of  the  capsule  colour)  and  swell 
simultaneously. At 60   70 seconds droplets appeared on the capsule shell wall, 
at 90 seconds the capsules started to wrinkle.  After 10 minutes, the capsules 
began to break, this occurred evenly across the shell. At 30 minutes, very little 
drug powder remained, however, the capsule shells were not fully dissolved, 
and  after  completion  of  the  5 hour  dissolution  period,  the  dissolution  media 
remained clear with pieces of the HPMC shells left undissolved. 
 
When the HPMC capsule shells were immersed in 0.5M KPB, the same stages 
as above occurred however, this time the capsules did not break even after five 
hours, and the theophylline plug remained intact (see Figures 5.8a –5.8d)  
 
 
 
               Figure 5. 8a: initial stages of New HPMC capsule shell dissolution in 0.5 M KPB  
 
 
Figure 5.8b: Capsules begin to wrinkle after 90 minutes In 0.5 M KPB 
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Figure 5.8c: Capsule shells after five hour dissolution in 0.5M KPB 
 
 
 
Figure 5.8d: Undissolved theophylline drug (removed from the HPMC 
capsule shells) after five hour dissolution in 0.5M KPB 
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To remove the effect of the capsule shells on drug dissolution, the studies were 
performed  using  theophylline  plugs  alone  (i.e.  the  theophylline  was  not 
encapsulated  in  to  capsule  shells)  in  0.1M  and  0.5M  KPB.  The  same 
experimental conditions were followed and the results are shown below in Table 
5.3 and Figure 5.9. 
 
 
Table 5. 3: Dissolution data of theophylline plugs in 0.1M and 0.5M KPB as 
dissolution media 
 
% Drug Release of theophylline  Time 
(mins)  0.1M KPB  0.5M KPB 
0  0.00  (0.00)  0.00  (0.00) 
3  38.97  (1.05)  38.17  (3.21) 
6  57.01  (6.84)  54.42  (13.89) 
9  63.53  (7.73)  62.10  (16.04) 
12  67.75  (8.10)  66.61  (15.08) 
15  72.09  (9.31)  67.93  (16.12) 
18  75.57  (7.82)  70.14  (14.63) 
21  78.22  (7.07)  71.82  (14.29) 
24  80.20  (6.12)  74.32  (13.81) 
27  83.41  (4.61)  76.66  (13.00) 
30  85.79  (4.86)  77.99  (12.89) 
35  88.44  (4.08)  79.87  (12.80) 
40  91.03  (3.74)  81.99  (13.13) 
45  93.01  (2.73)  84.08  (11.80) 
50  95.28  (1.98)  86.33  (11.80) 
55  96.56  (1.57)  88.75  (10.01) 
60  97.87  (1.25)  88.45  (9.76) 
75  99.67  (0.52)  92.44  (6.72) 
90  102.01  (0.98)  95.64  (8.29) 
120  101.57  (0.29)  99.58  (4.84) 
180  101.26  (0.96)  102.79  (1.91) 
240  102.15  (0.78)  104.25  (1.75) 
300  102.94  (0.89)  105.17  (1.59) 
       The results are the mean and (standard deviation) of 3  
        theophylline plugs 
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Figure 5. 9: Dissolution of theophylline plugs alone in 0.1 M and 0.5 M KPB at pH 7.4.  
 
 
Figure 5.9 shows rapid dissolution of the drug within the first two hours, with 
38.97% mean drug release at 3 minutes, 85.79% mean drug dissolution at 30 
minutes, and 102.01% at 1 hour 30 minutes in 0.1M KPB. The same was seen 
in 0.5M KPB. However, the % drug dissolved was slightly lower for example: 
72.09% vs 67.93% at 15 minutes and 85.79% vs 79.87% at 30 minutes for 0.1M 
and 0.5M respectively. It can also be seen from Table 5.3 that an increase in the 
molar strength from 0.1 M to 0.5 M increases the variability of the results as 
seen by the higher standard deviations, for example 1.05 vs 3.21 at 3 minutes, 
4.86 vs 12.89 at 30 minutes and 1.25 vs 9.76 at 60 minutes.  This shows that 
high molar concentrations of KPB, not only effects capsule shell dissolution, but 
also effects drug dissolution to a certain degree, however, the decreased drug 
release  from  HPMC  capsules  at  higher  molar  concentrations  (Figure  5.7)  is 
mainly due to the effect of the KPB on the capsule shells as was found in the 
ball bearing study (Chapter 4).  
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5.2.3 Drug Dissolution in Sodium Phosphate Buffer (NaPB) 
 
Drug release data and profiles of theophylline from gelatin and New HPMC hard 
shells in NaPB pH 7.4 (0.1 M and 0.5 M) and from New HPMC in KPB pH 7.4 
(0.1 M – 0.5 M) after storage at 35%RH/24 hr, are reported in Tables 5.4 and 
5.5, and represented in Figures 5.10 and 5.11 respectively.  
 
Table 5. 4: Dissolution data of theophylline filled gelatin and New HPMC  
capsule shells in 0.1M and 0.5M NaPB at pH7.4. 
 
% Drug Release  Time 
(mins)  Gelatin   
(0.1M NaPB) 
HPMC  
(0.1M NaPB) 
Gelatin  
(0.5M NaPB) 
HPMC 
 (0.5M NaPB) 
0  0.00  (0.00)  0.00  (0.00)  0.00  (0.00)  0.00  (0.00) 
3  7.67  (11.88)  0.09  (0.13)  0.13  (0.20)  0.01  (0.02) 
6  40.44  (6.10)  26.06  (15.88)  2.37  (1.13)  0.04  (0.00) 
9  46.45  (6.19)  72.19  (18.07)  5.14  (0.89)  0.05  (0.02) 
12  54.34  (5.06)  81.04  (15.99)  11.07  (2.19)  0.06  (0.04) 
15  63.42  (7.25)  90.60  (5.91)  13.55  (3.13)  0.06  (0.04) 
18  67.66  (7.40)  95.15  (2.64)  14.88  (3.54)  0.10  (0.05) 
21  71.53  (7.82)  98.57  (1.28)  17.02  (3.70)  0.18  (0.09) 
24  74.39  (8.44)  99.91  (0.83)  18.94  (4.45)  0.25  (0.08) 
27  77.70  (9.04)  100.65  (0.32)  21.14  (5.34)  0.30  (0.12) 
30  80.91  (7.97)  101.22  (0.29)  23.60  (5.78)  0.35  (0.14) 
35  83.35  (6.63)  101.65  (0.45)  25.75  (5.12)  0.57  (0.16) 
40  86.38  (4.76)  101.95  (0.56)  28.02  (5.81)  0.54  (0.19) 
45  88.27  (4.17)  101.81  (0.66)  31.24  (8.42)  0.66  (0.22) 
50  89.91  (4.97)  102.65  (0.77)  34.73  (9.08)  0.68  (0.26) 
55  93.25  (3.26)  102.80  (1.13)  39.27  (9.99)  0.77  (0.28) 
60  94.30  (3.45)  102.76  (1.01)  43.13  (11.32)  0.88  (0.31) 
75  96.12  (2.75)  102.95  (0.95)  52.59  (12.15)  1.68  (1.24) 
90  97.87  (2.70)  102.94  (0.94)  62.90  (12.25)  1.86  (1.30) 
120  100.65  (2.21)  103.05  (0.88)  71.46  (12.39)  2.10  (1.40) 
180  102.01  (1.99)  103.36  (0.75)  80.76  (13.92)  3.38  (2.77) 
240  101.55  (1.20)  102.99  (0.63)  93.70  (11.55)  5.39  (5.61) 
300  99.95  (0.73)  102.39  (0.91)  101.46  (7.30)  9.92  (9.57) 
The results are the mean and (standard deviation) of 6 capsules   
 
2
6
6
 
Table 5. 5:  Dissolution data of theophylline filled New HPMC capsule shells in 0.1M – 0.5M sodium phosphate buffer (NaPB) 
pH7.4. 
 
% Drug Release  Time 
(mins)  0.1M  0.2M  0.3M  0.4M  0.5M 
0  0.00  (0.00)  0.00  (0.00)  0.00  (0.00)  0.00  (0.00)  0.00  (0.00) 
3  0.09  (0.13)  0.09  (0.16)  0.04  (0.06)  0.02  (0.04)  0.01  (0.02) 
6  26.06  (15.88)  1.57  (1.29)  1.05  (2.22)  0.17  (0.12)  0.04  (0.00) 
9  72.19  (18.07)  21.60  (14.86)  3.31  (7.37)  0.26  (0.15)  0.05  (0.02) 
12  81.04  (15.99)  59.44  (14.56)  3.81  (8.33)  0.26  (0.21)  0.06  (0.04) 
15  90.60  (5.91)  77.61  (20.45)  5.37  (11.49)  1.52  (2.56)  0.06  (0.04) 
18  95.15  (2.64)  92.42  (7.45)  8.87  (19.48)  2.77  (4.71)  0.10  (0.05) 
21  98.57  (1.28)  96.15  (3.01)  10.50  (23.10)  4.27  (7.54)  0.18  (0.09) 
24  99.91  (0.83)  97.44  (2.22)  11.46  (24.94)  5.56  (9.30)  0.25  (0.08) 
27  100.65  (0.32)  98.12  (0.81)  15.89  (34.98)  6.31  (10.67)  0.30  (0.12) 
30  101.22  (0.29)  98.08  (0.54)  17.86  (39.02)  6.46  (10.63)  0.35  (0.14) 
35  101.65  (0.45)  98.88  (1.18)  19.39  (40.67)  6.92  (10.72)  0.57  (0.16) 
40  101.95  (0.56)  99.62  (1.26)  21.52  (44.15)  7.61  (11.90)  0.54  (0.19) 
45  101.81  (0.66)  98.29  (1.63)  22.92  (43.05)  8.68  (13.03)  0.66  (0.22) 
50  102.65  (0.77)  98.72  (1.49)  24.78  (41.23)  9.35  (13.92)  0.68  (0.26) 
55  102.80  (1.13)  99.07  (1.23)  25.35  (40.62)  9.89  (14.34)  0.77  (0.28) 
60  102.76  (1.01)  98.99  (1.06)  27.67  (39.04)  10.69  (14.68)  0.88  (0.31) 
75  102.95  (0.95)  99.56  (1.10)  30.27  (38.22)  12.18  (17.05)  1.68  (1.24) 
90  102.94  (0.94)  99.85  (1.12)  32.56  (37.47)  13.76  (18.82)  1.86  (1.30) 
120  103.05  (0.88)  99.66  (1.37)  36.94  (36.22)  18.50  (21.96)  2.10  (1.40) 
180  103.36  (0.75)  99.67  (1.99)  43.61  (33.01)  22.71  (26.13)  3.38  (2.77) 
240  102.99  (0.63)  99.41  (1.32)  50.60  (29.72)  29.63  (32.65)  5.39  (5.61) 
300  102.39  (0.91)  98.93  (0.68)  56.94  (25.16)  33.38  (35.69)  9.92  (9.57) 
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Figure 5. 10: Dissolution of theophylline from gelatin and New HPMC hard capsules in 0.1 M 
and 0.5 M NaPB pH 7.4 
 
 
 
Figure 5. 11: Dissolution of theophylline filled New HPMC capsules in 0.1 M – 0.5 M NaPB pH 
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The results presented in Table 5.4 and Figure 5.10 show the percentage drug 
release of theophylline from both gelatin and the New HPMC capsule shells in 
both 0.1M and 0.5M NaPB. The release of theophylline from both the gelatin 
and the HPMC shells in 0.1M NaPB was rapid with complete drug release. A lag 
time of 3 minutes was shown for the release of the drug from the New HPMC 
capsule shells (See Figure 5.12); however, this lag time was lower than when 
KPB was used as the dissolution media (10 minutes) (See Figure 5.7). As with 
KPB,  the  lag  time  was  followed  by  a  rapid  increase  in  %  drug  release,  for 
example  0.09%  mean  drug  was  released  at  3  minutes,  72.19%  after  only  9 
minutes,  and  100.65%  drug  release  occurring  only  after  27  minutes  into  the 
dissolution run when compared with the release from the gelatin capsules with 
100.65% drug release after 120 minutes.   
 
 
 
Figure 5. 12: Initial stages of dissolution of theophylline from New HPMC hard capsules in 0.1 M 
– 0.5 M NaPB pH 7.4  
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Figure 5. 13: Initial stages of dissolution of theophylline from New HPMC hard capsules in 0.1 M 
NaPB and KPB pH 7.4  
 
Drug release from the HPMC capsules in 0.1M NaPB was less variable than in 
0.1 M KPB. For example, the standard deviations between the two buffers were 
5.91 vs 13.51 at 15 minutes, 0.29 vs 1.64 at 30 minutes and 1.01 vs 1.11 at 60 
minutes in NaPB and KPB respectively. HPMC capsules dissolved completely in 
0.1  M  NaPB,  but  in  KPB,  un dissolved  pieces  of  the  capsule  shell  were  left 
behind after completion of the five hour dissolution run. In contrast, the drug 
release from the gelatin capsules was more variable in NaPB than in KPB with 
higher standard deviation values. For example, 11.88 vs 4.31 at 3 minutes, 7.25 
vs  6.49  at  15  minutes  and  3.45  vs  2.91  at  60  minutes  in  NaPB  and  KPB 
respectively (See Table 5.1 and Table 5.4). This mirrors the results found for the 
ball bearing study, where the effect of ionic strength on capsule shell dissolution 
was  investigated  (Chapter  4,  Figure  4.30),  and  it  was  demonstrated  that  the 
release of the ball bearings from the gelatin capsules was slower in NaPB when 
compared to KPB.  
The drug release from gelatin capsules in 0.5M NaPB was significantly slower 
than what occurred in 0.1M NaPB. With 23.60% mean drug release after 30 
minutes dissolution in 0.5M NaPB, compared with 80.91% drug release in 0.1M Chapter Five                                                                    Drug Dissolution Studies  
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NaPB, and 43.13% drug release in 0.5M NaPB after 60 minutes compared to 
94.30% drug release in 0.1M NaPB after 60 minutes. This shows that the 
Presence of high concentrations of Na
+ possibly effects the solubility of gelatin 
capsule shells and hence the release of the drug. 
 
A study by Bello et al (1956) investigated the effects of various salts at a 1 M 
concentration on the pH of 5% gelatin solutions. It was found that negative ions 
raised and positive ions lowered the pH: this behaviour was expected if binding 
of the ions occurs. They also found that NaCl reduced the pH of the acetylated 
gelatin  and  raised  that  of  the  non acetylated  gelatin,  which  suggested  that 
sodium binding occurs. This possibly suggests that the pH here is being shifted 
slightly towards the IEP of gelatin thus affecting the capsule shell dissolution 
since gelatin solubility is at a minimum at the IEP. 
 
The  effect  of  0.5M  NaPB  on  the  dissolution  behaviour  of  the  New  HPMC 
capsule  shells  was  similar  to  that  observed  in  0.5  KPB:  a  high  molar 
concentration retarded the capsule shell disintegration with only 9.92% mean 
drug release occurring after five hours, (Table 5.4 and Figure 5.10). However, 
this was greater than the drug release that occurred in KPB from these capsules 
(5.92% after five hours). The variability of these results was high  in both KPB 
and NaPB showing high standard deviations in both 0.4 M and 0.5 M. 
 
The dissolution of theophylline from New HPMC capsules shells in 0.1M – 0.5M 
NaPB is shown in Table 5.5 and Figure 5.11. The drug dissolution rate in 0.2M 
NaPB  was  similar  to  the  dissolution  rate  in  0.1M  NaPB,  with  100.65%  drug 
release in 0.1M and 98.12% drug release in 0.2M after 27 minutes. In both 0.1M 
and  0.2M  NaPB  the standard  deviations  were  also  much  smaller  than  those 
seen when KPB was used as the dissolution media (Table 5.2). For example: 
2.60 vs 0.32 at 30 minutes, and 1.72 vs 1.01 at 60 minutes for 0.1M KPB and 
NaPB respectively. Similarly, 30.92 vs 0.54 at 30 minutes, and 33.50 vs 1.06 at 
60 minutes for 0.2M KPB and NaPB respectively.  
 
When  the  dissolution  tests  were  carried  out  in  0.3M  and  0.4M  NaPB,  the 
dissolution  rates  were  significantly  decreased  to  56.94%  and  33.38% Chapter Five                                                                    Drug Dissolution Studies  
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respectively after five hours. However, this % release was greater than that from 
the 0.3 M and 0.4 M KPB, which was 44.11% and 16.02% respectively after five 
hours (Figure. 5.11). 
Similar stages of capsule shell dissolution in NaPB for both gelatin and HPMC 
capsule  shells  were  observed.  However,  in  0.1  M  NaPB  the  HPMC  capsule 
shells completely dissolved and the dissolution media acquired a cloudy/whitish 
colour in contrast with KPB where the dissolution media remained clear in 0.1 M 
KPB and pieces of the capsule shell were left undissolved.  This observation is 
most likely due to the gelling agent and gelling promoter used in the production 
of Quali V HPMC capsules. Gelation of HPMC by carrageenan is dependent on 
both  ionic  strength  and  the  identity  of  the  cation  (Grasdalen  and  Smidsord, 
1987; Cole et al, 2004). The  strongest gels of k carrageenan are formed with K
+ 
rather than Li
+, Na
+, Mg
2+, Ca
2+ or S
2+ (Kara et al., 2006). In the presence of Na
+, 
k carrageenan is found in the coil state at room temperature, whereas in the 
presence  of  K
+,  it  can  be  in  the  coil  or  helix  state,  depending  on  the  salt 
concentration. It has been suggested that the presence of Na
+ in solution can 
induce a conformational transition in k Carrageenan at high salt concentration 
and low temperature only (Mangione et al., 2005) (Further analysis of the results 
is shown is Section 5.4).  
 
5.2.4   Drug Dissolution in Hydrochloric Acid (HCl) 
 
In vitro dissolution of theophylline from gelatin and New HPMC capsules was 
conducted  in  0.1  M  HCL  (pH1.2).    High  and  low  ionic  strengths  were  also 
investigated by addition of NaCl and KCl to the 0.1 M HCl solution. The ionic 
strengths were calculated so that they were the same as the ionic strengths for 
the 0.1 M and 0.5 M phosphate buffers (see Chapter 4, Table 4.12). The results 
obtained are presented in Table 5.6 – 5.8 and Figures 5.14 – 5.16.  
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Table 5. 6: Dissolution data of theophylline filled gelatin and New HPMC  
capsule shells in 0.1 M HCl pH1.2. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The results are the mean and (standard deviation) of 6 capsule 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
% Drug Release   
Time 
(mins) 
Gelatin 
Capsules 
HPMC Capsules 
0  0.00  (0.00)  0.00  (0.00) 
3  1.22  (1.81)  0.22  (0.29) 
6  1.63  (1.76)  34.96  (9.19) 
9  9.11  (7.61)  64.34  (11.51) 
12  13.47  (7.89)  74.27  (11.42) 
15  22.09  (11.47)  82.32  (10.18) 
18  26.21  (13.17)  88.11  (5.56) 
21  28.93  (13.26)  91.04  (3.80) 
24  32.33  (14.78)  93.64  (1.98) 
27  35.80  (14.11)  95.30  (1.47) 
30  39.44  (15.12)  97.33  (1.18) 
35  45.64  (14.67)  97.92  (0.86) 
40  50.62  (13.36)  98.76  (0.72) 
45  57.45  (13.59)  99.65  (0.54) 
50  65.87  (11.73)  100.12  (0.37) 
55  69.28  (10.82)  100.89  (0.48) 
60  72.09  (10.34)  100.61  (0.99) 
75  86.58  (5.54)  101.01  (1.20) 
90  90.82  (4.93)  101.38  (1.05) 
120  95.34  (4.19)  101.81  (1.23) 
180  97.92  (2.63)  102.01  (0.88) 
240  99.38  (2.24)  102.43  (0.70) 
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Table  5.  7:  Dissolution  data  of  theophylline  filled  gelatin  and  New  HPMC 
capsule shells in 0.1 M HCL pH1.2 containing low and high concentrations of 
potassium ions. 
 
% Drug Release 
Gelatin Capsules 
 
New HPMC capsules 
 
  
  
Time 
(min)  0.1M HCl + 
0.1M KCL 
 
0.1M HCl + 0.5M 
KCL 
0.1M HCL + 0.1M 
KCL 
 
 
0.1M HCL + 
0.5M KCL 
 
 
0  0.00  (0.00)  0.00  (0.00)  0.00  (0.00)  0.00  (0.00) 
3  0.49  (0.91)  0.11  (0.18)  0.00  (0.00)  0.00  (0.00) 
6  5.72  (4.14)  0.38  (0.04)  0.14  (0.02)  0.14  (0.03) 
9  8.36  (5.43)  1.12  (0.16)  1.28  (1.51)  0.22  (0.01) 
12  11.07  (4.72)  2.62  (0.20)  2.08  (1.82)  0.41  (0.05) 
15  15.11  (4.77)  8.76  (3.72)  9.83  (1.77)  0.58  (0.10) 
18  17.94  (5.85)  10.71  (4.48)  14.68  (5.24)  0.74  (0.14) 
21  20.60  (6.84)  13.00  (3.83)  20.64  (8.29)  0.92  (0.23) 
24  23.91  (7.07)  15.44  (4.59)  22.64  (7.85)  1.11  (0.25) 
27  27.19  (6.70)  19.66  (6.54)  31.80  (11.81)  1.35  (0.30) 
30  30.28  (7.22)  23.89  (9.22)  36.56  (13.58)  1.60  (0.22) 
35  37.02  (6.01)  32.27  (15.38)  44.43  (17.08)  2.20  (0.13) 
40  42.49  (5.21)  34.58  (16.31)  48.77  (18.74)  2.63  (0.17) 
45  48.61  (3.96)  41.44  (17.12)  53.40  (20.33)  3.12  (0.34) 
50  53.63  (4.47)  44.50  (16.18)  57.33  (19.70)  7.81  (4.90) 
55  58.66  (4.88)  51.68  (15.27)  61.20  (20.65)  7.80  (4.86) 
60  64.93  (4.75)  55.80  (17.28)  65.30  (21.87)  7.98  (5.01) 
75  76.80  (5.64)  59.82  (18.01)  75.14  (18.17)  8.13  (5.02) 
90  86.83  (2.62)  65.92  (18.68)  85.96  (11.79)  8.28  (5.13) 
120  96.37  (3.75)  78.18  (20.01)  91.56  (10.49)  12.80  (5.09) 
180  104.20  (1.38)  91.77  (16.78)  102.40  (7.10)  22.93  (4.82) 
240  102.83  (1.54)  100.31  (10.29)  104.09  (3.93)  27.36  (5.84) 
300  101.78  (3.35)  104.99  (3.76)  102.93  (3.66)  33.48  (8.71) 
The results are the mean and (standard deviation) of 6 capsules  
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Table 5. 8: Dissolution data of theophylline filled gelatin and New HPMC  
capsule shells in 0.1 M HCL pH1.2 containing low and high concentrations  
of sodium ions. 
 
% Drug Release 
Gelatin Capsules  New HPMC capsules 
  
 
Time 
(mins) 
0.1M HCL + 
0.1M NaCl 
 
 
0.1M HCL + 
0.5M NaCl 
 
 
0.1M HCL + 
0.1M NaCl 
 
 
0.1M HCL 
+0.5M NaCl 
0  0.00  (0.00)  0.00  (0.00)  0.00  (0.00)  0.00  (0.00) 
3  0.54  (0.89)  0.03  (0.05)  0.00  (0.01)  0.34  (0.54) 
6  7.56  (5.30)  0.65  (0.27)  21.45  (12.73)  3.07  (6.80) 
9  14.55  (7.20)  1.67  (0.44)  64.89  (10).54)  5.27  (11.71) 
12  20.03  (7.33)  3.15  (0.54)  74.74  (10.09)  6.39  (12.30) 
15  24.33  (7.60)  4.53  (0.67)  88.41  (4.46)  8.88  (13.15) 
18  29.97  (4.08)  7.07  (1.21)  91.90  (3.63)  9.57  (13.59) 
21  35.87  (4.44)  8.13  (1.60)  95.72  (2.34)  10.81  (15.06) 
24  39.41  (5.00)  9.84  (1.75)  97.17  (2.27)  11.16  (15.08) 
27  45.17  (5.01)  11.15  (2.34)  98.64  (1.36)  11.55  (15.26) 
30  48.83  (5.54)  13.97  (1.97)  99.04  (1.15)  13.60  (15.76) 
35  54.83  (5.44)  16.48  (3.70)  100.85  (0.29)  14.73  (15.02) 
40  60.12  (5.91)  18.75  (3.37)  101.19  (0.84)  16.52  (15.10) 
45  66.09  (7.07)  20.16  (3.50)  101.45  (0.94)  18.45  (16.30) 
50  70.67  (6.76)  24.54  (2.46)  102.05  (0.72)  22.09  (14.50) 
55  76.30  (6.97)  27.39  (3.02)  101.71  (1.62)  23.25  (14.91) 
60  79.95  (7.27)  32.00  (3.02)  102.40  (0.87)  24.17  (15.54) 
75  87.44  (6.13)  42.45  (4.00)  102.76  (0.66)  29.19  (19.08) 
90  97.67  (1.89)  53.67  (7.28)  103.05  (0.99)  37.39  (24.69) 
120  100.89  (1.06)  59.55  (8.87)  103.65  (1.57)  42.02  (23.61) 
180  104.19  (0.51)  80.23  (10.24)  104.16  (1.04)  48.17  (24.24) 
240  107.15  (0.73)  93.61  (10.29)  103.95  (0.62)  55.39  (24.36) 
300  104.57  (3.97)  101.61  (8.72)  101.22  (6.50)  62.42  (24.96) 
The resulst are the mean and (standard deviation) of 6 capsules 
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Figure 5. 14: Dissolution of theophylline filled gelatin and New HPMC capsules in 0.1 M 
hydrochloric acid (HCl) pH 1.2 
 
 
 
 
Figure 5. 15: Dissolution of theophylline filled gelatin and New HPMC capsules in 0.1 M HCL pH 
1.2 with 0.1 M and 0.5 M KCl. 
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Figure 5. 16: Dissolution of theophylline filled gelatin and New HPMC capsules in 0.1 M HCL pH 
1.2 with 0.1 M and 0.5 M NaCl. 
 
 
From Table 5.6 and Figure 5.14 it can be seen that the % drug release from 
New HPMC and gelatin capsules in 0.1M HCL was both rapid and complete. 
However, the drug release from the gelatin capsule shells was slower than from 
the HPMC shells, with 1.63%  mean drug release occuring after 6 minutes when 
compared with 34.96% from the HPMC capsules, and at 21 minutes, 28.93% of 
the  drug  was  released  from  gelatin  capsules  compared  to  91.04%  from  the 
HPMC capsules shells. 
 
The addition of 0.1 M KCl to 0.1 M HCl (Table 5.7 and Figure 5.15) slowed the 
drug  release  from  the  HPMC  capsules,  with  0%  drug  release  at  3  minutes, 
2.09% drug release at 12 minutes and 9.83% drug release after 15 minutes. The 
drug release was completed after approximetly three hours had elapsed. The 
addition of 0.5M KCl to the 0.1M HCl hindered the capsule shell disintigration, 
and the HPMC capsules remained practically intact (33.48% drug release after 5 
hours). The addition of 0.1 M NaCl to 0.1 M HCl (Table 5.8 and Figure 5.16) did 
not effect drug release from the HPMC capsules, with complete release at 35 
minutes, when compared with complete drug release at 180 minutes when  0.1 Chapter Five                                                                    Drug Dissolution Studies  
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M KCl was added. The results also show that the lag time in the presence of 0.1 
M NaCl was shorter than that obseved in the presence of 0.1 M KCl (3 min vs 10 
mins respectively) (Figure 5.17).  
 
The effect of the different dissolution media (0.1 M) on the initial stages of drug 
dissolution from the New hypromellose capsules are summarised in Figure 5.17, 
where it can be seen that the lag time was the greatest in (0.1 M HCl + 0.1 M 
KCl)  follwed  by  0.1  M  KPB.  In  the  presence  of  Na+  ions    the  lag  time  is 
considerably reduced and the % drug release is greater.  
 
 
Figure 5. 17: Summary of initial stages of drug dissolution from HPMC capsule shells in different 
dissolution media (0.1 M). 
 
When the concentration of Na
+ ions in the dissolution media was increased to 
0.5  M  NaCl,  the  New  HPMC  capsules  again  remained  practically  intact. 
However, after completion of the dissolution run a greater amount of drug was 
released from the HPMC capsules (62.42%) when compared to that in 0.5 M 
KCl (33.48%) (Figure 5.18).  
 
The effect of the different dissolution media (0.5 M) on drug dissolution from the 
New hypromellose capsule shells is shown in Figure 5.18.  Where it can be seen Chapter Five                                                                    Drug Dissolution Studies  
 
  278 
that drug dissolution in the different dissolution mediadecreased in the rank 
order (HCl + 0.5 M NaCl) > (HCl + 0.5 M NaCl) > 0.5 M NaPB > 0.5 M KPB.  
 
 
Figure 5. 18: Drug dissolution from HPMC capsule shells in different dissolution media (0.5 M). 
 
The mean % drug release from gelatin capsule shells was more variable in 0.1 
M HCl with higher standard devations when compared to that in KPB and NaPB. 
For  example  11.47  vs  6.70 at 15  minutes, 15.12  vs  2.24  at  30 minutes and 
10.34 vs 2.91 at 60 minutes for 0.1 M HCl and 0.1 M KPB respectively, similary 
11.47 vs 7.25 at 15 minutes, 15.12 vs 7.97 at 30 minutes and 10.34 vs 3.45 at 
60  minutes  for  0.1M  HCl  and  NaPB  respectively.  In  contrast,  The  shell 
dissolution  and  %  drug  release  from  HPMC  capsules  was  faster  in  acidic 
conditions and in the presence of Na
+ ions when compared to the presence of 
K
+ ions, with 100.65 % drug release occuring after 27 minutes in 0.1 M NaPB 
(Table 5.4), and 100.85% drug release occuring after 35 minutes in 0.1 M HCl 
with the presence of 0.1 M NaCl (Table 5.8). This was also seen by the lower 
standard deviations compared with gelatin in those buffers. In the presence of 
K
+ ions, maximum drug release of theophylline from HPMC capsules occurred 
after 45 minutes in 0.1 M KPB  (Table 5.1). Similarly complete drug release of 
caffiene occurred after 45 minutes with high standard deviation values (Figure Chapter Five                                                                    Drug Dissolution Studies  
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5.3), and complete drug release of theophylline occured after 3 hours for both 
New HPMC and gelatin capsules in 0.1 M HCl prepared with 0.1 M KCl.  
 
The  effect  of  the  different  dissolution  media  (0.1  M  and  0.5  M)  on  drug 
dissolution  from  the  gelatin  shells  is  shown  in  Figures  5.19  and  5.20 
respectively.    The  fastest  drug  release  occured  in  the  phosphate  buffers, 
opposite to that found during the ball bearing studies (Chapter 4) where it was 
found that the time taken to the release of the ball bearing was fastest in acidic 
conditions. It can also be seen  (Figure 5.20) as mentioned previously (Section 
5.2.3, and ) that the drug dissolution from gelatin capsules was affected by the 
increase in ionic strength, however, this effect was more pronounced when the 
ion was sodium, this could be due to sodium binding occurring causing a shift in 
the pH towards the IEP of gelatin. (Further analysis of the results is shown in 
Section 5.4) 
 
Figure 5. 19: Drug dissolution from gelatin capsule shells in different dissolution media (0.1 M). Chapter Five                                                                    Drug Dissolution Studies  
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Figure 5. 20: Drug dissolution from gelatin capsule shells in different dissolution media (0.5 M). 
 
Lee et al (2006b) studied the influence of electrolytes in the gastric and intestinal 
fluids  (ionic  strengths  0.01  –  0.2)  on  the  dissolution  of  various  grades  of 
cellulose. Theophylline with lactose was filled into hard capsules and dissolution 
was  carried  out  in  acid  (pH  1.2)  and  basic  buffer  (pH  6.8),  with  adding  the 
following electrolytes (LiCl, NaCl, KCl, CaCl2 and AlCl3). It was found that drug 
release  from  gelatin  capsules  were  slightly  reduced  with  increasing  ionic 
strength (similar to that found in this study), and that the drug release from HPC 
capsules was markedly affected by electrolytes, and decreased in the following 
order (0.1 M LiCl, NaCl, KCl, CaCl2 and AlCl3). They also found that the lag time 
of  HPC  increased  with  increasing  viscosity  grade  of  the  polymers  and  that 
influences  of  electrolytes  on  the  lag  time  of  hard  gelatin  capsules  were  no 
markedly different. However, electrolytes had a greater effect on the lag time of 
HPC capsules. They also found that there is a correlation between the square 
root of ionic strength and lag time of dissolution, which showed that the increase 
of  valence  of  electrolyte  or  ionic  strength  leads  to  longer  lag  time  of  HPC 
capsules, which was thought to be due to lower water activity with increasing 
ionic strength. Further analysis of results is shown in Section 5.4. Chapter Five                                                                    Drug Dissolution Studies  
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5.3   Effect of Ionic Strength on the Dissolution of Theophylline from 
Hard Capsules after Storage at 35%RH for 6 Months 
5.3.1  Drug Dissolution in Sodium Phosphate Buffer (NaPB) 
 
The % drug release of theophylline from gelatin and New HPMC hard shells in 
NaPB pH 7.4 (0.1M and 0.5M) was determined after storing the capsules at 35% 
RH  for  6  months.  The  values  obtained  including  standard  deviations  are 
reported in Table 5.9 and represented in Figures 5.21 and 5.22 respectively.  
 
Table 5. 9: Dissolution data of theophylline filled gelatin and New HPMC 
capsule shells using 0.1M and 0.5M sodium phosphate buffer (NaPB) as 
dissolution media after storing the capsules at 35%RH for 6 months    
 
% Drug Release    
Time 
(mins) 
*Gelatin  
(0.1M NaPB) 
*HPMC (0.1M 
NaPB) 
**Gelatin (0.5M 
NaPB) 
**HPMC (0.5M 
NaPB) 
0  0.00  (0.00)  0.00  (0.00)  0.00  (0.00)  0.00  (0.00) 
3  4.65  (7.21)  0.07  (0.10)  3.03  (5.25)  0.01  (0.02) 
6  25.86  (5.81)  31.28  (6.65)  9.90  (1.73)  0.18  (0.05) 
9  33.73  (4.83)  76.66  (8.84)  20.18  (4.43)  0.23  (0.13) 
12  37.50  (4.88)  85.67  (3.05)  29.85  (6.12)  0.35  (0.25) 
15  45.26  (5.40)  91.45  (1.81)  35.43  (6.96)  0.52  (0.44) 
18  48.39  (5.81)  94.11  (2.54)  40.77  (7.65)  0.74  (0.75) 
21  52.13  (4.83)  96.17  (2.66)  45.49  (6.47)  1.25  (1.48) 
24  55.50  (4.52)  98.24  (1.83)  48.89  (5.90)  1.55  (1.82) 
27  59.62  (6.03)  99.29  (1.94)  51.42  (5.72)  1.99  (2.53) 
30  62.46  (6.02)  100.69  (1.95)  53.59  (6.44)  3.97  (5.81) 
35  64.91  (4.64)  101.49  (1.77)  59.65  (5.21)  4.25  (5.92) 
40  67.61  (4.85)  102.07  (1.22)  62.91  (6.45)  4.72  (6.67) 
45  73.51  (6.32)  101.78  (0.78)  65.16  (6.98)  6.10  (8.89) 
50  75.88  (6.76)  101.79  (1.02)  67.80  (6.69)  6.76  (9.92) 
55  78.26  (7.04)  101.94  (0.68)  70.41  (7.26)  8.32  (12.49) 
60  80.66  (6.87)  101.91  (0.32)  72.86  (7.89)  10.12  (15.21) 
75  85.20  (6.26)      76.96  (8.24)  10.96  (15.89) 
90  91.24  (4.40)      81.30  (7.37)  18.12  (26.97) 
120  95.85  (4.35)      86.47  (6.01)  25.12  (37.92) 
180  97.02  (4.60)      97.59  (5.84)  37.77  (46.50) 
240  96.46  (5.22)      100.10  (1.13)  49.36  (39.35) 
300  95.87  (5.63)      99.29  (1.24)  63.37  (31.54) 
The results are the mean and (standard deviation) of *6 capsule ** 3 capsules 
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Figure 5. 21: Dissolution of theophylline from gelatin and New HPMC hard capsules stored at 
35% RH for 6 months in 0.1M sodium phosphate buffer pH7.4. 
 
 
Figure 5. 22: Dissolution of theophylline from gelatin and New HPMC hard capsules stored at 
35% RH for 6 months in 0.5M sodium phosphate buffer pH7.4 
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The results presented in Table 5.9 and Figures 5.21 and 5.22 clearly show that 
the release of theophylline from the New HPMC capsules was not affected by 
the  long  storage  period  of  the  dosage  form  (6  months),  with  complete  drug 
release occurring between 24 and 30 minutes for both storage periods (24 hours 
and 6 months). For the 24 hr storage period, 99.9% ± 0.83 of drug was released 
at 24 minutes, 100.65% ± 0.32 at 27 minutes and 101.22% ± 0.29 was released 
at  30  minutes.  Similarly  after  6  months  storage,  98.24%  ±  1.83  drug  was 
released at 24 minutes, 99.29% ± 1.94 at 27 minutes and 100.69% ± 1.95 was 
released at 30 minutes.  
 
The % release of theophylline from the HPMC capsules in 0.5 M NaPB was 
higher with shorter lag time after 6 month storage when compared with 24 hour 
storage (Figure 5.21). However, the standard deviations were higher after the 
capsules were stored for 6 months. For example at 60 minutes (0.88% ± 0.31) 
vs (10.12% ± 15.21), at 120 minutes (1.86% ± 1.30) vs (25.12 ± 37.92) and at 
300 minutes (9.92% ± 9.57) vs (63.37%  ± 31.54 ) all for 24 hours and 6 months 
respectively. 
 
A decrease in the rate and extent of drug release from the gelatin capsules in 
0.1  M  NaPB  was  seen  after  6  months  storage  (Figure  5.21).  For  example 
(63.42% ± 7.25) vs (45.26% ± 5.40) drug was released at 15 minutes, (8.91% ± 
7.97) vs (62.46 ± 6.02) was released at 30 minutes, and (94.30% ± 3.45) vs 
(80.66% ± 6.87) drug was released at 60 minutes all for 24 hours and 6 months 
respectively.  
 
The drug release from gelatin capsules in 0.5 M NaPB was initially slower than 
the release in 0.1 M NaPB after 6 months storage of the capsules (Table 5.9). 
However, complete drug release was achieved between 180 minutes and 240 
minutes in both molar concentrations. Furthermore, the drug release in 0.5 M 
NaPB after 6 month storage occurred at a faster rate than that after 24 hour 
storage of the capsules (Figure 5.22). For example, (13.55% ± 3.13) vs (35.43% 
± 6.96) drug released at 15 minutes, (43.13% ± 11.32) vs (72.86 ± 7.89) at 60 
minutes and (80.76% ± 13.92) vs (97.59% ± 5.84) drug released at 180 minutes Chapter Five                                                                    Drug Dissolution Studies  
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for both 6 month and 24 hr storage respectively. This shows that the gelatin 
capsules  can  be  affected  by  long  storage  periods  causing  alteration  in  drug 
release properties with time.  
 
5.3.2   Drug Dissolution in Hydrochloric Acid (HCl) Containing Low and 
High Concentrations of Sodium Chloride (NaCl) 
 
The % drug release of theophylline from gelatin and New HPMC hard shells in 
0.1 M HCL  pH 1.2 containing low and high concentrations of NaCl (0.1M and 
0.5M) was determined after storing the capsules at 35% RH for 6 months. The 
values obtained including standard deviations are reported in Table 5.10, and 
represented in Figures 5.23 and 5.24 respectively. 
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Table 5. 10: Dissolution data of theophylline filled gelatin and New HPMC 
capsule shells in 0.1M HCL pH1.2 containing low and high concentrations of 
sodium ions after storing the capsules at 35%RH for 6 months 
 
% Drug Release 
Gelatin Capsules  New HPMC capsules 
  
Time 
(mins)  0.1M HCL + 
0.1M NaCl 
0.1M HCL + 
0.5M NaCl 
0.1M HCL + 
0.1M NaCl 
0.1M HCL 
+0.5M NaCl 
0  0.00  (0.00)  0.00  (0.00)  0.00  (0.00)  0.00  (0.00) 
3  0.00  (0.00)  0.00  (0.00)  0.00  (0.00)  0.09  (0.15) 
6  9.34  (3.69)  12.08  (1.52)  14.41  (6.98)  0.28  (0.25) 
9  18.52  (5.57)  14.90  (4.24)  60.29  (9.79)  0.43  (0.46) 
12  24.68  (5.38)  21.20  (5.59)  85.94  (6.06)  0.67  (0.72) 
15  29.45  (5.80)  28.73  (4.88)  92.93  (4.66)  1.16  (1.21) 
18  32.32  (4.88)  31.95  (5.65)  94.89  (4.28)  1.67  (1.92) 
21  36.93  (5.32)  35.59  (5.17)  96.23  (4.37)  2.21  (2.54) 
24  41.48  (4.23)  39.72  (4.11)  100.00  (2.92)  6.18  (1.70) 
27  45.52  (4.60)  42.89  (3.38)  103.04  (2.12)  10.60  (1.52) 
30  48.24  (3.46)  49.74  (3.07)  101.00  (4.17)  12.66  (0.97) 
35  57.17  (4.36)  57.16  (3.61)  101.76  (1.05)  17.46  (0.38) 
40  59.08  (4.23)  62.81  (7.06)  101.40  (1.04)  18.96  (0.70) 
45  63.44  (3.88)  66.22  (6.16)  101.57  (0.63)  20.71  (1.08) 
50  65.71  (3.51)  69.55  (6.17)  101.71  (0.34)  22.78  (1.35) 
55  68.11  (2.82)  80.35  (0.75)  101.17  (0.99)  28.32  (1.14) 
60  70.42  (1.58)  88.71  (1.69)      31.07  (1.18) 
75  72.29  (1.91)  94.50  (5.16)      33.27  (1.46) 
90  74.34  (1.91)  101.60  (1.60)      34.53  (2.32) 
120  76.50  (2.92)  103.06  (0.43)      37.24  (2.30) 
180  100.00  (2.43)  102.39  (0.77)      55.01  (2.55) 
240  102.02  (1.21)  101.63  (0.73)      72.67  (0.21) 
300  97.07  (6.67)  101.55  (0.25)      82.28  (2.70) 
The results are the mean and (standard deviation) of 3 capsules Chapter Five                                                                    Drug Dissolution Studies  
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Figure 5. 23: Dissolution of theophylline filled gelatin and New HPMC capsules stored at 
35%RH for 6 months, in 0.1M HCL pH 1.2 with 0.1M NaCl. 
 
 
Figure 5. 24: Dissolution of theophylline filled gelatin and New HPMC capsules stored at 
35%RH for 6 months, in 0.1M HCL pH 1.2 with 0.5M NaCl. 
 
 Chapter Five                                                                    Drug Dissolution Studies  
 
  287 
The release of theophylline from HPMC shells in 0.1 M HCl and 0.1 M NaCl was 
not  affected  by  long  storage  period  (6  months),  with  similar  drug  release 
occurring at the tested time intervals and with maximum drug release occurring 
between  24  and  30 minutes for  both  storage  conditions.  For  example,  at 15 
minutes:  (88.41% ± 4.46) vs (92.93% ± 4.66) drug was released and at 30 
minutes: (99.04% ± 1.15) vs (101% ± 4.17) drug was released, both after 24 
hours and 6 month storage respectively. Similarly, it was found that the amount 
of drug released from the HPMC capsule shells in 0.1 M HCl + 0.5 M NaCl 
following storage of the capsules for 6 months at 35%RH, was similar to the 
amount of drug released after 24 hours storage. However, a higher drug release 
from  the  HPMC  capsules  (stored  for  6  months)  occurred  after  3  hours  with 
(72.67% ± 0.21) and (82.28% ± 2.70) at 180 and 300 minutes respectively as 
compared to (55.39% ± 24.24) and (62.4% ± 24.96) at 180 and 300 minutes 
after 24 hour storage at 35%RH.  
 
The % drug release from the gelatin capsules in (HCl + 0.1 M NaCl) after 6 
month storage initially appeared to be very similar to that of the release when 
the capsules were stored for 24 hours (24.33% ± 7.60) vs (29.45% ± 5.80) at 15 
minutes; (48.83% ± 5.54) vs (48.24% ± 3.46) at 30 minutes, both for 24 hours 
and 6 month storage respectively. The drug release for capsules stored for 24 
hours gradually increased between 60 and 120 minutes [79.95% (60 min) ￿ 
87.44% (75 min) ￿ 97.67% (90 min) ￿ 100.89% (120 min)]. However, this was 
not seen for the capsules which were stored for 6 months [70.42% (60 min) ￿ 
72.29% (75 min) ￿ 74.34% (90 min) ￿ 76.5% (120 min)] followed by a 20% 
increase  in  drug  release  at  180  minutes  (100%).  This  shows  that  the  drug 
release from gelatin capsules in HCl with low Na
+ ion concentration (0.1 M) was 
affected  to  some  degree  by  long  storage  periods.  However,  as  seen  for  the 
NaPB, drug release from gelatin capsules stored for 6 months was faster in HCl 
+ 0.5 M NaCl compared to capsules stored for 24 hours at 35% RH (Figure 
5.24).  
 
This study has shown that the mechanical properties of HPMC capsules acquire 
a higher phase angle (more viscous) than the gelatin capsules when stored at 
different conditions, and that their phase angle increased with an increase in Chapter Five                                                                    Drug Dissolution Studies  
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relative humidity and storage time, whereas no change was seen for the gelatin 
shells, see Chapter 3, Section 3.3. Therefore, the increase in moisture uptake 
into the HPMC capsule shells could explain their improved dissolution rate after 
6 month storage at 35% RH. The results for gelatin are also supported by the 
findings in Chapter 3, Section 3.2 for Linear Creep. It was found that storage 
conditions could have a significant effect on the mechanical properties of the 
capsules shells. Gelatin capsules become the less elastic the higher the storage 
humidity and the longer the storage period and do not recover fully, which could 
explain the decreased % drug release at low ionic strength concentrations as 
apposed to the HPMC capsules which are better in terms of recovery.  
 
One of the problems associated with gelatin based formulations, is the fall in 
dissolution upon aging (as seen above), which is attributed to the cross linking 
of stressed gelatin. The cross linking causes the formation of a swollen, rubbery, 
water insoluble membrane (Chapter one, Section 1.6.2.2) leading to a decrease 
in the dissolution rate (Singh et al., 2002). Langenbucher (1972) found that the 
dissolution  of  capsules  containing  lactose  formulations  was  retarded  after 
storage for 2 – 8 weeks at 11 – 67%.  York (1977) studied the effect of storage 
of chloramphenicol and tetracycline capsules at 75% RH (30
oC) for 1 month and 
found a significantly slower drug release compared with the initial values. Signs 
of physical aging were also observed in the MDSC signals presented in Chapter 
3, but this was not seen for the HPMC capsules, thus indicating that gelatin 
capsules are more prone to aging.   
 
The increase in drug dissolution from gelatin capsules in 0.5 M NaPB and 0.1 M 
+ 0.5 M NaCl, could be related to osmotic pressure. Dong et al (2006) studied 
the influence of ionic strength on drug release from alginate and gelatin films. 
They added an appropriate amount of NaCl to 10 mM NaH2PO4  Na2HPO4 
buffered solution pH 7.4, and found that an increase in ionic strength, increased 
the rate of drug release. Dong et al showed that an increase in ionic strength 
increased drug release from gelatin and alginate films, which they attributed to 
the  decrease  of  osmotic  pressure  inside  the  film  with  the  increase  of  salt 
concentration.  Jalil  and  Ferdous  (1993)  found  an  increase  in  theophylline 
release from HPMC matrix based sustained release capsules with the increase Chapter Five                                                                    Drug Dissolution Studies  
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in  ionic  strength.  It  was  thought  that  high  osmotic  pressure  created  by  the 
presence  of  ionic  species  in  the  dissolution  fluid  could  have  caused  rapid 
dissolution of the matrices.  
 
5.4  Analysis of Release Data 
 
The in vitro dissolution profiles were compared using both model independent 
and  dependent  methods.  The  model  independent  methods,  encompassed 
calculating the mean dissolution time (MDT) as suggested by Podczeck (1993) 
using  pragmatic  plane  geometry  method;  based  on  the  trapezoidal  rules  as 
discussed  earlier  (Section  1.8).  The  drug  release  profile  and  the  maximal 
amount  of  the  drug  substance  dissolved  are  calculated  using  a  suitably 
customised  software  package  (GW Basic,  3.23,  Microsoft,  1998).  The  MDT 
determines  the  rate  of  the  dissolution  process,  the  lower  the  MDT  value  the 
faster is the release rate of the drug from the capsule. The mechanism of drug 
release from hard capsules determined using the model dependent approach, 
involved defining a specific kinetic law from the % amount of drug remaining 
undissolved versus time curve. Any one method used in turn has its limitations, 
for  example,  the  use  of  kinetic  equations  in  the  dependent  methods  rarely 
results  in adequate  quantification  of  the  total  dissolution profile, similarly,  the 
quality of the adaption of the values in the model independent method depends 
on the numerical errors, which arise in the calculation (Podczeck, 1993).  
 
5.4.1   Model Independent Approach  
 
The MDT results obtained from the drug dissolution data in all dissolution media 
are presented In Table 5.11. The lower the MDT value, the faster is the release 
rate of the drug from the capsule shell.  
 
2
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Table 5. 11: Mean dissolution time (MDT, min) for gelatin and hypromellose hard capsules containing theophylline formulation 
(450 mg) stored at 35%RH/24 hr and 35% RH for 6 months. 
 
DISSOLUTION MEDIA  
KPB  NaPB  HCl  HCl + KCl  HCl + NaCl 
 
0.1 M  0.5 M  0.1 M  0.5 M  0.1 M  0.1 M  0.5 M  0.1 M  0.5 M 
 
 
Capsule 
Type  
35%RH/24hr 
Gelatin 
 
25.9 ± 1.6  30.5 ± 11.0  20.4 ± 4.9  94.8 ± 16.1  46.6 ±  
9.1 
55.7 ± 3.1  81.0 ±35.1*  41.3 ± 3.25  111.0 ±12.0 
HPMC 
 
17.3 ± 2.4  > 100  8.7 ± 1.71  > 100  10.1 ± 1.6  43.8 ±3.7**  > 100  9.8 ± 1.2  > 100 
Plug  
 
16.6 ± 2.9  24.5 ± 7.6        3.2 ± 0.05  3.2 ± 0.4     
  35%RH/6 months 
Gelatin 
 
    29.6±0.22  49.8±12.5        59.3 ±7.0  33.9 ± 3.3 
HPMC 
 
    7.8± 0.07  176.7±62.8        9.3 ± 0.9  128.4 ± 9.5  
The Results and the Mean (n) and Std. Dv. of 6 replicates. * n = 3, ** n = 5Chapter Five                                                                    Drug Dissolution Studies  
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A one way and two way ANOVA was performed on the MDT values to identify 
differences seen between type of capsule shell material and dissolution media 
composition. The Scheffe’ post hoc test was carried out in conjunction with the 
ANOVA to identify the influence of the two aforementioned variables on the MDT 
of the drug. 
 
The results generally show that in all 0.1 M dissolution media the MDT values 
for  the  HPMC  capsules  are  significantly  smaller  than  those  obtained  using 
gelatin capsules (p< 0.001), i.e. a faster dissolution rate of the drug occurred 
from the HPMC capsules. This agrees with the findings of Podczeck and Jones 
(2002)  who  investigated  the  in vitro  dissolution  of  theophylline  from  different 
types of hard shell capsules using distilled water as the dissolution media and 
found that that the MDT was significantly reduced when gelatin capsules were 
replaced with HPMC. Therefore, although the HPMC capsules have an initial lag 
phase before drug dissolution begins (Figures 5.7 and 5.16) and the empty shell 
dissolution is slower than gelatin (Chapter 4), they still appear produce a higher 
dissolution rate for theophylline in all selected media (0.1 M) when compared to  
gelatin  capsules.  This  could  be  because  gelatin  shells  dissolve  first  at  the 
shoulder  of  the  round  ends  and  later  on  dissolve  across  the  whole  body, 
whereas the HPMC capsules, after the first split, dissolve across the whole shell 
simultaneously (Chiwele, 2000;  Podczeck and Jones, 2002;  Lee et al., 2006b; 
Jones, 2009). This could be due to the different ways in which the walls are 
formed by dipping. Gelatin capsules are formed on mould pins by a temperature 
change forming a film by a sol/gel transformation, thus have a more ordered 
structure. Whereas Quali V® hypromellose capsules, the temperature change 
forms a network of Carrageenan that holds the polymer on the mould pins. Once 
this is disrupted, the hypromellose will disperse more freely (Jones, 2009).   
 
It is evident from the results presented in Table 5.11 that the presence of K
+ ions 
whether in alkaline or acidic conditions slows down the dissolution rate of the 
drug  from  both  gelatin  and  HPMC  capsules  (shown  as  higher  MDT  values), 
however, this increase in MDT is more pronounced when HPMC capsules are 
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The results obtained from the Post hoc (Scheffe’) test comparing the effect of 
the different dissolution media on the drug dissolution rate from both gelatin and 
HPMC capsule shells are presented below in Tables 5.12 and 5.13.   
 
Table 5. 12: Post hoc (Scheffé) test showing the effect of dissolution media on 
the MDT of gelatin capsule shells. 
Subset for alpha = 0.05 
Media  N  1  2  3 
NaPB  6  20.3883     
KPB  6  25.9083     
HCl+NaCl  6    41.2967   
HCL  6    46.6050  46.6050 
HCL+KCL  6      55.7183 
Sig.    .490  .529  .077 
Means for groups in homogeneous subsets are displayed. 
 
 
The  data  obtained  in  Table  5.12  show  that  the  differences  in  MDT  values 
obtained  using  gelatin  capsules  are  significantly  different  when  comparing 
alkaline conditions (KPB + NaPB) with acidic conditions (HCl; HCl + NaCl; HCl + 
KCl). Whereas,  the  difference  between  the  individual  groups  (KPB  +  NaPB), 
(HCl + NaCl) and (HCl + KCl) are insignificant. However, the presence of K
+ ions 
does seem to slow down the drug dissolution rate to some degree in alkaline 
conditions and significantly in acidic conditions.  
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Table 5. 13: Post hoc (Scheffé) test showing the effect of dissolution media on 
the MDT of HPMC capsule shells. 
 
Subset for alpha = 0.05 
Media  N  1  2  3 
NaPB  6  9.7350     
HCl+NaCl  6  9.7467     
HCL  6  10.0683     
KPB  6    17.2900   
HCL+KCL  5      43.7680 
Sig.    1.000  1.000  1.000 
Means for groups in homogeneous subsets are displayed. 
 
The data reported in Table 5.13 shows that the differences seen in MDT values 
using HPMC capsules are significantly different, but the differences seen are not 
strictly  between  alkaline  and  acidic  conditions  as  was  seen  for  the  gelatin 
capsules.  It  can  be  seen  that  the  significant  differences  actually  lie  between 
NaPB and KPB, between NaPB and HCl + KCl and between KPB and all other 
dissolution media. This again shows that it is the K
+ ions that have the greatest 
effect on the drug dissolution rate. 
 
The increase in molar concentration of the dissolution media from 0.1 M (ionic 
strength = 0.22) to 0.5 M (ionic strength = 1.18) slows down the dissolution rate 
of the drug from both gelatin and HPMC capsules (Table 5.11), however, this is 
more  pronounced  for  the  HPMC  capsules.  The  MDT  values  for  the  gelatin 
capsules in KPB were increased from 25.9 min to 30.5 min, in  NaPB  this effect 
was much greater from 20.4 min to 94.8 min, in HCl + KCl from 55.7 min  to 81.0 
min and in HCl + NaCl from 41.3 min to 111.0 min. The MDT values obtained for 
the HPMC capsules were increased to > 100 min in all dissolution media. Figure 
5.15 below shows the increase in MDT with an increase in molar concentration 
using HPMC capsules (0.4 M and 0.5 M of KPB were excluded due to their very 
low dissolution times, which could result in inaccurate MDT values obtained). 
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Figure 5. 25 Effect of molar concentration of NaPB and KPB on MDT from HPMC capsule shells 
 
 
Figure 5.25 shows that an increase in molar concentration from 0.1 M to 0.2 M 
significantly slows down the dissolution rate of the drug from the HPMC capsule 
shells in KPB 17.3 min vs 87.7 min respectively. However, when the K
+ cation is 
substituted by the Na
+ cation then differences between the 0.1 M and 0.2 M 
NaPB are statistically insignificant (p< 0.05), nevertheless further increases in 
molar concentration and hence ionic strength significantly slow down the drug 
dissolution rate not only in KPB but also in NaPB, although to a smaller degree. 
These  findings  support  the  previous  discussion  (Section  5.2.3  and  Section 
4.10.2) that the HPMC capsule shells are affected to a greater degree by the 
presence  of  K
+  ions  in  the  dissolution  media.  The  presence  of  sufficient  K
+ 
(gelling promotor) retains the structure of the carrageenan gel and the solubility 
is  reduced  (Rochas  and  Rinaudo,  1984;  Ridout  et  al.,  1996).  This  effect  is 
reduced in the presence of  Na
+ ions where disruption of the film is faster. This is 
thought to be due to the binding efficiency with which ions of different sizes can 
fit into potential sites on the helices (Cole et al., 2004). K+ ions induce coil 
double helix transition, promoting polymer aggregation. Na+ ions do not induce 
coil double  helix  transition,  however,  they  do  take  part  in  the  aggregation 
process  possibly  through  a  phase  separation  mechanism,  leading  to  the 
formation of a weak gel, and the structure is more disorderd compared to that Chapter Five                                                                    Drug Dissolution Studies  
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obtained in the presence of KCl (Mangione et al., 2005). This could also explain 
the differences seen in the presence of K
+ or Na
+ ions.  
 
Figure 5.16 presented below compares the effect of storage period (24 hours 
and 6 months ) on the MDT of both gelatin and HPMC capsules  
 
 
Figure 5. 26: Mean dissolution time (MDT, min) for gelatin and hypromellose hard shell capsules 
containing theophylline (450 mg) stored at 35%RH/24 hr and 35% RH/ 6 months in 0.1 M and 
0.5 M NaPB and in 0.1 M HCl containing low and high ionic concentrations of Na
+ ions  
 
The MDT of gelatin in 0.1 M NaPB after 6 month storage (29.6 min) was slightly 
greater than its MDT in 0.1 M NaPB after 24  hour storage  (20.4 min), see 
Figure 5.26, suggesting that the drug release rate slightly decreases. This was 
similarly seen in 0.1 M HCl with low (0.1 M) and high (0.5 M) concentrations of 
Na
+  ions:  there  was  an  increase  in  MDT  from  41.3  min  to  59.3  min  with 
increased storage. For 0.5 M NaPB, there was a decrease in MDT of gelatin 
capsules when stored for 6 months: (94.8 min (24hr) vs 49.8 min (6 months). 
The MDT of HPMC capsules stored for 6 months decreased very slightly in both 
dissolution  media  (NaPB  and  HCl  +  NaCl)  and  at  both  low  and  high  ionic 
concentrations for NaPB, but not in 0.1 M HCl + 0.5 M NaCL where the MDT 
increased from 114.5 min to 128.4 min, which contradicts the release profiles 
shown  in  Figure  5.24,  where  the  dissolution  of  theophylline  from  HPMC Chapter Five                                                                    Drug Dissolution Studies  
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capsules stored for 6 months in 0.1 M HCl + 0.5 M NaCl slightly improved after 
200 minutes in to the dissolution test.  
5.4.2  Model Dependent Approach  
 
The dependent method was used to describe the release kinetics of the drug 
from gelatin and HPMC capsules in the different dissolution media. The kinetic 
models  most  suitable  with  their  corresponding  correlation  coefficient  are 
presented in Table 5.12 below.  
 
The  mathematical  models  applied  to  the  data  were  zero  order,  first  order 
(Gibaldi and Feldman, 1967), Higuchi square root of time (Higuchi, 1963), cubic 
root  law  (Hixson  and  Crowell,  1931)  and  the  Korsmeyer Peppas  equation 
(Korsmeyer et al, 1983). (See Section 1.8 for description of the models and the 
limitations of this test).  
 
The applicability of the above models was tested and the following plots were 
made:  
 
% amount remaining vs time (zero order) 
ln % amount remaining vs time (first order) 
% amount remaining vs square root of time (Higuchi square root law) 
% amount remaining vs cube root of time (Hixon Crowel cube root law). 
% amount of drug remaining vs cube root of time (korsmeyer Peppas model).  
 
In 0.1 M buffers the lag time for HPMC capsules was omitted, since no drug 
release or very small amounts of drug was released, and points were selected 
upto complete drug release. This ensured that all important data points were 
selected. For gelatin capsules, the first 3 minutes and in some cases 6 minutes 
were  excluded,  depending  on  the  amount  released,  since  inclusion  of  these 
points did not allow for good correleation coefficients to be obtained. Again data 
points  were  selected up  to  complete drug  release. In 0.5  M buffers,  all  data 
points  for  HPMC  capsules  were  included,  and  provided  good  correlation Chapter Five                                                                    Drug Dissolution Studies  
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coeficients. For gelatin capsules the same method as for 0.1 M was addapted. 
The selection of the best fit was based on the higher correlation coefficient. 
 
The  correleation  coefficient  values  obtained  from  all  tested  models  are 
presented below in Table  5.14 
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Table 5. 14: Correlation coefficients obtained using mathematical modeling and 
the corresponding drug release kinetics of theophylline from gelatin and HPMC 
hard capsules 
 
 
 
  Correlation coefficient, r
2   
Capsule 
Type 
Dissolution  
Media 
Buffer 
Strength 
Zero 
Order 
First 
Order 
Higuchi 
Model 
Hixson 
Crowell 
cube 
root 
Korsmeyer 
Peppas 
Model 
Models 
0.1M  0.8606  0.9864  0.9435  0.9169  0.8802  First 
Order 
KPB 
0.5M  0.9645  0.997  0.9921      First 
Order 
0.1M  0.7828  0.9931  0.9045  0.9364  0.9308  First 
Order 
NaPB 
(24 hr) 
0.5M  0.9827  0.9915  0.8475      First 
Order 
0.1M  0.922  0.9954  0.9835  0.9931  0.9169  First 
Order 
NaPB 
(6 mon.) 
0.5M  0.8262  0.9784  0.9513  0.969  0.9751  First 
Order 
0.1M  0.9991  0.9782  0.9659  0.9362  0.7593  Zero 
Order 
0.1M HCl+ 
KCl 
0.5M  0.9902  0.9749  0.8685      Zero 
Order 
0.1M  0.9823  0.9979  0.9965  0.9184    First 
Order 
0.1 HCl + 
NaCl 
(24 hr)  0.5M  0.993  0.984  0.9442      Zero 
Order 
0.1 M  0.9473  0.9917  0.9949  0.9958  0.9025  Higuchi 
Gelatin 
0.1 HCl + 
NaCl 
(6 mon.) 
0.5 M  0.9747  0.9941  0.9767  0.9859  0.9428  First 
Order 
0.1M  0.8391  0.9791  0.8819  0.892  0.9574  First 
Order 
KPB 
0.5M  0.988  0.7239  1      Higuchi 
0.1M  0.7688  0.9859  0.834  0.8547  0.927  First 
Order 
NaPB 
0.5M  0.9326  0.724  0.9999      Higuchi 
0.1 M  0.742  0.9884  0.9364  0.9483  0.9559  First 
Order 
NaPB 
(6 mon.) 
0.5 M  0.995  0.9915  0.9627  0.9048  0.68  Zero 
Order 
0.1M  0.9736  0.9922  0.9846  0.9596  0.7593  First 
Order 
0.1M HCl+ 
KCl 
0.5M  0.9818  0.788  0.9993      Higuchi  
0.1M  0.8474  0.9939  0.8864  0.9128  0.8416  First 
Order 
0.1M HCl + 
NaCl 
0.5M  0.9168  0.7172  0.9958      Higuchi 
0.1 M  0.8178  0.9943  0.8748  0.8922  0.9794  First 
Order 
HPMC  
0.1M HCl + 
NaCl 
(6 mon.)  0.5 M  0.9755  0.9809  0.9795  0.9795  0.9542  First 
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It was found that the gelatin formulations (stored at 35%RH for 24 hr and 6 
months  in  KPB  and  NaPB  followed  first  order  kinetics:  the  release  rate  is 
concentration dependent indicationg that the dissolution rate of the drug in the 
dissolution media depends on the relationship between the dissolved amount of 
the drug and the remaining amount of it in the capsule shell. Pinheriro et al, 
(2007) looking at the in vitro evaluation of extended release theophylline matrix 
capsules also found that the dissolution in pH 7.5 intestinal fluid followed first 
order  kinetics.  It  was suggested  that  to  be as  a  results  of  the drug  diffusion 
through the jelly layer and the erosion of the matrix system (Non Fikian). i.e this 
release is intermediate between Fickian and case II transport corresponding to 
coupled diffusion/polymer relaxation. This process could also be occuring from 
the capsule shells. 
 
The  gelatin  formualtions  stored  at  35%RH  for  24  hours  and  tested  in  acidic 
medium, apart from 0.1 M HCl + 0.1 M NaCl, followed zero order kinetics, which 
is defined as the drug release rate being independent on the amount of drug 
available for dissolution and diffusion from the capsule shell. In this case the rate 
of  diffusion  was  possibly  much  less  than  that  of  polymer  relaxation  (Fickian) 
which can be supported by the slower dissolution rates (MDT) reported in Table 
5.9 in acidic media when compared with basic media. For example the MDT in 
0.1  M  and  0.5  M  KPB  for  gelatin  capsules  were  25.9  min  and  30.5  min 
respectively and that in 0.1 M HCl + 0.1 M and 0.5 M KCl was 55.9 min and 81.0 
min  respectively.  These  results  support  the  previous  results  that  gelatin 
capsules behave differently in acidic and basic media. 
 
The  dissolution data of  HPMC  capsule formualtions  stored at  35%RH  for  24 
hours and 6 months in all dissolution media with a molar concentration of 0.1 M 
followed  first  order  kinetics.  These  date  show  that  HPMC  capsules,  unlike 
gelatin are not affected by pH since HPMC is a non ionic polymer (discussed 
previosuly in Chapter 4). At higher molar concentration (0.5 M) corresponding to 
higher  ionic  strength, the  dissolution  data of  the  HPMC  capsule formulations 
stored at 35% RH for 24 hours followed Higuchi square root low, which is plotted 
as the percent dissolved vs square root of time, i.e the quantity of drug released 
is directly proportional to the time. This model considers the drug release as a Chapter Five                                                                    Drug Dissolution Studies  
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diffusion  process  based  in  Ficks  first  law  and  does  not  concider  other 
mechanisms such as drug release by erosion (Pinheiro et al., 2007). This could 
explain the small % drug release obtained  in 0.5 M of the tested buffers (9% in 
some cases) and observations made during the dissolution process in 0.5 M 
buffers because the HPMC capsules in most cases remained intact.  
 
When  the  HPMC  capsules  were  stored  for  6  months,  the  dissolution  data 
obtained in 0.5 M NaPB followed zero order kinetics and 0.1 M HCl + 0.5 M 
NaCl showed a good fit into both first order and Hixon Crowell cube root (which 
was a plot of cube root vs % amount of drug remaining). This suggests that the 
release process involved erosion/diffusion and an alteration in the surface area 
and diameter of the shell system. This was also found in a study by Raslan and 
Maswadeh  (2006)  investigating  the  in vitro  dissolution  kinetic  study  of 
theophylline from mixed controlled release matrix tablets containing HPMC and 
glycerylbehenate,  where  a  relationship  was  found  between  the  first  order 
dissolution    rate  constant  and  the  Hixson Crowell  cube  root  dissolution  rate 
constant. These results agree  with the dissolution data obtained in this work 
after 6 months storage which showed higher % drug release in 0.5 M dissolution 
media. 
 
5.5   Effect of Dissolution Media and Composition on the Initial Stages of 
Capsule Shell Dissolution 
 
5.5.1  Determination of Capsule Shell Thickness at Different Storage 
Conditions  
 
Table 5.15 shows the thickness of Gelatin and HPMC capsule shell bodies after 
storing the capsules at different relative humidities (35%RH and 53%RH both for 
24 hours and 3 days). The results are presented below in Table 5.13  
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Table 5. 15: Body shell thickness of HPMC and Gelatin after storage at different 
relative humidities 
 
Shell Thickness ( m)   
Storage Conditions  HPMC  Gelatin 
35%RH/24hr  121 (9)  125 (4) 
53%RH/24hr  124 (5)  127 (3) 
35%RH/3days  131 (8)  130 (6) 
53%RH/3days  133 (7)  129 (4) 
The results are the mean and (standard deviation) of 10 capsules 
 
Table 5.15 shows an increase in capsule shell thickness with a general increase 
in storage relative humidity and time for both gelatin and HPMC capsule shells. 
The  increase  in  capsule  shell  thickness  for  the  HPMC  capsules  when  the 
storage increases from 35% RH/24 hr to 53%RH/3 days is greater than that of 
the gelatin shells (121  m to 133  m  vs 125  m to 129  m) for HPMC and 
gelatin respectively. 
 
Statistical analysis using one way ANOVA reveals that the difference seen in 
capsule  shell  thickness  for  the  HPMC  shells  are  statistically  significant  (p  = 
0.008). Referring to the Scheffé test in Table 5.16, this difference seems to be 
between  the  two  extreme  storage  conditions  (35%RH/24  hr  and  53%RH/3 
days). Although there is a tendency for the capsule shell thickness to increase, 
this increase is insignificant between the three storage groups (35%RH/24 hr, 
53%RH/24 hr and 35%RH/ 3 days). 
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Table 5. 16: Scheffé test for shell thickness ( m) of HPMC capsule bodies 
Subset for alpha = 0.05  Storage condition for 
HPMC  N  1  2 
35%RH/24hr  10  122.3000   
53%RH/24hr  10  123.6000  123.6000 
35%RH/3days  10  130.7000  130.7000 
53%RH/3days  10    133.0000 
Sig.    .134  .077 
Means for groups in homogeneous subsets are displayed. 
 
Statistical analysis using one way ANOVA for the gelatin shells reveals that the 
change in shell thickness is insignificant (p = 0.061) 
 
This could be due to the lower moisture content of the HPMC capsule shells 
when compared to gelatin, allowing for more moisture to be taken up into the 
HPMC capsule shells. This can be supported by the previous findings (Section 
3.3.1.3.2),  showing  that  the  storage modulus  increased  and  the  phase angle 
decreased for the HPMC capsule shells, with an increase in humidity and elapse 
of  time,  which  indicated  an  increase  in  the  viscoelastic  nature  of  the  HPMC 
capsule  shells.  However,  the  storage  modulus  decreased  and  phase  angle 
tended to increase for the gelatin capsules, which could lead to a decrease in 
their viscoelasticity.  
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5.5.2   Determination of Capsule Shell Thickness in Various Dissolution 
Media 
 
Table  5.17  and  Figure  5.27,  show  the  thickness  of  the  shell  bodies  of  both 
HPMC  and  gelatin  after  immersion  of  the  capsules  in  various  buffers  at 
concentrations of both 0.1 M and 0.5 M (KPB, NaPB, HCl + NaCl or KCl) for 30 
seconds and 2 minutes.  
 
Table 5. 17: Body shell thickness of gelatin and HPMC after immersion in 
various buffers for different times  
The results are the mean (standard deviation) of 10 replicates; * Results are the mean (standard 
deviation) of 5 replicates 
 
 
shell thickness µm  Capsule 
Type 
Dissolution  
Media 
Buffer 
Strength  0.5  
minutes 
1.5  
minutes 
2.0  
minutes 
3.0 
minutes  
0.1M  122 (4)    197 (7)    KPB 
0.5M  121 (4.2)    185 (7.8)   
0.1M  125 (5)    216 (6)    NaPB 
0.5M  139 (5)    209 (18)   
0.1M  106 (3.7)  159 (8.4)*      0.1M HCl+ 
KCl  0.5M  113 (6.9)  148 (15.4)*  178 (4.3)*   
0.1M  105 (3.9)    173 (10.0)*   
Gelatin 
0.1 HCl + 
NaCl  0.5M  114 (5.8)  142 (10.4)  180 (2.8)*   
0.1M  148 (13.3)    156 (5.4)  165 (9.4)    KPB 
0.5M  146 (7.6)    148 (10.7)  150 (7.3) 
0.1M  137 (9)    163 (5)    NaPB 
0.5M  158 (9)    164 (8)   
0.1M  143 (13)    150 (5.5)  147 (4.9)    0.1M HCl+ 
KCl  0.5M  142 (7.0)    141 (9.2)  141 (8.7) 
0.1M  138 (10.1)    138 (10.1)  145 (3.7)   
HPMC  
0.1M HCl + 
NaCl  0.5M  141 (9.9)    141 (6.2)  145 (8.2) Chapter Five                                                                    Drug Dissolution Studies  
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Figure 5. 27: Thickness of capsule shell bodies (n = 10) after immersion in various 
buffers for different times.  
 
5.5.2.1   Effect of Time on Capsule Shell Thickness 
 
The results presented in Table 5.17 and Figure 5.27 generally show differences 
in capsule shell thickness between gelatin and HPMC capsules. Gelatin shells 
have  a  thinner  shell  thickness  at  30  seconds  in  all  dissolution  media  when 
compared with the HPMC capsules. However, after 2 minutes the gelatin shells 
are thicker.  
 
For gelatin, the shell thickness is shown to significantly increase with time in all 
0.1  M  and  0.5  M  buffers.  For  example,  as  time  increases  from  0.5  to  2.00 
minutes, the gelatin shell thickness in 0.1 M KPB increases from 122  m to 197 
 m (p < 0.001);   in (0.1 M HCl + 0.1 M NaCl) the shell thickness increases from 
105  m to 173  m (p < 0.001), and in 0.5 M NaPB increases from 139  m to 
209  m (p < 0.001). 
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Similarly  for  HPMC  capsules,  the  shell  thickness  increases  with  time  in  the 
phosphate dissolution media, however in all cases (apart from 0.1 M NaPB) this 
increase  is  insignificant.  For  example,  an  increase  in  time  from  0.5  to  2.00 
minutes leads to an insignificant increase in HPMC shell thickness in 0.1 M KPB 
from 148  m to 156  m (p > 0.05) and then to 165  m with a further increase in 
time  to  3  minutes.    However,  the  shell  thickness  of  HPMC  in  0.1  M  NaPB 
significantly increases from 137  m to 163  m (p < 0.001).  This could explain 
the shorter lag time before drug release from HPMC capsules in NaPB when 
compared with KPB (Figure 5.17).  
 
The increase in HPMC shell thickness in HCl is very small and in some cases 
does not change. For example, an increase in time from 0.5 minutes to 2.00 
minutes leads to an insignificant increase in HPMC shell thickness in (0.1 M HCl 
+ 0.1 M KCl) from 143  m to 150  m and then to 147  m with a further increase 
in time to 3.00 minutes. In 0.1 M HCl + 0.1 M NaCl, the shell thickness is 138 
 m at both 0.5 minutes and 2.00 minutes and then slightly increases to 145  m 
after 3.00 minutes.  
 
When  comparing  the  gelatin  and  HPMC  capsules,  it  is  clear  that  the  shell 
thickness of the gelatin after 0.5 minutes in all dissolution media is thinner than 
that of the HPMC capsules. For example: (122  m vs 148  m) in 0.1M KPB, and 
(105  m vs 138  m) in (0.1M HCL + 0.1M NaCl), both for gelatin and HPMC 
respectively. On the contrary, the shell thickness of the gelatin capsules after 
2.00  minutes  in  all  dissolution  media  is  thicker  than  that  of  the  HPMC.  For 
example: (163  m vs 216  m) in 0.1 M NaPB and (138  m vs 173  m) in 0.1 M 
HCl + 0.1M NaCl, both for HPMC and gelatin respectively.  
 
The increase in shell thickness for the gelatin shells after 2 minutes is almost 
twice the increase in thickness of the HPMC capsules. It can be seen from these 
results that at the initial stages (30 seconds) HPMC shells uptake more buffer 
and then swell gradually over a longer period of time, on the other hand the 
gelatin capsules at the initial stages (30 seconds) uptake less buffer and then 
swell rapidly over a short period. This could explain the lag time seen for the 
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Lee  et  al  (2006a)  investigated  the  drug  release  from  HPC  (Hydroxypropyl 
Cellulose)  and  PEO  (Polyethylene  Oxide)  capsules,  by  studying  the  water 
uptake  and  swelling  of  capsule  shells  in  0.1  N  HCl  (pH  1.2),  0.1  N  tris 
(hydroxymethyl) aminomethane buffer (pH 6.8) and water at 37
oC, and found 
that the swelling of the polymer shell depends on the rate of water penetration 
into the shell. A faster water uptake rate of capsules resulted in a shorter water 
uptake saturation time. The greatest water uptake saturation time was found for 
HPC 370 K capsules (10 mins) as appose to the gelatin shells (0.6 mins).  
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Figure 5.28 shows cross sections of HPMC and gelatin shell bodies taken using 
image analysis after immersion in 0.1 M and 0.5 M KPB and NaPB for 0.5 
minutes and 2.00 minutes 
 
 
Figure 5. 28: Cross sections of HPMC shell bodies  (a – d) after immersion in 0.1 M KPB for (a) 
0.5 mins, (b) 2.00 mins; 0.5 M KPB for (c) 0.5 mins, (d) 2.00 mins and gelatin shell bofies (e – h) 
0.1 M KPB for (e) 0.5 mins, (f) 2.00 mins; 0.5 M KPB for (g) 0.5 mins, (h) 2.00 mins Chapter Five                                                                    Drug Dissolution Studies  
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The images clearly show an increase in shell thickness with time (0.5 mins – 
2.00 mins). For HPMC at 30 seconds (a) and (c) the shells are fairly smooth with 
few wrinkles. When the shell is immersed for 2.0 mins (b) and (d) the surface 
appears rough with many wrinkles or pores. Similar observations can be made 
for the gelatin capsules which appears rougher with wrinkles after immersion for 
2.0 mins in dissolution media. It can also be noted that the edges of the gelatin 
cross sections are uneven in some cases, this is because they become very 
brittle after drying and hence difficult to handle when cutting.  
 
5.5.2.2  Effect of Ionic Strength 
 
Referring to Table 5.17 and Figure 5.27, differences in gelatin shell thickness 
can be seen between high and low molar concentrations (0.1 M and 0.5 M) of 
phosphate  buffers  with  less  gelatin  shell  swelling  in  the  0.5M  buffers  when 
compared to the 0.1M buffers, this effect is not so clear in HCl. For example: 
(197  m vs 185  m) for 0.1M and 0.5M KPB respectively, and (216  m vs 209 
 m) for 0.1M and 0.5M NaPB respectively. One way ANOVA shows that the 
difference between 0.1M KPB and 0.5M KPB are statistically significant (p = 
0.003),  however  the  difference  between  0.1M  NaPB  and  0.5M  NaPB  are 
statistically insignificant (p = 0.256). This supports the previous findings that the 
type  of  ion  influences  gelatin  shell  thickness  to  some  degree  and  the 
concentrations of the ions present.  
 
For HPMC, differences in HPMC shell thickness can be seen between low and 
high molar concentrations, see Table 5.15, with less shell swelling at high molar 
concentration (0.5M) buffers when compared to low molar concentrations (0.1 
M) buffers: for example at 2.00 minutes: (148 vs 156) for 0.5 M and 0.1 M KPB 
respectively and (141 vs 150) for 0.5 M and 0.1 M KCl respectively.  
 
Kavanagh and Corrigan (2004) in a study looking at the erosion properties of 
HPMC matrices found that the erosion rate increased with a decrease in ionic 
strength, and decreased as the ionic strength increased. They attributed this to 
the salting out of the polymer by the inorganic ions present in the dissolution Chapter Five                                                                    Drug Dissolution Studies  
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media. The polymer still appears able to form a protective gel layer and in turn 
does not disintegrate. In another study, Lee et al (2006b) found a correlation 
between the square root of ionic strength of the electrolytes and water saturation 
time. The increase of the valence of the electrolyte or ionic strength prolongs the 
water uptake saturation time. They also found a correlation between the square 
root of ionic strength and lag time of dissolution of various capsules. An increase 
of the valence of electrolyte or ionic strength lead to a longer lag time of the 
HPC  capsules,  which  was  thought  to  be  a  result  of  lower  water  activity  with 
increasing ionic strength.  
 
5.5.2.3  Effect of Dissolution Media Composition  
 
For gelatin capsules in a phosphate buffer, the data clearly shows a difference in 
the increase in shell thickness with a change in the type of ion present in the 
solution,  indicating  that  the  type  of  salt  influences  their  behaviour  to  some 
degree. Gelatin shells tend to swell more in the NaPB when compared to KPB. 
The  shell  thickness  of  gelatin  capsules  after  immersion  in  0.1M  KPB  for  2 
minutes is 197  m and in 0.1M NaPB is 216  m, the same is seen for the 0.5M 
phosphate buffer where the gelatin shell thickness in 0.5M KPB is 185  m and 
that  in  0.5M  NaPB  is  209   m.    One  way  ANOVA  shows  that  the  difference 
between 0.1M KPB and 0.1M NaPB are statistically significantly different (p < 
0.001)  and  that  the  difference  between  0.5M  KPB  and  0.5M  NaPB  are  also 
statistically significantly different (p = 0.002). Again, this effect is not very clear in 
acidic media.  
 
Comparing the basic and acidic buffers, the results show that the gelatin shells 
swell more in the phosphate buffers than in HCl at both 0.5 minutes and 2.00 
minutes. For example in 0.1 M KCl and 0.1 M KPB at 0.5 minutes: (106  m vs 
122  m) respectively, in (HCl + 0.5M KCl) and 0.5M KPB at 2.00 minutes: (178 
 m vs 185  m) respectively, and in (HCl + 0.1M NaCl) and 0.1M NaPB at 2.00 
minutes (173  m vs 216  m) respectively. This supports the results presented 
earlier in Sections 5.2.2 – 5.3.4, where it was found that the drug dissolution 
from gelatin capsules in HCl was much slower than that found in the phosphate Chapter Five                                                                    Drug Dissolution Studies  
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buffers (Figure 5.19). The MDT of the gelatin shells in HCl was greater than that 
in phosphate buffers, see Table 5.11, and followed zero order kinetics, however, 
in phosphate buffer they followed first order kinetics, see Table 5.12.  
 
HPMC capsules show differences in capsule shell thickness between different 
ions  present  in  the  dissolution  media,  the  capsules  swell  more  in  NaPB 
compared to  KPB.<colon> For example at 2.00 minutes: (122  m vs 148  m) 
for 0.1 M KPB and NaPB respectively, and (164  m vs 148  m) in 0.5 M NaPB 
and KPB respectively. This could explain the results reported in section 5.2.2 
and 5.2.3 where it was found that the lag time for HPMC capsules to open and 
release the theophylline was nearly twice as long in 0.1M KPB than in 0.1M 
NaPB. Similarly, it was found that a greater amount of drug was released in 
0.5M NaPB when compared to 0.5 M KPB.  One way ANOVA showed that the 
differences seen in shell thickness at 2.0 minutes between 0.1M KPB and 0.1M 
NaPB were significant (p = 0.008) and between 0.5M KPB and 0.5M NaPB (p = 
0.019). These effects were not very clear in HCl.  
 
Comparing the basic and acidic buffers, the results show that the HPMC shells 
swell more in the phosphate buffers than in HCl at both 0.5 minutes and 2.00 
minutes, however, to a smaller degree than that found for the gelatin capsules. 
For example at 0.5 minutes (143  m vs 148  m) for 0.1 M KCl and 0.1 KPB 
respectively and at 2.00  minutes: (150  m vs 156  m) for 0.1 KCl and 0.1 M 
KPB respectively.  
 
5.6  General Conclusions  
 
In general, it was found that drug release occurred at a faster rate from gelatin 
capsules compared to HPMC in all dissolution media. However, once the HPMC 
capsules disintegrated drug release from them reached maximum values within 
a shorter period. The results are in agreement with those found for capsule shell 
dissolution (Chapter 4) showing that the presence of high concentrations of K
+ 
and Na
+ ions whether in alkaline or acidic conditions slows down the dissolution 
rate  of  the  drug  from  HPMC  capsules.  However,  this  effect  was  more Chapter Five                                                                    Drug Dissolution Studies  
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pronounced in the former. Further investigations had also demonstrated that the 
shell walls of HPMC swell more in the presence of Na
+ ions when compared 
with the K
+ ions. Drug dissolution from gelatin capsules was also affected by the 
presence of high concentrations of both K
+ and Na
+ ions. This effect was greater 
when Na+ ions were present (See Table 5.11) which could be shifting the pH of 
the gelatin towards its IEP. The effect of Na+ on drug dissolution from gelatin 
capsules was also seen by the continuous change in release mechanism in the 
tested dissolution media containing Na
+ ions.  
 
The mechanism of drug release from gelatin capsules was found to be different 
in  both  basic  and  acidic  media.  This  was  constant  for  the  HPMC  capsules, 
showing that the change in pH did not affect the release mechanism. However, 
the change in ionic concentration produced different release mechanisms from 
the HPMC capsules, and was similar regardless of the dissolution media tested. 
 
It was also found that HPMC capsules are not affected by long storage periods, 
where  drug  dissolution  rate  was  similar  after  both  24  hours  and  6  months 
storage in 0.1 M of the tested dissolution media. However, drug dissolution from 
gelatin  capsules  was  slightly  reduced  after  6  months.  Long  storage  period 
showed an improvement in drug release from HPMC and gelatin capsules in the 
presence of high Na
+ concentrations, this was also reflected by the change in 
release mechanism.  
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6  Summary, General Conclusions and Potential Future Work  
 
Hypromellose  capsules  are  a  new  type  of  hard  two piece  capsule  that  were 
developed as an alternative to the two piece gelatin capsules in an attempt to 
overcome some of the drawbacks that are associated with the gelatin capsules. 
They have been developed by several companies, Qualicaps (Shionogi) S.A. 
(Quali V
®  capsule),  Capsugel  Division  of  Pfizer  Inc.  (Vcaps  TM),  Natural 
Capsules Ltd. (Cellulose capsule), and Associated Capsules Ltd. (Naturecaps) 
(Honkanen, 2004). However, unlike gelatin capsules they all have either unique 
formulations  or  manufacturing  methods,  which  have  been  patented,  because 
hypromellose  solutions  do  not  undergo  a  gelling  reaction.  This  results  in 
hypromellose  capsules  from  each  manufacturer  having  different  properties, 
particularly the first company to be granted patents for a gelling system was the 
Japanese  company,  Qualicaps  (Shionogi).  Their  patent  used  hypromellose 
solutions to which carrageenan was added as a network former and potassium 
chloride as a gelation promoter (Yamamoto et al, 1993, 1995, 1998; Matsuura 
and Tanjoh, 2003).   
 
 
The aim of this work was to provide novel methods to investigate the physical, 
mechanical and chemical properties of a new type of HPMC capsule shell, and 
to  investigate  the  relationship  between  physical  fundamental  properties  and 
capsule  dissolution/drug  delivery,  and  compare  them  to  conventional  gelatin 
capsule shells. Initially, an extensive literature review was undertaken to assess 
the  knowledge  relating  to  the  properties  of  HPMCcarr  (Hydroxypropyl  methyl 
cellulose)  hard  capsules.  It  was  found  that  few  studies  have  investigated  the 
physico chemical properties of hypromellose capsules. Studies by Chiwele, et al 
(2000) and Podczeck & Jones (2002) compared the solubility of capsule shells 
and the dissolution of an active from standard gelatin and the first generation of 
hypromellose capsules, and recently El Malah and Nazzal (2007) studied the 
rupture  time  of  the  capsules  using  real  time  dissolution  spectroscopy.  In 
addition, both Podczeck (2002) and Jones (2003) have compared the physical 
properties  of  gelatin  and  hypromellose  capsules  either  by  measuring 
fundamental mechanical properties or by puncture testing (See Chapter One). Chapter Six               Summary, General Conclusions and Potential Future Work   
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In  Chapter  3  (physical  and  mechanical  properties),  the  influence  of  storage 
conditions (RH) and time on the physical properties of HPMC capsule shells was 
investigated  and  compared  with  the  gelatin  and  gelatin/PEG  shells.  Thermal 
behaviour  (in  particular  Tg  temperature)  of  the  capsules  was  studied  using 
MDSC. The effect of moisture on changes in the glass transition temperatures 
was also investigated. The rheological properties of the capsules (elasticity and 
viscosity) were determined using DMA.  
 
In Chapter 4 (capsule shell dissolution), the shell dissolution properties of HPMC 
capsules (of different batches and sizes) were determined and compared with 
those of the gelatin and gelatin/PEG shells. The influence of storage conditions 
(RH)  and  time,  pH,  dissolution  medium  composition  and  ionic  strength  on 
capsule shell dissolution times was investigated. 
 
In Chapter 5 (drug dissolution studies), in vitro dissolution of theophylline from 
HPMC  capsules  in  a  number  of  dissolution  media  was  investigated  and 
compared with gelatin shells. The influence of storage time, dissolution media 
composition and  ionic  strength  on  in vitro  drug  dissolution from  the  capsules 
was determined.  
 
This  work  has  demonstrated  that  the  hypromellose  capsules  have  many 
advantages  over  the  conventional  gelatin  capsules,  showing  no  signs  of 
brittleness, even at very low moisture contents, and no signs of physical aging 
as was observed in the MDSC signals for the gelatin. The HPMC capsules were 
more  elastic  with  a  greater  degree  of  recovery  to  an  applied  stress  when 
compared with the gelatin capsules as found from the DMA results. This could 
be due to the Tg temperature of the two materials, since changes in Tg reflects 
the  material’s  molecular  structure  that  can  influence  physical  stability  and 
viscoelastic  properties  (Hancock  and  Zografi,  1994;  Siepmann  and  Peppas, 
2001). It has been described that the decrease in material resistance could be a 
result of a decrease in the material’s Tg (Vanin et al., 2005). The results in this 
work demonstrated that it took longer for the HPMC capsules to change from a 
glassy to a rubbery state, therefore it is likely that they are more resistant to 
thermo mechanical  stresses.  It  was  also  found  that  an  increase  in  RH  and Chapter Six               Summary, General Conclusions and Potential Future Work   
 
  315 
storage time leads to an increase in the viscoelastic nature of these capsules, 
whereas the opposite was seen for gelatin. A clear relationship was observed 
between these findings and between the Tg temperature of HPMC capsules, 
where  it  was  found  that  the  Tg  of  the  HPMC  capsules  decreased  as  the 
moisture  content  increased,  therefore  the  change  in  glassy  –  rubbery  state 
appeared at lower temperatures.  
 
Capsule shell dissolution time from HPMC capsules was longer in all dissolution 
media  compared  with  gelatin  shells.  It  was  also  found  that  Capsule  shell 
dissolution was affected by dissolution media composition and ionic strength. If 
the dissolution medium contained a greater amount of K
+ ions to Na
+ ions, then 
the shell dissolution time was higher as seen in SPB pH 8. Generally, it was 
found that an increase in ionic strength, and the presence of high concentrations 
of K
+ ions slowed down HPMC capsule shell dissolution, this effect was greater 
in phosphate buffer when compared with HCl.  The capsules were also affected 
by the presence of high concentrations of Na
+ ions, however this effect was less 
pronounced. Although the effects of K
+ and Na
+ ions on gelatin capsules were 
not as pronounced as those found for the HPMC capsules, they were in many 
cases significant, showing increases in shell dissolution times with an increase 
in molarity (or ionic strength) from 0.1 M – 0.5 M of all tested media (Section 4.9, 
Figures 4.21 – 4.28). Other increases in shell dissolution times such as those 
found in AB for both gelatin and HPMC capsules were thought to be due to 
salting out of the polymer by inorganic ions.  
 
Drug dissolution studies (Chapter 5) showed that Initial drug release from HPMC 
capsules in all dissolution mediums was slower than the release from gelatin 
shells, However, once the HPMC capsules disintigrated, maximum drug release 
occurred at a faster rate. The release rate was fastest from the New HPMC 
capsules in all 0.1 M dissolution media, but the MDT in KPB for both New HPMC 
and theophylline plugs alone was essentially the same (Table 5.11). The MDT of 
theophylline for both gelatin and hyperomellose capsules was reduced with an 
increase  in  molarity  from  0.1  M  –  0.5  M,  this  effect  was  larger  for  the 
hypromellose  capsules.  The  decrease  In  drug  release  from  HPMC  with  an Chapter Six               Summary, General Conclusions and Potential Future Work   
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increase in molarity from 0.1 M – 0.5 M could allow for further investigations into 
controlled drug release.  
 
Drug release from HPMC capsules in 0.1 M HCl, 0.1 M NaPB, and 0.1 M HCl + 
0.1 M NaCl was equivalent, however was slower in both 0.1 M HCl + 0.1 M KCl 
and 0.1 M KPB. The mean % drug release from gelatin capsule shells was more 
variable in 0.1 M HCl with higher standard deviations when compared to that in 
KPB and NaPB, and was slightly reduced with the increase in ionic strength 
similar to what was found by Lee et al (2006b). In contrast, The shell dissolution 
and % drug release from HPMC capsules was faster in acidic conditions and in 
the presence of Na
+ ions when compared to the presence of K
+ ions. The MDT 
of  theophylline  for  the  gelatin  capsules,  showed  that  the  gelatin  shells  were 
effected by prolonged storage periods, with an increase in MDT after 6 months 
storage in both 0.1 M NaPB and 0.1 M HCl + 0.1 M NaCl, this effect was not 
seen  with  the  HPMC  capsules.  Furthermore,  it  was  found  that  MDT  of 
theophylline from gelatin capsules in phosphate buffer was significantly different 
to that in acidic media. In contrast, MDT from HPMC capsules was similar in 
both phosphate and acidic media (Table 5.12 and 5.13). This was also seen by 
the different drug release mechanisms, which for gelatin capsules in 0.1 M and 
0.5 M phosphate buffer pH 7.4 followed first order kinetics, here the relase rate 
is concentration dependent. In acidic media (apart from 0.1 M HCl + 0.1 M NaCl) 
drug release followed zero order, i.e. the drug release rate is independent of the 
amount of drug available for dissolution and diffusion from the capsule shell. 
However in all 0.1 M dissolution media for New HPMC capsules, drug release 
followed  first  order,  and  in  all  0.5  M  dissolution  mediums  the  drug  release 
followed the Higuchi model. In the Higuchi model the drug release occurs as a 
diffusion process and not by erosion of the capsule shell, which explained the 
slower release rates at higher molarities. The improved drug release from the 
New HPMC capsules in 0.5 M buffers after 6 months storage is seen by the 
change in release mechanism to zero order in NaPB and first order in 0.1 M HCl 
+ 0.5 M NaCl.  
The  higher  shell  dissolution  time  and  the  initial  lag  phase  observed  for  the 
HPMC  capsules  compared  with  the  gelatin  shells,  is  possibly  due  to  their 
molecular structure and the different ways in which the capsule shell walls are Chapter Six               Summary, General Conclusions and Potential Future Work   
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formed. Gelatin capsules are formed on mould pins by a temperature change 
forming a film by a sol/gel transformation, whereas for Quali V (hypromellose) 
capsules, the temperature change forms a network of carageenan that holds the 
polymer on the mould pins, leading to a more disordered structure compared to 
that of the gelatin (Jones, 2009). This is also seen by the high Tg temperature of 
the  HPMC,  which  as  suggested  previously,  leads  to  greater  resistance  to 
thermo mechanical stresses, hence the increased time to shell dissolution, and 
by the greater elasticity which is associated with those capsules as found from 
the  DMA  results.  This  can  also  be  explained  by  the  capsule  shell  thickness 
studies  reported  in  chapter  5  (Section  5.5.2).  It  was  found  that  the  gelatin 
capsules had a thinner shell thickness after being immersed for 30 seconds in 
the different dissolution media when compared to the HPMC capsules, however, 
after 2 minutes, the gelatin shells became thicker and were almost twice as thick 
compared to the HPMC capsules. Generally, the HPMC capsules were found to 
take up more buffer and then swell gradually over a long period of time, on the 
other hand the gelatin capsules, at the initial stages (30 seconds) the uptake of 
buffer was less and then they swelled rapidly over a shorter period.  
 
The change in shell dissolution and drug dissolution properties of the HPMC 
capsules can be attributed to a number of reasons: 
 
(i) Type of ion: Carrageenan is the gelling agent for HPMC capsules and KCl is 
the gelling promoter, where Carrageenan undergoes a coil helix transition upon 
temperature reduction in the presence of K
+ ions, which affects the solubility of 
the polymer and promotes aggregation. If the dissolution medium contains high 
concentrations of K
+ ions, then the dissociation of the aggregates is hindered 
and the gel retains its structure, therefore the capsules will not dissolve as seen 
in 0.4 M and 0.5 M of KPB and HCl+KCl . On the other hand, dissociation of the 
aggregates is faster in the presence of Na
+ ions, this is thought to be due to the 
binding efficiency with which ions of different sizes can fit into potential sites on 
the helices (Rochas and Rinaudo, 1984; Ridout et al., 1996; Cole et al., 2004). 
In the presence of Na
+ ions, Carrageenan can be found in the coil state at room 
temperature (depending on the salt concentration), but in the presence of K
+ 
ions, it can be found in the coil or helix state. Although Na
+ ions do not promote Chapter Six               Summary, General Conclusions and Potential Future Work   
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coil – helix transition, they take part in the aggregation process probably through 
a  phase  separation  mechanism,  leading  to  the  formation  of  a  weak  gel 
(Mangione et al., 2005). This was observed during the drug dissolution studies, 
where  drug  dissolution  from  HPMC  capsules  in  0.2  M  NaPB  was  almost 
equivalent to that in 0.1 M NaPB, however, it was considerably reduced when 
the buffer used was KPB.  
 
(ii) Presence of phosphate ions: Vazquez et al (1992) attributed the differences 
in release from HPMC matrices to high concentrations of phosphate ions being 
present. This could be the reason why capsule shell dissolution occurred when 
the dissolution medium was composed of HCl with high concentrations (0.4 M 
and 0.5 M) of either KCl or NaCl, but did not occur when it was composed of 
potassium or sodium phosphate at high concentrations. Therefore, the higher 
the  concentration,  the  more  phosphate  ions  will  be  required  resulting  in  a 
slowdown of capsule shell dissolution.  
 
(iii) Ionic strength: it was found that an increase in buffer concentration leads to 
an increase in ionic strength, and an increase in pH of all tested media leads to 
an  increase  in  ionic  strength,  the  higher  the  ionic  strength,  the  slower  the 
capsules shell dissolution time.  
 
(iv) Salting out of the polymer by inorganic ions present in the dissolution media: 
this is because as the ionic strength of the medium is increased, the polymer 
molecular chains lose water of hydration due to ions competing for the available 
water of hydration (Kavanagh and Corrigan, 2004). .  
 
The  investigations  carried  out  both  support  work  that  has  been  previously 
reported concerning the properties of the Quali V capsules, and provide new 
information In terms of their viscoelasticity, interactions with various ions present 
in  different  dissolution  media,  drug  dissolution  behaviour  before  storage  and 
upon storage for prolonged periods, and the mechanisms of drug release. This 
information, amongst the other extensive results presented throughout this study 
is not only vital for the development of the new capsules on an industrial scale, 
but also for their efficacy, safety and acceptability to patients worldwide Chapter Six               Summary, General Conclusions and Potential Future Work   
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6.1  Potential Future Work  
 
Since dosage forms are an essential part of drug delivery to the site of action in 
a safe, effective and efficient manner, further research will always be essential, 
and this work has highlighted a number of avenues that could be explored in 
order to enhance, complete and progress this work, the first two of which would 
have been investigated if time had not been an issue, these include: 
 
•  Laser scanning confocal microscopy, to develop a novel method to study 
the  penetration  of  chemical  molecules  into  the  capsule  shells  during 
storage  and  wetting.  This  could  help  in  predicting  incompatibilities 
between  capsule  shell  and  filling  and  other  long time  storage  issues, 
especially when using semi solid and liquid fills. 
 
•  High speed digital camera imaging to observe the dissolution process of 
the  capsules.  This  would  help  to  identify  how  the  shell  dissolution 
contributes  or  hinders  the  plug  disintegration  and  drug  dissolution 
process. 
 
•  Stability  testing,  utilising  a  novel  method  to  study  oxygen  permeability 
through the shell to provide an insight into the stability properties found. 
 
•  Adding enzymes, fatty acids, bile salts etc to the dissolution media, to 
mimic  the  effect  of  in vivo  conditions  on  shell  dissolution  and  drug 
release. 
 
•  Devising a method for studying the mechanical properties of the capsule 
shells  using  DMA  after  treatment  in  buffer  containing  various  ionic 
concentrations, this would provide an insight into the effects of dissolution 
media composition and ionic strength on the mechanical properties of the 
capsules.  
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•  Carrying out MDSC experiments after immersion of the capsules in the 
different  dissolution  media,  this  would  determine  the  effect  of the  ions 
present in the dissolution media on the capsule’s thermal properties.  
 
•  The effect of ionic charge on capsule shell dissolution properties could 
also  be  investigated  by  filling  the  capsules  with  anionic  and  cationic 
drugs.  
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Appendix 1: Physical and Mechanical Properties – Method Development 
 
1.1 Modulated Differential Scanning Calorimetry    Method Development  
1.1.1 Glass Transition (Tg) Temperature of Hypromellose (HPMC) Capsules 
 
The HPMC glass transition has been quoted between 150 180
oC (Sakellarious 
et al, 1985, McPhillips et al., 1999, Harwood, 2006), therefore, it was expected 
that a glass transition temperature between these values would be found. The 
parameters used for the gelatin capsules did not produce any glass transition for 
the HPMC capsule shells.  (Figure 1.1) 
 
Figure 1.1: HPMC capsule shells sample in hermetically sealed pans. MDSC scan (ramp rate = 
3.00
oC/min, modulation period of 60s, and a modulation temperature amplitude ±1.0
oC)  
 
Figure 1.1 shows a broad endotherm in the non reversible heat flow signal at 
135
oC corresponding to a moisture loss, and no glass transition was seen in the 
reversing heat flow (blue) signal.  
The next step was to run the same method on a pure HPMC sample (Figure 1.2) 
to determine whether a glass transition is achievable with those parameters or 
whether a similar profile to the one obtained previously was observed. However, 
the only clear peak was that of the moisture loss appearing as a broad peak 
above 100
oC.                                                                                                               Appendix 1  
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Figure 1.2: Pure HPMC powder sample in hermetically sealed pans (ramp rate = 3.00
oC/min, 
modulation period of 60s, and a modulation temperature amplitude ±1.0
oC)   
 
Previous studies by McPhillips et al (1999) had demonstrated that an increase in 
ramp rate leads to an enhancement of the glass transition signal due to the 
reversing  heat  flow  being  the  product  of  the  complex  heat  capacity  and  the 
underlying heating rate. Therefore, the next step was to increase the heating 
rate to 4.0
oC/min (Figure 1.3). 
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Figure 1.3 HPMC capsule shell sample in hermetically sealed pans. MDSC scan (ramp rate = 
4.00
oC/min, modulation period of 60s, and a modulation temperature amplitude ±1.0
oC)   
 
Figure 1.3 shows that a steeper reversible heat flow signal was  produced in 
regions  of  the  glass  transition  temperature  when  compared  to  the  previous 
parameters used. However, their was no clear indication of the presence of a 
glass transition. The ramp rate was further increased to 5.00
oC/min, and a slight 
improvement was seen (Figure 1.4) and therefore further tests were carried out 
using a 5.00
oC/min ramp rate.  
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Figure 1.4 HPMC capsule shell sample in hermetically sealed pans. MDSC scan (ramp rate = 
5.00
oC/min, modulation period of 60s, and a modulation temperature amplitude ±1.0
oC)   
 
However, it was noticed that the broad peak that appears in the non reversing 
heat flow  signal  was  shifted to  lower  temperatures  (compare  Figure  1.1  with 
Figure 1.4), which was attributed to the fact that the hermetically sealed pans 
were not crimped fully. The crimper setting was adjusted to allow for correct 
sealing  of  the  hermetic  pans.  This  then  lead  to  moisture  loss  at  higher 
temperatures  as  before  and  no  glass  transition  was  observed  even  at  ramp 
rates of 5.00
oC/min.  
 
The  next  step  consisted  of  increasing  the  modulation  temperature  amplitude 
because  the  modulation  amplitude  should  be  large  enough  to  provide  good 
sensitivity  but  not  so  large  that  it  will  reduce  resolution.  Furthermore,  large 
amplitudes  should  be  used  when  measuring  weak  transitions.  Therefore,  the 
modulation amplitude was increased from 1.00
oC to 2.00
oC and since a ramp 
rate did not provide sufficient modulation cycles (a minimum of 4 modulation 
cycles  must  be  produced)  the  heating  rate  was  also  reduced  back  down  to 
3.00
oC/min  (Figure  1.5).  However,  the  alternations  in  the  methods  did  not 
produce any glass transition signals since correctly sealing the pans.                                                                                                                Appendix 1  
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Figure 1.5 HPMC capsule shell sample in hermetically sealed pans. MDSC scan (ramp rate = 
2.00
oC/min, modulation period of 60s, and a modulation temperature amplitude ±3.0
oC)   
 
As  a  result  of  the  above,  it  seemed  logical  to  try  and  use  non hermetically 
sealed pans. The scans produced using non hermetically sealed pans with a 
ramp rate of 2.00
oC/min, a modulation period of 60s and a modulation amplitude 
of ± 2.00
oC formed a visible glass transition with sufficient modulation cycles for 
all the different HPMC capsules shells (Figure 1.6). 
When  moisture  was  lost  at  higher  temperatures  near  to  the  glass  transition 
temperatures of HPMC as in the hermetically sealed pans, no obviously visible 
glass transition was seen. However, the use of non hermetically sealed pans 
reduced the temperature at which the moisture was lost and produced a visible 
glass transition. Furthermore, the use of non hermetically sealed pans allows for 
a large sample mass to be tested due to the larger area of the base of the pan.                                                                                                               Appendix 1  
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Figure 1.6 HPMC capsule shell sample in non hermetically sealed pans. MDSC scan (ramp rate 
= 2.00
oC/min, modulation period of 60s, and a modulation temperature amplitude ±2.0
oC)   
 
1.2  Dynamic Mechanical Analysis Method Development 
1.2.1 Static Scans 
 
The  method  used  for  the  static  scans  was  one  that  had  previously  been 
optimized for film coatings on pellets. The parameters were initially tested on 
gelatin capsule caps and when they were found to work, were tested on the 
HPMC capsule caps to make sure that the method was acceptable for use on all 
different types of capsule shells. The method consisted of applying a static force 
from 0.00mN to 2500mN, increasing at a rate of 200.00mN/min.  
 
1.2.2  Linear Creep 
 
The  method  development  for  linear  creep  was  initially  undertaken  using  the 
gelatin and Old HPMC capsule shells. A number of different static forces were 
tested. Once the correct static force was obtained, the test was repeated on the 
gelatin/PEG, New HPMC, and E0501493 HPMC capsule shells.                                                                                                                Appendix 1  
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Initially the creep tests were determined with a static force of 100mN. However, 
the  capsule  remained  in  position  underneath  the  probe  only  during  one  test. 
When this was repeated, the cap shell kept on slipping from beneath the probe 
during the recovery period. Therefore, the static force was lowered to 80mN. 
However, the same problem occurred on more than one occasion during the 
recovery period: 3 out of 5 capsules slipped from beneath the probe. The static 
force  was  then  further  decreased  to  60mN  with  more  or  less  the  same 
observations.  
At  this  point,  the  static  force  was  further  decreased  to  40.00mN  and  all  five 
capsules tested remained underneath the probe. A static force of 20mN was 
also tried but the capsules either slipped from beneath the probe early during 
the loading step (Figure 1.7), or produced a noisy static strain (Figure 1.8). 
 
 
 
Figure 1.7. Linear Creep profile –Method Development (Creep: 20.0mN, 10.0 min; Recovery 
10.0mN, 10.0min for Old HPMC size 0 cap shells) 
 
                                                                                                               Appendix 1  
  354 
 
 
Figure 1.8. Linear Creep profile – Method Development (Creep: 20.0mN, 10.0 min; Recovery 
10.0mN, 10.0min for Gelatin size 0 cap shells) 
 
 
The best profiles obtained were those produced with a static force of 40mN as 
shown below in Figure 1.9. Before this static force was used the gelatin/PEG 
and new HPMC capsule shells were tested using the same method, and were 
found to give similar profiles. 
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Figure 1.9 Linear Creep profile – Method Development (Creep: 40.0mN, 15.0 min; Recovery 
20.0mN, 3.00min for Gelatin size 0 cap shells) 
 
1.2.3  Dynamic Scans 
 
The method for the dynamic scans was tested initially on the gelatin capsule 
shells to obtain the best results possible. The resultant optimized method was 
then tested on the other capsule shells to see if the results resembled that of the 
gelatin  in  terms  of  being  clear,  readable  and  reproducible.  The  parameters 
optimized here were the static force and the frequency. Initially low static forces 
were employed starting from 100.0mN, in a 100mN intervals up to 600.0mN, 
however,  these  scans  were  too  short  i.e.  did  not  give  enough  time  for  the 
modulus to become linear and were therefore not meaningful moreover, they 
were too noisy. Therefore, the static force was first increased to 800.0mN with a 
frequency of 1 Hz shown below in Figure 1.10. However, the profile showed 
noise. Furthermore, the results were not repeatable, and in some cases had a 
tendency to change shape (Figure 1.11 see phase angle and tan delta) 
                                                                                                               Appendix 1  
  356 
 
.  Figure 1.10 Dynamic Scan Profile – Method Development (dynamic scan from    0.00mN to   
600.00mN at 25.0mN/min using gelatin cap shells). Static force = 800mN and frequency 1Hz. 
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Figure 1.11 Dynamic Scan Profile – Method Development (dynamic scan from 0.00mN to 600.00mN at 25.0mN/min for gelatin cap shells). Static force = 
800 mN and frequency = 1Hz                                                                                                               Appendix 1  
  358 
 
However,  since  the  modulus dynamic  force  curve  remained  similar  when  the 
experiment  was  repeated,  it  was  thought  that possibly  altering  the frequency 
may  reduce  the  noise,  which  was  seen,  and  would  produce  better  profiles. 
Decreasing  the  frequency  to  0.5  Hz  produced  irregular  signals  in  the  three 
curves (modulus, phase angle and tan delta) as shown below in Figure 1.12. 
 
 
Figure 1.12 Dynamic Scan profile – method development using gelatin cap shells (Frequency = 
0.5Hz, scan from 0.00mN to 600.00mN at 25.0mN/min). 
 
The frequency was then increased to 2 Hz. However, the curves were too noisy 
with no obvious slope in the modulus dynamic force curve. See Figure 1.13. 
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Figure 1.13 Dynamic Scan profile – method development using gelatin cap shells (Frequency = 
2Hz, scan from 0.00mN to 600.00mN at 25.0mN/min). 
The frequency was then increased to 2.5Hz, with no improvement in the signals. 
See Figure 1.14. 
 
 
Figure 1.14 Dynamic Scan profile –method development using gelatin cap shells (Frequency = 
2.5HZ, static force = 800mN, scan from 0.00mN to 600.00mN at 25.0mN/min 
 
Two  further  frequencies  were  tested;  these  were  3  Hz  and  3.5  Hz.  These 
profiles were too noisy and were not suitable for use, see Figures 1.15 and 1.16.                                                                                                               Appendix 1  
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It can be seen that with a frequency of 3Hz, the curves are too wavy and it 
would not be possible to calculate any meaningful results from these curves. 
 
 
Figure 1.15 Dynamic Scan profile –method development using gelatin cap shells (Frequency = 
3HZ, static force = 800mN, scan from 0.00mN to 600.00mN at 25.0mN/min 
 
 
 
Figure 1.16 Dynamic Scan profile –method development using gelatin cap shells (Frequency = 
3.5HZ, static force = 800mN, scan from 0.00mN to 600.00mN at 25.0mN/min                                                                                                               Appendix 1  
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As a result the static force was increased to 900mN, using a frequency of 1Hz. 
At  this  point,  the  profiles  produced  seemed  to  be  clearer,  with  no  noise. 
Furthermore, the results were repeatable, and when tested on the gelatin/PEG 
capsules, old HPMC, new HPMC and E0504193 HPMC cap shells, they were 
repeatable and not noisy. An example of the profile is shown below in Figure 
1.17 
 
 
Figure 1.17 Dynamic Scan profile – Method Development using gelatin cap shells (Frequency = 
1Hz, static force = 900mN, scan from 0.00mN to 700.00mN at 30.0mN/min 
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Appendix 2: Capsule Shell Dissolution – Preparation of Dissolution Media 
2  Capsule Shell Dissolution   
2.1   Preparation of Dissolution Media 
 
The  following  dissolution  media  were  prepared  according  to  the  methods 
published in the British Pharmacopeia (Appendix ID, 2008d) these include:  
 
8)  Sörensen  phosphate buffer  (pH  5  – 8)  which  was  prepared  using  two 
solutions:  solution  A,  1/15M  of  anhydrous  disodium  hydrogen 
orthophosphate  (11.876g/L)  Na2HPO4  and  solution  B:  1/15M  of 
anhydrous    potassium  dihydrogen  orthophosphate  (9.078g/L)  KH2PO4. 
The amounts measured are shown below in Table 2.1 
 
Table 2.1: volumes of anhydrous Na2HPO4  and  anhydrous KH2PO4. 
        measured to produce 100 ml of solution  
pH  A  B 
5  0.95 ml  99.05 ml 
6  12.1 ml  87.9 ml 
7  61.2 ml  38.8 ml 
8  96.9 ml  3.1 ml 
 
9)  Citro phosphate buffer (pH 5 – 7): 
•  pH5  was  prepared  using  0.1M  citric  acid  and  0.2M  disodium 
hydrogen  orthophosphate.  To  prepare  100ml  of  pH5  48.5  ml  of 
0.1M  Citric  acid  (C6H8O7.  H2O)    was  mixed  with  sufficient  0.2M 
disodium hydrogen orthophosphate (Na2HPO4 .12H2O). 
•  PH  6  was  prepared  using  2.1%w/v  solution  of  citric  acid  and 
7.15%w/v  solution  of  disodium  hydrogen  orthophosphate.  To                                                                                                               Appendix 2 
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prepare 100 ml  of pH6  as  the BP  states  36.8ml  of a  2.1%  w/v 
solution  of  citric  acid  was  mixed  with  63.2  ml  of  a  7.15%  w/v 
solution of disodium hydrogen orthophosphate. 
•  pH7 was prepared using 7.15% w/v solution of disodium hydrogen 
orthophosphate and 2.1% w/v citric acid. To prepare 100 ml as 
stated  by  the  BP,  82.4  ml  of  a  7.15%  w/v  solution  of  disodium 
hydrogen orthophosphate was mixed with 17.6 ml of a 2.1% w/v 
solution of citric acid. 
10)  Phosphate borax buffer (pH 7, 8) this was prepared using two solutions, 
solution A: 13.62g/L of 0.1M anhydrous KH2PO4 and solution B: 10.1g/L 
of 0.05M anhydrous Borax. The amounts measured are shown below in 
Table 2.2  
 
Table 2.2: Volumes of anhydrous KH2PO4 and anhydrous Borax measured 
to make 100 ml of solution  
pH  A  B 
pH 7  62.5 ml  37.5 ml 
pH 8  46.5 ml  53.5 ml 
 
11)   Borate Buffer (pH 8) which  was prepared using boric acid, potassium 
chloride and 0.2M sodium hydroxide. To prepare 200 ml as stated by the 
BP, 3.97 ml of 0.2 M sodium hydroxide was added to 50 ml of a solution 
containing 0.6189 g of boric acid and 0.7456 g of potassium chloride and 
diluted to 200 ml with water. 
 
12)   Acetate buffer (pH 5, 6)  
•  pH 5 was prepared using sodium acetate and glacial acetic acid. To 
prepare 1000 ml of the buffer as stated by the BP 13.6 g of sodium 
acetate  (C2H3O2Na.  3H2O)  and  6  ml  of  glacial  acetic  acid  was 
dissolved in sufficient water.                                                                                                               Appendix 2 
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•  pH6 was prepared using ammonium acetate and glacial acetic acid. 
To prepare 500 ml as stated by the BP, 100 g of ammonium acetate 
was dissolved in 300 ml of water and 4.1 ml of glacial acetic acid was 
added  to  this  and  then  diluted  to  500  ml  with  water.  The  pH  was 
adjusted using 5M acetic acid. 
 
13)   Distilled  water  (glass  distillery,  Sanyo,  Gallenkamp  PLC)  was  used 
throughout  the  study  and  was  produced  by  a  distillation  process  that 
involved boiling the water in a 3KW still ball and then condensing the 
steam into a clean container leaving all impurities behind. 
  
14)   Artificial gastric juice (pH 1.2) which was prepared with sodium chloride 
(NaCl) and 1M Hydrochloric acid (HCl).  80 ml of 1M HCl was prepared 
and added to approximately 500 ml of water containing 2 g of dissolved 
NaCl and diluted to 1000 ml with water (British Pharmacopeia, 2008e). 
 
2.2  Effect of Ionic Strength 
 
The dissolution medias used for this test were: 
•  Potassium phosphate buffer pH 7.4 which was prepared using K2HPO4 
(dipotassium  hydrogen  orthophosphate)  and  KH2PO4  (potassium 
dihydrogen  orthophosphate)  in  varying  concentrations  of  K
+  (0.1M  – 
0.5M) see Table 2.3.  
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Table 2.3: Amounts of potassium phosphate salts weighed per 1000 ml of 
solution 
K2HPO4 (MW: 174.18)  KH2PO4 (MW: 136.09) 
Molarity  Weight (g/L)  Weight (g/L) 
0.1M  10.71  5.24 
0.2M  22.68  9.5 
0.3M  34.96  13.51 
0.4M  47.17  17.58 
0.5M  59.31  21.71 
 
•  Sodium phosphate buffer pH 7.4, which was prepared using Na2HPO4 
(disodium hydrogen orthophosphate) and NaH2PO4 (sodium dihydrogen 
orthophosphate) in varying concentration of Na
+ (0.1M – 0.5M) see Table 
2.4. 
 
Table 2.4: Amounts of sodium phosphate salts weighed per 1000 ml of solution 
 
Anhydrous Na2HPO4 
(MW: 141.96) 
 NaH2PO4. 2H2O         
(MW: 156.01) 
 
Molarity 
Weight (g/L)  Weight (g/L) 
0.1M  8.73  6.01 
0.2M  18.48  10.89 
0.3M  28.49  15.49 
0.4M  38.44  20.15 
0.5M  48.34  24.89 
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•  0.1M hydrochloric acid (HCl) containing either sodium chloride (NaCl) or 
potassium chloride (KCl) with different concentration of Na
+ or K
+ to give 
the same ionic strengths of that of the 0.1M   0.5M potassium and sodium 
phosphate buffers. See Table 2.5. 
 
Table 2.5: Amounts of NaCl and KCL salts weighed per 1000 ml of solution  
NaCl (MW: 58.44)  KCl (MW: 74.56)   
Molarity  Weight (g/L)  Weight (g/L) 
0.1M  7.013  8.947 
0.2M  21.038  26.842 
0.3M  35.064  44.736 
0.4M  49.089  62.630 
0.5M  63.115  80.525 
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Appendix 3: Physical and Mechanical Properties – Statistical Analysis 
3.1  Statistical Analysis for Moisture Uptake of Capsule Shells   Post hoc 
(Scheffé
a) Tests 
 
Table 3.1 % Moisture Uptake by Old HPMC capsule shells, effect of storage 
conditions (RH) and time  
Subset for alpha = .05  Old HPMC 
  
N 
   1  2 
35%RH 24 hours 
53%RH 24 hours 
35%RH 3 days 
53%RH 3 days 
Sig. 
3 
3 
3 
3 
  
.0540 
  
  
  
1.000 
  
1.6067 
1.6600 
2.0967 
.519 
Means for groups in homogeneous subsets are displayed. a Uses Harmonic Mean Sample Size 
= 3. 
 
Table 3.2 % Moisture Uptake by New HPMC capsule shells, effect of storage 
conditions (RH) and time  
Means for groups in homogeneous subsets are displayed. a Uses Harmonic Mean Sample Size 
= 3. 
             
 
Table 3.3 % moisture uptake by E0501493 HPMC capsule shells, effect of 
storage conditions (RH) and time  
E0501493 HPMC  N  Subset for alpha = .05 
      1  2  3 
35%RH 24 hours  3  .4767       
53%RH 24 hours  3     1.7633    
53%RH 3 days  3        2.8600 
35%RH 3 days  3        2.8700 
Sig.     1.000  1.000  1.000 
 Means for groups in homogeneous subsets are displayed. a Uses Harmonic Mean Sample Size 
= 3. 
 
 
 
New HPMC  N  Subset for alpha = .05 
      1  2  3 
35%RH 24 hours  3  .6233       
53%RH 24 hours  3     1.7933    
53%RH 3 days  3        2.7700 
35%RH 3 days  3        2.9033 
Sig.     1.000  1.000  .958                                                                                                              Appendix  3 
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Table 3.4 % moisture uptake by Gelatin capsule shells, effect of storage 
conditions (RH) and time  
Subset for alpha = .05 
Gelatin  N  1  2  3  4 
35%RH 24 hours  3  .2633          
53%RH 24 hours  3     .7500       
35%RH 3 days  3        1.5433    
53%RH 3 days  3           2.1933 
Sig.     1.000  1.000  1.000  1.000 
Means for groups in homogeneous subsets are displayed. a Uses Harmonic Mean Sample Size 
= 3. 
 
 
 Table 3.5 % moisture uptake by Gelatin/PEG capsule shells, effect of storage 
(RH) and time   
Subset for alpha = .05 
Gelatin/PEG Capsule shells  N  1  2 
35%RH for 24 hours  3  .2567    
53%RH for 24 hours  3  .7133    
35%RH for 3 days  3     1.4900 
53%RH for 3 days  3     1.8667 
Sig.     .071  .148 
Means for groups in homogeneous subsets are displayed. a Uses Harmonic Mean Sample Size 
= 3. 
 
3.2  Statistical Analysis for Moisture Loss of Capsule Shells – Post hoc    
(Scheffé) Tests.  
 
 
 
Table 3.6 % moisture loss from Gelatin/PEG capsule shells, effect of storage 
(RH) and time   
Subset for alpha = 0.05 
Storage condition  N  1  2  3 
35%RH/24hr  3  12.8667    
53%RH/24hr  3   13.7367  
35%RH/3 days  3     16.3867 
53%RH/3days  3     16.5300 
 
Sig. 
 
1.000  1.000  .896 
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Table 3.7 % moisture loss from Gelatin capsule shells, effect of storage (RH) 
and time  
Subset for alpha = 0.05 
Storage condition  N  1  2 
35%RH/24hr  3  12.4567  
53%RH/24hr  3  13.7833  
35%RH/3 days  3   16.5233 
53%RH/3days  3   16.5833 
Sig.    .069  .999 
Means for groups in homogeneous subsets are displayed 
 
 
Table 3.9 % Moisture Loss from New HPMC capsule shells, effect of storage 
(RH) and time  
Subset for alpha = 0.05 
Storage conditions  N  1  2 
35%RH/24hr  3  6.2000  
35%RH/3 days  3   8.5667 
53%RH/3days  3   8.5833 
53%RH/24hr  3   8.6700 
Sig.    1.000  .996 
Means for groups in homogeneous subsets are displayed. 
 
 
 
 
Table 3.8  % Moisture Loss from Old HPMC capsule shells, effect of storage 
(RH) and time  
Subset for alpha = 0.05 
Storage conditions  N  1  2 
35%RH/24hr  3  6.5067  
53%RH/3days  3   8.2233 
35%RH/3 days  3   8.2867 
53%RH/24hr  3   9.0833 
Sig.    1.000  .238 
Means for groups in homogeneous subsets are displayed.                                                                                                              Appendix  3 
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Table 3.10 % moisture loss from E0501493 HPMC capsule shells, effect of 
storage (RH) and time   
Subset for alpha = 0.05 
Storage condition  N  1  2 
35%RH/24hr  3  6.4733  
53%RH/24hr  3  8.2633  8.2633 
53%RH/3days  3   8.5867 
35%RH/3 days  3   8.6167 
Sig.    .064  .932 
Means for groups in homogeneous subsets are displayed. 
 
3.3  Statistical Analysis for Glass Transition Temperatures of Capsule 
Shells (Scheffé
a Tests) 
 
Table 3.11 Tg temperatures of gelatin capsules, effect of storage conditions 
(RH) and time 
Subset for alpha = .05  Storage 
Conditions  N  2  3  1 
53%RH/ 3 
days  3  64.0567       
35%RH/ 3 
days  3     66.2767    
53%RH/24 hr  3     66.8467    
35%RH/24 hr  3        69.4267 
Sig.     1.000  .568  1.000 
Means for groups in homogeneous subsets are displayed. a  Uses Harmonic Mean Sample Size 
= 3. 
 
 
Table 3.12 Tg temperatures of gelatin/PEG capsules, effect of storage 
conditions (RH) and time   
Subset for alpha = .05  Storage 
Conditions  N  2  3  1 
53%RH/ 3 
days  3  63.4700       
35%RH/ 3 
days  3     65.7033    
53%RH/24 hr  3     66.3367  66.3367 
35%RH/24 hr  3        67.1767 
Sig.     1.000  .252  .101 
Means for groups in homogeneous subsets are displayed. a  Uses Harmonic Mean Sample Size 
= 3. 
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Table 3.13 Tg temperature of gelatin and gelatin/PEG capsules, effect of 
storage (RH) and time  
Subset for alpha = .05 
Storage RH  N  2  3  4  1 
53%RH/3 d 
(gel/peg)  3  63.4700          
53%RH/3 d 
(gel)  3  64.0567          
35%RH/3 d 
(gel/peg)  3     65.7033       
35%RH/3 d 
(gel)  3     66.2767  66.2767    
53%RH/24 
hr (gel/peg)  3     66.3367  66.3367    
53%RH/24 
hr (gel)  3     66.8467  66.8467    
35%RH/24 
hr (gel/peg)  3        67.1767    
35%RH/24 
hr (gel)  3           69.4267 
Sig.     .873  .202  .466  1.000 
Means for groups in homogeneous subsets are displayed. a  Uses Harmonic Mean Sample Size 
= 3. 
 
 
Table 3.14 Scheffé test for the Tg temperature of new HPMC capsules at 
various storage conditions. 
Subset for alpha = .05  Storage 
Conditions  N  2  3  1 
53%RH/ 3 
days  3  150.5400       
35%RH/ 3 
days  3     151.2667    
53%RH/ 24  hr  3        152.1933 
35%RH/ 24 hr  3        152.3500 
Sig.     1.000  1.000  .342 
Means for groups in homogeneous subsets are displayed. a  Uses Harmonic Mean Sample Size 
= 3. 
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Table 3.15 Tg temperature of E0501493 HPMC capsules at various storage 
conditions.   
Subset for alpha = .05  Storage 
Conditions  N  2  1 
53%RH/3days  3  151.3467    
35%RH/3days  3  151.4200  151.4200 
35%RH/24 hr  3  151.6933  151.6933 
53%RH/24 hr  3     151.8500 
Sig.     .188  .088 
Means for groups in homogeneous subsets are displayed. a  Uses Harmonic Mean Sample Size 
= 3. 
 
3.4   Statistical Analysis of Original Young’s Modulus (Static Scans) 
Values – Post hoc (Scheffé) Tests 
 
Table 3.16 Young's modulus (MPa) results for capsule samples stored at 
35%RH for 24 hours 
Subset for alpha = .05  Capsule shell type 
  
N 
   1  2 
E0501493 HPMC (35%RH 
24hr storage)  5  0.862    
Gelatin (35%RH 24hr storage)  5  1.102  1.102 
Gelatin/PEG (35%RH 24hr 
storage)  5  1.182  1.182 
Old HPMC (35%RH 24hr 
storage)  5     1.251 
New HPMC (35%RH 24hr 
storage)  5     1.274 
Sig.     .088  .614 
Means for groups in homogeneous subsets are displayed. a  Uses Harmonic Mean Sample Size 
= 5. 
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Table 3.17 Young's modulus (MPa) results for capsule samples stored at 
35%RH for 3 days. 
Subset for alpha = .05  Capsule type 
  
N 
   1  2 
E0501493 HPMC 35%RH 3 
days  5  0.816    
Gelatin 35% 3 days  5     1.046 
New HPMC 35%RH 3 days  5     1.077 
Old HPMC 35% 3 days  5     1.094 
Gelatin/PEG 35% 3 days  5     1.173 
Sig.     1.000  .122 
Means for groups in homogeneous subsets are displayed. a  Uses Harmonic Mean Sample Size 
= 5. 
 
 
Table 3.18 Young's modulus (MPa) results for capsule samples stored at 
53%RH for 24 hours.   
N  Subset for alpha = .05 
Capsule type     1  2  3 
New HPMC  5  0.748       
E0501493 HPMC  5  0.799       
Gelatin  5     0.979    
Old HPMC  5        1.166 
Gelatin/PEG  5        1.257 
Sig.     .917  1.000  .575 
Means for groups in homogeneous subsets are displayed. a  Uses Harmonic Mean Sample Size 
= 5. 
 
Table 3.19 Young's modulus (MPa) results for capsules samples stored at 
53%RH for 3 days. 
N  Subset for alpha = .05 
capsule type     1  2  3 
New HPMC  5  0.728       
E0501493 HPMC  5  0.762       
Old HPMC  5     0.885    
Gelatin/PEG  5        1.051 
Gelatin  5        1.092 
Sig.     .847  1.000  .732 
Means for groups in homogeneous subsets are displayed. a  Uses Harmonic Mean Sample Size 
= 5.. 
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Table 3.20 Young's modulus (MPa) results for Old HPMC capsule shell caps 
effect of storage (RH) and time 
Subset for alpha = .05 
Storage Condition  N  1  2 
53%RH 3 days  5  0.885    
35%RH 3 days  5     1.094 
53%RH 24hours  5     1.166 
35%RH 24 hours  5     1.251 
Sig.     1.000  .054 
Means for groups in homogeneous subsets are displayed. a  Uses Harmonic Mean Sample Size 
= 5.. 
 
Table 3.21 Young's modulus (MPa) results for New HPMC capsule shell caps 
effect of storage (RH) and time  
Subset for alpha = .05 
Storage Conditions  N  1  2 
53%RH 24 Hour  5  0.728    
53%RH 3 days  5  0.748    
35%RH 3 days  5     1.077 
35%RH 24 Hour  5     1.274 
Sig.     .998  .320 
Means for groups in homogeneous subsets are displayed. a  Uses Harmonic Mean Sample Size 
= 5. 
 
3.5   Statistical Analysis of the Modified Young’s Modulus (Static Scans) 
Values – (Scheffé) Tests 
 
Table 3.22 ’Young’s modulus (MPa) for capsules stored at 35%RH/24hr   
Subset for alpha = .05  Capsule 
Type   N  2  3  4  1 
Gelatin  5  154.4060          
Gelatin/PE
G  5  165.5280          
S00 HPMC  5  169.6000          
E050 
HPMC  5  181.6300  181.6300       
S1 Cap  5  185.9860  185.9860       
S4 Body  5     260.5160  260.5160    
S1 body  5        295.5580  295.5580 
Old HPMC  5        314.1080  314.1080 
new HPMC  5        319.8620  319.8620 
S4 caps  5           342.4800 
Sig.     .959  .056  .338  .676 
Means for groups in homogeneous subsets are displayed. a  Uses Harmonic Mean Sample Size 
= 5. 
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Table 3.23 Young's modulus (MPa) for capsules stored at 35%RH/3 days 
Subset for alpha = .05  Capsule 
Type  N  2  3  4  5  6  1 
S1 Body  5  129.5020                
S00 
HPMC  5  132.8620  132.8620             
S1 Cap  5  140.7440  140.7440  140.7440          
Gelatin  5  146.5700  146.5700  146.5700          
Gelatin/P
EG  5     170.2800  170.2800  170.2800       
E050 
HPMC  5        171.9960  171.9960       
S4 Body  5           194.9140  194.9140    
New 
HPMC  5              227.0560    
Old 
HPMC  5              230.6460    
S4 Cap  5                 362.0680 
Sig.     .905  .051  .192  .522  .076  1.000 
Means for groups in homogeneous subsets are displayed. a  Uses Harmonic Mean Sample Size 
= 5. 
 
Table 3.24 Young's modulus (MPa) for capsules stored at 53%RH/24 hr. 
Subset for alpha = .05  Capsule 
Type  N  2  3  4  5  6  1 
S00 
HPMC  5  112.1960                
S1 Cap  5  131.6380  131.6380             
Gelatin  5  137.2320  137.2320  137.2320          
S1 Body  5  138.7020  138.7020  138.7020          
New 
HPMC  5     153.4800  153.4800  153.4800       
S4 Body  5        164.4900  164.4900       
E050 
HPMC  5           168.3960       
Gelatin/P
EG  5           176.1200       
Old 
HPMC  5              245.7960    
S4 cap  5                 295.1480 
Sig.     .101  .313  .081  .265  1.000  1.000 
Means for groups in homogeneous subsets are displayed. a  Uses Harmonic Mean Sample Size 
= 5. 
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Table 3.25 Young's modulus (MPa) for capsules stored at 53%RH/3 days  
Subset for alpha = .05 
VAR00001  N  2  3  4  5  1 
S1 Body  5  131.6260             
S1 cap  5  131.9660             
S00 
HPMC  5  136.6140  136.6140          
Gelatin/PE
G  5  147.2100  147.2100          
Gelatin  5  152.9360  152.9360          
New 
HPMC  5     157.6660          
E050 
HPMC  5     160.5520  160.5520       
S4 Body  5        184.1600  184.1600    
Old HPMC  5           186.5920    
S4 Cap  5              282.5540 
Sig.     .153  .065  .073  1.000  1.000 
Means for groups in homogeneous subsets are displayed. a  Uses Harmonic Mean Sample Size 
= 5. 
 
Table 3.26 Young's modulus (MPa) for old HPMC capsules effect of storage 
(RH) and time  
Subset for alpha = .05  Storage 
Conditions  N  2  3  1 
53%RH/3 
days  5  186.5920       
35%RH/3 
days  5     230.6460    
53%RH/24 hr  5     245.7960    
35%RH/24 h r  5        314.1080 
Sig.     1.000  .678  1.000 
Means for groups in homogeneous subsets are displayed.. a  Uses Harmonic Mean Sample 
Size = 5. 
 
 
Table 3.27 Young's modulus (MPa) for new HPMC capsules, effect of storage 
(RH) and time 
Subset for alpha = .05  Storage 
Conditions  N  2  1 
53%RH/24 hr  5  153.4800    
53%RH/3 days  5  157.6660    
35%RH/3 days  5  227.0560    
35%RH/24 hr  5     319.8620 
Sig.     .071  1.000                                                                                                              Appendix  3 
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Means for groups in homogeneous subsets are displayed. a  Uses Harmonic Mean Sample Size 
= 5. 
 
Table 3.28 Young's modulus (MPa) for Size 4 HPMC caps, effect of storage 
(RH) and time   
Subset for alpha = .05  Storage 
Conditions  N  2  1 
53%RH/3days  5  282.5540    
53%RH/24 hr  5  295.1480    
35%RH/24 hr  5     342.4800 
35%RH/3days  5     362.0680 
Sig.     .610  .250 
Means for groups in homogeneous subsets are displayed. a  Uses Harmonic Mean Sample Size 
= 5 
 
Table 3.29 Young's modulus (MPa) for Size 4 HPMC bodies, effect of storage 
(RH) and time   
Subset for alpha = .05  Storage 
Conditions   N  2  3  1 
53%RH/24 hr  5  164.4900       
53%RH/3 days  5  184.1600  184.1600    
35%RH/days  5     194.9140    
35%RH/24 hr  5        260.5160 
Sig.     .122  .581  1.000 
Means for groups in homogeneous subsets are displayed. a  Uses Harmonic Mean Sample Size 
= 5. 
 
Table 3.30 Young's modulus (MPa) for Size1 HPMC caps, effect of storage 
(RH) and time  
Subset for alpha = .05 
Storage Conditions  N  2  1 
53%RH/24  hr  5  131.6380    
53%RH/3 days  5  131.9660    
35%RH/3 days  5  140.7440    
35%RH/24 hr  5     185.9860 
Sig.     .474  1.000 
Means for groups in homogeneous subsets are displayed. a  Uses Harmonic Mean Sample Size 
= 5. 
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Table 3.31 Young's modulus (MPa) obtained for Size1 HPMC bodies, effect of 
storage (RH) and time 
Subset for alpha = .05 
Storage Conditions  N  2  1 
35%RH/3 days  5  129.5020    
53%RH/3 days  5  131.6260    
53%RH/24 hr  5  138.7020    
35%RH/24 hr  5     295.5580 
Sig.     .389  1.000 
Means for groups in homogeneous subsets are displayed. a  Uses Harmonic Mean Sample Size 
= 5. 
 
Table 3.32 Young's modulus (MPa) obtained for Size00 HPMC caps, effect of 
storage (RH) and time  
Subset for alpha = .05  Storage 
Conditions  N  2  3  1 
53%RH/24 hr  5  112.1960       
35%RH/3 days  5     132.8620    
53%RH/3 days  5     136.6140    
35%RH/24 hr  5        169.6000 
Sig.     1.000  .809  1.000 
Means for groups in homogeneous subsets are displayed. a  Uses Harmonic Mean Sample Size 
= 5. 
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3.6 Statistical Analysis for % Retarded Compliance (JR) (Linear Creep) 
Values – Post hoc (Scheffé) Tests  
 
Table 3.33 % JR obtained for capsules stored at 35%RH for 24 hours 
Subset for alpha = 0.05 
Capsule type  N  1  2 
Gelatin  5  98.414  
Gelatin//PEG  5  98.536  
Old HPMC   5   99.132 
New HPMC  
5 
 
99.262 
E050 HPMC   5   99.320 
Sig.    .970  .869 
Means for groups in homogeneous subsets are displayed. 
 
Table 3.34 % JR obtained for  capsules stored at 35%RH for 3 days 
Subset for alpha = 0.05 
Capsule type  N  1  2  3 
Gelatin  5  98.422    
Gelatin/PEG  5  98.472    
S4  5   98.930  
E050 HPMC   5   98.956  
S1  5   99.002  99.002 
Old HPMC  5   99.102  99.102 
New HPMC 
5 
   
99.194 
S00  5     99.208 
Sig.    .995  .180  .055 
Means for groups in homogeneous subsets are displayed. 
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Table 3.35 % JR obtained on capsules stored at 53%RH for 24 hours 
 
N  Subset for alpha = .05 
Capsule type     1  2  3 
Gelatin  5  98.3500       
Gelatin/PEG  5  98.4360       
New HPMC  5     98.6700    
E0501493 HPMC  5     98.7480  98.7480 
Old HPMC  5        98.9540 
Sig.     .766  .823  .065 
Means for groups in homogeneous subsets are displayed. 
 
Table 3.36 % JR obtained for capsules stored at 53%RH for 3 days 
Subset for alpha = 0.05 
Capsule type  N  1  2 
PEG  5  98.038  
Gelatin  5  98.302  98.302 
S4  5  98.514  98.514 
S1  5  98.644  98.644 
New HPMC 
5  98.676  98.676 
E0501493  5  98.714  98.714 
S00  5   98.830 
Old HPMC  5   98.890 
Sig.    .066  .163 
Means for groups in homogeneous subsets are displayed. 
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Table 3.37 % JR for Old HPMC capsules, effect of storage (RH) and time  
Subset for alpha = 0.05  Storage 
Conditions   N  1  2  3 
53%RH/3 days   5  98.8900
   
53%RH/24 hr   5  98.9500 98.9500   
35%RH/3 days   5    99.1020  99.1020
35%RH/24 hr   5      99.1320
Sig.    .722 .069  .952
Means for groups in homogeneous subsets are displayed. a. Uses Harmonic Mean Sample Size 
=5. 
 
Table 3.38 % JR for New HPMC capsules, effect of storage (RH) and time 
Subset for alpha = 0.05  Storage Conditions 
  N  1  2 
53%RH/24 hr   5 98.6700  
535RH/3 days   5 98.6760  
35%RH/3 days   5   99.1940 
35%RH/24 hr   5
 
99.2620 
Sig. 
 
.997 .117 
Means for groups in homogeneous subsets are displayed. a. Uses Harmonic Mean Sample Size 
=5. 
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Table 3.39 % JR for E050 HPMC capsules, effect of storage (RH) and time  
Subset for alpha = 0.05  Storage Conditions  
N  1  2 
53%RH/3 days  5  98.7140 
 
53%RH/24 hr   5  98.7400  98.7400 
35%/3 days  5  98.9560  98.9560 
35%RH/ 24 hr   5    99.3200 
 
Sig.    .654  .053 
Means for groups in homogeneous subsets are displayed. a. Uses Harmonic Mean Sample Size 
=5. 
 
3.7  Statistical Analysis for % Newtonian Compliance (JN) (Linear Creep) 
Values – Post hoc (Scheffé) Tests  
 
Table 3.40 % JN for capsules stored at 35%RH for 24 days 
Subset for alpha = 0.05 
Capsule type  N  1  2 
New HPMC  5  .7380  
E0501493  5  .7500  
Old HPMC  5  .8680  
Gelatin/PEG  5   1.4640 
Gelatin  5   1.5860 
Sig.    .900  .919 
Means for groups in homogeneous subsets are displayed. 
 
 
Table 3.41 % JN for capsules stored at 35%RH for 3 days 
Subset for alpha = 0.05 
Capsule type  N  1  2  3 
S00  5  .7920    
New HPMC  5  .8060    
Old HPMC  5  .8980  .8980  
S1  5  .9980  .9980  
E0501493  5   1.0440  
S4  5   1.0700  
Gelatin/PEG  5     1.5280 
Gelatin  5     1.5780 
Sig.    .055  .180  .995 
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Table 3.42 % JN for capsules stored at 53%RH for 24 hours   
Subset for alpha = .05 
Capsule type  N   1  2  3 
Old HPMC  5  1.0620       
E0501493 
HPMC  5     1.2540    
New HPMC  5     1.4040    
Gelatin/PEG  5        1.5640 
Gelatin  5        1.6500 
Sig.     1.000  .073  .521 
Means for groups in homogeneous subsets are displayed. a  Uses Harmonic Mean Sample Size = 5.000. 
 
 
Table 3.43 % JN for capsules stored at 53%RH for 3 days 
Subset for alpha = 0.05 
Capsule type  N  1  2 
Old HPMC  5  1.1100  
S00  5  1.1700  
E0501493  5  1.2860  1.2860 
New HPMC 
5  1.3240  1.3240 
S1  5  1.3560  1.3560 
S4  5  1.4860  1.4860 
Gelatin  5  1.6980  1.6980 
PEG  5   1.9620 
Sig.    .163  .066 
Means for groups in homogeneous subsets are displayed. 
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Table 3.44 % JN for Old HPMC capsule, effect of storage (RH) and time  
Subset for alpha = 0.05  Storage Conditions  
N  1  2 
35%RH/24 hr   5  .8680   
35%RH/3 days   5  .8980   
53%RH/24 hr   5    1.0600 
53%RH/3 days   5    1.1100 
Sig. 
 
.952  .817 
Means for groups in homogeneous subsets are displayed. a. Uses Harmonic Mean Sample Size 
=5. 
 
 
Table 3.45 % JN for New HPMC capsule, effect of storage (RH) and time  
Subset for alpha = 0.05  Storage Conditions  
N  1  2 
35%RH/24 hr   5  .7380   
35%RH/3 days   5  .8060   
53%RH/3 days   5    1.3240 
53%RH/24 hr   5    1.3300 
Sig.    .117  .997 
Means for groups in homogeneous subsets are displayed. a. Uses Harmonic Mean Sample Size 
=5. 
 
 
Table 3.46 % JN for E050 HPMC capsules, effect of storage (RH) and time 
 
Subset for alpha = 0.05  Storage Conditions  
N  1  2 
35%RH/24 hr   5  .7500   
35%RH/3 days  5  1.0440  1.0440 
53%RH/24 hr   5    1.2600 
53%RH/3 days   5    1.2860 
Sig. 
 
.264  .424 
Means for groups in homogeneous subsets are displayed. a. Uses Harmonic Mean Sample Size 
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3.8  Statistical Analysis for Storage Modulus (MPa) (Dynamic Scans)  
Values – Post hoc (Scheffé) Tests  
 
 
 
Table 3.48 Storage Modulus (MPa) for capsules stored at 35%RH for 3 days 
Subset for alpha = 0.05 
Capsule Type  N  1  2  3 
S1  5  14.5560    
S4  5  16.2304    
E0504193 
HPMC  5  16.8322  16.8322  
New HPMC  5  20.3634  20.3634  20.3634 
S00  5   22.4418  22.4418 
Old HPMC  5     24.6276 
gelatin/peg  5     24.7432 
gelatin  5     25.6124 
Sig.    .081  .102  .154 
Means for groups in homogeneous subsets are displayed. 
 
 
 
 
 
 
 
Table 3.47 Storage Modulus (MPa) for capsules stored at 35%RH for 24 hours 
Subset for alpha = 0.05 
Capsule type  N  1  2  3 
S1  5  15.7860    
S4  5  17.2900  17.2900  
E0504193 HPMC  5  17.8882  17.8882  
S00  5  19.0080  19.0080  
New HPMC  5  21.6200  21.6200  21.6200 
Old HPMC  5   23.5348  23.5348 
gelatin  5     26.6098 
gelatin/peg  5     27.2174 
Sig.    .198  .136  .242 
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Table 3.49 Storage Modulus (MPa) for capsules stored at 53%RH for 24 hours 
 
 
 
 
Table 3.50 Storage Modulus (MPa) for capsules stored at 53%RH for 3 days 
Subset for alpha = 0.05 
Capsule Type  N  1  2  3  4 
S1  5  14.5560      
S4  5  16.2304  16.2304    
E0504193 
HPMC  5  16.3460  16.3460    
New HPMC  5  20.9336  20.9336  20.9336  
Old HPMC  5  22.1476  22.1476  22.1476  
S00  5   22.4418  22.4418  
gelatin  5     24.7630  
gelatin/peg  5       32.7804 
Sig.    .060  .210  .781  1.000 
   Means for groups in homogeneous subsets are displayed 
 
 
 
 
 
 
Subset for alpha = 0.05 
Capsule type  N  1  2 
S4  5  15.9234  
S1  5  16.8212  
E0504193 HPMC  5  20.8566  
S00  5  21.6334  
New HPMC  5  23.2412  
Old HPMC  5  24.5690  24.5690 
gelatin  5  25.3158  25.3158 
gelatin/PEG  5   35.6116 
Sig.    .180  .064 
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Appendix 4: Capsule Shell Dissolution – Statistical Analysis 
 
4.1 Three way ANOVA (univariate analysis of variance) – Post hoc 
(Scheffé) tests showing the effect of Sorensen phosphate buffer (SPB) on 
capsule  
 
Table 4.2: Capsule shell dissolution times, the effect of SPB pH 7 
Subset  Capsule 
type   N  1  2  3  4  5  6 
Gelatin  40  1.667          
Gelatin/Pe
g 
40  2.159 
         
S00  40   4.078        
S1  40   4.446  4.446      
New 
HPMC 
40 
   
4.753 
     
E0501493  40       5.830    
S4  40         7.587  
Old HPMC  40           8.417 
Sig.    .319  .708  .866  1.000  1.000  1.000 
Means for groups in homogeneous subsets are displayed.   
 
Table 4.1: Capsule shell dissolution times, the effect of SPB pH 6  
Subset 
Capsule type  N  1  2  3  4  5 
Gelatin  40  1.653        
Gelatin/Peg  40  1.875        
S00  40   4.214      
S1  40   4.893  4.893    
New HPMC  40   5.062  5.062    
E0501493  40     5.292    
S4  40       8.157  
Old HPMC  40         9.110 
Sig.    .996  .069  .888  1.000  1.000 
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Table 4.3: Capsule shell dissolution times, effect of  SPB pH 8 
Subset 
Capsule type  N  1  2  3  4  5 
Gelatin  40  1.981        
Gelatin/Peg  40  2.210        
S00  40   3.665      
S4  40   3.962  3.962    
New HPMC  40   4.128  4.128  4.128  
S1  40     4.278  4.278  
E0501493  40       4.589  
Old HPMC  40         8.464 
Sig.    .894  .109  .597  .114  1.000 
Means for groups in homogeneous subsets are displayed.   
 
 
Table 4.4: Two  way ANOVA (Univariate Analysis of Variance) – Post hoc test 
(Scheffe
a,b) 
 effect of capsule type on shell dissolution time in Sorensen 
phosphate buffer at all pHs
  
Subset  Capsule 
type  N  1  2  3  4  5 
Gelatin  40  2.0077         
Gelatin/peg  40  2.1438         
S00  40    4.5603       
S1  40    4.9390  4.9390     
new HPMC  40    5.0013  5.0013     
E0504193  40      5.7658     
S4  40        7.6750   
old HPMC  40          8.9028 
Sig.    1.000  .784  .057  1.000  1.000 
Means for groups in homogeneous subsets are displayed. Based on observed means. a. Uses 
Harmonic Mean Sample Size = 40.000.b. Alpha = .05. 
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Table 4.5: Two  way ANOVA (Univariate Analysis of Variance) – Post hoc 
Scheffé  test showing the effect of pH on shell dissolution time in SPB 
Subset 
SPB pH  N  1  2  3 
pH 8  80  4.2092    
pH 7  80   5.1034  
pH 5  80   5.4946  5.4946 
pH 6  80     5.6905 
Sig.    1.000  .104  .669 
Means for groups in homogeneous subsets are displayed.  
 
4.2 Three way ANOVA (univariate analysis of variance) – Post hoc 
(Scheffé) tests showing the effect of citro phosphate buffer (CPB) on 
capsule shell dissolution 
Table 4.6: Capsule shell dissolution times, effect of CPB pH 5 
Subset 
Capsule type   N  1  2  3  4 
Gelatin  40  1.968      
Gelatin/Peg  40  2.054      
S4  40   4.543    
S00  40   4.638    
S1  40   4.779  4.779  
New HPMC  40   4.874  4.874  
E0501493  40     5.387  
Old HPMC  40       8.339 
Sig.    1.000  .895  .208  1.000 
Means for groups in homogeneous subsets are displayed.  
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Table 4.8: Capsule shell dissolution times, effect of CPB pH 7 
Subset 
Capsule type  N  1  2  3  4  5 
Gelatin  40  2.026        
Gelatin/Peg  40  2.048        
New HPMC  40   6.144      
S00  40   6.368  6.368    
S4  40   6.562  6.562    
S1  40     7.336  7.336  
E0501493  40       7.914  
Old HPMC  40         10.491 
Sig.    1.000  .938  .088  .722  1.000 
Means for groups in homogeneous subsets are displayed.  
 
 
 
 
 
 
Table 4.7: Capsule shell dissolution times, effect of CPB pH 6 
Subset 
Capsule type   N  1  2  3 
Gelatin/Peg  40  2.089    
Gelatin  40  2.115    
S4  40   5.179  
S00  40   5.236  
New HPMC  40   5.276  
S1  40   5.644  
E0501493  40   5.823  
Old HPMC  40     9.516 
Sig.    1.000  .262  1.000 
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Table 4.9: Two  way ANOVA (Univariate Analysis of Variance) – Post hoc 
(Scheffé) test 
 effect of capsules type on shell dissolution time in citro 
phosphate buffer at all pHs 
Subset 
Capsule type  N  1  2  3  4 
Gelatin  30  2.062      
Gelatin/peg  30  2.097      
S00  30   5.482    
new HPMC  30   5.674  5.674  
S4  30   5.796  5.796  
S1  30   6.511  6.511  
E0504193  30     6.694  
old HPMC  30       9.361 
Sig.    1.000  .072  .077  1.000 
Means for groups in homogeneous subsets are displayed.  
 
Table 4.10: Two   way ANOVA (Univariate Analysis of Variance) – Post hoc 
Scheffé  test showing the  effect of pH on shell dissolution time in citro 
phosphate buffer 
Subset 
CPB pH  N  1  2 
pH 5  80  4.909  
pH 6  80  5.289  
pH 7  80   6.181 
Sig.    .092  1.000 
Means for groups in homogeneous subsets are displayed.  
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4.3 Three way ANOVA (univariate analysis of variance) – Post hoc 
(Scheffé) tests showing the effect of Phosphate Borax Buffer (PBB) on 
capsule shell dissolution 
Table 4.11: Capsule shell dissolution times, effect of PBB pH 7 
Subset 
Capsule type   N  1  2  3 
Gelatin  40  1.727    
Gelatin/Peg  40  1.834    
S00  40   4.163  
New HPMC  40   4.585  
S1  40   4.907  
E0501493  40   5.431  
Old HPMC  40     9.320 
S4  40     9.493 
Sig.    1.000  .240  1.000 
Means for groups in homogeneous subsets are displayed 
 
Table 4.12: Capsule shell dissolution times, effect of PBB pH 8 
Subset 
Capsule type  N  1  2  3  4  5 
Gelatin  40  1.784        
Gelatin/Peg  40  1.807        
S00  40   3.829      
New HPMC  40   4.636  4.636    
S1  40   4.783  4.783    
E0501493  40     5.207    
S4  40       8.281  
Old HPMC  40         10.686 
Sig.    1.000  .066  .682  1.000  1.000 
Means for groups in homogeneous subsets are displayed.  
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4.4 Three way ANOVA (univariate analysis of variance) – Post hoc 
(Scheffé) tests showing the effect of Acetate Buffer (AB) and Artificial 
Gastric Juice (AGJ) on capsule shell dissolution 
 
Table 4.13: Capsule shell dissolution times, effect of acetate buffer pH 5 
Subset 
Capsule type   N  1  2  3  4 
Gelatin/Peg  40  2.009      
Gelatin  40  2.019      
New HPMC  40   3.507    
S4  40   3.621    
S00  40   3.799  3.799  
S1  40   3.806  3.806  
E0501493  40     4.234  
Old HPMC  40       7.975 
Sig.    1.000  .803  .336  1.000 
Means for groups in homogeneous subsets are displayed.  
 
 
 
Table 4.14: Capsule shell dissolution times, effect of AGJ pH 1.2 
 
Subset 
Capsule type   N  1  2  3 
Gelatin  40  1.603    
Gelatin/Peg  40  1.623    
S4  40   3.087  
New HPMC  40   3.098  
S1  40   3.217  
S00  40   3.270  
E0501493  40   3.504  
Old HPMC  40     6.220 
Sig.    1.000  .174  1.000 
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4.5 One way ANOVA – Post hoc (Scheffé
a) tests showing the effect of 
various dissolution media on capsule shell dissolution 
   
Table 4.15. Statistical analysis for Old HPMC capsule shells in various 
dissolution media pH5, AGJ (pH1.2) and in deionised water (pH 5.8)  
 
N  Subset for alpha = .05  Buffer type (Old HPMC, 
pH5)  1  2  1 
Water  10  6.1330    
AGJ pH1.2  10  6.1870    
AB pH5  10     8.0490 
CPB pH5  10     8.5270 
SPB pH5  10     9.0690 
Sig.     1.000  .265 
Means for groups in homogeneous subsets are displayed.  
a  Uses Harmonic Mean Sample Size = 10 
 
 
Table 4.16 Statistical analysis for New HPMC capsule shells in various 
dissolution media pH5, AGJ (pH1.2) and in deionised water (pH 5.8)  
 
Subset for alpha = .05  Buffer type 
(New HPMC, 
pH5)  N  1  2 
AGJ pH5  10  3.1800   
AB pH5  10  3.3590   
Water  10  3.9410   
SPB pH5  10    5.0700 
CPB pH5  10    5.2900 
Sig.    .104  .952 
Means for groups in homogeneous subsets are displayed.   
a  Uses Harmonic Mean Sample Size = 10. 
 
 
Table 4.17 Statistical analysis for E0504193 HPMC capsule shells in various 
dissolution media pH5, AGJ (pH1.2) and deionised water (pH5.8) 
 
Subset for alpha = .05  Buffer type 
(E0504193, 
pH5)  N  1  2  3 
AGJ pH1.2  10  3.5510     
AB pH5  10  4.0340  4.0340   
Water  10    4.7420   
CPB pH5  10      5.8670 
SPB pH5  10      6.0580 
Sig.     .685  .313  .985 
Means for groups in homogeneous subsets are displayed.  
 a  Uses Harmonic Mean Sample Size = 10. 
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Table 4.18. Statistical analysis for Gelatin capsule shells in various dissolution 
media pH5, AGJ (pH1.2) and deionised water (pH5.8) 
 
Subset for alpha = .05  Buffer type 
(Gelatin, 
pH5)  N  1  2  3 
Water  10  1.3430     
AGJ pH1.2  10  1.6460  1.6460   
CPB pH5  10    1.9940   
AB pH5  10    2.0180   
SPB pH5  10      2.4970 
Sig.     .177  .056  1.000 
Means for groups in homogeneous subsets are displayed.  
a  Uses Harmonic Mean Sample Size = 10. 
 
 
Table 4.19 Statistical analysis for Old HPMC capsule shells in various 
dissolution media pH6, AGJ (pH1.2) and deionised water (pH5.8)  
 
Subset for alpha = .05  Buffer type 
(Old HPMC, 
pH6)  N  1  2 
Water  10  6.1330    
AGJ pH1.2  10  6.1870    
CPB pH6  10     9.0100 
SPB pH6  10     9.5690 
Sig.     1.000  .756 
Means for groups in homogeneous subsets are displayed.     
a  Uses Harmonic Mean Sample Size = 10. 
 
 
Table 4.20 Statistical analysis for New HPMC capsule shells in various 
dissolution media pH6, AGJ (pH1.2) and deionised water (pH5.8)  
 
Subset for alpha = .05  Buffer type 
(New HPMC, 
pH6)  N  1  2  3 
AGJ pH1.2  10  3.1800       
Water  10     3.9410    
SPB pH6  10        5.4420 
CPB pH6  10        5.4550 
Sig.     1.000  1.000  1.000 
Means for groups in homogeneous subsets are displayed.      
a  Uses Harmonic Mean Sample Size = 10. 
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Table 4.21 Statistical analysis for E0504193 HPMC capsule shells in various 
dissolution media pH6, AGJ (pH1.2) and deionised water (pH5.8)  
 
Subset for alpha = .05  Buffer type 
(E0504193, 
pH6)  N  1  2 
AGJ pH1.2  10  3.5510    
Water  10  4.7420    
SPB pH6  10     6.5070 
CPB pH6  10     6.6650 
Sig.     .066  .987 
Means for groups in homogeneous subsets are displayed.     
 a  Uses Harmonic Mean Sample Size = 10. 
 
   
Table 4.22 Statistical analysis for Gelatin capsule shells in various dissolution 
media pH6, AGJ (pH1.2) and deionised water (pH5.8)  
 
Subset for alpha = .05   
Buffer type 
(Gelatin, pH6)  N  1  2  3 
Water  10  1.3430       
AGJ pH1.2  10  1.6460  1.6460    
SPB pH6  10  1.7850  1.7850    
CPB pH6  10     2.0540    
AB  10        3.1990 
Sig.     .115  .171  1.000 
Means for groups in homogeneous subsets are displayed.     
a  Uses Harmonic Mean Sample Size = 10. 
 
   
Table 4.23 Statistical analysis for Gelatin/PEG capsule shells in various 
dissolution media pH6, AGJ (pH1.2) and deionised water (pH5.8) 
 
Subset for alpha = .05  Buffer type 
(Gelatin/PEG, 
pH6)  N  1  2 
AGJ pH1.2  10  1.6660    
Water  10  1.7970    
SPB pH6  10  1.9380    
CPB pH6  10  1.9840    
AB pH6  10     3.8370 
Sig.     .605  1.000 
Means for groups in homogeneous subsets are displayed. 
a  Uses Harmonic Mean Sample Size = 10. 
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Table 4.24 Statistical analysis for Old HPMC capsule shells in various 
dissolution media pH7, AGJ (pH1.2) and deionised water (pH5.8) 
 
Subset for alpha = .05  Buffer type 
(Old HPMC, 
pH7)  N  2  1 
Water  10  6.1330    
AGJ  10  6.1870    
SPB pH7  10     9.1850 
PBB pH7  10     9.8630 
CPB pH7  10     10.5450 
Sig.     1.000  .405 
Means for groups in homogeneous subsets are displayed.     
 a  Uses Harmonic Mean Sample Size = 10. 
 
 
Table 4.25. Statistical analysis for New HPMC capsule shells in various 
dissolution media pH7, AGJ (pH1.2) and deionised water (pH5.8) 
 
Subset for alpha = .05  Buffer type 
(New HPMC, 
pH7)  N  1  2  3 
AGJ pH1.2  10  3.1800       
Water  10  3.1800       
PBB pH7  10     4.6540    
SPB pH7  10     5.0600  5.0600 
CPB pH7  10        6.2760 
Sig.     1.000  .896  .063 
Means for groups in homogeneous subsets are displayed.      
a  Uses Harmonic Mean Sample Size = 10. 
 
 
Table 4.26 Statistical analysis for E0504193 HPMC capsule shells in various 
dissolution media pH7, AGJ (pH1.2) and deionised water (pH5.8) 
Subset for alpha = .05  Buffer type 
(E0504193, 
pH7)  N  1  2  3 
AGJ pH1.2  10  3.5510       
Water  10  4.7420  4.7420    
PBB pH7  10     5.7130    
SPB pH7  10     5.7210    
CPB pH7  10        7.5500 
Sig.     .102  .252  1.000 
Means for groups in homogeneous subsets are displayed.     
 a  Uses Harmonic Mean Sample Size = 10. 
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Table 4.27 Statistical analysis for Gelatin capsule shells in various dissolution 
media pH7, AGJ (pH1.2) and deionised water (pH5.8) 
   
N  Subset for alpha = .05 
Buffer type (Gelatin, pH7)  1  2  3  1 
Water  10  1.3430       
SPB pH7  10  1.5890  1.5890    
AGJ pH1.2  10  1.6460  1.6460    
PBB pH7  10     1.8230  1.8230 
CPB pH7  10        2.1380 
Sig.     .226  .484  .193 
Means for groups in homogeneous subsets are displayed.  
a  Uses Harmonic Mean Sample Size = 10. 
 
   
Table 4.28 Statistical analysis for Old HPMC capsule shells in various 
dissolution media pH8, AGJ (pH1.2) and deionised water (pH5.8) 
 
Subset for alpha = .05  Buffer type 
(Old HPMC, 
pH8)  N  1  2  3 
Water  10  6.1330       
AGJ pH1.2  10  6.1870       
SPB pH8  10  7.7880  7.7880    
BB pH8  10     9.0710  9.0710 
PBB pH8  10        10.1450 
Sig.     .220  .473  .644 
Means for groups in homogeneous subsets are displayed.    
 a  Uses Harmonic Mean Sample Size = 10. 
 
 
Table 4.29 Statistical analysis for New HPMC capsule shells in various 
dissolution media pH8, AGJ (pH1.2) and deionised water (pH5.8) 
Subset for alpha = .05  Buffer type 
(New HPMC, 
pH8)  N  1  2  3 
AGJ pH1.2  10  3.1800       
Water  10     3.9410    
BB pH8  10     4.0980  4.0980 
SPB pH8  10     4.4330  4.4330 
PBB pH8  10        4.7550 
Sig.     1.000  .333  .096 
Means for groups in homogeneous subsets are displayed.     
 a  Uses Harmonic Mean Sample Size = 10. 
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Table 4.30. Statistical analysis for E0504193 HPMC capsule shells in various 
dissolution media pH8, AGJ (pH1.2) and deionised water (pH5.8) 
 
Subset for alpha = .05  Buffer type 
(E0504193, 
pH8)  N  1  2 
AGJ pH1.2  10  3.5510    
BB pH8  10  4.5650  4.5650 
Water  10  4.7420  4.7420 
SPB pH8  10  4.7770  4.7770 
PBB pH8  10     5.5560 
Sig.     .101  .267 
Means for groups in homogeneous subsets are displayed.    
 a  Uses Harmonic Mean Sample Size = 10. 
 
 
Table 4.31 Statistical analysis for Gelatin capsule shells in various dissolution 
media pH8, AGJ (pH1.2) and deionised water (pH5.8) 
 
Subset for alpha = .05  Buffer type 
(Gelatin, Ph8)          N  1  2  3 
Water  10  1.3430       
BB pH8  10  1.6390  1.6390    
AGJ pH1.2  10  1.6460  1.6460    
PBB pH8  10     1.7290    
SPB pH8  10        2.1600 
Sig.     .129  .954  1.000 
Means for groups in homogeneous subsets are displayed.      
a  Uses Harmonic Mean Sample Size = 10. 
 
 
Table 4.32 Statistical analysis for Gelatin/PEG capsule shells in various 
dissolution media pH8, AGJ (pH1.2) and deionised water (pH5.8)  
 
Subset for alpha = .05  Buffer type 
(gelatin/PEG, 
pH8)  N  1  2 
AGJ pH1.2  10  1.6660    
BB pH8  10  1.7520  1.7520 
Water  10  1.7970  1.7970 
PBB pH8  10  1.8910  1.8910 
SPB pH8  10     2.2300 
Sig.     .758  .094 
Means for groups in homogeneous subsets are displayed.      
a  Uses Harmonic Mean Sample Size = 10. 
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Appendix 5: Drug Dissolution 
 
5.1 Powder Characterisation  
 
As  discussed  earlier  in  Chapter  2  (Section  2.3.5.4),  particle  size  analysis  of 
theophylline was determined using laser light scattering and image analysis. 
 
From the image analysis technique, a quantitative description of the morphology 
of  the  crystals  could be  achieved  (Figure  5.1),  as  expected,  the  theophylline 
consisted  of  elongated  needle  shape  crystals  which  was  consistent  with  the 
findings of Pather et al (1998)  
 
 
 
 
                    
 
 
 
 
 
 
 
 
 
 
Figure 5.1: Images of theophylline crystals showing needle shape, obtained by image analysis 
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The particle size determined by image analysis and laser light scattering and the 
% moisture content of theophylline are listed in Table 5.1 
 
Table 5.1: physical characterization of theophylline 
  Particle Size (µm)  Moisture content (%) 
  Laser light Scattering  Image analysis   
Theophylline   153.86 (0.13)*  101.69 (3.53)**  0.15 (0.017)*** 
The results are the means and (standard deviation) of * 15 replicates, ** 90 replicates, and *** 3 replicates 
 
5.2  Calibration of theophylline  
 
Table 5.1: Calibration plot results of Theophylline in the various dissolution 
media  
 
Dissolution Media  Gradient (m)  Intercept 
(c) 
Correlation Coefficient 
(R
2) 
0.1 M KPB pH 7.4  0.0549    0.0063  0.9965 
0.5 M KPB pH 7.4  0.0053  0.0079  0.9995 
0.1 M NaPB pH 7.4  0.0577    0.026  0.9982 
0.5 M NaPB pH 7.4  0.0565    0.0115  0.999 
0.1 M HCL  0.0531  + 0.0207  0.9999 
0.1 M HCL + 0.1 M KCl  0.0537    0.0216  0.9999 
0.5 M HCL + 0.5 M KCl  0.0514    0.0078  0.9998 
0.1 M HCL + 0.1 M 
NaCl 
0.0529  + 0.0246  1 
0.5 M HCL + 0.5 M 
NaCl 
0.0516    0.014  0.9999 
 
 
 
 
 
 
                                                                                                               Appendix 6 
  402 
Appendix 6: Abstracts 
 
 
a) Mechanical Properties of Capsule shells made from Hydroxypropyl 
methylcellulose (Hypromellose)  
6
th World Meeting on Pharmaceutics, Biopharmaceutics and 
Pharmaceutical Technology. Barcelona, Spain 7  10 April 2008 – Poster 
Presentation 
 
b) Effect of Ionic Strength on Drug Release form Hard Capsules  
AAPS National Biotechnology Conference, Seattle, Washington USA, 21 
– 24 June, 2009    Poster Presentation  
 
C) Factors affecting Hard Capsule Shell Dissolution  
2
nd International Conference on Drug Discovery and Therapy, Dubai, 1 – 
4 February 2010 – Poster Presentation  
 
D) Effect of Dissolution Media Composition and Ionic Strength on Drug Release 
and Dissolution Properties of Hard Capsules  
UKICRS – UK and Ireland controlled release society 2010 symposium., 
Controlled Release in Drug Delivery, Right time, Right Place, 14
th April.  
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Mechanical Properties of Capsule Shells made from Hydroxypropyl Methylcellulose 
(Hypromellose) 
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2 
 
1 School of Health, Natural & Social Sciences, Sunderland University, UK 
2 Qualicaps, Europe, S.A., Alcobendas (Madrid), Spain.  
Introduction 
 
When  formulating  a  pharmaceutical 
capsule, there are a number of important 
factors  that  need  to  be  taken  into 
consideration. Some of these include the 
chemical  and  physical  stability  of  the 
capsule  shell  and  its  acceptability  to 
patients.  The  use  of  gelatin  in  the 
pharmaceutical  industry  has  certain 
drawbacks.  The  water  in  gelatin  shells 
operates as a plasticizer for the film, and 
when the moisture content decreases the 
capsules become brittle and break [1 2]. 
The presence of aldehyde groups in the 
material can cause crosslinking between 
the  gelatin  films  which  reduces  the 
solubility of the capsule shell [3 4].   
 
The  rheological  properties  of 
biomaterials directly affect their clinical 
performance. It is therefore essential to 
characterise the rheological properties of 
biomaterilas  accurately  to  ensure 
optimisation  of    their  design  and 
performance.  
 
A  new  type  of  two piece  hard  shell 
capsules  made  from  hypromellose 
(hydroxypropyl  methylcellulose, 
HPMC) has been launched and proposed 
as  an  alternative  to  the  conventional 
gelatin  capsules  for  oral  drug  delivery. 
The aim of this work was to carry out 
rheological  studies  using  Dynamic 
Mechanical  Analysis  (DMA)  to 
investigate  and  compare  the  different 
viscoelastic  properties  of  both  gelatin 
and  the  new  hypromellose  capsules. 
Static scans to study the elastic modulus, 
and  linear  creep  to  determine  the 
behaviour  of  the  capsule  shells  under 
stress were undertaken. 
 
 
Mg(NO3)2 x 6H2O and calcium chloride 
x 6H2O to provide two different relative 
humidity  conditions  (i.e.  53%RH  and 
35%RH,  respectively)  with  a  defined 
storage  temperature  (22
oC).  Capsules 
were  stored  in  the  desiccators  for  24 
hours,  after  removal  were  tested 
immediately and handled carefully with 
gloves  or  tweezers.  The  above  was 
repeated  for  capsules  stored  in 
desiccators for 72 hours and the two sets 
of results were compared. 
 
DMA experiments were performed using 
a  Dynamic  Mechanical  Analyzer, 
DMA7,  (Perking  Elmer  Corp.,  High 
Wycombe,  UK)  with  parallel  plate 
geometry (diameter of plate 5mm) and a 
personal  computer  (DELL,  Optiplex 
GX1) which was attached to the DMA7 
via  a  Perkin  Elmer  Thermal  Analysis 
Controller, TAC7/DX and Perkin Elmer 
Intracooler  1.  The  whole  system  was 
controlled  by  Pyris  software  version  4 
for  windows.  The  samples  were 
equilibrated at 20 ± 0.100°C and purged 
with Helium gas at a rate of  20 mL / 
min
 1.   
 
￿ ￿ ￿ ￿  Static Scans 
 
The  static  scan  method  performed 
started with a static force scan from 0.00 
mN increasing to 2500.00 mN at a rate 
of 200.0mN / min and a frequency of 1 
Hz.  
The modulus of elasticity was calculated 
for  all  tested  capsule  shells  from  the 
slope of the linear portion of the stress 
strain curve. 
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Results and Discussion 
 
￿ ￿ ￿ ￿   Static Scans 
 
The modulus of elasticity of the capsule 
shells was calculated from the slope of 
the  linear  portion  of  the  stress strain 
curve. The values obtained for Young’s 
modulus  at  storage  conditions  of 
35%RH and 53%RH are represented in 
Figures 1 and 2, respectively 
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Figure  1. Young’s Modulus of 
elasticity of hard shell size 0 capsule 
caps after storage at 35%RH 
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Figure 2. Young’s Modulus of elasticity 
of hard shell size 0 capsule caps after 
storage at 53%RH 
 
Static  scans  have  shown  that  with  an 
increase in RH and storage time HPMC 
capsules  decreased  statistically 
significantly in their stiffness. Capsules 
made  from  gelatin  and  gelatin/PEG 
exhibited  in  general  higher  stiffness 
values compared to the HPMC capsules.  
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Figure 3. Percentage Retarded 
compliance of the various capsule shell 
caps after storage under different RH 
conditions 
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Figure 4. Percentage Newtonian 
Compliance of the various capsule shell 
caps after storage under different RH 
conditions 
 
The findings from the linear creep scans 
have  demonstrated  that  the  gelatin  and 
gelatin/PEG  shells  are  less  elastic  than 
the corresponding HPMC shells and do 
not fully recover from an applied stress, 
whereas  the  HPMC  capsule  shells 
responded  with  almost  complete 
recovery. 
 
Conclusion 
In terms of the mechanical properties of 
the capsule shells, the findings show that 
the HPMC capsules are more elastic than 
gelatin and gelatin/PEG capsules. 
 
Acknowledgments 
AS is greatfull for the financial support 
from    Qualicaps,  Europe,  S.A., 
Alcobendas (Madrid), Spain. 
 
References                                                                                                               Appendix 6 
  405 
 
 
 
Effect of Ionic Strength on Drug Release from Hard Capsules 
A. Solaiman, P.A. Carter, P.A. Hambleton, B. E. Jones* 
Department  of  Pharmacy,  Health  and  Well being,  University  of  Sunderland,  UK, 
*Qualicaps, Europe, S.A., Alcobendas, Spain. 
 
Purpose:  To  compare  the  drug  release  characteristics  of  hydroxypropyl 
methylcellulose (HPMC) and gelatin hard capsules, after different storage conditions, in 
media composed of selected ionic strengths.  
 
Methods: Size 0 HPMC and gelatin capsules were filled with a 450 mg theophylline 
anhydrous (99.5 %w/w)/magnesium stearate (0.5 %w/w) mix using a tamping method
1 
and stored at either 35 % or 53 % relative humidity for 24 and 72 hours. Dissolution 
studies were undertaken using a Caleva dissolution tester (Caleva Ltd, Dorset, UK) at 
37
oC and paddle speed 50 rpm using either 900 ml of potassium phosphate buffer (KPB) 
or  sodium  phosphate  buffer  (NaPB),  both  pH  7.4  (0.1 0.5  M).  Also,  0.1  M  HCl 
containing either KCl or NaCl (0.1 0.5 M) was used to enable comparison at similar 
ionic strengths.  
 
Results: In all cases, the drug release was not dependant on the storage conditions. For 
HPMC capsules, there was a decrease in drug release rate and extent as ionic strength 
was increased in KPB, an effect less significant in NaPB.  After 5 hours, < 4 % and 10 % 
drug release was obtained in 0.5 M KPB and NaPB respectively, whereas   complete 
release occurred in 0.1 M after 30 and 15 mins respectively. For gelatin capsules, release 
rate was unaffected by increase in KPB concentration, but decreased with increase in 
NaPB concentration, with complete release after 5 hours in 0.5 M, whereas complete 
release in 0.1 M took 1 hour. Similarly in HCl, HPMC capsules gave a decreased drug 
release rate with increase in KCl and NaCl concentration, however, release from gelatin 
capsules  was  only  affected  by  increase  in  NaCl  concentration.  For  the  lowest  ionic 
strengths, HPMC capsules showed a short initial lag time which was followed by a 
higher release rate than from the gelatin capsules. 
 
Conclusions: Drug dissolution rate and extent were influenced by capsule type and 
ionic content of the dissolution medium, with release from HPMC capsules affected by 
ionic strength of all selected media, whereas gelatin capsules were influenced only by 
the presence of sodium ions.  
 
1. Podczeck, F. and Jones, B. E. Drug Dev. Ind. Pharm. 28: 9 (2002) 1163 1169 
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Factors Affecting Hard Capsule Shell Dissolution  
A. Solaiman, P.A. Carter, P.A. Hambleton, B. E. Jones* 
Dept. of Pharmacy, Health and Well being, University of Sunderland, UK, *Qualicaps, 
Europe, S.A., Alcobendas, Spain. 
  
To investigate the influence of dissolution medium composition, ionic strength and pH 
on the shell dissolution time of hydroxypropyl methylcellulose (HPMC) and gelatin hard 
capsules (size 0) after storage at 35 % and 53 % RH for 24 & 72 hours. Shell dissolution 
time was recorded as the time for a steel ball bearing to be released from the capsule 
body after immersing in stirred media.
1 
  Shells were unaffected by storage conditions. For HPMC, dissolution time in 
Sörensen phosphate buffer (pH 5 8) decreased as pH increased and in citro phosphate 
buffer dissolution time increased from pH 5 to 7. Gelatin dissolved more rapidly in these 
buffers and was unaffected by pH. In acetate buffer, HPMC did not dissolve in pH 6, 
whereas gelatin dissolution time increased as pH increased.  Both gelatin and HPMC 
dissolved slowest in artificial gastric juice (pH 1.2). In potassium phosphate buffer (pH 
7.4), HPMC gave an increased dissolution time with increase in concentration (0.1 0.5 
M) whereas gelatin was unaffected. In sodium phosphate buffer (pH 7.4), increase in 
concentration affected HPMC dissolution to a lesser extent and gelatin remained 
unaffected.  
  Differences have been shown between the dissolution of gelatin and HPMC hard 
capsule shells due to dissolution media composition, ionic strength and pH. 
 
1. Chiwele, I et al, Chem. Pharm.Bull. 48: 7 (2000) 951 956 
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DRUG RELEASE AND DISSOULTION PROPERTIES OF HARD CAPSULES 
 
A. Solaiman, P.A. Carter, P.A. Hambleton, B. E. Jones* 
Dept. of Pharmacy, Health and Well being, University of Sunderland, UK, *Qualicaps, 
Europe, S.A., Alcobendas, Spain. 
 
The  influence  EFFECT  OF  DISSOLUTION  MEDIA  COMPOSITION  AND  IONIC 
STRENGTH ON of dissolution media composition, and ionic strength on the in vitro shell 
dissolution  and  drug  release  properties  of  HPMC  and  gelatin  hard  capsules,  after 
storage at 35% relative humidity for 24 hours was investigated.  
 
Shell  dissolution  time  of  empty  hydroxypropyl  methylcellulose  (HPMC)  and  gelatin 
capsules (size 0) was measured following the method described by Chiwele et al
1. Drug 
dissolution studies were then undertaken following the BP paddle method in a Caleva 
dissolution tester (Caleva Ltd, Dorset, UK) at 37
oC and paddle speed 50 rpm using 900 
ml  of  dissolution  medium.  In  both  studies,  dissolution  medium  used  was  potassium 
phosphate buffer (KPB), sodium phosphate buffer (NaPB), both pH 7.4 (0.1 0.5 M), and 
0.1 M HCl containing either KCl or NaCl (0.1 0.5 M). 
 
Increase  in  K
+  salt  concentration  and  ionic  strength  hindered  empty  HPMC  shell 
dissolution and slowed down the dissolution of gelatin. However, the increase in Na
+ 
salt concentration did not affect the shell dissolution properties of the HPMC shells to 
the  same  extent.  Drug  dissolution  tests  for  HPMC  showed,  <  4  %  and  10  %  drug 
release in 0.5 M KPB and NaPB respectively after 5 hours, complete release occurred 
in 0.1 M after 30 and 15 mins respectively. For gelatin, release rate decreased with 
increase in NaPB concentration, with complete release after 5 hours in 0.5 M, and after 
1  hour  in  0.1  M.  In  HCl,  HPMC  capsules  gave  a  decreased  drug  release  rate  with 
increase in KCl and NaCl concentration, however, release from gelatin capsules was 
only affected by increase in NaCl concentration.  
 
Shell dissolution and drug dissolution properties of HPMC and gelatin capsules differ 
from one another due to dissolution media composition and ionic strength. HPMC shells 
were affected by the ionic strength of all selected media, whereas gelatin capsules were 
influenced only by the presence of sodium ions.  
  
 
1. Chiwele, I et al, Chem. Pharm.Bull. 48: 7 (2000) 951 956 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 